{"idx": 0, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher's disease (GD) results from a deficiency of the lysosomal enzyme glucocerebrosidase and, in very rare occasions, a deficiency of its activator, the saposin C.", "model_answer": "Answer: GBA1", "model_support": "Supporting sentence: The complexity of identification and characterization of mutations in the gene of glucocerebrosidase (GBA1) is caused by a great amount of mutated alleles...", "retries": 1}
{"idx": 1, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 2, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by introducing 'chronic' and 'calcium cycling defect in dilated cardiomyopathy,' which are not strictly necessary to explain the regulatory role of phospholamban in SERCA2a function.\", \"match\": true}", "gold_answer": "phospholamban", "gold_support": "The ablation of a muscle-specific sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) inhibitor, phospholamban, rescued the spectrum of phenotypes that resemble human heart failure.", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.", "retries": 1}
{"idx": 3, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical connection to the role of SAMe as a methyl donor by mentioning its effect on H3K27me3, a histone methylation mark. However, it does not explicitly state that SAMe is the major methyl donor for histone methylation, which makes it slightly less direct compared to the gold supporting sentence. The implied context adds clarity but introduces minor redundancy.\", \"match\": true}", "gold_answer": "S-adenosylmethionine", "gold_support": "S-adenosylmethionine (SAMe), the major methyl donor for DNA and histone methylation was fed with ethanol for 1month in order to modify the effects of ethanol on rat liver.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: H3K27me3 was significantly increased by SAMe with or without ethanol feeding.  \n(Implied context: S-adenosylmethionine (SAMe) is a known methyl donor for histone methyltransferases, and its role in increasing H3K27me3—a histone methylation mark—supports its function as the methyl donor.)", "retries": 1}
{"idx": 4, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold answer specifies only 'stroke.' Although the ROSIER scale is used for identifying both stroke and TIA, the gold answer focuses solely on stroke. The supporting sentence is relevant but slightly verbose, as it mentions a broader context of the study rather than directly focusing on the ROSIER scale's use for stroke. Overall, the logic is sound, but there is minor redundancy.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: **\"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"**  \n\nThis sentence explicitly states the purpose of the study, which is to evaluate clinical scores (including the ROSIER scale) for identifying **stroke** and **transient ischaemic attack (TIA)**.", "retries": 1}
{"idx": 5, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It succinctly mentions the key detail that nonsense mutations in the ZFHX1B gene are associated with Mowat-Wilson syndrome, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B gene", "model_support": "Supporting sentence: Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 6, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the association between FSHD and DUX4 expression, covering the key concept of the disease mechanism.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 7, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer is factually correct and matches the gold standard, but the supporting sentence does not cover the gold answer because it incorrectly states that the context does not mention the receptor. In fact, the context explicitly describes telcagepant as a 'calcitonin gene-related peptide receptor antagonist,' which directly supports the gold answer. The failure to utilize this information reduces the logical support for the answer.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is an oral calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.", "model_answer": "Answer: Calcitonin gene-related peptide (CGRP) receptor.", "model_support": "The context provided does not explicitly mention the receptor targeted by telcagepant. The answer \"Calcitonin gene-related peptide (CGRP) receptor\" is based on external knowledge of telcagepant's pharmacology, but **no sentence in the given context supports this claim**. The text focuses on the study design, results, and tolerability of telcagepant without discussing its molecular mechanism or receptor target. \n\n**Note:** While the answer is factually correct in real-world pharmacology, the context does not include any information about the receptor targeted by telcagepant.", "retries": 1}
{"idx": 8, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically with minor extra details that do not detract from clarity.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "CT-011 is a humanized IgG1 monoclonal antibody that modulates the immune response through interaction with PD-1, a protein belonging to the B7 receptor family present on lymphocytes.", "model_answer": "Answer: PD-1", "model_support": "Supporting sentence: \"CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.\"", "retries": 1}
{"idx": 9, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is unnecessarily verbose and includes speculative reasoning about external knowledge and the relationship between K201 and JTV519, which is not required. The gold supporting sentence is more concise and directly references the relevant information from the context.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The context does not explicitly mention \"JTV519\" or its chemical classification. However, based on prior knowledge from the example provided earlier, JTV519 is a 1,4-benzothiazepine derivative. In the current context, the drug **K201** is discussed, but its chemical group is not explicitly stated. If JTV519 is equated to K201 (as in the previous example), the answer would still rely on external knowledge, as the current context does not clarify this relationship. \n\n**Note**: The current context does not directly address JTV519 or its chemical group. The answer \"1,4-benzothiazepine\" is inferred from prior examples, not the provided text.", "retries": 1}
{"idx": 10, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "This progress has largely revolved around the discovery of the X inactive specific transcript (Xist) gene, which is known now to represent the master switch locus regulating X inactivation.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: In adult cells Xist is transcribed exclusively from the inactive X chromosome.", "retries": 1}
{"idx": 11, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('adenosylmethionine') in meaning, though it includes 'S-' which is technically correct but not required. The supporting sentence is relevant and supports the answer by referencing AdoMet as a methyl donor; however, it contains slight redundancy by introducing yeast HMT mutants, which is unnecessary for directly supporting the answer.\", \"match\": true}", "gold_answer": "adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "Answer: S-adenosylmethionine (AdoMet)", "model_support": "Supporting sentence: \"Both enzymes also use either methyl donor in vivo because both restore the ability to utilize AdoMet or SMM to a yeast HMT mutant.\"  \nThis sentence explicitly states that **S-adenosylmethionine (AdoMet)** is one of the methyl donors utilized by the enzymes (HMTs) in the context, supporting the answer.", "retries": 1}
{"idx": 12, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK.", "retries": 1}
{"idx": 13, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence mentions 'genome instability,' which is accurate but less specific than the gold supporting sentence, which explicitly details hypersensitivity to DNA crosslinking agents and chromosomal aberrations.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "The disease is manifested by defects in DNA repair, hypersensitivity to DNA crosslinking agents, and a high degree of chromosomal aberrations.", "model_answer": "Answer: Fanconi anemia", "model_support": "Supporting sentence: Fanconi anemia (FA) is an autosomal disorder that causes genome instability.  \n\n**Analysis**: The question asks about a disease characterized by sensitivity to DNA crosslinking agents and chromosomal instability. The context explicitly states that Fanconi anemia (FA) causes \"genome instability,\" which directly corresponds to the \"high frequency of chromosomal aberrations\" mentioned in the question. Additionally, the FA pathway's role in DNA repair (specifically interstrand crosslink repair) implies sensitivity to DNA crosslinking agents, as highlighted in the context.", "retries": 1}
{"idx": 14, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose. It provides additional details about dosages and combinations which are not necessary to support the answer directly, but the logic connecting it to the answer is strong.\", \"match\": true}", "gold_answer": "Ibrutinib", "gold_support": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: \"In phase I/II trials, ibrutinib 420 mg or 840 mg - given continuously as single agent or at a dose of 420 mg daily in combination with a monoclonal antibody or chemoimmunotherapy - has been associated with high response rates and durable clinical remissions.\"", "retries": 1}
{"idx": 15, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "p53 is well known as the 'guardian of the genome' for differentiated and neoplastic cells.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: p53 is well known as the \"guardian of the genome\" for differentiated and neoplastic cells.", "retries": 1}
{"idx": 16, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as the logic is strong and there is no excessive content.\", \"match\": true}", "gold_answer": "acute ischemic stroke", "gold_support": "MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: \"The aim of this study is to assess the effect of IAT on functional outcome in patients with acute ischemic stroke.\"", "retries": 1}
{"idx": 17, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the calcium-binding property of calsequestrin, but it lacks the broader context provided in the gold supporting sentence, such as its role as a calcium buffer and sensor. The model's supporting sentence is slightly narrow in scope but still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium for release through the RyR and acts as a luminal calcium sensor for the channel via its interactions with triadin and junctin.", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: \"the Ca(2+) binding capacity of calsequestrin\" (Paragraph 4).", "retries": 1}
{"idx": 18, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly identifies that DX-88 was not explicitly mentioned, but it fails to connect the investigational name DX-88 with ecallantide from the context. The supporting sentence is relevant but does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "Several novel therapies have completed phase III trials in the US, including: (i) plasma-derived C1-INH replacement therapies (Berinert P and Cinryze); (ii) a recombinant C1-INH replacement therapy (conestat alfa; Rhucin); (iii) a kallikrein inhibitor (ecallantide [DX-88]); and (iv) a bradykinin-2-receptor antagonist (icatibant).", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The context does not mention \"DX-88\" or any drug with that investigational name. The text discusses Berinert P, Cinryze, and other novel agents pending FDA approval, but no specific reference to DX-88 is provided.", "retries": 1}
{"idx": 19, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically ties the ectopic expression of DUX4 to FSHD, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.\"  \n\nThis sentence directly links the ectopic expression (due to inefficient repression) of the DUX4 retrogene to FSHD.", "retries": 1}
{"idx": 20, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'Papulovesicular rash' is very close to the gold standard 'Dermatitis herpetiformis,' as the rash is a characteristic feature of the disease. However, it does not fully match the gold answer. The supporting sentence provides relevant information about the rash but could be more precise in directly linking it to dermatitis herpetiformis as an entity rather than just describing the rash itself.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "Answer: Papulovesicular rash", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 21, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the context includes information about hyperinsulinemic hypoglycemia and unregulated insulin secretion, it also clearly mentions growth hormone deficiency as an endocrine abnormality associated with Costello syndrome. The supporting sentence focuses on hyperinsulinemic hypoglycemia but does not address growth hormone deficiency, which is relevant to the gold answer. Therefore, the answer is incorrect, though the supporting sentence is relevant to the broader context of the disease.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Endocrine abnormalities including growth hormone deficiency, adrenal insufficiency, glucose intolerance, parathyroid adenoma with hyperprolactinemia and hypoglycemia have been described.", "model_answer": "Answer: None; Costello syndrome is not characterized by hormone deficiency but rather by hyperinsulinemic hypoglycemia due to unregulated insulin secretion.", "model_support": "Supporting sentence: \"Both patients required diazoxide therapy to stop the unregulated insulin secretion and maintain normoglycemia.\"  \nThis sentence highlights that the condition involves **hyperinsulinemic hypoglycemia** (excess insulin secretion, not a deficiency) in Costello syndrome, directly contradicting the notion of hormone deficiency.", "retries": 1}
{"idx": 22, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the conclusion by referencing the 'dominant form' related to acromicric dysplasia (AD). However, it contains slight redundancy by including extra details about GD and FBN1 mutations that are not strictly necessary for supporting the mode of inheritance of AD alone. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).", "model_answer": "Answer: Autosomal dominant", "model_support": "Supporting sentence: \"a hotspot of mutations in FBN1 in the dominant form of GD and in AD (exon 41-42, encoding TGFβ binding protein-like domain 5 (TB5) of FBN1).\"  \n\nThis sentence implies that **acromicric dysplasia (AD)** is associated with a **dominant form** (autosomal dominant), as it explicitly links AD to the \"dominant form\" of GD and FBN1 mutations, which are inherited in an autosomal dominant manner in other contexts (e.g., dominant WMS). While the text does not explicitly state \"autosomal dominant\" for AD, the phrasing \"dominant form of GD and in AD\" supports this conclusion.", "retries": 1}
{"idx": 23, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions post-translational modifications (SUMOylation and acetylation), which are relevant to SERCA2a regulation but do not directly cover the role of phospholamban as the main regulatory molecule. Therefore, while the information is somewhat related, it fails to address the specific gold answer.\", \"match\": false}", "gold_answer": "phospholamban", "gold_support": "SERCA2a activity can be regulated at multiple levels of a signaling cascade comprised of phospholamban, protein phosphatase 1, inhibitor-1, and PKCα.", "model_answer": "Answer: SERCA2a activity is regulated by post-translational modifications including SUMOylation and acetylation.", "model_support": "Supporting sentence: \"SERCA2 activity is also regulated by post-translational modifications including SUMOylation and acetylation.\"", "retries": 1}
{"idx": 24, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but focuses specifically on subclinical hypothyroidism, while the gold answer is more general ('thyroid'). The supporting sentence is relevant and provides specific data about subclinical hypothyroidism, but it does not fully align with the broader context of the gold supporting sentence, which refers to thyroid morphology and function in general. The logic is reasonable but could be more encompassing.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "Answer: Subclinical hypothyroidism is common in Williams syndrome.", "model_support": "Supporting sentence: \"29 patients (31.5%) had subclinical hypothyroidism.\"", "retries": 1}
{"idx": 25, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that gevokizumab targets IL-1β by describing its effect on IL-1β binding affinity, aligning well with the gold answer.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: \"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"", "retries": 1}
{"idx": 26, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence provided by the model is irrelevant to the question, as it discusses the controversy surrounding p73 isoforms in tumorigenesis but does not address the number of TAp73 isoforms identified in humans. There is no logical support for the gold answer in the model's response.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The context does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: The role of various p73 isoforms in tumorigenesis has been controversial.  \n**Analysis**: The context discusses \"various p73 isoforms\" but does not specify the number of TAp73 isoforms identified in humans. It focuses on the functional role of TAp73 rather than quantifying its isoforms.", "retries": 1}
{"idx": 27, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "Selenocysteine (Sec, U) insertion into proteins is directed by translational recoding of specific UGA codons located upstream of a stem-loop structure known as Sec insertion sequence (SECIS) element.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: Both eukaryotic and bacterial SelL genes use single SECIS elements for insertion of two Sec.", "retries": 1}
{"idx": 28, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The supporting sentence explicitly identifies naloxone as the medication used for managing suspected opioid overdose, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: \"CONCLUSION: There was no clinical difference in the time interval to respiratory rate > or =10 breaths/min between naloxone 0.8 mg s.q. and naloxone 0.4 mg i.v. for the out-of-hospital management of patients with suspected opioid overdose.\"  \n\nThis sentence explicitly identifies **naloxone** as the medication used for managing suspected opioid overdose in the study.", "retries": 1}
{"idx": 29, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in **XK**.", "retries": 1}
{"idx": 30, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is less informative compared to the gold supporting sentence. It provides a correct but minimal detail about the database's availability without elaborating on its function or content as the gold supporting sentence does.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 31, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('FSHD' and 'Facio-scapulo-humeral dystrophy (FSHD)' are equivalent). The supporting sentence is concise, directly relevant, and logically connects the dysregulation of DUX4 to FSHD through the mention of the short D4Z4 array. It effectively supports the answer without unnecessary verbosity.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "Answer: Facio-scapulo-humeral dystrophy (FSHD)", "model_support": "Supporting sentence: \"Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.\"  \n\nThis sentence explicitly connects the short D4Z4 array (associated with DUX4 dysregulation) to facio-scapulo-humeral dystrophy (FSHD), establishing the disease's association with DUX4-related molecular defects.", "retries": 1}
{"idx": 32, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and provides information about the IOMT enzyme's involvement in medicarpin biosynthesis, which indirectly supports the answer. However, it includes additional details about the A-ring methylation that are not directly necessary to justify the answer, making it slightly verbose compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"IOMT, which is induced along with other enzymes involved in medicarpin biosynthesis, methylates the A-ring 7-hydroxyl group of daidzein in vitro...\"  \nThis sentence explicitly connects the IOMT enzyme (involved in medicarpin biosynthesis) to the production of medicarpin, indicating its role as a key compound in alfalfa's stress response.", "retries": 1}
{"idx": 33, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('ibrutinib'), but the supporting sentence provided does not cover the gold answer. The model incorrectly claims that no sentence in the context supports the answer, while the gold supporting sentence explicitly mentions ibrutinib as a Bruton's tyrosine kinase inhibitor. Therefore, the supporting sentence is relevant but fails to correctly identify or utilize the information from the context.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Furthermore, we demonstrate that the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib block B-cell receptor induced activation of LCP1.", "model_answer": "Answer: Ibrutinib", "model_support": "The context provided does not mention **Bruton's tyrosine kinase (BTK) inhibitors** or **Ibrutinib**. The text focuses on **LCP1** as a membrane-associated target in CLL and its role in migration, but it does not discuss therapeutic agents like BTK inhibitors. Therefore, **no sentence in the context supports the answer \"Ibrutinib.\"**", "retries": 1}
{"idx": 34, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' whereas the gold answer specifies only 'stroke.' The supporting sentence is relevant but slightly lengthy and not as direct as it could be. It introduces TIA, which adds extra information not required by the gold standard, making the response less concise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"Clinical scores for the identification of **stroke and transient ischaemic attack** in the emergency department: a cross-sectional study.\"", "retries": 1}
{"idx": 35, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but slightly more verbose than necessary ('Thyroid hormone abnormalities' vs. the gold standard 'thyroid'). The supporting sentence provides relevant information about thyroid hormone testing, but it is lengthier and less direct than the gold supporting sentence, which concisely mentions the specific thyroid-related abnormalities. The logic is reasonable, but the supporting sentence could be more focused.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities.", "model_support": "Supporting sentence: For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scyntography were conducted.", "retries": 1}
{"idx": 36, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly captures the essence of the gold supporting sentence without unnecessary details.\", \"match\": true}", "gold_answer": "development", "gold_support": "Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development.", "model_answer": "Answer: Development.", "model_support": "Supporting sentence: \"some of which have been implicated in the regulation of crucially important processes, including development.\"", "retries": 1}
{"idx": 37, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct compared to the gold supporting sentence. The model's supporting sentence implies the connection between SEA0400 and NCX by stating that 'These effects of SNP were prevented by SEA0400,' which aligns with the context but lacks explicit mention of NCX or its inhibition. The gold supporting sentence is more comprehensive as it explicitly names NCX and ties it directly to SEA0400's action.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400. \n\n**Analysis**: The context implies that SEA0400 inhibits the Na(+)/Ca(2+) exchanger (NCX) because the effects of SNP (which are mediated via NCX) are blocked by SEA0400. While the sentence does not explicitly name NCX as the target, the conclusion in the final sentence of the context (\"Ca²⁺ influx via the reverse of NCX...\") and the experimental results (SEA0400 preventing SNP's effects) logically connect SEA0400 to NCX inhibition.", "retries": 1}
{"idx": 38, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Rheumatoid Arthritis is more common in women') does not directly match the gold standard ('women'), but it is consistent with general medical knowledge and indirectly supported by the context, which shows a higher number of women (312) compared to men (126). However, the supporting sentence provided by the model is incorrect as it claims that no sentence in the context supports the claim, while the gold supporting sentence clearly highlights the female-to-male ratio from the results. The model's supporting sentence fails to reference this critical data point, making it irrelevant.\",\n  \"match\": false\n}", "gold_answer": "women", "gold_support": "RESULTS: We studied 312 women and 126 men with early RA.", "model_answer": "Answer: Rheumatoid Arthritis is more common in women.", "model_support": "The context does not explicitly state whether rheumatoid arthritis (RA) is more common in men or women. However, the answer provided (\"Rheumatoid Arthritis is more common in women\") is based on general medical knowledge rather than the specific data presented in the context. The context only discusses differences in disease expression (e.g., ESR, follow-up duration) between genders in patients with early RA but does not provide prevalence rates or indicate that RA is more common in one gender over the other. Thus, **no sentence in the context directly supports the claim that RA is more common in women**.", "retries": 1}
{"idx": 39, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about p53's role in genomic stability, with slight redundancy but overall logical support. The phrase 'guardian of the genome' is not directly quoted, but the concept is well-supported.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"Loss of p53 function confers genomic instability, impaired apoptosis and diminished cell cycle restraint.\"  \n\n**Note:** While the exact phrase \"guardian of the genome\" is not explicitly stated in the context, the sentence highlights p53's critical role in maintaining genomic stability, which is the basis for its well-known nickname. The context directly attributes p53's functions (DNA repair, cell cycle regulation, apoptosis) to its role in preventing genomic instability, aligning with the concept of \"guardian of the genome.\"", "retries": 1}
{"idx": 40, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning. Although the model notes that the context does not explicitly mention betrixaban, it still correctly identifies the clotting factor based on external knowledge, which aligns with the gold answer. Minor extra details about the lack of context are acceptable as they do not detract from the clarity or correctness of the response.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given context to answer the question about which clotting factor is inhibited by betrixaban. The answer \"Factor Xa\" may be based on external knowledge, but the context does not provide evidence for this. \n\n**Note**: If the question intended to refer to **rivaroxaban** (which is mentioned in the context as a Factor Xa inhibitor), the supporting sentence would be:  \n*\"Dabigatran and rivaroxaban have been the firsts of the new oral anticoagulants to be licensed... rivaroxaban... [as a Factor Xa inhibitor].\"*  \nHowever, this does not apply to betrixaban as stated in the question.", "retries": 1}
{"idx": 41, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is close to the gold standard but includes 'transient ischaemic attack (TIA),' which is not part of the gold answer. The supporting sentence is relevant and provides context for the use of the ROSIER scale, though it mentions both stroke and TIA, aligning with the model's broader answer rather than the more specific gold answer.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"  \n\n**Analysis**: The title explicitly states the purpose of the study, which is to evaluate clinical scores (including the ROSIER scale) for identifying **stroke and transient ischaemic attack (TIA)**. This directly supports the answer.", "retries": 1}
{"idx": 42, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, while noting a lack of explicit mention of SEA0400 in the context, correctly identifies the Na(+)/Ca(2+) exchanger (NCX) as the target and aligns with the gold supporting sentence in highlighting the role of NCX. Although it points out the missing detail about SEA0400, this does not detract from the accuracy or relevance of the answer and reasoning.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "Concerning the role of NCX in NO cytotoxicity, we have found, using the specific inhibitor of NCX 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400), that NCX is involved in NO-induced cytotoxicity in cultured microglia, astrocytes, and neuronal cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "The context does not mention the small molecule **SEA0400** or its interaction with any ion antiporter/exchanger. The provided text discusses the **Na(+)/Ca(2+) exchanger (NCX)** and its role in cellular toxicity but does not reference **SEA0400** as an inhibitor. Therefore, the answer \"Na(+)/Ca(2+) exchanger (NCX)\" is not supported by the given context. \n\n**Note**: The question appears to contain an error or mismatch, as the context does not include information about **SEA0400**.", "retries": 1}
{"idx": 43, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'Facioscapulohumeral muscular dystrophy (FSHD)' is a correct and equivalent response to 'FSHD'. The supporting sentence is relevant and directly ties DUX4 expression to FSHD, but it contains slight redundancy by specifying details about repeat contraction without clearly emphasizing the ectopic expression aspect. Despite this, the logic connecting the disease to DUX4 expression is strong.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\"", "retries": 1}
{"idx": 44, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE), a widely recognized animal model of multiple sclerosis (MS), is highly useful for studying inflammation, demyelination, and neurodegeneration in the central nervous system (CNS).", "model_answer": "Answer: Experimental Autoimmune Encephalomyelitis (EAE)", "model_support": "Supporting sentence: \"EAE exhibits many similarities with MS, which is a chronic inflammatory disease affecting CNS white matter in humans. Various studies have indicated that EAE is a particularly useful animal model for understanding both the mechanisms of immune-mediated CNS pathology and also the progressive clinical course of MS.\"", "retries": 1}
{"idx": 45, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'). However, the supporting sentence is incorrect as it states there is no explicit mention of factor Xa inhibition in the context, whereas the gold supporting sentence directly provides this information from the context. Despite this oversight, the answer itself is correct and aligns with external knowledge of betrixaban.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context provided does not explicitly state which clotting factor is inhibited by betrixaban. The text only mentions that betrixaban is an oral anticoagulant being evaluated in clinical trials, but it does not specify its mechanism of action (e.g., factor Xa inhibition). The answer \"factor Xa\" is likely based on external knowledge of betrixaban's pharmacology, not the information provided in the context. Therefore, **there is no supporting sentence** in the given context for the answer \"Betrixaban inhibits factor Xa.\"", "retries": 1}
{"idx": 46, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('1,4-benzothiazepine' is synonymous with 'benzothiazepine'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although there is a minor conflation of S107 and JTV519 in the context, this does not detract from the correctness and relevance of the provided answer and supporting sentence.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107.  \n\n**Note:** While the context refers to **S107** (not JTV519), the question appears to conflate the two compounds. However, based on the provided answer and the structure of the example, the sentence explicitly identifies **1,4-benzothiazepine** as the chemical group for **S107**, which may have been mistakenly associated with JTV519 in the question.", "retries": 1}
{"idx": 47, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by emphasizing co-localization rather than directly stating the interaction between FANCA and BRG1 as a component of SWI/SNF. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: \"we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"", "retries": 1}
{"idx": 48, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by referencing the validation of 5-HT2AR quantification with PET, which aligns well with the context provided. Minor additional details in the supporting sentence do not detract from its clarity or relevance.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"in vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals.\"", "retries": 1}
{"idx": 49, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. Although the model's supporting sentence mentions that the context does not explicitly link LY450139 to Semagacestat, the gold supporting sentence shows that this information is indeed present in the context provided. Despite this minor misinterpretation, the logic and conciseness of the evaluation are strong, and the correct relationship can be reasonably inferred from the gold context.\", \"match\": true}", "gold_answer": "Semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "Answer: Semagacestat", "model_support": "The provided context does not mention **LY450139** or its relationship to **Semagacestat**. The sentence \"Semagacestat is currently being studied in two phase III clinical trials\" only states the drug's name and its trial status but does not provide the investigational name (LY450139). Therefore, **no supporting sentence exists in the given context** to answer the question. \n\nHowever, if this is based on external knowledge (e.g., public records), the answer would rely on prior information rather than the context provided.", "retries": 1}
{"idx": 50, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence provides relevant information and logically supports the answer by referencing betrixaban's anti-Xa activity. However, the supporting sentence includes additional details about PRT4445, which are not necessary to answer the question, making it slightly verbose.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis implies that betrixaban has anti-Xa activity, indicating it inhibits factor Xa.", "retries": 1}
{"idx": 51, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa') when accounting for the abbreviation of 'Factor Xa' to 'xa'. The supporting sentence is relevant and correctly identifies that factor Xa inhibitors are part of the discussed drug class, but it does not directly mention betrixaban or provide the explicit clarity found in the gold supporting sentence. It contains slight redundancy by mentioning both factor Xa and IIa inhibitors, which is unnecessary for answering the specific question.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\n**Note:** While the context does not explicitly mention *betrixaban*, it categorizes the class of drugs to which it belongs (factor Xa inhibitors). The answer relies on general knowledge that betrixaban is an indirect factor Xa inhibitor, but the context supports the broader classification of factor Xa inhibitors as a group of emerging anticoagulants.", "retries": 1}
{"idx": 52, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about alpha-synuclein positivity, but it includes additional details that are not necessary to directly support the answer, making it slightly verbose compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals, the degree of which was greater for cases with granular staining in the putamen, and which was proportional to the number of alpha-synuclein-positive neurons in the substantia nigra.", "retries": 1}
{"idx": 53, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer correctly identifies the AIP gene (aryl hydrocarbon receptor-interacting protein) as being implicated in familial isolated pituitary adenoma, which matches the gold standard. However, the supporting sentence is incorrect because it states that the context does not mention the AIP gene, when in fact the context explicitly refers to 'aryl hydrocarbon receptor interacting protein gene mutations' in connection with familial isolated pituitary adenomas. The supporting sentence fails to cover the gold answer adequately and introduces confusion by incorrectly claiming the context lacks this information.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "Answer: The mutation of the AIP (aryl hydrocarbon receptor-interacting protein) gene is implicated in familial isolated pituitary adenoma.", "model_support": "The provided context does **not** mention the **AIP (aryl hydrocarbon receptor-interacting protein)** gene or its association with familial isolated pituitary adenoma. The text discusses general challenges in identifying molecular markers for pituitary tumors but does not specify any gene mutations, including AIP, as causative factors. \n\n**Answer:** The context does not provide a supporting sentence for the claim about the AIP gene mutation. The statement in the answer is not supported by the given text.", "retries": 1}
{"idx": 54, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically. Although the model notes that the context does not explicitly state the target molecule, the provided gold supporting sentence confirms the direct relevance and accuracy of the answer.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "Supporting sentence: **Not explicitly stated in the provided context.**  \nThe context does not mention the molecular target of mepolizumab (e.g., IL-5). The answer relies on external knowledge (mepolizumab is a monoclonal antibody targeting **Interleukin-5 (IL-5)**), which is not directly supported by the text provided.", "retries": 1}
{"idx": 55, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The supporting sentence mentions 'all 5 N-terminal isoforms' but fails to acknowledge that TAp73 itself can have multiple isoforms, leading to an incorrect count. While the supporting sentence is relevant to the context, it does not cover the gold answer and misinterprets the question by focusing only on TAp73 as a single entity rather than its variants.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR...\"  \n**Analysis**: The sentence explicitly lists **TAp73** as one of the five N-terminal p73 isoforms, confirming that **TAp73 is a single isoform** (not multiple variants of TAp73). The answer \"1\" refers to the count of **TAp73 itself** as one distinct isoform among the five total.", "retries": 1}
{"idx": 56, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard, using 'actively transcribed' which is conceptually equivalent to 'transcribed strand.' The supporting sentence is relevant and supports the answer by highlighting the deficiency in TCR for active genes. However, it does not directly mention the 'transcribed strand,' leading to slight imprecision compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "Answer: The gene strand that is actively transcribed.", "model_support": "Supporting sentence: \"CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes.\"", "retries": 1}
{"idx": 57, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context for the answer, but it includes additional information about other disorders (DMD, CYBB, RPGR, OTC) that are not directly needed to support the specific relationship between XK and McLeod syndrome. This makes it slightly verbose compared to the more concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: \"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\"", "retries": 1}
{"idx": 58, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical basis for the answer, but it is slightly less detailed compared to the gold supporting sentence. It does not explicitly mention PBT2 or its mechanism, which results in minor redundancy when contrasted with the more comprehensive gold sentence.\",\n  \"match\": true\n}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "Answer: Alzheimer's disease", "model_support": "Supporting sentence: Drug development based on the metals hypothesis of Alzheimer's disease.  \n\n**Analysis**: The context begins by framing the discussion around Alzheimer's disease through the \"metals hypothesis,\" which directly links the development of compounds like PBT2 to this disorder. While PBT2 is explicitly mentioned later, the disorder it is tested for is established in the opening sentence.", "retries": 1}
{"idx": 59, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer '5-HT2A receptors' matches the gold standard '5-HT2A'. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking the reproducibility of measurements to 5-HT2A receptors. Minor extra details in the supporting sentence do not detract from the strong logic.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: In cortical brain regions with a high density of 5-HT2A receptors, the outcome parameter (binding potential, BP1) showed high reproducibility...", "retries": 1}
{"idx": 60, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'PCSK9' matches the gold standard conceptually, as it is an accepted abbreviation for 'proprotein convertase subtilisin/kexin type 9.' However, the supporting sentence discusses tolerability and adverse events of PCSK9 inhibitors rather than directly explaining that Evolocumab targets PCSK9 or its full name. While the logic connecting the model's answer to the context is sound, the supporting sentence is slightly off-topic and does not fully cover the gold answer. Therefore, a score of 4 is appropriate.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab and alirocumab are fully human monoclonal antibodies inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds to hepatic LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Answer: PCSK9", "model_support": "Supporting sentence: Phase II (for evolocumab and alirocumab) and III (for evolocumab) trials show that PCSK9 inhibitors are equally well tolerated, with adverse events mainly limited to mild-to-moderate nasopharyngitis, injection-site pain, arthralgia and back pain.", "retries": 1}
{"idx": 61, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on the unknown etiology rather than the association with iron deficiency.\", \"match\": false}", "gold_answer": "iron", "gold_support": "The syndrome is increasingly often diagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy.", "model_answer": "Answer: The cause of restless leg syndrome is unknown.", "model_support": "Supporting sentence: \"The etiology is unknown, sometimes it is familial.\"", "retries": 1}
{"idx": 62, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke', with only a minor difference in specificity. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for acute stroke differentiation, but it contains slight redundancy by specifying 'in the ER,' which is implied in the context. Overall, the logic is strong, but the gold supporting sentence is more concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: *The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.*", "retries": 1}
{"idx": 63, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but notes the lack of explicit context in the provided text. The answer 'BCR-ABL' is equivalent to 'Bcr-Abl', and though the model correctly identifies this, it explains that the supporting sentence isn't present in the given context, which introduces slight redundancy.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) arises as a consequence of a chromosomal translocation giving rise to the Philadelphia chromosome and Bcr-Abl oncogene.", "model_answer": "Answer: BCR-ABL", "model_support": "The context provided does not explicitly mention the specific tyrosine kinase (BCR-ABL) targeted by Imatinib (Gleevec). The text discusses tyrosine kinase inhibitors as first-line therapies for CML but does not specify the molecular target (e.g., BCR-ABL). Therefore, **no supporting sentence is present in the given context** to directly answer the question. The answer relies on external knowledge rather than the provided text.", "retries": 1}
{"idx": 64, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about imatinib and its impact on CML patients, but it does not explicitly mention BCR-ABL or the Philadelphia chromosome. The supporting sentence provides useful context but lacks the direct logical connection to the specific kinase targeted by imatinib.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) originates from a hematopoietic stem cell carrying the Philadelphia (Ph) chromosome and oncogenic BCR-ABL1 fusion gene.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The first tyrosine-kinase inhibitor (TKI) imatinib was introduced to clinical practice 10 years ago, and it radically improved the outcome of CML patients.  \n\n**Note:** While the context does not explicitly name the target kinase (BCR-ABL), the question assumes prior knowledge that imatinib targets the BCR-ABL tyrosine kinase in Philadelphia chromosome-positive CML. The context supports the general category of \"tyrosine-kinase inhibitor\" but does not provide the specific kinase name.", "retries": 1}
{"idx": 65, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa' and 'Factor Xa' are equivalent in this context). The supporting sentence is relevant and provides logical support by referencing the factor Xa decoy, PRT4445, which implies betrixaban's role as an inhibitor of factor Xa. However, the supporting sentence contains slight redundancy and does not directly cite the concise phrase from the context that explicitly describes betrixaban as a 'direct factor Xa inhibitor,' which would have been more straightforward.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban is an anticoagulant with anti-Xa activity, as it is being paired with a factor Xa decoy (PRT4445) as a potential reversal agent. While the text does not explicitly state that betrixaban directly inhibits factor Xa, the context of its clinical evaluation and the role of PRT4445 as a decoy strongly suggest that betrixaban targets factor Xa.", "retries": 1}
{"idx": 66, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1, one of the most inducible phase 2 proteins.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"the transcriptional repressor Bach1.\"", "retries": 1}
{"idx": 67, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context about alpha-synuclein deposition, but it is slightly more general than the gold supporting sentence, which specifically mentions Lewy bodies and dystrophic neurites. This makes the model's supporting sentence less direct, though still logically connected.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.", "retries": 1}
{"idx": 68, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Tick') does not match the gold standard ('Ixodes ricinus') but is present in the context as a general term. The supporting sentence mentions 'tick-borne,' which is relevant but does not directly cover the specific vector (Ixodes ricinus) mentioned in the gold answer. Therefore, while the information is somewhat related, it lacks specificity and fails to fully support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "Ixodes ricinus", "gold_support": "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.", "model_answer": "Answer: Tick", "model_support": "Supporting sentence: We used Susceptible Infected Recovered (SIR) models parameterized for the **tick-borne** louping ill virus (LIV) system.", "retries": 1}
{"idx": 69, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('cytoplasmic') does not match the gold standard ('nuclear'), but it is present in the context as APOBEC3B is described as being excluded from chromatin during mitosis. However, the supporting sentence focuses on mitosis and does not address the post-mitotic nuclear localization explicitly mentioned in the gold supporting sentence. The logic is relevant but incomplete, and the supporting sentence does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "Answer: Cytoplasmic", "model_support": "Supporting sentence: \"APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis.\"  \n**Analysis**: While this sentence explicitly describes APOBEC3B's exclusion from chromatin *during mitosis*, the broader context states that during interphase, APOBEC3 proteins have varying subcellular localizations (cytoplasmic, nuclear, or cell-wide). However, the answer \"cytoplasmic\" aligns with the implication that APOBEC3B is not nuclear during mitosis (when chromatin is condensed) and may reside in the cytoplasm, consistent with its exclusion from nuclear DNA access.", "retries": 1}
{"idx": 70, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Eosinophils,' does not match the gold standard, 'interleukin-5,' but is related to the context as mepolizumab indirectly targets eosinophils by targeting interleukin-5. The supporting sentence is relevant and mentions that mepolizumab targets eosinophils, but it does not directly address interleukin-5, which is the actual molecule targeted by the monoclonal antibody. Thus, while there is some relevance, the answer is incorrect and the supporting sentence does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "interleukin-5", "gold_support": "We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome.", "model_answer": "Answer: Eosinophils", "model_support": "Supporting sentence: \"Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.\"", "retries": 1}
{"idx": 71, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the characterization of Mecp2 mutant mice, which aligns well with the gold standard context.\", \"match\": true}", "gold_answer": "methyl-CpG-binding protein 2 (Mecp2)", "gold_support": "The last decade has seen the identification of the disease-causing gene, methyl-CpG-binding protein 2 (Mecp2) and the development of mouse models that phenocopy many aspects of the human syndrome, including breathing dysfunction.", "model_answer": "Answer: MECP2", "model_support": "Supporting sentence: Recent studies have begun to characterize the breathing phenotype of **Mecp2** mutant mice and to define underlying electrophysiological and neurochemical deficits.  \n\n**Analysis**: The context explicitly links *Mecp2* (the gene encoding MECP2) mutations to Rett syndrome (RTT) through studies on mutant mice, establishing MECP2 as the methyl-CpG-binding protein associated with the disorder.", "retries": 1}
{"idx": 72, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less comprehensive compared to the gold supporting sentence. It mentions the association with gluten sensitivity and coeliac disease but does not fully elaborate on dermatitis herpetiformis as a skin manifestation of gluten sensitivity or the role of autoantibodies. The logic is sound but could be more detailed.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "Answer: Dermatitis herpetiformis.", "model_support": "Supporting sentence: Dermatitis herpetiformis is associated with gluten sensitive enteropathy, coeliac disease, which is characterised by IgA type autoantibodies to a closely related enzyme, tissue transglutaminase.", "retries": 1}
{"idx": 73, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and connects flumazenil to benzodiazepine toxicity, but it is slightly less detailed compared to the gold supporting sentence, which explicitly mentions its use in overdose and reversal of sedation. The logic is sound, but the supporting sentence could be more comprehensive.\", \"match\": true}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: \"Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.\"  \n(Alternatively, the sentence: \"Bolus doses of flumazenil are usually adequate to achieve reversal\" also supports this, but the first sentence explicitly links flumazenil to managing benzodiazepine toxicity.)", "retries": 1}
{"idx": 74, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold answer specifies only 'stroke.' Although TIA is mentioned in the context, the ROSIER scale is specifically used for identifying stroke. The supporting sentence is somewhat relevant but lengthy and mixes information about other scales and the general objective of the study rather than focusing solely on the ROSIER scale's use for stroke identification. Logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"", "retries": 1}
{"idx": 75, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('PCSK9' is an acceptable abbreviation for 'proprotein convertase subtilisin/kexin type 9'). However, the supporting sentence incorrectly states that the context does not mention the enzyme targeted by evolocumab, when in fact the gold supporting sentence directly provides this information from the context. The supporting sentence includes unnecessary commentary about external knowledge and lacks conciseness, though it does not introduce incorrect information. Therefore, a score of 4 is appropriate.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "BACKGROUND: Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in phase 2 studies.", "model_answer": "Answer: PCSK9", "model_support": "The context provided does not explicitly mention the enzyme targeted by evolocumab (PCSK9). However, based on external knowledge, evolocumab is a PCSK9 inhibitor. Since the context does not include this information, **no sentence in the provided text supports the answer**. \n\nIf the question assumes prior knowledge (e.g., evolocumab is a PCSK9 inhibitor), the answer would rely on external information, not the given context.", "retries": 1}
{"idx": 76, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less specific than the gold supporting sentence. It implies the distinction between LAD and dermatitis herpetiformis without directly emphasizing the gluten dependency of the rash in dermatitis herpetiformis, leading to minor redundancy.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "This contrasts to the situation in dermatitis herpetiformis, where both the rash and the enteropathy are gluten dependent.", "model_answer": "Answer: Dermatitis herpetiformis.", "model_support": "Supporting sentence: These data add further to the evidence that LAD and dermatitis herpetiformis are separate entities.", "retries": 1}
{"idx": 77, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer without unnecessary information.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a **1,4-benzothiazepine derivative** and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 78, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and contains accurate information about DNMT1, but it is slightly more detailed than necessary. The focus on the crystal structure, while correct, is not as directly relevant to the question as the gold supporting sentence, which succinctly explains DNMT1's role in maintaining DNA methylation.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DNMT1, the major maintenance DNA methyltransferase in animals, helps to regulate gene expression, genome imprinting, and X-chromosome inactivation.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: We report on the crystal structure of a productive covalent mouse DNMT1(731-1602)-DNA complex containing a central hemimethylated CpG site.", "retries": 1}
{"idx": 79, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning 'these enzymes' instead of focusing solely on Dnmt1. The logic is sound but could be more direct.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for maintaining the methylation marks through cell division.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: \"Manipulation of these enzymes, especially Dnmt1, provides a means to alter DNA methylation levels.\"", "retries": 1}
{"idx": 80, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking medicarpin to its biosynthesis in alfalfa, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"The isoflavone-O-methyltransferase (IOMT), which is induced along with other enzymes involved in medicarpin biosynthesis, methylates the A-ring 7-hydroxyl group of daidzein in vitro...\"  \n**Analysis**: The sentence explicitly links IOMT to **medicarpin biosynthesis**, which is a key process in the production of phytoalexins. Since the study focuses on stress responses and the enzymatic pathway for medicarpin (a known phytoalexin in *Medicago sativa*), this implies medicarpin is the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 81, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'BCR-ABL tyrosine kinase' is essentially correct and matches the gold standard conceptually, though it uses a slightly different but equivalent phrasing ('bcr-abl'). The supporting sentence chosen by the model is relevant, as it mentions the *bcr-abl* levels, which are tied to the target of Imatinib. However, the supporting sentence is less direct compared to the gold standard, as it focuses on measuring disease burden rather than explicitly stating that Imatinib inhibits bcr-abl tyrosine kinase. This results in slight redundancy and less clarity.\", \"match\": true}", "gold_answer": "bcr-abl", "gold_support": "Imatinib mesylate (Glivec) is a selective inhibitor of bcr-abl tyrosine kinase, the product of the Philadelphia chromosome, which is the hallmark of chronic myeloid leukaemia (CML).", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: \"the level of leukaemia as measured by serial blood bcr-abl levels using real-time quantitative PCR with either protocol.\"  \n**Analysis**: The context explicitly references the *bcr-abl* gene, which encodes the BCR-ABL tyrosine kinase fusion protein characteristic of Philadelphia chromosome-positive chronic myeloid leukemia (CML). Imatinib (Gleevec) is specifically designed to inhibit this kinase, as implied by the focus on monitoring *bcr-abl* levels as a surrogate for disease burden. While the term \"BCR-ABL tyrosine kinase\" is not explicitly stated, the molecular context of *bcr-abl* directly ties to the target of Imatinib.", "retries": 1}
{"idx": 82, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('xa' is an acceptable shorthand for 'Factor Xa'). The supporting sentence provides relevant information about factor Xa inhibitors and their mechanism, but it is slightly more verbose than necessary and contains additional details that are not directly required to support the answer. A more concise statement focusing on betrixaban’s role as a factor Xa inhibitor would have been ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation. \n\n(Note: While the context does not explicitly name *betrixaban*, it establishes that all drugs in the class of direct factor Xa inhibitors target factor Xa, which is the basis for the answer.)", "retries": 1}
{"idx": 83, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard in identifying 'Na+/Ca²⁺ exchanger (NCX)' as the correct target of SEA0400. However, the supporting sentence chosen by the model is less direct compared to the gold supporting sentence. While it correctly references NCX1’s role in retinal cell death, it does not explicitly mention SEA0400 as a selective NCX inhibitor or directly connect SEA0400 to NCX inhibition, which would have made the reasoning more precise and aligned with the gold standard. The provided sentence implies the involvement of NCX1 but lacks specificity regarding the inhibitory action of SEA0400 on NCX.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: \"In conclusion, these results suggest that NCX1 may play a role in retinal cell death induced by NMDA and ischemia-reperfusion.\" \n\n**Note**: While the context does not explicitly state that SEA0400 directly inhibits NCX1, the experimental findings (e.g., SEA0400 reducing NMDA- and OGD-induced damage, which is linked to NCX1 activity in the context) and the conclusion collectively imply that SEA0400 acts on NCX1. However, the most direct connection is the conclusion's implication of NCX1's involvement in the pathophysiology, with SEA0400's protective effects aligning with NCX1 modulation.", "retries": 1}
{"idx": 84, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as both specify '5-HT2A' receptors. The supporting sentence is relevant and provides accurate information about the investigation of 5-HT2A receptor binding using [(18) F]altanserin. However, it contains slight redundancy by mentioning additional tracers like [(3) H]MDL 100907 and [(18) F]MH.MZ, which are not necessary to directly support the answer. The gold supporting sentence is more concise while still being fully relevant.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Imaging the cerebral serotonin 2A (5-HT2A ) receptors with positron emission tomography (PET) has been carried out in humans with [(11) C]MDL 100907 and [(18) F]altanserin.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"5-HT2A receptor binding in pig cortex and cerebellum was investigated by autoradiography with [(3) H]MDL 100907, [(18) F]MH.MZ, and [(18) F]altanserin.\"", "retries": 1}
{"idx": 85, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains the mechanism of factor Xa inhibition, which applies to betrixaban as part of the drug class.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation. \n\n**Note:** While the context does not explicitly mention *betrixaban*, it establishes that all drugs in the class of direct factor Xa inhibitors (including betrixaban, which is a known factor Xa inhibitor) target **factor Xa**. The quoted sentence supports the general mechanism of this drug class.", "retries": 1}
{"idx": 86, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.\"", "retries": 1}
{"idx": 87, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly ('NF1 gene' is equivalent to 'NF1'). The supporting sentence is relevant but contains slight redundancy. It mentions the association of NF1 with pilocytic astrocytoma and optic glioma, which, while true, does not directly explain why NF1 is the mutated gene in type 1 neurofibromatosis. The gold supporting sentence more directly explains the genetic mechanism (deletion or mutation in NF1).\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis 1 gene (NF1 ) fulfills the criteria of a tumor suppressor gene and is deleted or mutated heterozygously in patients with NF1.", "model_answer": "Answer: NF1 gene.", "model_support": "Supporting sentence: Neurofibromatosis type 1 (NF1) is strongly associated with the development of pilocytic astrocytoma (PA), frequently appearing as optic glioma.", "retries": 1}
{"idx": 88, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer includes 'transient ischaemic attack (TIA)' in addition to 'stroke,' which makes it slightly broader than the gold standard, but it is still relevant and mostly correct based on the context. The supporting sentence provides relevant information about the consensus diagnosis involving stroke or TIA, but it introduces slight redundancy by discussing the expert panel process. The logic is sound, but the focus could be more concise.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"Reference standard A consensus diagnosis of stroke or transient ischaemic attack (TIA) made after discussion by an expert panel...\"  \n\nThis sentence explicitly identifies the disorder (stroke and transient ischaemic attack) for which the ROSIER scale is used, as the study focuses on evaluating diagnostic tools for these conditions.", "retries": 1}
{"idx": 89, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly ('naloxone'). However, the supporting sentence provided by the model is unnecessarily lengthy and indirect. While it conveys relevant information about the study design, it does not directly mention naloxone as clearly as the gold supporting sentence. The gold supporting sentence is concise and directly ties naloxone to the management of opioid overdose, making it more effective.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: \"A prospective, sequential, observational cohort study of 196 consecutive patients with suspected opioid overdose was conducted in an urban out-of-hospital setting, comparing time intervals from arrival at the patient's side to development of a respiratory rate > or =10 breaths/min, and durations of bag-valve-mask ventilation.\"  \n\n**Note**: While this sentence does not explicitly name \"naloxone,\" the entire context revolves around the administration of **naloxone** (subcutaneously vs. intravenously) for opioid overdose management, as indicated in the methods and results sections. The conclusion explicitly states the comparison is about **naloxone** for out-of-hospital management. A more precise supporting sentence would be:  \n**\"comparing time intervals from arrival at the patient's side to development of a respiratory rate > or =10 breaths/min, and durations of bag-valve-mask ventilation\"** (implying naloxone administration, as the study's focus is on opioid overdose reversal).  \n\nHowever, the direct mention of the medication is in the **results** section:  \n**\"Cost of materials for administering naloxone 0.4 mg i.v. was $12.30/patient, compared with $10.70/patient for naloxone 0.8 mg s.q.\"**  \n\n**Final Answer**:  \nSupporting sentence: \"Cost of materials for administering naloxone 0.4 mg i.v. was $12.30/patient, compared with $10.70/patient for naloxone 0.8 mg s.q.\"", "retries": 1}
{"idx": 90, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Xist' is equivalent to 'XIST'). The supporting sentence provided by the model is concise and directly addresses the role of XIST/Xist in X-chromosome inactivation. It explains that deletions or mutations involving the XIST/Xist gene result in failure of X-inactivation, which is a clear and logical explanation derived from the context. Although there is minor additional information about other mechanisms (e.g., Xce locus), this does not detract from the direct relevance and accuracy of the supporting sentence.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "Answer: Xist (X-inactive specific transcript)", "model_support": "The context does not explicitly mention the **Xist** (X-inactive specific transcript) gene or its role in X-chromosome inactivation. The provided text discusses the **Xce locus**, **parental origin of X-inactivation**, and **cell selection mechanisms**, but **no sentence directly identifies Xist as the transcript responsible for X-chromosome inactivation**. \n\nThus, the answer **\"Xist\"** is not supported by the given context. The context focuses on regulatory loci (e.g., Xce) and epigenetic mechanisms rather than the Xist transcript itself.", "retries": 1}
{"idx": 91, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly references the SECIS element. However, it introduces slight redundancy by discussing the removal of the SECIS element in variant 1, which is not necessary to define what the stem-loop is. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "Cotranslational incorporation of Sec into SelS depends on the recoding of the UGA codon, which requires a Selenocysteine Insertion Sequence (SECIS) element in the 3'UTR of the transcript.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: \"the variant 1 transcript... removes the SECIS element from the variant 1 transcript.\" \n\nThis sentence directly references the **SECIS element** as a critical component of the 3'UTR in selenoprotein-encoding genes, confirming its role as the stem-loop structure involved in selenocysteine incorporation.", "retries": 1}
{"idx": 92, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly captures the key fact that orteronel inhibits CYP17A1 activity, aligning well with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"In summary, orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through **selective inhibition of CYP17A1 activity**.\"", "retries": 1}
{"idx": 93, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer logically. However, it is slightly redundant by emphasizing 'immunoreactivity' and 'targets alpha-synuclein', which could be more concise. The chosen supporting sentence from the model is valid but not as direct or concise as the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein.\"  \nThis indicates that the antibody used for immunostaining specifically targets **alpha-synuclein**, as it detects immunoreactivity for this protein in PD brain tissue.", "retries": 1}
{"idx": 94, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the supporting sentence is not present in the provided context, this observation is accurate because the context does indeed lack an explicit statement tying imatinib to BCR-ABL as its target. The gold supporting sentence, however, provides the necessary information from a different part of the text, confirming the correctness of the answer. Since the evaluation criteria allow for external knowledge in answering while assessing the relevance of the supporting sentence within the given context, the score reflects perfect alignment with the gold answer and an honest acknowledgment of context limitations.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib mesylate is a tyrosine kinase inhibitor with high affinity for the BCR-ABL fusion protein expressed by the hematopoietic cells in chronic myelogenous leukemia (CML).", "model_answer": "Answer: BCR-ABL", "model_support": "The context provided does not explicitly mention the specific tyrosine kinase (BCR-ABL) targeted by imatinib. The text focuses on the clinical outcomes of dose escalation in patients with chronic myelogenous leukemia (CML) but does not identify the molecular target of imatinib (e.g., BCR-ABL). Thus, **there is no supporting sentence in the given context** that directly answers the question about the tyrosine kinase targeted by imatinib. The answer (BCR-ABL) relies on external biomedical knowledge, not the provided text.", "retries": 1}
{"idx": 95, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly verbose and could be more concise. The key idea about celiac disease being associated with small bowel lymphoma is present, though the model supporting sentence indirectly references the detection of celiac disease rather than directly stating its association.\", \"match\": true}", "gold_answer": "celiac disease", "gold_support": "Retrospective chart review was performed to detect associated disease processes, such as celiac disease.", "model_answer": "Answer: Celiac disease", "model_support": "Supporting sentence: \"We describe the characteristics of small-bowel lymphoma on MR enterography, identifying a number of key features that may help the interpreting radiologist in suggesting the underlying histologic subtype and whether the presence of underlying celiac disease is likely.\"", "retries": 1}
{"idx": 96, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'XK gene' matches the gold standard 'XK'. The supporting sentence provided by the model acknowledges that the context does not explicitly mention the XK gene but correctly infers it based on external knowledge. Although the model notes no direct supporting sentence is present in the context, the logic aligns with the gold supporting sentence when external knowledge is considered. This reflects strong reasoning despite the lack of explicit context.\", \"match\": true}", "gold_answer": "XK", "gold_support": "Molecular genetic analysis revealed a small deletion in the XK gene (938-942delCTCTA), which has been already described in a North American patient of Anglo-Saxon descent and a Japanese family, presenting with seizures, muscle atrophy or chorea yet absence of psychiatric features.", "model_answer": "Answer: XK gene", "model_support": "The context does not explicitly mention the specific gene (XK) associated with McLeod syndrome. The text only states that McLeod syndrome is **X-linked** (\"The X-linked McLeod neuroacanthocytosis syndrome...\"), but it does not name the **XK gene** as the causative mutation. The answer \"XK gene\" is likely based on external knowledge, not the provided context. \n\n**No supporting sentence is present in the context** for the answer \"XK gene.\"", "retries": 1}
{"idx": 97, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions five N-terminal isoforms, which includes TAp73, but the question specifically asks about TAp73 isoforms, and the context implies there are seven. The supporting sentence is relevant but does not directly support the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR...\"  \n**Note**: While the sentence lists *five* N-terminal p73 isoforms (including TAp73), the question specifically asks about *TAp73 isoforms* (singular), implying TAp73 itself is a single isoform. The context does not explicitly state that TAp73 has subtypes, so the answer \"1\" is inferred from the naming convention (TAp73 is treated as a single distinct isoform).", "retries": 1}
{"idx": 98, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that mutations in the ZFHX1B gene are associated with Mowat-Wilson syndrome.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 99, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (NCX), though it includes additional detail ('Na+/Ca²⁺ exchanger') which is technically correct but not required. The supporting sentence is relevant and aligns with the context, as it mentions NCX1's involvement in retinal cell death, which is connected to SEA0400's action. However, it does not explicitly state that SEA0400 is a selective NCX inhibitor, making it slightly less direct than the gold supporting sentence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: A Na+/Ca²⁺ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.  \n\n**Analysis**: The context explicitly identifies NCX1 as the Na+/Ca²⁺ exchanger isoform implicated in retinal cell death. While the text does not directly state that SEA0400 inhibits NCX, the experimental results (e.g., SEA0400 reducing NMDA-induced retinal damage, which is linked to NCX1 activity) and the conclusion that NCX1 plays a role in retinal cell death imply that SEA0400 targets NCX1. However, the **most direct supporting sentence** is the one defining NCX1's role, as the question asks for the ion antiporter/exchanger inhibited by SEA0400, and the context frames NCX1 as the relevant target.", "retries": 1}
{"idx": 100, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While it includes additional information about other repair mechanisms, this does not detract from the clarity or correctness of the support for the answer.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) acts solely on the transcribed strand of expressed genes, while global genomic repair (GGR) is responsible for the ubiquitous repair of the genome.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"(i) TCR, responsible for maintenance of transcribed strands; (ii) GGR, responsible for ubiquitous genome repair; and (iii) non-transcribed strand repair (NTSR), predominantly responsible for the repair of the NTS in arrested cells.\"", "retries": 1}
{"idx": 101, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Serotonin 5-HT2A receptors' is correct and matches the gold standard '5-HT2A'. The supporting sentence provided by the model is relevant and covers the answer, but it is slightly more verbose than necessary. It introduces additional context about test-retest variability and development of [18F]altanserin as a radiotracer, which is not essential to directly support the specific answer about 5-HT2A receptors. The gold supporting sentence is more concise and directly ties [18F]altanserin binding to 5-HT2A receptors.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: \"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 102, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' exactly, as 'acute stroke' is a precise descriptor within the context of the ROSIER scale. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating the purpose of the ROSIER scale in differentiating acute stroke in the ER. Minor additional detail about 'stroke mimics' is acceptable as it enhances clarity without being excessive.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 103, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'GBA (glucocerebrosidase)' is correct and matches the gold standard conceptually, as GBA is the gene encoding glucocerebrosidase. However, the gold answer specifically asks for the name of the gene rather than its encoded protein. The supporting sentence provided by the model is relevant but slightly indirect, referencing mutations in the gene rather than directly linking it to Gaucher disease. It could be more concise and explicit about the gene's role in the disease.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "In Gaucher disease (GD), the inherited deficiency of glucocerebrosidase results in the accumulation of glucocerebroside within lysosomes.", "model_answer": "Answer: GBA (glucocerebrosidase)", "model_support": "Supporting sentence: \"Although almost 300 mutations in the glucocerebrosidase gene (GBA) have been identified...\"  \n(While the context does not explicitly mention \"Gaucher disease,\" the GBA gene is well-established in the field as the causative gene for Gaucher disease, and the sentence directly identifies the gene in question.)", "retries": 1}
{"idx": 104, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('autosomal recessive'), but the supporting sentence is incorrect in stating that the context does not mention the mode of inheritance. The context explicitly states that Wilson's disease is an 'autosomal recessive inheritance disorder,' which directly supports the gold answer. Thus, while the answer is correct, the supporting sentence fails to accurately reflect the information provided in the context.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation.", "model_answer": "Answer: Autosomal recessive", "model_support": "The context does not explicitly mention the mode of inheritance of Wilson's disease. The provided text only states that Wilson's disease (WD) is \"an inherited disease of the nervous system\" but does not specify whether it is autosomal recessive, autosomal dominant, or any other mode of inheritance. Therefore, the answer \"Autosomal recessive\" cannot be directly supported by the given context.", "retries": 1}
{"idx": 105, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as 'thyroid' encompasses thyroid hormone abnormalities like elevated TSH levels. However, the supporting sentence focuses on the decline of TSH elevation with age, which does not directly support the specific point about the commonality of thyroid hormone abnormalities in Williams syndrome. The logic is reasonable but could be more concise and aligned with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid involvement in Williams syndrome (WS) was recently reported in two small groups of patients, both showing an increased prevalence of elevation of TSH serum concentration; in one of the two reports, 70% of the patients demonstrated a hypoplasia of thyroid gland as well.", "model_answer": "Answer: Thyroid hormone abnormalities, including elevated TSH levels.", "model_support": "Supporting sentence: \"we demonstrated that TSH elevation declines with age.\"  \nThis indicates that **elevated TSH levels** are a common thyroid hormone abnormality in Williams syndrome, even though the elevation diminishes over time.", "retries": 1}
{"idx": 106, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Facioscapulohumeral muscular dystrophy (FSHD)' matches the gold standard 'FSHD' in meaning, albeit with slightly more detail. The supporting sentence provided is relevant and supports the answer by discussing the role of DUX4 expression and its suppression in FSHD1, which aligns with the context of the disease mechanism. However, it contains some redundancy and does not directly reference the contraction of the D4Z4 array, which is central to the gold supporting sentence. Overall, it is logical but slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array on chromosome 4 to a size of 1-10 units.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"Because SMCHD1 directly binds to D4Z4 and suppresses somatic expression of DUX4, we hypothesized that SMCHD1 may act as a genetic modifier in FSHD1.\"  \n\nThis sentence establishes the link between DUX4 expression and FSHD1, as the suppression of DUX4 by SMCHD1 is central to the disease mechanism. The conclusion further reinforces this by stating that FSHD1 and FSHD2 share a common pathophysiological pathway involving DUX4.", "retries": 1}
{"idx": 107, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by referencing Xce haplotypes, which is not directly necessary to explain the role of Xist in X-chromosome inactivation. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The recently characterized Xist sequence (X-inactive-specific transcript) is thought to be a possible candidate for Xic.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"Xce haplotypes show modified methylation in a region of the active X chromosome lying 3' to Xist.\"  \n(Note: While the context does not explicitly state that *Xist* is the transcript responsible for X-chromosome inactivation, *Xist* (X-inactive specific transcript) is a well-established non-coding RNA central to XCI in mammals, and its mention in proximity to the active X chromosome's methylation pattern aligns with its role in this process.)", "retries": 1}
{"idx": 108, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and supports the answer by referencing betrixaban's anti-Xa activity. However, it contains slight redundancy by introducing PRT4445, which is not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban has anti-Xa activity, indicating it inhibits factor Xa.", "retries": 1}
{"idx": 109, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model incorrectly states that the context does not mention the type of lung cancer, while the gold supporting sentence clearly identifies small-cell lung cancer in the context. The model's supporting sentence introduces unnecessary confusion by implying a lack of support in the context, which slightly lowers the quality of an otherwise correct response.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.", "model_answer": "Answer: Small cell lung cancer", "model_support": "The context provided does not mention the type of lung cancer associated with Lambert-Eaton myasthenic syndrome (LEMS). The answer \"small cell lung cancer\" is a general medical fact, but **no sentence in the given context supports this specific association**. The context focuses on the clinical presentation, antibody findings, and treatment response of a case involving LEMS and paraneoplastic opsoclonus-myoclonus syndrome, without specifying the underlying cancer type.", "retries": 1}
{"idx": 110, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking 'X-linked dystonia-parkinsonism' to 'Lubag disease'.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-Linked Dystonia-Parkinsonism (XDP or \"Lubag\") is a progressive neurodegenerative disorder unique to the Island of Panay in the Philippines.", "model_answer": "Answer: X-linked dystonia-parkinsonism (XDP)", "model_support": "Supporting sentence: \"Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease.\"", "retries": 1}
{"idx": 111, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about dermatitis herpetiformis being associated with gluten sensitivity, but it is slightly verbose and less direct compared to the gold supporting sentence. It implies the connection rather than stating it as clearly as the gold standard.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "Answer: Dermatitis herpetiformis.", "model_support": "Supporting sentence: \"Eleven patients with dermatitis herpetiformis in remission on a gluten-free diet were challenged daily with 50 g oats for six months.\"  \n(Implied context: Dermatitis herpetiformis is a skin manifestation of gluten sensitivity, as the study investigates its response to oats in a gluten-free diet.)  \n\n**Note:** While the exact phrase \"typical rash associated with gluten\" is not explicitly stated, the condition **dermatitis herpetiformis** is directly tied to gluten sensitivity in the context (as the study focuses on its tolerance to oats in a gluten-free diet). The conclusion further links the rash to gluten sensitivity by stating that the rash in dermatitis herpetiformis is not activated by oats, reinforcing the association.", "retries": 1}
{"idx": 112, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning 'meta-analysis' which is not directly necessary for supporting the specific answer. The logic is clear but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.", "retries": 1}
{"idx": 113, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa', though it includes the word 'Factor', which is not strictly necessary but still correct. The supporting sentence is relevant and provides context for the class of drugs that betrixaban belongs to, but it does not explicitly mention betrixaban itself, making it slightly less precise compared to the gold supporting sentence. Overall, the logic is sound, but there is a minor lack of specificity.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin.\"  \n(Note: While the context does not explicitly name *betrixaban*, it describes the class of drugs as \"direct factor Xa inhibitors,\" which directly answers the question about the clotting factor inhibited by such agents.)", "retries": 1}
{"idx": 114, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence chosen by the model does not directly state that the heterodimer is antiparallel, which is critical for fully supporting the answer. Instead, it discusses binding affinity without explicitly mentioning the orientation of the subunits. The gold supporting sentence clearly establishes the antiparallel nature of the heterodimer. Despite this, the model's supporting sentence still relates to spectrin dimerization and indirectly supports the correct answer.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: \"the alpha20-21/beta1-2 complex showed stoichiometric binding with similar binding affinities (K(d) approximately 10 nM) using isothermal titration calorimetry.\"\n\n**Note:** The context does not explicitly state whether the heterodimers are parallel or antiparallel. However, the term \"heterodimer\" (composed of alpha and beta subunits) is commonly associated with antiparallel orientation in biological contexts, such as spectrin dimers, which are well-known to form antiparallel structures. While the text does not directly specify this, the answer \"antiparallel\" aligns with established biochemical knowledge about spectrin dimerization.", "retries": 1}
{"idx": 115, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' with only a minor difference in specificity. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for stroke recognition, but it includes slight redundancy by mentioning the comparison to other instruments, which is not necessary to support the answer. Overall, the logic is strong, but the extra detail slightly reduces conciseness.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"  \n(Also supported by: \"The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population,\" where \"this population\" refers to patients with suspected acute stroke.)", "retries": 1}
{"idx": 116, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The mention of 'nuclear import' and 'nuclear localization determinant' aligns well with the gold supporting sentence's emphasis on A3B's steady-state nuclear localization.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear.", "model_support": "Supporting sentence: Here, we show that A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID.  \n\n**Analysis**: This sentence explicitly describes the mechanism by which APOBEC3B is transported into the nucleus (\"nuclear import\"), indicating its predominant localization in the nucleus. The mention of a \"nuclear localization determinant\" and the requirement for active import further supports that A3B is primarily nuclear.", "retries": 1}
{"idx": 117, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: \"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"", "retries": 1}
{"idx": 118, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly identifies BACH1 as a repressor using logical reasoning from the context provided.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: \"Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.\"  \nThe term \"BACH1 repressor\" directly identifies BACH1 as a repressor.", "retries": 1}
{"idx": 119, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states '1' while the gold answer specifies '7'. The supporting sentence discusses the existence of two types of p73 isoforms (TA and deltaN), but this does not logically support the model’s claim that there is only one TAp73 isoform. The explanation in the supporting sentence is irrelevant to the specific question about the number of TAp73 isoforms. Thus, both the answer and supporting sentence fail to align with the gold standard.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (deltaN) p73 isoforms.\"  \n**Note**: While the sentence mentions two p73 isoforms (TA and deltaN), the question specifically asks about **TAp73** (the full-length isoform), which is **one** distinct isoform. The context does not indicate the existence of multiple TAp73 isoforms, only the distinction between TAp73 and deltaNp73.", "retries": 1}
{"idx": 120, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence incorrectly states that no supporting sentence exists in the context, while the context does mention betrixaban as a factor Xa inhibitor. Despite this error, the answer is correct and the intended logic can be inferred from the provided context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or **Factor Xa**. Therefore, **no supporting sentence exists in the given context** to justify the answer \"Factor Xa\" for the question about betrixaban. The context only discusses **dabigatran** (a direct thrombin inhibitor) and does not reference betrixaban or its mechanism of action.", "retries": 1}
{"idx": 121, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: \"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"", "retries": 1}
{"idx": 122, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking MLL complexes to H3K4 trimethylation, though it introduces slight redundancy by discussing the knockdown of Wdr82, which is not directly necessary for the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "In yeast, the macromolecular complex Set1/COMPASS is capable of methylating H3K4, a posttranslational modification associated with actively transcribed genes.", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: \"RNA interference-mediated knockdown of Wdr82 results in a reduction in the H3K4 trimethylation levels, although these cells still possess active MLL complexes.\"  \nThis sentence implies that MLL complexes (including MLL1) are involved in H3K4 trimethylation, as the reduction in H3K4 methylation occurs despite the presence of active MLL complexes.", "retries": 1}
{"idx": 123, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Insulin receptor function,' is related but does not match the gold standard 'insulin.' The supporting sentence references mutations in the insulin receptor gene but focuses on Rabson-Mendenhall syndrome rather than Donohue syndrome. While relevant, it does not directly support the gold answer and mixes information from a different condition, leading to some confusion.\",\n  \"match\": false\n}", "gold_answer": "insulin", "gold_support": "Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (\"Leprechaunism\"), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.", "model_answer": "Answer: Insulin receptor function", "model_support": "Supporting sentence: \"Two novel mutations in the insulin binding subunit of the insulin receptor gene without insulin binding impairment in a patient with Rabson-Mendenhall syndrome.\"", "retries": 1}
{"idx": 124, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate, mentioning medulloblastoma in the context of its metastatic behavior. However, it does not directly state that medulloblastoma is the most common pediatric cerebellar tumor, which is the core requirement of the question. The gold supporting sentence more clearly establishes medulloblastoma's association with pediatric cerebellar tumors. Thus, while the logic is sound, the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally.", "model_answer": "Answer: Medulloblastoma", "model_support": "Supporting sentence: The skeleton is the most common site of extraneural metastases, but metastases to the bone marrow can also occur.  \n\n**Note:** While the context does not explicitly state that *medulloblastoma* is the most common pediatric cerebellar tumor, the term \"medulloblastoma\" is repeatedly used in the context (e.g., \"four cases of medulloblastoma metastatic to the marrow\"). However, the question assumes general medical knowledge that medulloblastoma is the most common pediatric cerebellar tumor, which is not directly supported by the provided text. If strictly relying on the context, no sentence explicitly identifies medulloblastoma as the most common type.", "retries": 1}
{"idx": 125, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer 'The GBA gene' does not match the gold standard 'glucocerebrosidase,' which refers to the enzyme encoded by the GBA gene. The supporting sentence explains that the context does not explicitly mention the GBA gene, which is accurate, but it fails to cover the gold answer or provide direct logical support from the given text. The answer relies on external knowledge and is not fully grounded in the provided context.\", \"match\": false}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population.", "model_answer": "Answer: The GBA gene.", "model_support": "The context does not explicitly mention the **GBA gene** or any specific gene associated with Gaucher disease. The text only refers to the **N370S mutation** and its frequency in the Portuguese population but does not specify which gene this mutation belongs to. Therefore, **no sentence in the provided context directly supports the answer \"the GBA gene.\"** The answer relies on external knowledge (Gaucher disease is caused by mutations in the *GBA* gene encoding glucocerebrosidase), which is not stated in the given text.", "retries": 1}
{"idx": 126, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It effectively highlights the key distinction between repair in the transcribed versus non-transcribed strand, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "Answer: The transcribed strand of an active gene.", "model_support": "Supporting sentence: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"", "retries": 1}
{"idx": 127, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying the receptor as 'CGRP (calcitonin gene-related peptide) receptor.' The supporting sentence correctly notes that the context does not explicitly mention the receptor, which aligns with the provided context. Although external knowledge is required to answer the question, the reasoning is clear and concise, acknowledging the absence of explicit information in the context.\",\n  \"match\": true\n}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant (MK-0974) is a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development.", "model_answer": "Answer: CGRP (calcitonin gene-related peptide) receptor", "model_support": "The context provided does not explicitly mention the receptor targeted by telcagepant. The passage focuses on the development of a liquid chromatography-tandem mass spectrometry assay for quantifying telcagepant in human plasma and its validation, but it does not discuss the molecular target (e.g., CGRP receptor) of the drug. The answer \"CGRP (calcitonin gene-related peptide) receptor\" would require external knowledge, as the context does not include this information. \n\n**Supporting sentence:** *None* (The context does not provide information about the receptor targeted by telcagepant.)", "retries": 1}
{"idx": 128, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard, albeit with a slightly different but acceptable phrasing ('AIP (aryl hydrocarbon receptor-interacting protein) gene' vs. 'Aryl hydrocarbon receptor interacting protein'). The supporting sentence provides relevant information about AIP-mutated FIPA patients but contains some redundancy by discussing the range of symptoms rather than focusing solely on the identification of the AIP gene mutations as the gold supporting sentence does. This makes it less concise but still logically connected to the answer.\",\n  \"match\": true\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP (aryl hydrocarbon receptor-interacting protein) gene.", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", "retries": 1}
{"idx": 129, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, DNMT3B, does not match the gold standard, DNMT1, but is present in the context as one of the enzymes involved in DNA methylation. The supporting sentence mentions DNMT3B and its role in modulating DNA methylation, which is relevant but does not cover the gold answer, DNMT1. Therefore, while the information is related to DNA methylation, it fails to directly support the correct enzyme responsible for maintaining cytosine methylation.\", \"match\": false}", "gold_answer": "DNMT1", "gold_support": "DNA methylation patterns are established and maintained by three DNA methyltransferases: DNMT1, DNMT3A, and DNMT3B.", "model_answer": "Answer: DNMT3B", "model_support": "Supporting sentence: \"A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding.\"  \nThis sentence directly links DNMT3B to its role in DNA methylation, confirming its involvement in the process.", "retries": 1}
{"idx": 130, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly by identifying ZFHX1B as the responsible gene. The supporting sentence correctly acknowledges that the context does not explicitly mention the gene but provides a logical explanation for how the answer was derived from external knowledge. Although the model notes no direct supporting sentence is available from the context, this aligns with the gold supporting sentence, which highlights the same issue.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Genitourinary anomalies in Mowat-Wilson syndrome with deletion/mutation in the zinc finger homeo box 1B gene (ZFHX1B).", "model_answer": "Answer: The gene responsible for the development of Mowat-Wilson syndrome is the ZFHX1B (also known as SIP1) gene.", "model_support": "The context provided does **not** mention the specific gene responsible for Mowat-Wilson syndrome (ZFHX1B/SIP1). The answer (ZFHX1B/SIP1) relies on **external knowledge**, as the context only describes the clinical features of MWS (e.g., facial phenotype, Hirschsprung disease, microcephaly, mental retardation, and genitourinary anomalies) and the association of hypospadias with the syndrome. No genetic information is explicitly stated in the text. \n\n**Supporting sentence**: *None* (the context does not provide the gene name).", "retries": 1}
{"idx": 131, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence introduces additional context about the clinical importance of RET mutations, which, while accurate, is not necessary to directly support the answer. The gold supporting sentence is more concise and directly tied to the identification of RET mutations in MEN2 and related diseases.\", \"match\": true}", "gold_answer": "RET", "gold_support": "RESULTS: We identified RET mutations in seven of 13 MTCs: five RET-positive cases revealed a mutation in exon 16 (M918T) and two a mutation in exon 10 (C618S and C620S).", "model_answer": "Answer: RET", "model_support": "Supporting sentence: \"Screening medullary thyroid carcinomas (MTCs) for rearranged during transfection (RET) mutations becomes increasingly important for clinical assessment of the disease.\"  \n(Implied connection: RET mutations are central to MTC, a component of Multiple Endocrine Neoplasia 2 (MEN2), and RET is also associated with Hirschsprung disease based on external medical knowledge.)", "retries": 1}
{"idx": 132, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentence is relevant and provides evidence for hypothyroidism being common in Williams syndrome; however, it does not cover the gold answer ('thyroid') directly. The focus of the gold answer is broader, encompassing thyroid abnormalities in general rather than specifying hypothyroidism.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "Answer: Hypothyroidism, including both subclinical and overt forms.", "model_support": "Supporting sentences:  \n1. \"Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).\"  \n2. \"In all WS patients with diagnosis of subclinical or overt hypothyroidism, thyroid hypoplasia was detected.\"  \n\nThese sentences explicitly state the prevalence of both subclinical and overt hypothyroidism in Williams syndrome.", "retries": 1}
{"idx": 133, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod syndrome resulting from a novel XK mutation.", "retries": 1}
{"idx": 134, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'AIP (aryl hydrocarbon receptor-interacting protein) gene' is equivalent to 'aryl hydrocarbon receptor interacting protein.' The supporting sentence is relevant and directly references the R304* AIP mutation, which aligns with the gold supporting sentence. However, it contains slight redundancy by specifying 'R304*' rather than focusing solely on the general implication of the AIP mutation in familial isolated pituitary adenoma.\",\n  \"match\": true\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.", "model_answer": "Answer: AIP (aryl hydrocarbon receptor-interacting protein) gene.", "model_support": "Supporting sentence: We describe our experience with a large family with **R304* AIP mutation** and discuss some of the diagnostic dilemmas and management issues.", "retries": 1}
{"idx": 135, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('RET'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although it references additional information about Hirschsprung disease, this does not detract from the core relevance of the sentence to the question and gold answer.\", \"match\": true}", "gold_answer": "RET", "gold_support": "Multiple endocrine neoplasia type 2 (MEN2) is an inherited, autosomal-dominant disorder caused by deleterious mutations within the RET protooncogene.", "model_answer": "Answer: RET", "model_support": "Supporting sentence: \"Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation...\"  \nThis sentence explicitly identifies the **RET** gene as the one associated with Multiple Endocrine Neoplasia type 2 (MEN2). While the context does not mention Hirschsprung disease, it is a well-established clinical fact that **RET** mutations are also linked to Hirschsprung disease. The context focuses on MEN2, but the gene in question is **RET**.", "retries": 1}
{"idx": 136, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'BACH1 is a repressor' matches the gold standard ('repressor'), but the supporting sentence states that there is no relevant information in the context to support this claim. While the model's answer is correct based on external knowledge, the lack of proper justification from the context reduces its score. The gold supporting sentence directly references the role of BACH1 as a transcriptional repressor, which the model failed to extract.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1, a transcriptional repressor that is negatively regulated by heme in mammalian cells;", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "The context provided does not mention **BACH1** or its role as an activator or repressor. Therefore, **no supporting sentence** exists in the given context to validate the claim that \"BACH1 is a repressor.\" The answer likely relies on external knowledge not included in the text. \n\n**Note:** The context discusses heme-regulated transcription factors like Hap1 and the heme-regulated inhibitor but does not reference BACH1.", "retries": 1}
{"idx": 137, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about p53, but it does not directly mention the phrase 'guardian of the genome,' which would make it more concise and explicit. The supporting sentence focuses on a specific molecular function of p53 rather than its broader role as the 'guardian of the genome,' introducing slight redundancy.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Analysis:** While the context does not explicitly use the term \"guardian of the genome,\" the sentence introduces **p53** as the central protein being studied, establishing its role in stabilizing its tetrameric structure and enhancing transcriptional activity—functions directly tied to its well-known identity as the \"guardian of the genome\" in broader biomedical literature. The context implicitly identifies p53 as the tumor suppressor through its detailed discussion of its molecular mechanisms.", "retries": 1}
{"idx": 138, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"Genetic ablation of transcription repressor Bach1 reduces neural tissue damage...\"  \nThis explicitly identifies BACH1 as a **transcription repressor**.", "retries": 1}
{"idx": 139, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by explicitly mentioning 'antiparallel spectrin heterodimers.'\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: *Influence of lateral association on forced unfolding of antiparallel spectrin heterodimers.*  \n\nThis sentence explicitly states that the spectrin heterodimers in question are **antiparallel**.", "retries": 1}
{"idx": 140, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides context about factor Xa inhibitors, including betrixaban. However, it is slightly verbose and does not directly quote the most concise and relevant part of the context, which would be the title itself ('Evaluation of the oral direct factor Xa inhibitor - betrixaban').\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.", "retries": 1}
{"idx": 141, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by referencing the broader study findings rather than directly stating the aberrant DUX4 expression as the cause of FSHD.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Aberrant expression of DUX4 from the last unit of the D4Z4 array has been proposed to be the cause of FSHD.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: The findings of this study suggest that the same principle may be applied to suppress the aberrantly expressed DUX4 in FSHD.", "retries": 1}
{"idx": 142, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying 'CGRP (calcitonin gene-related peptide) receptor' as the target. However, the supporting sentence is missing and flagged as 'Not explicitly stated,' which reduces clarity. While the context does provide a relevant sentence in the BACKGROUND section that directly links telcagepant to CGRP receptor antagonism, the model failed to extract it. Including this sentence would have made the support stronger and more aligned with the scoring criteria.\",\n  \"match\": true\n}", "gold_answer": "Calcitonin gene-related peptide", "gold_support": "BACKGROUND: Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a population for whom triptans are contraindicated.", "model_answer": "Answer: CGRP (calcitonin gene-related peptide) receptor", "model_support": "Supporting sentence: **Not explicitly stated in the provided context.**  \nThe context does not mention the specific receptor targeted by telcagepant. The answer (CGRP receptor) relies on external knowledge, as the text only discusses the drug's efficacy in migraine treatment and safety in coronary artery disease patients without specifying its mechanism of action or receptor target.", "retries": 1}
{"idx": 143, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is slightly redundant as it quotes the title of the article rather than providing a concise explanation directly relevant to the abnormality in the lumbosacral region. It could be more specific to the condition and its relation to the lumbosacral region, but it still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "lumbosacral", "gold_support": "Bertolotti's syndrome is a spine disorder characterized by the occurrence of a congenital lumbar transverse mega-apophysis in a transitional vertebral body that usually articulates with the sacrum or the iliac bone.", "model_answer": "Answer: Lumbosacral region", "model_support": "Supporting sentence: Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.", "retries": 1}
{"idx": 144, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('ultrasound') but is present in the context as a related concept (automated techniques are discussed as a new development). The supporting sentence mentions standardization and automation but does not directly cover the gold answer ('ultrasound'), making it relevant yet incomplete.\", \"match\": false}", "gold_answer": "ultrasound", "gold_support": "PURPOSE OF REVIEW: This manuscript reviews the information that became available over the last 12 months on the measurement of bladder/detrusor wall thickness and ultrasound-estimated bladder weight in patients with benign prostatic enlargement.", "model_answer": "Bladder wall thickness is measured using automated techniques, which have been developed to standardize and improve the accuracy of the measurement.", "model_support": "Supporting sentence: \"novel technological developments may help to standardize and automate the measurement technique.\"", "retries": 1}
{"idx": 145, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by emphasizing co-localization rather than directly stating the association between FANCA and BRG1 as a component of SWI/SNF. The logic is clear but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: \"we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"", "retries": 1}
{"idx": 146, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, acknowledges the lack of explicit support in the provided context, and logically explains that the answer relies on external knowledge. This aligns with the gold supporting sentence, which directly mentions '15 members of the kallikrein-related serine peptidase (KLK) family,' confirming the correctness of the answer.\",\n  \"match\": true\n}", "gold_answer": "15", "gold_support": "The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and putative proteolytic functions.", "model_answer": "Answer: 15", "model_support": "The context does not explicitly state the number of tissue kallikrein genes in the human genome. The provided text discusses the kallikrein locus, hormone response elements, and regulatory mechanisms but does not specify the total count of tissue kallikrein genes (e.g., KLK1–KLK15). The answer \"15\" likely relies on external knowledge (e.g., the KLK gene family includes 15 members), but **no sentence in the given context directly supports this numerical claim**.", "retries": 1}
{"idx": 147, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by including information about the atopy patch test which is not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a monoclonal antibody to interleukin-5, which reduces peripheral blood eosinophils.", "model_answer": "Answer: Interleukin-5", "model_support": "Supporting sentence: No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.", "retries": 1}
{"idx": 148, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard ('benzothiazepine' is equivalent to '1,4-benzothiazepine' in this context). The supporting sentence provided by the model explains that the answer is derived from a different context where JTV519 is explicitly described as a 1,4-benzothiazepine derivative. Despite referencing an external context, the explanation aligns with the gold supporting sentence in logical reasoning and directly supports the answer. The logic is clear and concise.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The provided context does not explicitly mention the chemical group (e.g., 1,4-benzothiazepine) to which JTV519 belongs. However, the answer **\"1,4-benzothiazepine\"** is derived from a **different context** (as shown in the initial example), where JTV519 is explicitly described as a **1,4-benzothiazepine derivative**. In the current context, there is **no supporting sentence** for this answer. \n\nIf the question and answer were based on the **previous example's context**, the supporting sentence would be:  \n*\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"*  \n\nHowever, in the **current context**, this information is **not present**.", "retries": 1}
{"idx": 149, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "intermediate filaments", "gold_support": "Keratins form the intermediate filaments of the cytoskeleton and provide scaffold structures within cells.", "model_answer": "Answer: Intermediate filaments", "model_support": "Supporting sentence: \"Keratins K8, K18, K19 and vimentin are intermediate filament proteins with altered expression profiles during tumour development.\"", "retries": 1}
{"idx": 150, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model does not directly mention BCR-ABL or provide clear reasoning for why BCR-ABL is the target of imatinib. Instead, it discusses the era of TKIs and imatinib's role in CML treatment, which is relevant but lacks specificity. The gold supporting sentence is more precise in linking the BCR-ABL transcript to CML. Thus, while correct, the model’s supporting sentence could be more focused.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "There followed definition of the breakpoint cluster region on chromosome 22 in 1984 and the demonstration of the BCR-ABL transcript in CML in 1985.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: The era of tyrosine kinase inhibitors (TKI) began in 1998 and today the use of the original TKI, imatinib, has replaced SCT as initial therapy for patients who present with CML in chronic phase.  \n\n**Note**: While the context does not explicitly name *BCR-ABL* as the target of imatinib, the historical context of the Philadelphia chromosome (linked to the *BCR-ABL* fusion gene) and the role of tyrosine kinase inhibitors (TKIs) in treating CML are implied. The direct identification of *BCR-ABL* as the target requires prior knowledge, as it is not explicitly stated in the provided text.", "retries": 1}
{"idx": 151, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX'). The supporting sentence is relevant and covers the answer, but it is slightly indirect and requires additional context to fully explain why SEA0400's effects imply NCX inhibition. While logical, it could be more explicit and concise, as the gold supporting sentence directly links SEA0400 to NCX inhibition without requiring inference.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400.  \n(Implied context: The \"effects\" (Ca²⁺ influx, ROS production, cytotoxicity) are linked to NCX activity, as the study explicitly connects NCX to NO-induced apoptosis. SEA0400's ability to block these effects suggests it inhibits the NCX pathway.)", "retries": 1}
{"idx": 152, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about Xist and its function, but it is slightly more focused on the inefficiency of autosomal silencing rather than directly stating its role in X-chromosome inactivation. This introduces a minor degree of redundancy, though the logic connecting Xist to X-inactivation is still present.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X inactivation in female mammals involves transcriptional silencing of an entire chromosome in response to a cis-acting noncoding RNA, the X inactive-specific transcript (Xist).", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: Xist can also inactivate autosomal sequences, for example, in X;autosome translocations; but here, silencing appears to be relatively inefficient.", "retries": 1}
{"idx": 153, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details in the explanation are acceptable as they enhance clarity without being excessive.\", \"match\": true}", "gold_answer": "p53", "gold_support": "For this reason it is called 'the guardian of the genome' and is considered one of the most important players in the development of cancer.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The classical functions of p53 protein are those related to its role on DNA damage, cell growth arrest, senescence and apoptosis.  \n\nThis sentence highlights p53's well-established role in DNA repair and preventing genomic instability, which is why it is famously referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 154, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect as it states there is no supporting sentence in the context, while the gold supporting sentence is indeed present and directly relevant to the answer. The correct supporting sentence from the context provides clear evidence for 'tofacitinib' being a JAK inhibitor used in rheumatoid arthritis treatment. Thus, the model's answer is correct but its claim about the lack of supporting evidence is inaccurate.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "In patients treated with the JAK inhibitor tofacitinib, RR for hypercholesterolaemia was 1.70 (1.10 to 2.63) that was dose related.", "model_answer": "Answer: Tofacitinib", "model_support": "The context provided does not explicitly mention **Tofacitinib** or any specific JAK inhibitor approved for rheumatoid arthritis. The text discusses the **safety profile of protein kinase inhibitors (PKi)** in RA, including JAK inhibitors, but does not name individual drugs or their approval status. Therefore, **no supporting sentence exists in the given context** to justify the answer \"Tofacitinib.\" The answer relies on external knowledge rather than the provided text.", "retries": 1}
{"idx": 155, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 156, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Serotonin 5-HT2A receptors,' matches the gold standard '5-HT2A' in meaning, though it is slightly more verbose. The supporting sentence provided by the model is relevant and supports the answer, but it contains some redundancy and does not directly quote the most concise evidence from the context. It could be more focused on the correlation between [18F]altanserin binding and 5-HT2A receptors as stated in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "The regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: \"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 157, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2a'). The supporting sentence is concise, directly relevant, and logically covers the interaction between [18F]altanserin and 5-HT2a receptors in the orbitofrontal cortex. It effectively supports the answer without unnecessary verbosity or irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "5-HT2a", "gold_support": "Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.", "model_answer": "Answer: 5-HT2a receptors", "model_support": "Supporting sentence: \"A higher BP(nd) for [(18)F]altanserin during WM versus control was found in the orbitofrontal cortex (OFC) pointing towards an increased [(18)F]altanserin/5-HT2aR interaction in OFC...\"", "retries": 1}
{"idx": 158, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning JAK1/JAK3 inhibition which is not necessary to answer the question directly. The logic is strong, but it could be more concise.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "OBJECTIVE: Tofacitinib, which is a Janus kinase (JAK) inhibitor, has shown clinical effects in the treatment of rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"Tofacitinib, a JAK1/JAK3 inhibitor, affected the activities of human DCs.\"  \n\n**Note:** While the context does not explicitly state that tofacitinib is *approved* for rheumatoid arthritis, it identifies tofacitinib as a JAK inhibitor, which aligns with external knowledge that tofacitinib (Xeljanz) is a JAK inhibitor approved for rheumatoid arthritis. However, the direct evidence in the provided context is the classification of tofacitinib as a JAK inhibitor.", "retries": 1}
{"idx": 159, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by discussing TCR's role in repairing transcribed strands, but it includes slight redundancy by mentioning Cockayne syndrome gene products without directly referencing the 'transcribed strand of active genes,' which would have made it more precise.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 160, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "PURPOSE: The phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin (mTOR) pathway is involved in the development of tumor resistance to endocrine therapy in breast cancer cell lines and represents an attractive target for pharmacologic intervention.", "model_answer": "Answer: mTOR (molecular target of rapamycin)", "model_support": "Supporting sentence: Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.", "retries": 1}
{"idx": 161, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (ZFHX1B/SALL1) does not match the gold standard (ZEB2). However, the gene mentioned by the model is related to other genetic disorders, making it somewhat relevant but incorrect for this specific syndrome. The supporting sentence acknowledges that the context does not provide the gene name and explains that external knowledge was used, which aligns with the instructions. However, since the answer itself is wrong, the score reflects that the response fails to meet the gold standard while still demonstrating some understanding of genetic diseases.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene rarely diagnosed prenatally and with little fetal description reported.", "model_answer": "Answer: The gene responsible for the development of Mowat-Wilson syndrome is the ZFHX1B (also known as SALL1) gene.", "model_support": "The context does not explicitly mention the gene responsible for Mowat-Wilson syndrome (ZFHX1B/SALL1). Therefore, **no supporting sentence** from the provided context directly answers the question about the causative gene. The answer relies on external biomedical knowledge rather than the text provided. \n\nHowever, if the question assumes the answer is derived from the context, it would be incorrect, as the context only describes clinical features and diagnostic methods (e.g., genetic testing guided by phenotypic findings) but does not name the specific gene.", "retries": 1}
{"idx": 162, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but more specific than required ('hypothyroidism' vs. 'thyroid'). The supporting sentence is somewhat detailed and includes numerical values that, while accurate, are not strictly necessary to support the answer. It mixes biochemical details with the core concept of thyroid abnormality, making it less concise but still logically relevant.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Hypothyroidism, characterized by raised TSH and low free T4 levels.", "model_support": "Supporting sentence: Thyroid function tests showed a raised TSH (42 mIU/l; normal range 0.5-4 mIU/l) with a low FT(4) concentration (10.21 pmol/l; normal range: 10.29-24.45 pmol/l).", "retries": 1}
{"idx": 163, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions thyroid dysfunction, which is related to the gold answer 'thyroid,' but it does not explicitly focus on hormone abnormalities as requested by the question. The supporting sentence discusses the lack of explicit information in the context regarding hormone abnormalities, which is accurate but does not directly support the gold answer. While the answer is present in the broader understanding of Pendred syndrome, the supporting sentence fails to cover the gold answer appropriately.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by congenital deafness and thyroid goiter.", "model_answer": "Answer: Pendred syndrome is characterized by sensorineural hearing loss and goiter, often with thyroid dysfunction.", "model_support": "The provided context does not explicitly mention hormone abnormalities characteristic of Pendred syndrome. The text focuses on the molecular and cellular role of pendrin (encoded by the *PDS* gene) in iodide transport in the thyroid, its regulation by thyroglobulin, and findings in Graves' disease. It does not discuss clinical features such as sensorineural hearing loss, goiter, or thyroid dysfunction, which are typically associated with Pendred syndrome but are not addressed in the given context. Thus, **no sentence in the context supports the answer** about hormone abnormalities in Pendred syndrome.", "retries": 1}
{"idx": 164, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is less direct compared to the gold supporting sentence. While the chosen sentence ('X inactivation... relative to XY males') provides relevant context about X inactivation, it does not explicitly mention *Xist* as the responsible transcript. The additional note supplied acknowledges this and points out a more specific sentence that directly references *Xist*, which aligns better with the gold supporting sentence. Despite this, the logical connection between the model's supporting sentence and the answer is still clear, though slightly indirect.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "In eutherian mammals X inactivation is regulated by the X-inactive specific transcript (Xist), a cis-acting non-coding RNA that triggers silencing of the chromosome from which it is transcribed.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"X inactivation, the transcriptional silencing of one of the two X chromosomes in female mammals, achieves dosage compensation of X-linked genes relative to XY males.\" \n\n**Note:** While the sentence does not explicitly name *Xist*, the context heavily implies *Xist* as the transcript responsible for X inactivation through its discussion of the *Xist* locus and evolutionary relationships. However, a more direct reference is:  \n\"the interval defined by the Chic1 and Slc16a2 genes that in eutherians flank the Xist locus.\"  \n\nThis sentence explicitly links *Xist* to the X chromosome region studied, which is central to X inactivation mechanisms.", "retries": 1}
{"idx": 165, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions 'TAp73 isoforms' in the plural, which aligns with the idea of multiple isoforms; however, it does not explicitly state the number 7 or provide sufficient clarity to support the gold answer. The logic connecting the supporting sentence to the gold answer is weak because the sentence focuses on promoters rather than enumerating isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.\"  \n\nThis sentence explicitly mentions \"TAp73 isoforms\" in the plural, but the answer \"1\" may refer to the fact that the context discusses TAp73 as a single isoform (not multiple distinct variants) regulated by the P1 promoter, while ΔΝp73 is another isoform regulated by the P2 promoter. However, the phrasing \"TAp73 isoforms\" (plural) in the context contradicts the answer \"1,\" suggesting a possible ambiguity in the question or answer. If forced to align with the answer, the sentence above is the only one mentioning TAp73 isoforms.", "retries": 1}
{"idx": 166, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard but is present in context only through external knowledge; the supporting sentence discusses diltiazem, which is irrelevant to JTV519's classification as a 1,4-benzothiazepine derivative.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Note:** While the context explicitly identifies diltiazem as a 1,5-benzothiazepine derivative, it does **not** directly state JTV519's chemical group. However, based on prior biomedical knowledge (as implied by the example provided earlier), JTV519 is a **1,4-benzothiazepine** derivative. The current context may lack this detail, but the answer aligns with established literature.", "retries": 1}
{"idx": 167, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy. The model's supporting sentence mentions the regulation of Xist without directly stating its role as a switch in X chromosome inactivation, which makes it less concise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "The X-inactive-specific transcript (Xist) locus is a cis-acting switch that regulates X chromosome inactivation in mammals.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"Over recent years an important goal has been to understand how Xist is regulated at the initiation of X inactivation.\"", "retries": 1}
{"idx": 168, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'XK gene' matches the gold standard 'XK' exactly. The supporting sentence, although noting that the context does not explicitly mention the XK gene, correctly references external knowledge that aligns with the gold supporting sentence. It acknowledges the factual correctness of the answer while explaining why the context alone is insufficient, which demonstrates precise reasoning.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod Syndrome, one of the core neuroacanthocytosis syndromes, is a rare X-linked disorder caused by mutations of the XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic abnormalities and late-onset neurological and muscular defects.", "model_answer": "Answer: XK gene", "model_support": "The context provided does not explicitly mention the **XK gene** or any specific genetic mutation associated with McLeod syndrome. The text only states that McLeod syndrome is \"linked to the X chromosome\" and describes clinical features (e.g., neuroacanthocytosis, psychiatric symptoms) and diagnostic challenges. The answer **\"XK gene\"** is factually correct based on external knowledge (McLeod syndrome is caused by mutations in the **XK gene**), but **no supporting sentence is present in the given context**. \n\nIf the question were based solely on the provided context, the answer could not be determined from the text. However, the user's answer assumes prior knowledge of the XK gene's association with McLeod syndrome.", "retries": 1}
{"idx": 169, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('0') but is present in the context as the context indeed lacks specific information about off-label drug trials in neonates. However, the supporting sentence repeats the answer rather than providing relevant reasoning or extracting a relevant part of the context that aligns with the gold supporting sentence. While the conclusion drawn by the model is correct, it fails to utilize the provided context effectively.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "Answer: The context does not provide information on the number of clinical trials for off-label drugs in neonates cited in the literature.", "model_support": "Supporting sentence: The context does not provide information on the number of clinical trials for off-label drugs in neonates cited in the literature.  \n**Analysis**: The context discusses Paediatric Investigation Plans (PIPs) submitted to regulatory agencies but does not mention clinical trials, off-label drugs, or neonates specifically. Therefore, no sentence in the context supports an answer to the question.", "retries": 1}
{"idx": 170, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Stroke recognition in adults,' does not match the gold standard 'Stroke' but is related to the context. The supporting sentence is relevant as it mentions stroke recognition tools improving diagnostic accuracy in adults, but it does not directly cover the gold answer or provide clear support for the ROSIER scale being specifically used for stroke. Therefore, the answer and supporting sentence are somewhat relevant but lack precision and clarity.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "Two adult stroke recognition tools; ROSIER (Recognition of Stroke in the Emergency Room) and FAST (Face Arm Speech Test) scales were applied retrospectively to all patients to determine test sensitivity.", "model_answer": "Answer: Stroke recognition in adults.", "model_support": "Supporting sentence: \"Stroke recognition tools have been shown to improve diagnostic accuracy in adults.\"", "retries": 1}
{"idx": 171, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('GBA gene') is correct but does not exactly match the gold standard ('Glucocerebrosidase'). The supporting sentence explains that the context does not provide explicit support for the answer, which is accurate. However, the lack of a relevant supporting sentence from the text means the model fails to logically connect its answer to the provided context. While the answer is valid based on external knowledge, it does not align with the scoring criteria prioritizing alignment with the gold standard and contextual support.\", \"match\": false}", "gold_answer": "Glucocerebrosidase", "gold_support": "SHORT INTRODUCTION: Gaucher's disease (GD) is an autosomal recessive disease produced by mutations of the Glucocerebrosidase gene.", "model_answer": "Answer: The gene mutated in Gaucher disease is the GBA gene, which encodes the enzyme glucocerebrosidase.", "model_support": "The context provided does not explicitly mention the specific gene (GBA) mutated in Gaucher disease. The text discusses epidemiological findings related to co-morbidities in Gaucher patients and carriers but does not reference the genetic basis of the disease. Therefore, **no sentence in the context supports the answer** about the GBA gene. The answer relies on external biomedical knowledge rather than the provided text.", "retries": 1}
{"idx": 172, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence appropriately introduces Dnmt1 in the context of the study, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "The DNA methyltransferase Dnmt1 is responsible for the propagation of methylation patterns to the next generation via its preferential methylation of hemimethylated CpG sites in the genome; however, how Dnmt1 maintains methylation patterns is not fully understood.", "model_answer": "Answer: DNA methyltransferase 1 (Dnmt1)", "model_support": "Supporting sentence: \"Here we report the crystal structure of the large fragment (291-1620) of mouse DNA methyltransferase 1 (Dnmt1)...\"", "retries": 1}
{"idx": 173, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'HSPA8/HSC70,' does not match the gold standard 'LAMP2A.' While HSPA8/HSC70 is mentioned in the context as a chaperone recognizing CMA substrates, it is not the receptor for these substrates. The supporting sentence correctly describes the role of HSPA8/HSC70 but does not cover the gold answer, LAMP2A, which is the actual receptor protein that binds the substrates at the lysosomal membrane.\", \"match\": false}", "gold_answer": "LAMP2A", "gold_support": "Once there, substrate proteins bind to the lysosome-associated membrane protein type 2 isoform A (LAMP2A), inducing assembly of this receptor protein into a higher molecular weight protein complex that is used by the substrate proteins to reach the lysosomal lumen.", "model_answer": "Answer: HSPA8/HSC70", "model_support": "Supporting sentence: \"CMA substrates are cytosolic proteins bearing a pentapeptide motif in their sequence that, when recognized by the cytosolic chaperone HSPA8/HSC70, targets them to the surface of the lysosomes.\"", "retries": 1}
{"idx": 174, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' in meaning, as 'acute stroke' is a specific and accurate descriptor within the context of the ROSIER scale. The supporting sentence is concise, directly relevant, and logically supports the answer by highlighting the effectiveness of the ROSIER scale in differentiating acute stroke in the emergency room.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 175, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 176, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by discussing the protective effects of SEA0400 in relation to NCX-mediated Ca(2+) influx. However, it contains slight redundancy by elaborating on downstream effects (ERK phosphorylation and lipid peroxidation), which are not necessary to directly support the answer. The gold supporting sentence is more concise and directly states the role of SEA0400 as an inhibitor of the Na+/Ca2+ exchanger.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These findings suggest that SEA0400 protects against MPTP-induced neurotoxicity probably by blocking ERK phosphorylation and lipid peroxidation which are downstream of NCX-mediated Ca(2+) influx.  \n\n**Note**: While the context does not explicitly state that SEA0400 directly inhibits the Na(+)/Ca(2+) exchanger (NCX), the protective effects of SEA0400 are described as being \"downstream of NCX-mediated Ca(2+) influx,\" implying a functional relationship with NCX activity. However, the direct inhibition of NCX by SEA0400 is not explicitly confirmed in the text. The answer provided may rely on indirect inference from the context.", "retries": 1}
{"idx": 177, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it focuses on a specific step in the biosynthesis process rather than directly stating that medicarpin is the major phytoalexin in alfalfa. This introduces slight redundancy and shifts emphasis from the central fact, making it less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: One of the final steps of medicarpin biosynthesis, from vestitone to 7,2'-dihydroxy-4'-methoxyisoflavanol, is catalyzed by vestitone reductase.  \n\nThis sentence explicitly identifies **medicarpin** as the product of the biosynthetic pathway involving vestitone reductase, directly linking the enzyme's function to the synthesis of medicarpin.", "retries": 1}
{"idx": 178, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context as it correctly identifies Pendred syndrome's association with goiter and impaired thyroid function. However, the supporting sentence provided by the model is incorrect because it states that no sentence in the context supports the answer, whereas the gold supporting sentence demonstrates that relevant information (e.g., defective iodide organification and goiter) is indeed present in the context. The supporting sentence should have highlighted the thyroid-related abnormalities instead of dismissing the context entirely.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "The discovery of mutations in the SLC26A4 gene in patients with Pendred syndrome (congenital deafness, goiter, and defective iodide organification) suggested a possible role for the encoded protein, pendrin, as an apical iodide transporter.", "model_answer": "Answer: Pendred syndrome is characterized by congenital sensorineural hearing loss and goiter, often with impaired thyroid function due to defects in the SLC26A4 gene, which encodes pendrin.", "model_support": "The context does not mention Pendred syndrome, its associated hormone abnormalities (e.g., congenital sensorineural hearing loss, goiter, or SLC26A4 gene defects), or any direct connection between pendrin dysfunction and these clinical features. The provided answer relies on external knowledge, not the information in the given context. Therefore, **no sentence in the context supports the answer** to the question about Pendred syndrome.", "retries": 1}
{"idx": 179, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Two' does not match the gold standard '7', but the context does mention 'transactivating p73 isoforms (TAp73),' which implies multiple forms. The supporting sentence is relevant but fails to cover the correct number of isoforms and is overly focused on justifying the incorrect answer rather than providing concise support for what the text actually states.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "The context does not explicitly mention the number of TAp73 isoforms identified in humans. The provided text refers to \"transactivating p73 isoforms (TAp73)\" but does not specify how many isoforms exist. Therefore, the answer \"Two\" is not directly supported by the given context. The context only discusses TAp73 as a single entity without quantifying its isoforms. \n\n**Supporting sentence:** \"increased expression of transactivating p73 isoforms (TAp73).\"  \n(Note: While this sentence introduces the term \"isoforms,\" it does not specify the number, making the answer \"Two\" unsupported by the provided text.)", "retries": 1}
{"idx": 180, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The supporting sentence references two isoforms (TAp73β and TAp73α), but this is insufficient to cover the gold answer of seven isoforms. While the context provided mentions interactions with p53 isoforms, it does not explicitly state the total number of TAp73 isoforms, leading to an incorrect conclusion.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 2", "model_support": "Supporting sentence: \"co-immunoprecipitation assays show that all six p53 isoforms examined can form complexes with TAp73β, whereas only Δ133p53α/β/γ isoforms form complex with TAp73α.\"  \nThis sentence explicitly references **TAp73β** and **TAp73α**, indicating two distinct TAp73 isoforms.", "retries": 1}
{"idx": 181, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's answer is correct and aligns with the gold answer ('Aryl hydrocarbon receptor interacting protein'). The supporting sentence provides accurate context about AIP-mutated FIPA patients but includes additional details (e.g., 'range from a complete lack of symptoms...') that are not strictly necessary to support the answer, making it slightly verbose compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP (aryl hydrocarbon receptor-interacting protein) gene.", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", "retries": 1}
{"idx": 182, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('AUS') but is present in the context as an alternative treatment. The supporting sentence is relevant and mentions BAUS, but it does not cover or compare with the gold answer ('AUS'), which weakens its logical connection to the correct treatment.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "Answer: Bone-anchor sub-urethral sling (BAUS) implantation.", "model_support": "Supporting sentence: CONCLUSIONS: BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD.", "retries": 1}
{"idx": 183, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('alpha-synuclein'), but the supporting sentence provided by the model is incorrect as it states there is no support in the context for the answer. In fact, the context does provide a relevant and concise sentence that directly supports the gold answer. The model failed to identify this support accurately.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "LBD has neuropathological characteristics whereby numerous Lewy bodies are present in the central and sympathetic nervous systems, and it is a type of alpha-synucleinopathy because the main component of Lewy body is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein protein.", "model_support": "The answer \"Alpha-synuclein protein\" is **not supported** by the provided context. The context discusses the classification and historical terminology of Lewy body disease (LBD) but does **not mention** the biochemical composition of Lewy bodies (e.g., alpha-synuclein). No sentence in the context addresses the main component of Lewy bodies.", "retries": 1}
{"idx": 184, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking CENP-A to centromere-specific proteins, but it is slightly indirect and contains additional details (e.g., listing specific proteins) that are not necessary for answering the question. The gold supporting sentence is more concise and directly states CENP-A's localization to centromeres.\",\n  \"match\": true\n}", "gold_answer": "centromeres", "gold_support": "CENP-A is an essential histone H3-like protein that localizes to the centromeric region of eukaryotic chromosomes.", "model_answer": "Answer: Centromeres.", "model_support": "Supporting sentence: Cenpag/g embryos assemble functional kinetochores that bind to a host of centromere-specific structural and mitotic spindle checkpoint proteins (Cenpc, BubR1, Mad2 and Zw10).  \n**Analysis**: The sentence directly links Cenpa (CENPA) to centromere-specific proteins (Cenpc, BubR1, Mad2, Zw10), which are localized to centromeres. This implies CENPA's preferential localization at centromeres.", "retries": 1}
{"idx": 185, "gptscore_json": "{\"score\": 2, \"reason\": \"Answer matches the gold standard but the supporting sentence is incorrect. The model incorrectly states that there is no supporting sentence in the context, while the context explicitly mentions '1,4-benzothiazepine derivative, JTV-519,' which directly supports the answer.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not include information about the chemical group of JTV-519 (e.g., 1,4-benzothiazepine). The question and answer (\"1,4-benzothiazepine\") are based on prior context, but **no sentence in the current context supports this answer**.", "retries": 1}
{"idx": 186, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly state the connection between BCR-ABL and imatinib, this is correct as the context lacks a clear supporting sentence. The gold supporting sentence is concise and directly ties BCR-ABL to CML and the Philadelphia chromosome, which aligns with the required knowledge for the answer. Therefore, despite the model's observation about the lack of explicit support in the text, its answer is accurate.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia).", "model_answer": "Answer: BCR-ABL", "model_support": "The context provided does not explicitly mention the **BCR-ABL** tyrosine kinase or its association with imatinib (Gleevec). The question requires prior biomedical knowledge (BCR-ABL is the well-established target of imatinib in Philadelphia chromosome-positive CML), but **no sentence in the given context supports this answer**. \n\nHowever, if forced to infer based on the context's mention of imatinib and CML, the answer would rely on external knowledge rather than the provided text. Thus, **no supporting sentence exists in the context** for the answer \"BCR-ABL.\"", "retries": 1}
{"idx": 187, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in meaning, though it is slightly more verbose. The supporting sentence refers to a factor Xa decoy but does not directly state that betrixaban inhibits factor Xa, which makes it somewhat indirect and less concise than ideal. It mixes relevant content with additional details about a reversal agent, which is not necessary for supporting the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"", "retries": 1}
{"idx": 188, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'GBA' is correct and matches the gold standard indirectly, as GBA is the gene for glucocerebrosidase. However, the gold answer specifies the full name 'glucocerebrosidase,' which is more precise. The supporting sentence is relevant but contains slight redundancy by mentioning details about probes and controls that are not essential to directly support the answer. Overall, it provides logical support but could be more concise.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "The glucocerebrosidase gene (GBA), located in a gene-rich region on chromosome 1q 21, is mutated in Gaucher disease.", "model_answer": "Answer: GBA", "model_support": "Supporting sentence: \"Genomic DNA from 20 patients with recombinant GBA alleles and five controls was evaluated to identify DNA rearrangements or copy number variation using six probes specific for either the GBA gene or pseudogene.\"", "retries": 1}
{"idx": 189, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "PURPOSE: The tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib are effective in non-small cell lung cancers (NSCLCs) with epidermal growth factor receptor (EGFR) gene mutations.", "model_answer": "Answer: EGFR", "model_support": "Supporting sentence: Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.  \n\n**Analysis**: The context explicitly links the efficacy of erlotinib and gefitinib to **EGFR mutations** in non-small cell lung cancer (NSCLC), as both drugs are EGFR tyrosine kinase inhibitors (TKIs) targeting this gene. The sentence directly states the relevance of EGFR mutations to the therapeutic use of erlotinib, confirming the gene as the determinant of response.", "retries": 1}
{"idx": 190, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and contains information about alpha-synuclein immunoreactivity, but it is less comprehensive compared to the gold supporting sentence. The chosen sentence focuses on a specific observation ('rare neuronal soma'), while the gold sentence provides a broader and more direct explanation of alpha-synuclein's role in Lewy bodies.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein.\"", "retries": 1}
{"idx": 191, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly verbose and does not directly mention that Dnmt1 is a maintenance methyltransferase responsible for DNA (cytosine-5-)-methylation. Instead, it provides broader context about the study without focusing on the specific role of Dnmt1 in methylation maintenance.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "In the absence of a human pituitary tumor cell line, small interfering RNA-mediated knockdown of the maintenance methyltransferase DNA methyltransferase (cytosine 5)-1 (Dnmt1) was used in the murine pituitary adenoma cell line AtT-20.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: \"Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.\"  \n**Analysis**: The context explicitly refers to \"Dnmt1 knockdown,\" indicating that Dnmt1 (DNA methyltransferase 1) is the enzyme involved in maintaining DNA (cytosine-5-)-methylation, as its reduction leads to changes in methylation patterns and gene expression.", "retries": 1}
{"idx": 192, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Regulatory functions,' does not match the gold standard 'development.' However, the answer is present in the context as conserved noncoding elements are indeed associated with regulatory roles. The supporting sentence is relevant but overly general and does not specifically cover the gold answer ('development'), which is a more precise aspect of the role of UCEs.\",\n  \"match\": false\n}", "gold_answer": "development", "gold_support": "The majority of tetrapod-specific UCEs are noncoding and associated with genes involved in regulation of transcription and development.", "model_answer": "Answer: Regulatory functions.", "model_support": "Supporting sentence: \"Mammalian genomes contain millions of highly conserved noncoding sequences, many of which are regulatory.\"", "retries": 1}
{"idx": 193, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is synonymous with '5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains the connection between [18F]altanserin and 5-HT2A receptors, aligning well with the gold supporting sentence. Minor differences in wording do not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 194, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('Na+/Ca²⁺ exchanger (NCX)' is a correct and equivalent phrasing of 'NCX'). The supporting sentence provided by the model is relevant and supports the answer, but it contains slight redundancy by mentioning the MEMRI technique and other details that are not necessary to directly support the answer. A more concise statement focusing solely on NCX inhibition by SEA0400 would have been ideal.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The sodium-calcium exchanger (NCX) is one of the transporters contributing to the control of intracellular calcium (Ca(2+)) concentration by normally mediating net Ca(2+) efflux.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: \"This study used the MEMRI technique to examine the temporal features of cardiac Mn(2+) efflux by implementing a T(1)-mapping method and inhibiting the NCX with SEA0400.\"", "retries": 1}
{"idx": 195, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct compared to the gold supporting sentence. The model's supporting sentence mentions the association of the McLeod phenotype with an XK missense mutation, which is correct but does not explicitly mention the exon 3 mutation (E327K) like the gold supporting sentence does. This makes it somewhat less precise but still logically sound.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"", "retries": 1}
{"idx": 196, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "The molecular target of rapamycin (mTOR), which is a member of the phosphoinositide 3-kinase related kinase (PIKK) family and a central modulator of cell growth, is a prime strategic target for anti-cancer therapeutic development.", "model_answer": "Answer: mTOR (molecular target of rapamycin)", "model_support": "Supporting sentence: The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.", "retries": 1}
{"idx": 197, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Non-small cell lung cancer (NSCLC),' is correct but too general and does not match the gold standard, which specifies 'EGFR-mutant NSCLC.' The supporting sentence mentions non-small cell lung cancer but does not cover the specific context of EGFR mutations, which are crucial to the gold answer. While relevant, it lacks precision and does not fully support the gold standard.\", \"match\": false}", "gold_answer": "EGFR-mutant NSCLC", "gold_support": "Reversible ATP-competitive inhibitors targeting the epidermal growth factor receptor (EGFR) have been established as the most effective treatment of patients with advanced non-small cell lung cancer (NSCLC) harboring \"activating\" mutations in exons 19 and 21 of the EGFR gene.", "model_answer": "Answer: Non-small cell lung cancer (NSCLC)", "model_support": "Supporting sentence: \"Clinical perspective of afatinib in non-small cell lung cancer.\"", "retries": 1}
{"idx": 198, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides experimental evidence about tofacitinib's efficacy in reducing inflammation and cytokine levels, which aligns with its role as a JAK inhibitor for RA treatment. However, the chosen sentence is slightly indirect compared to the gold supporting sentence, which explicitly identifies tofacitinib as a JAK inhibitor. This makes the model's sentence less concise but still logically supportive.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "The in vitro, ex vivo and in vivo effects of a JAK inhibitor CP-690,550 (tofacitinib) for the treatment of RA are reported.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"A treatment study was conducted in the severe combined immunodeficiency (SCID)-HuRAg mice, an RA animal model using SCID mice implanted with synovium and cartilage from patients. Tofacitinib reduced serum levels of human IL-6 and IL-8 in the mice and also reduced synovial inflammation and invasion into the implanted cartilage.\"  \n\n**Note**: While the context does not explicitly state that tofacitinib is *approved*, the experimental and clinical evidence (e.g., ACR20 response rates in patients and efficacy in preclinical models) supports its role as a JAK inhibitor investigated for RA treatment. The final sentence (\"Tofacitinib at 5 and 10 mg twice a day appears suitable for further evaluation to optimise the treatment of RA\") also indirectly implies its therapeutic relevance. However, the most direct evidence of its classification as a JAK inhibitor is in the first paragraph.  \n\n**Alternative supporting sentence**: \"In vitro experiments indicated that the effects of tofacitinib were mediated through suppression of interleukin 17 (IL-17) and interferon γ production and proliferation of CD4 T cells...\" (This highlights tofacitinib's mechanism as a JAK inhibitor, though the term \"JAK inhibitor\" is not explicitly used in the context).  \n\n**Clarification**: The context does not explicitly name tofacitinib as a *JAK inhibitor* but describes its effects consistent with JAK inhibition. The answer relies on external knowledge (tofacitinib is a known JAK inhibitor) and the experimental data provided.", "retries": 1}
{"idx": 199, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it includes 'Factor' which is not strictly necessary but still correct. The supporting sentence provides relevant information and logical reasoning by explaining the connection between betrixaban and Factor Xa inhibition through the mention of PRT4445 as a reversal agent for anti-Xa activity. However, it is slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis implies that betrixaban, like other anticoagulants with anti-Xa activity, inhibits Factor Xa, as PRT4445 is specifically designed to reverse anti-Xa drugs.", "retries": 1}
{"idx": 200, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence by specifying 'Thyroid hormone (TH) concentrations,' which is a more detailed but accurate response. The supporting sentence provides relevant information about MCT8 and its association with AHDS and thyroid hormone levels. However, it introduces additional details about mice lacking neurological defects, which are not necessary for directly supporting the answer, making it slightly redundant.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS) is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid hormone (TH) levels.", "model_answer": "Answer: Thyroid hormone (TH) concentrations.", "model_support": "Supporting sentence: Mutations in the TH transporter, monocarboxylate transporter 8 (MCT8), are associated with AHDS. MCT8 knock-out mice exhibit impaired TH levels; however, they lack neurological defects.", "retries": 1}
{"idx": 201, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by linking the HEXA gene to Tay-Sachs disease as stated in the context. Minor additional details are acceptable since they do not detract from the clarity or correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "HEXA", "gold_support": "We have identified three mutations in the beta-hexoseaminidase A (HEXA) gene in a juvenile Tay-Sachs disease (TSD) patient, which exhibited a reduced level of HEXA mRNA.", "model_answer": "Answer: HEXA", "model_support": "Supporting sentence: \"Two novel exonic point mutations in HEXA identified in a juvenile Tay-Sachs patient...\"  \nThis sentence explicitly links the *HEXA* gene to Tay-Sachs disease, confirming it as the gene most commonly mutated in this condition.", "retries": 1}
{"idx": 202, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, but the supporting sentence does not directly support the correct classification of JTV519 as a 1,4-benzothiazepine. Instead, it discusses diltiazem as a 1,5-benzothiazepine derivative, which is not relevant to the specific question about JTV519. The logic is weakened by the lack of direct evidence from the context for the stated answer, though the answer itself is correct.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: **\"The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.\"**  \n\n**Note:** While this sentence explicitly identifies *diltiazem* as a **1,5-benzothiazepine** derivative, the original question's answer (**1,4-benzothiazepine**) is not directly supported by the provided context. However, if the user assumes that JTV519 shares the same structural class as diltiazem (despite the numerical difference in the ring positions), this could be inferred indirectly. For a precise answer, the context must explicitly state JTV519's chemical classification, which is absent here.", "retries": 1}
{"idx": 203, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa' and 'Factor Xa' are equivalent in this context). However, the supporting sentence is relevant but includes information about PRT4445, which is not directly necessary to support the answer. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n(Implied: Betrixaban's mechanism involves anti-Xa activity, as PRT4445 is described as a factor Xa decoy for reversing anticoagulants with anti-Xa properties.)", "retries": 1}
{"idx": 204, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' is equivalent to 'Xa'). The supporting sentence explains that no information about betrixaban is present in the context, which aligns with the fact that the gold supporting sentence is not reflected in the provided text. The reasoning is strong and concise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention **betrixaban** or provide any information about its mechanism of action. Therefore, **no supporting sentence** exists in the provided text to answer the question about which clotting factor is inhibited by betrixaban. The answer \"Factor Xa\" cannot be validated based on the given context.", "retries": 1}
{"idx": 205, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('JNK'). However, the supporting sentence is somewhat redundant and verbose, stating that the context does not explicitly mention the MAP kinase while also explaining unrelated details about tylophorine. The gold supporting sentence is more concise and directly addresses the phosphorylation of c-Jun by JNK. Despite this, the model's supporting sentence still provides relevant reasoning.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "The context does not explicitly mention which MAP kinase phosphorylates c-Jun. The provided text focuses on tylophorine's effects on c-Jun protein accumulation, cyclin A2 regulation, and translational control via the PI3K_PDK1_eEF2 pathway, but it does not specify a MAP kinase (e.g., JNK, ERK, or p38) involved in c-Jun phosphorylation. The answer \"JNK\" likely relies on external biochemical knowledge rather than the given context. \n\n**Supporting sentence**: None of the sentences in the context directly address the phosphorylation of c-Jun by a MAP kinase.", "retries": 1}
{"idx": 206, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly provide a synonym for 'lubag disease.' However, the supporting sentence fails to cover the gold answer, as it discusses a newly recognized syndrome rather than directly addressing the relationship between 'lubag disease' and 'X-linked dystonia-parkinsonism.' The logic is somewhat relevant but misses the key point.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Three affected siblings were found to share an identical haplotype at the X-linked dystonia-parkinsonism locus (XDP; Lubag; OMIM*314250).", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The condition we describe could be a newly recognized dystonia syndrome with parkinsonism.  \n**Analysis**: The context does not mention \"lubag disease\" or any synonym for it. The term \"lubag disease\" is not referenced or equated with any other disease or syndrome in the provided text.", "retries": 1}
{"idx": 207, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Chiari-I malformation,' does not match the gold standard, 'craniosynostosis.' However, the supporting sentence is relevant to the context of Shprintzen-Goldberg syndrome and mentions specific features associated with the disease. Despite this, it does not cover the gold answer, which focuses on craniosynostosis as a defining characteristic. The mismatch in the answer and the lack of direct support for the gold answer result in a lower score.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Shprintzen-Goldberg syndrome is one of a group of disorders characterized by craniosynostosis and marfanoid habitus.", "model_answer": "Answer: Chiari-I malformation", "model_support": "Supporting sentence: \"an abnormality of the first and second cervical vertebrae, hydrocephalus, dilatation of the lateral ventricles, and a Chiari-I malformation of the brain were found only in the patients with Shprintzen-Goldberg syndrome.\"", "retries": 1}
{"idx": 208, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly more specific than necessary, focusing on arsenite rather than the general role of DUSP8 in JNK modulation. The logic is clear, but there's a minor redundancy in specifying 'arsenite,' which isn't critical to the core explanation.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "Dual-specificity phosphatases (DUSPs) play a very important role in these events by modulating the extent of JNK phosphorylation and activation and thus regulating cellular responses to stress.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite.", "retries": 1}
{"idx": 209, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context about flumazenil being a benzodiazepine antagonist, but it is slightly indirect and does not explicitly state its effectiveness or safety in treating benzodiazepine overdose, as the gold supporting sentence does. It contains minor redundancy by referencing the study design rather than focusing solely on the conclusion about flumazenil's role.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "We conclude that flumazenil is an effective and safe drug in the treatment of benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: \"In a double-blind placebo-controlled prospective clinical trial we studied the efficacy and safety of the benzodiazepine antagonist, flumazenil.\"", "retries": 1}
{"idx": 210, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer logically, but contains additional details about the drug's indications, making it slightly more verbose than necessary.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 211, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to TAp73 isoforms but fails to specify the correct number or provide evidence for the existence of seven isoforms. It focuses on functionality rather than enumeration, which leads to an incorrect conclusion.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"inducing the pro-apoptotic and anti-proliferative TAp73 isoforms and by repressing the anti-apoptotic and pro-proliferative DeltaNp73 isoforms.\"  \n(Note: While the sentence uses the plural \"isoforms,\" the answer assumes the context implies a single TAp73 isoform, possibly due to the focus on its functional role without specifying subtypes. However, this interpretation may require clarification, as the term \"isoforms\" typically denotes multiple variants.)", "retries": 1}
{"idx": 212, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'peroxidase enzyme,' does not match the gold standard 'antioxidant.' While peroxidase activity is related to its function, the context explicitly describes PRDX2 as an 'antioxidant enzyme,' which is the more accurate term in this case. The supporting sentence focuses on a specific experimental observation ('the ability to eliminate the exogenous H(2)O(2) was attenuated') rather than directly addressing the classification of PRDX2 as an antioxidant enzyme. Thus, although relevant, it fails to fully support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2) has been known to act as an antioxidant enzyme whose main function is H(2)O(2) reduction in cells.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is a peroxidase enzyme.", "model_support": "Supporting sentence: \"the ability to eliminate the exogenous H(2)O(2) was attenuated.\"  \n**Note**: While the context does not explicitly use the term \"peroxidase,\" the function of PRDX2 in eliminating hydrogen peroxide (a hallmark of peroxidase activity) implies its classification as a peroxidase enzyme. However, the context does not directly state this classification.", "retries": 1}
{"idx": 213, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Nuclear' matches the gold standard but the supporting sentence is incorrect. The model's supporting sentence claims that the context does not provide information about subcellular localization, which is false because the gold supporting sentence explicitly states that APOBEC3B is predominantly nuclear. Therefore, while the answer is correct, the reasoning provided is flawed.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "Answer: Nuclear.", "model_support": "The provided context does not explicitly state whether APOBEC3B is predominantly cytoplasmic or nuclear. The answer \"Nuclear\" is not directly supported by any sentence in the given text. The context focuses on APOBEC3B's enzymatic activity, mRNA expression, and mutagenic effects but does not mention its subcellular localization. Therefore, the answer cannot be validated based on the provided information.", "retries": 1}
{"idx": 214, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK gene' is equivalent to 'XK'). The supporting sentence is relevant and covers the answer, but it includes additional clinical details about the patient that are not strictly necessary for supporting the answer. This makes it slightly more verbose than the gold supporting sentence, which directly explains the association between McLeod syndrome and the XK gene mutation.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"A novel XK splice site mutation (IVS1-1G>A) has been identified in a McLeod patient who has developed hematologic, neuromuscular, and neurologic symptoms.\"", "retries": 1}
{"idx": 215, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, but it is slightly less direct compared to the gold supporting sentence. While it correctly points to the GPi being targeted, it does not explicitly state that BP-DBS of the GPi is effective for dystonia, which is a key part of the reasoning in the gold sentence. Thus, there is minor redundancy and less clarity.\",\n  \"match\": true\n}", "gold_answer": "globus pallidus internus", "gold_support": "Bilateral pallidal deep brain stimulation (BP-DBS) of the globus pallidus internus (GPi) is an effective treatment for primary dystonia, but the effect of this reversible surgical procedure on dystonia-choreoathetosis CP, which is a subtype of secondary dystonia, is unknown.", "model_answer": "Answer: Globus pallidus internus (GPi)", "model_support": "Supporting sentence: \"the accuracy of surgical targeting to the GPi was assessed masked to the results of neurostimulation.\"  \n(Additionally, the title explicitly mentions \"Bilateral pallidal deep brain stimulation,\" and the interpretation notes that \"the optimum placement of the leads seemed to be a crucial... factor,\" which aligns with targeting the GPi.)", "retries": 1}
{"idx": 216, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Matriptase,' does not match the gold standard, 'LEKTI.' However, 'Matriptase' is mentioned in the context as a contributing factor in the disease onset. The supporting sentence is relevant but focuses on matriptase's role rather than LEKTI's deficiency, which is the primary cause of Netherton syndrome according to the gold supporting sentence.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.", "model_answer": "Answer: Matriptase", "model_support": "Supporting sentence: Here we show that the membrane protease matriptase initiates Netherton syndrome in a LEKTI-deficient mouse model by premature activation of a pro-kallikrein cascade.", "retries": 1}
{"idx": 217, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly name Rac1 as essential for lamellipodia formation. However, the supporting sentence fails to cover the gold answer (Rac1) and instead dismisses the possibility of answering altogether. While relevant information about Rac1 is present in the context, the model does not extract or use it, leading to a lower score.\", \"match\": false}", "gold_answer": "Rac1", "gold_support": "We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination.", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The question cannot be answered based on the provided context.  \n**Reason:** The context discusses light-activated dimerization (LAD) using FKF1 and GIGANTEA (GI) proteins in *Arabidopsis thaliana* and their application in transcription factor engineering. It does **not mention** any G proteins (e.g., Rho, Rac, Cdc42) or lamellipodia formation, which are typically associated with actin regulation in mammalian cells. Thus, no relevant information is present to answer the question.", "retries": 1}
{"idx": 218, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and correct but contains some redundancy by mentioning that the context does not explicitly state the bacterium, which is unnecessary given the clear implication in the context. A more concise supporting sentence focusing on the mention of Clostridium botulinum in the provided context would have earned a full score.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "An epidemiological investigation and laboratory detection studies showed that sausage contaminated by type A Clostridium botulinum caused this outbreak of food poisoning.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly mention the bacterium responsible for botulism. However, based on general biomedical knowledge, the most known bacterium responsible for botulism (including sausage poisoning) is **Clostridium botulinum**. The context only describes an outbreak linked to contaminated sausage but does not provide the specific pathogen name. \n\n**Answer:** Clostridium botulinum  \n**Supporting sentence:** *None* (The context does not include the specific bacterium responsible for botulism).", "retries": 1}
{"idx": 219, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer does not match the gold standard ('iron') but is present in the context as a contributing factor. The supporting sentence is absent, and while iron deficiency is mentioned in the context as relevant to secondary RLS, the model does not utilize this information effectively. The lack of a supporting sentence further weakens the response.\", \"match\": false}", "gold_answer": "iron", "gold_support": "RLS may also be secondary to a number of conditions including iron deficiency, pregnancy and end-stage renal failure and, perhaps, neuropathy.", "model_answer": "Answer: Restless leg syndrome is not caused by a specific deficiency; it is a neurological disorder with genetic and environmental factors. However, iron deficiency can contribute to or exacerbate symptoms in some cases.", "model_support": "Supporting sentence: **None**.  \nThe provided context does not explicitly mention any specific deficiency (e.g., iron deficiency) as a cause of restless leg syndrome. The text states that RLS is a neurological disorder with genetic and environmental factors and emphasizes the importance of correcting underlying problems in secondary RLS, but it does not specify deficiencies as a cause. The answer incorporating \"iron deficiency\" relies on external knowledge, not the given context.", "retries": 1}
{"idx": 220, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX'), though it includes additional detail by specifying 'Na+/Ca²⁺ exchanger (NCX)', which is acceptable and aligns with the context. The supporting sentence is relevant but slightly more verbose than necessary, as it mentions patch clamp techniques and fluorescence measurements, which are not directly required to justify the answer. A more concise statement focusing solely on SEA0400's role as an NCX inhibitor would have been ideal.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: \"we examined the effect of SEA0400 on NCX currents and I/R induced intracellular Ca2+ overload in mouse ventricular myocytes using patch clamp techniques and fluorescence measurements.\"", "retries": 1}
{"idx": 221, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides logical reasoning by indicating that the ROSIER scale is used as a stroke recognition tool, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 222, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly provide the supporting sentence, this is accurate because the context indeed lacks an explicit statement about the mode of inheritance. The gold supporting sentence is derived from external knowledge rather than the provided context. Thus, the model's handling reflects precision and correctness.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context does not explicitly state the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD). While the genetic basis (a deletion of 3.3kb DNA repeats on chromosome 4q35) is described, the inheritance pattern (e.g., autosomal dominant) is not mentioned in the provided text. Thus, **no supporting sentence** from the context directly addresses the mode of inheritance. \n\n**Note:** The answer \"Autosomal dominant\" is a known clinical fact about FSHD but is not derived from the given context.", "retries": 1}
{"idx": 223, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the specificity of alpha-synuclein in identifying Lewy bodies, aligning well with the context and gold answer.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: \"alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles.\"", "retries": 1}
{"idx": 224, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard 'p53'. However, PTEN is mentioned in the context as a 'new guardian of the genome,' which makes it relevant but incorrect for this specific question. The supporting sentence provided by the model is relevant to its answer but does not cover the gold answer, as it focuses on PTEN instead of p53.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: Thus, we propose that PTEN is a new guardian of the genome.", "retries": 1}
{"idx": 225, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence appropriately references the context of pridopidine being tested in patients with Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 226, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less specific than the gold supporting sentence. It does not mention the exact detail of the missense mutation (E327K), which makes it less precise. However, it still supports the answer logically by linking the McLeod phenotype to a mutation in the XK gene.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"", "retries": 1}
{"idx": 227, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it states '1' when the gold answer is '7'. The supporting sentence does not logically support the gold answer, and instead highlights only one isoform (TAp73) out of the five N-terminal isoforms mentioned in the context. This makes the answer and supporting sentence irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR...\"  \nThis sentence explicitly lists **TAp73** as **one** of the five N-terminal p73 isoforms identified in the study.", "retries": 1}
{"idx": 228, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model correctly states that there is no relevant supporting information in the given context, which aligns with the fact that the context does not explicitly discuss the mode of inheritance despite containing the correct information elsewhere. This reflects an accurate and concise evaluation.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease is a rare genetic disorder of copper metabolism with autosomal recessive inheritance.", "model_answer": "Answer: Autosomal recessive", "model_support": "The context provided does not mention or imply the mode of inheritance of Wilson's disease. Therefore, **there is no supporting sentence** in the context for the answer \"Autosomal recessive.\" The context focuses on breast milk composition, treatment, and clinical management, but does not discuss genetic inheritance patterns.", "retries": 1}
{"idx": 229, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about gevokizumab's interaction with IL-1β, though it includes extra details not strictly necessary to support the answer, making it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"gevokizumab occupies an allosteric site on IL-1β and complex formation results in a minor reduction of binding affinity to IL-1RI.\"", "retries": 1}
{"idx": 230, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides genetic evidence that supports autosomal dominant inheritance by mentioning familial segregation of the mutation. However, it is slightly verbose and contains extra details about the specific mutation and linkage, which are not strictly necessary to justify the answer. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "Supporting sentence: \"multiple families, predominantly of German descent and with clinically variable presentation that included proximal myotonic myopathy (PROMM) and type 2 DM (DM2) but without the DM1 mutation, showed linkage to the 3q21 region and were recently shown to segregate a (CCTG)n expansion mutation in intron 1 of ZNF9.\"  \n\n**Analysis**: The mention of \"families\" and \"segregate\" implies the mutation is passed down through generations, a hallmark of autosomal dominant inheritance. While the context does not explicitly state \"autosomal dominant,\" the genetic segregation of the mutation in families supports this conclusion.", "retries": 1}
{"idx": 231, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation. \n\n**Note**: While the context does not explicitly mention *betrixaban* by name, it discusses the class of **direct factor Xa inhibitors** (which includes betrixaban) and their mechanism of action. The answer \"Factor Xa\" is inferred from the general description of the drug class in the context.", "retries": 1}
{"idx": 232, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard ('antiparallel'). The supporting sentence acknowledges that the context does not explicitly provide the answer but fails to identify the correct information present in the gold supporting sentence. Instead of leveraging the text where 'antiparallel chains' is explicitly mentioned, the model relies on external assumptions without addressing the provided context properly. This results in an irrelevant answer and lack of logical support.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Mapping the stress-dependent labeling kinetics of α- and β-spectrin by LC-MS/MS identifies Cys in these antiparallel chains that are either force-enhanced or force-independent in labeling, with structural analyses indicating the force-enhanced sites are sequestered either in spectrin's triple-helical domains or in interactions with actin or ankyrin.", "model_answer": "Answer: Parallel", "model_support": "The context does not explicitly mention whether alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers. The provided text focuses on the structural changes in the spectrin-actin membrane skeleton under shear stress and does not discuss the orientation (parallel/antiparallel) of spectrin subunits. Therefore, **no supporting sentence** from the context directly addresses this question. The answer (\"Parallel\") likely relies on external biochemical knowledge rather than the given text.", "retries": 1}
{"idx": 233, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (Nf1 is the gene symbol for neurofibromatosis type 1, equivalent to NF1); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about strain-specific effects are acceptable as they do not detract from the core relevance.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas.", "model_answer": "Answer: Nf1", "model_support": "Supporting sentence: Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.  \n\n**Note:** While the context does not explicitly name \"type 1 neurofibromatosis,\" the gene **Nf1** (Neurofibromin 1) is well-established in biomedical literature as the causative gene for neurofibromatosis type 1 (NF1). The sentence above introduces **Nf1** as part of the genetic mutation in the mouse model, which aligns with the answer.", "retries": 1}
{"idx": 234, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical link to DNMT1's involvement in DNA-related processes, although it focuses more on its recruitment to double-strand breaks rather than explicitly stating its role as the maintenance methyltransferase. This results in slight redundancy but still supports the answer reasonably well.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We and others have shown that DNA methyltransferase 1 (DNMT1), the maintenance methyltransferase, contributes to the cellular response to DNA damage, yet DNMT1's exact role in this process remains unclear.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery.  \n\n**Note:** While the context primarily discusses DNMT1's role in DNA damage response rather than its direct involvement in DNA methylation maintenance, the question assumes DNMT1 as the answer based on general knowledge. The context does not explicitly state that DNMT1 is the enzyme responsible for DNA (cytosine-5-)-methylation maintenance, but the first sentence introduces DNMT1 as a key player in DNA-related processes, which may be interpreted as the intended support.", "retries": 1}
{"idx": 235, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Serotonin 5-HT2A receptors' is correct and matches the gold standard '5-HT2A', though it is slightly more verbose. The supporting sentence is relevant and supports the answer by mentioning the development of [18F]altanserin as a radiotracer for PET studies of the serotonin 5-HT2A receptor, but it includes additional details about test-retest variability that are not strictly necessary to justify the answer. This makes it somewhat redundant compared to the gold supporting sentence, which directly ties [18F]altanserin binding to 5-HT2A receptors.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: \"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 236, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and mentions p53 in the context of tumor suppression, but it includes additional information about TA-p73 and p63, which introduces slight redundancy. While the logic is sound, the sentence could be more concise to directly support the specific role of p53 as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors. \n\n**Note**: While the context does not explicitly use the term \"guardian of the genome,\" the phrase is a well-established scientific description of p53's role, which is implicitly referenced here by its classification as a tumor suppressor. The sentence above introduces p53 as a key tumor suppressor, aligning with the broader biological context of its nickname.", "retries": 1}
{"idx": 237, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning additional effects of L-DOPA/benserazide (e.g., increased locomotion, improved parkinsonism, induced dyskinesias) that are not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "L-DOPA", "gold_support": "They were injected subcutaneously (s.c.) with L-DOPA methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-DOPA/benserazide) alone or in combination with (-)-OSU6162 (1.0, 3.0, 6.0 or 10 mg/kg, s.c.).", "model_answer": "Answer: L-DOPA", "model_support": "Supporting sentence: \"L-DOPA/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\"", "retries": 1}
{"idx": 238, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence implies the correct context by referring to the phytoalexin release, which aligns with the findings on medicarpin in the text, but it does not directly state the rapid accumulation of medicarpin as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"suggesting that the phytoalexin could be released from a preformed conjugate under these conditions.\"  \n\n(Note: While the sentence does not explicitly name \"medicarpin\" as the phytoalexin, the preceding context establishes that medicarpin is the compound being discussed in relation to the phytoalexin release. The direct link is implied through the experimental findings about medicarpin's synthesis and conjugation.)", "retries": 1}
{"idx": 239, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: Calcineurin (CaN)", "model_support": "Supporting sentence: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\"", "retries": 1}
{"idx": 240, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of ZFHX1B mutations in causing the syndrome, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "\"Mowat-Wilson\" syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: \"direct sequencing demonstrated truncating ZFHX1B mutations in all four patients with the characteristic facial phenotype, but not in the patient with syndromic Hirschsprung disease without the distinct facial appearance.\"  \n\nThis sentence directly links ZFHX1B mutations to the clinical features of the syndrome (facial phenotype, mental retardation, and variable malformations), confirming the gene's role in Mowat-Wilson syndrome.", "retries": 1}
{"idx": 241, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical connection between DUX4 and FSHD, but it contains slight redundancy by mentioning PITX1, which is not necessary for directly supporting the answer. The gold supporting sentence is more concise and directly ties DUX4 to FSHD without additional details.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: Our results suggest that up-regulation of both DUX4 and PITX1 in FSHD muscles may play critical roles in the molecular mechanisms of the disease.", "retries": 1}
{"idx": 242, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions the active nuclear import process of APOBEC3B, which aligns well with the gold supporting sentence indicating its steady-state nuclear localization.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: \"A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID.\"  \n\nThis sentence explicitly states that APOBEC3B undergoes an active nuclear import process, confirming its predominant nuclear localization.", "retries": 1}
{"idx": 243, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"", "retries": 1}
{"idx": 244, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains some redundancy by mentioning 'SERCA2a superinhibition' rather than directly focusing on PLN as the regulatory molecule. While logical, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban (PLN), the reversible inhibitor of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a), is a key regulator of myocyte Ca(2+) cycling with a significant role in heart failure.", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: \"SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.\"  \nThis sentence explicitly identifies **phospholamban (PLN)** as the regulatory molecule responsible for modulating **SERCA2a** function in cardiac muscle.", "retries": 1}
{"idx": 245, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by explaining the role of ibrutinib in targeting BTK to delay CLL development. Minor additional details in the supporting sentence do not detract from the strong logical connection.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: \"Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.\"", "retries": 1}
{"idx": 246, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but focuses specifically on hypothyroidism rather than 'thyroid' abnormalities in general. The supporting sentence provides relevant information about thyroid function tests showing raised TSH and low free T4, which supports the answer but is somewhat more detailed than necessary. While logical, it could be more concise to align better with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Hypothyroidism, characterized by raised TSH and low free T4 levels.", "model_support": "Supporting sentence: \"Thyroid function tests showed a raised TSH (42 mIU/l; normal range 0.5-4 mIU/l) with a low FT(4) concentration (10.21 pmol/l; normal range: 10.29-24.45 pmol/l).\"", "retries": 1}
{"idx": 247, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less precise than the gold supporting sentence. The model's supporting sentence refers to cases of DH appearing after celiac disease but lacks the explicit description of DH as a 'chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy,' which would have made it more directly aligned with the gold standard.\", \"match\": true}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.", "model_answer": "Answer: Dermatitis herpetiformis (DH)", "model_support": "Supporting sentence: \"We report eight cases in which DH appeared many years after celiac disease (CD) in child.\"  \n**Analysis**: The context explicitly links dermatitis herpetiformis (DH) to celiac disease (CD), which is a gluten-related autoimmune disorder. This establishes DH as the typical rash associated with gluten sensitivity. Additionally, the title and discussion further reinforce this connection by framing DH as a manifestation of gluten-sensitive enteropathy.", "retries": 1}
{"idx": 248, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by mentioning the TCL1 mouse model, which is not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: \"Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL...\"", "retries": 1}
{"idx": 249, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'DNA methyltransferase (DNMT),' is correct in a general sense but does not match the gold standard 'DNMT1,' which is more specific and directly mentioned in the context. The supporting sentence provided by the model acknowledges that the context does not explicitly mention DNMT, making it relevant but insufficient to cover the gold answer. Therefore, while the answer is present in the broader context of DNA methylation, it lacks precision and fails to directly reference DNMT1 as required.\", \"match\": false}", "gold_answer": "DNMT1", "gold_support": "We propose a new model that suggests that the maintenance of DNA methylation relies not only on the recognition of hemimethylated DNA by DNA methyltransferase 1 (DNMT1) but also on the localization of the DNMT3A and DNMT3B enzymes to specific chromatin regions that contain methylated DNA.", "model_answer": "Answer: DNA methyltransferase (DNMT)", "model_support": "The context provided does not explicitly mention the enzyme **DNA methyltransferase (DNMT)** or any specific enzyme involved in DNA methylation maintenance. The answer \"DNA methyltransferase (DNMT)\" relies on general scientific knowledge rather than the given context.  \n\n**Supporting sentence:** *None* (The context does not provide information about the enzyme involved in DNA methylation maintenance).", "retries": 1}
{"idx": 250, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions congenital sensorineural hearing loss and defects in thyroid hormone synthesis, which are characteristic of Pendred syndrome, but it does not directly match the gold answer ('thyroid'). The supporting sentence is relevant to the context of Pendred syndrome but does not explicitly cover the gold answer or provide direct support for 'thyroid' abnormalities. It discusses therapeutic strategies rather than focusing on the specific hormone abnormality.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome confirmed by mutations in the PDS/SLC26A4 gene.", "model_answer": "Answer: Pendred syndrome is characterized by congenital sensorineural hearing loss and goiter due to defects in thyroid hormone synthesis, often involving mutations in the SLC26A4 gene.", "model_support": "Supporting sentence: **\"We report a young woman with genetically confirmed Pendred syndrome and discuss the current therapeutic strategies of dyshormonogenetic goitre.\"**  \n(Note: While the context does not explicitly detail the hormone abnormalities (e.g., congenital sensorineural hearing loss, SLC26A4 mutations), the mention of **\"dyshormonogenetic goitre\"** (a condition caused by defects in thyroid hormone synthesis) and **\"Pendred syndrome\"** (a known genetic disorder associated with thyroid dysfunction and hearing loss) indirectly supports the answer. However, the specific hormone abnormalities described in the answer are not explicitly stated in the provided context.)", "retries": 1}
{"idx": 251, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that no supporting sentence is available from the provided context, this is accurate since the context does not explicitly include a direct quote covering the enzyme inhibited by Orteronel. The gold supporting sentence relies on external knowledge, which the model correctly identifies as missing in the given text.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Answer: CYP17A1 (cholesterol side-chain cleavage enzyme)", "model_support": "The provided context does not explicitly mention the enzyme inhibited by Orteronel (CYP17A1). The text discusses Orteronel's effects on androgen suppression and prostate-specific antigen levels but does not specify the target enzyme. Therefore, **no supporting sentence** from the given context directly answers the question about the enzyme inhibited by Orteronel. The answer (CYP17A1) would require external knowledge beyond the provided text.", "retries": 1}
{"idx": 252, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that bortezomib is used for the treatment of multiple myeloma in Brazil. The logic is strong, and there is no excessive or irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, indicated for multiple myeloma (MM) treatment, is available in 3.5-mg vials, a quantity higher than the average dose commonly prescribed.", "model_answer": "Multiple myeloma", "model_support": "Supporting sentence: \"Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in Brazil.\"", "retries": 1}
{"idx": 253, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by explaining how mutations in BCR-ABL lead to imatinib resistance, which indirectly confirms BCR-ABL as the target. However, it contains slight redundancy by discussing resistance rather than directly stating that BCR-ABL is the driver of CML and the target of imatinib.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a hematopoietic stem cell cancer driven by the BCR-ABL fusion protein that arises from the translocation of chromosomes 9 and 22.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"Imatinib resistance may develop at any time and inevitably leads to disease progression. Resistance is usually caused by mutations within BCr-ABL, decreasing the affinity of imatinib binding.\"  \n\nThis sentence directly links imatinib's mechanism of action to its target (BCR-ABL) by explaining that resistance arises from mutations in BCR-ABL that reduce imatinib's binding affinity, confirming BCR-ABL as the tyrosine kinase targeted by imatinib.", "retries": 1}
{"idx": 254, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is a plausible response given the context. The supporting sentence is relevant in stating that no synonym is mentioned, but it fails to recognize the gold answer present in the context. The gold supporting sentence directly provides the synonym within parentheses, which the model missed.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The context does not mention \"lubag disease\" or any synonyms for it.", "retries": 1}
{"idx": 255, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning both 'cutaneous DH blisters' and 'spontaneous and induced DH rash,' which could be more concise while still providing sufficient support.\",\n  \"match\": true\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "BACKGROUND: Dermatitis herpetiformis (DH) is a specific dermatological manifestation of coeliac disease and 80% of DH patients have gluten sensitive enteropathy manifested by crypt hyperplasia and villous atrophy.", "model_answer": "Answer: Dermatitis herpetiformis (DH)", "model_support": "Supporting sentence: \"cutaneous DH blisters\" and \"spontaneous and induced DH rash\" (the context explicitly associates dermatitis herpetiformis (DH) with the rash in the context of gluten-related pathology).", "retries": 1}
{"idx": 256, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the context does not specify the subcellular localization, while the gold answer clearly identifies APOBEC3B as predominantly nuclear. The supporting sentence is also incorrect because the context explicitly mentions that APOBEC3B appeared predominantly nuclear. Both the answer and supporting sentence fail to align with the gold standard and lack logical support.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The context does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear.", "model_support": "Supporting sentence: The context does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear.", "retries": 1}
{"idx": 257, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context, but it is slightly less specific than the gold supporting sentence, as it does not explicitly mention the MR CLEAN study or its findings. It could be more concise by directly referencing MR CLEAN.\",\n  \"match\": true\n}", "gold_answer": "acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.", "retries": 1}
{"idx": 258, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in essence, as both refer to the same clotting factor. The supporting sentence is relevant and provides reasoning that connects betrixaban to Factor Xa inhibition; however, it includes additional information about a potential reversal agent (PRT4445), which introduces slight redundancy. Despite this, the logic connecting the answer to the supporting sentence remains strong.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis implies that betrixaban, like other anticoagulants with anti-Xa activity, inhibits Factor Xa.", "retries": 1}
{"idx": 259, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer with a focus on PD-1 expression and CT-011's effects, but it contains slight redundancy by summarizing additional details not directly needed to support the answer. The logic is strong, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "Answer: PD-1 (Programmed Cell Death Protein 1)", "model_support": "Supporting sentence: \"In summary, we demonstrate that PD-1 expression is increased in T cells of patients with active myeloma, and that CT-011 enhances activated T-cell responses after DC/tumor fusion stimulation.\"  \n(While the context explicitly mentions **CT-011**, the implication of targeting **PD-1** is derived from the study's focus on PD-1/PD-L1 pathways and the observed effects of CT-011 on PD-1-related T-cell responses. The name **MK-3475** (a known PD-1 inhibitor) is not directly mentioned in the context but is contextually linked to the PD-1 pathway.)", "retries": 1}
{"idx": 260, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'FGFR3,' matches the gold standard conceptually as it correctly identifies the gene associated with Achondroplasia (fibroblast growth factor receptor 3). However, the gold answer is more detailed by specifying the full name of the gene. The supporting sentence is relevant and covers the answer but contains slight redundancy by mentioning hypochondroplasia and Down syndrome in the same sentence when only FGFR3 mutation is needed to support the answer.\",\n  \"match\": true\n}", "gold_answer": "fibroblast growth factor receptor 3 (FGFR3)", "gold_support": "These phenotypic findings were later confirmed by the presence of fibroblast growth factor receptor 3 (FGFR3) gene mutation N540K.", "model_answer": "Answer: FGFR3", "model_support": "Supporting sentence: *Hypochondroplasia due to FGFR3 gene mutation (N540K) and mosaic form of Down syndrome in the same patient.*  \n\n**Note**: While the question refers to *Achondroplasia* and the context explicitly mentions *Hypochondroplasia*, both conditions are caused by mutations in the **FGFR3** gene. The answer aligns with the context, as the FGFR3 mutation is directly linked to the skeletal dysplasia described (hypochondroplasia), which shares a genetic basis with achondroplasia.", "retries": 1}
{"idx": 261, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('JNK'). The supporting sentence provided by the model acknowledges that the context does not explicitly mention JNK, but correctly infers that external knowledge supports this answer. Although the model notes the lack of explicit support in the provided context, the gold supporting sentence confirms that the answer is indeed correct and directly referenced in the original text. Thus, the reasoning aligns with the scoring criteria for a perfect score.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "Answer: c-Jun is phosphorylated by JNK (c-Jun N-terminal kinase).", "model_support": "Supporting sentence: **[Not explicitly stated in the provided context.]**  \nThe context does not mention **JNK (c-Jun N-terminal kinase)** or any MAP kinase involved in phosphorylating c-Jun. The answer \"JNK\" likely relies on external knowledge rather than the provided text, which focuses on **tylophorine's effects on c-Jun translation via the PI3K_PDK1_eEF2 pathway** and its role in cyclin A2 regulation, but does not discuss phosphorylation of c-Jun by MAP kinases.", "retries": 1}
{"idx": 262, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 263, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing the NF1 gene, but it focuses on a technical detail (LOH analysis) rather than directly emphasizing the germline mutations that predispose patients to tumors, as in the gold supporting sentence. This makes it slightly less concise and direct compared to the gold standard.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "It is well known that patients with von Recklinghausen syndrome (NF-1) (OMIM 162200) carrying NF1 germline mutations are predisposed to endocrine tumors including pheochromocytomas and duodenal somatostatinomas.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: \"LOH analysis of the NF1 gene was carried out using 3 intragenic microsatellite markers on 17q11.2.\"  \n(Additionally, the context explicitly refers to \"the NF1 gene\" in multiple sections, including the mutation analysis and expression studies.)", "retries": 1}
{"idx": 264, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'peroxidase enzyme,' does not match the gold standard 'antioxidant.' However, the term 'peroxiredoxin' is indeed associated with both peroxidase activity and antioxidant functions, so the answer is present in the context. The supporting sentence discusses the role of peroxiredoxin-2 but does not directly cover the gold answer ('antioxidant'). It is relevant but fails to explicitly mention the antioxidant property, which is central to the gold standard.\", \"match\": false}", "gold_answer": "antioxidant", "gold_support": "Here, we offer the first evidence that an antioxidant enzyme has a key role in this transition.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is a peroxidase enzyme.", "model_support": "Supporting sentence: Peroxiredoxin-2 represses melanoma metastasis by increasing E-Cadherin/β-Catenin complexes in adherens junctions.  \n(Note: While the context does not explicitly state \"peroxidase,\" the term \"peroxiredoxin\" in the name directly implies its classification as a peroxidase enzyme, as peroxiredoxins are a family of peroxidase enzymes. The supporting sentence provides the full name, which is sufficient to infer the enzyme type.)", "retries": 1}
{"idx": 265, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: \"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.\"", "retries": 1}
{"idx": 266, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly (S-adenosylmethionine). The supporting sentence is relevant and provides some context about Ezh2 and its enzymatic activity. However, it introduces unnecessary information about the lack of explicit mention in the text, which adds verbosity without enhancing logical support. The gold supporting sentence is more concise and directly ties the methyl donor to the enzyme activity.\", \"match\": true}", "gold_answer": "S-Adenosyl methionine", "gold_support": "To investigate if tumor growth is dependent on the enzymatic activity of Ezh2, we developed a potent and selective small molecule inhibitor, EI1, which inhibits the enzymatic activity of Ezh2 through direct binding to the enzyme and competing with the methyl group donor S-Adenosyl methionine.", "model_answer": "Answer: S-adenosylmethionine (SAM)", "model_support": "The context does not explicitly mention the methyl donor of histone methyltransferases (S-adenosylmethionine, SAM). The provided text describes the function of Ezh2 in methylating H3K27 but does not specify the methyl donor. The answer \"S-adenosylmethionine (SAM)\" is based on general biochemical knowledge rather than direct evidence from the context. \n\n**Note**: The context does not contain a sentence that supports the answer to this question.", "retries": 1}
{"idx": 267, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the broader context of radiological findings associated with Dyke-Davidoff-Masson syndrome. However, the supporting sentence incorrectly states that the context does not include relevant information, when in fact the gold supporting sentence directly references cerebral hemiatrophy as the characteristic feature. The model's supporting sentence fails to recognize the provided context and adds confusion by suggesting no support exists.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Presence of a unilateral encephalomalacia with ipsilateral ventricular enlargement and increased intracranial pressure.", "model_support": "The provided context does not include the specific characteristic feature of Dyke-Davidoff-Masson syndrome (unilateral encephalomalacia, ipsilateral ventricular enlargement, or increased intracranial pressure). The context only describes clinical manifestations (seizures, spastic hemiplegia, microcephaly, developmental delay) without mentioning anatomical or radiological findings. Thus, **no sentence in the given context supports the provided answer**. The answer appears to rely on external knowledge rather than the text.", "retries": 1}
{"idx": 268, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The gold answer specifies 7 TAp73 isoforms, while the model incorrectly infers '1.' The supporting sentence mentions 'TAp73 isoforms' in plural, which suggests more than one isoform exists, but it fails to clarify the correct number or align with the gold answer. While the supporting sentence is relevant and provides some context about TAp73 isoforms, it does not sufficiently cover or logically support the gold answer of '7.'\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.\"  \n\n**Note:** While the sentence uses the plural \"TAp73 isoforms,\" the context does not explicitly clarify how many distinct TAp73 isoforms exist. However, the answer \"1\" may be inferred if the question assumes the TAp73 isoform refers to the single transcriptionally active variant (as opposed to multiple variants), though the phrasing in the context is ambiguous.", "retries": 1}
{"idx": 269, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the conclusion that BACH1 is a repressor, but it does not explicitly state that BACH1 is a 'transcriptional repressor,' which would make it more direct and concise. Instead, it discusses the feedback regulation of HO-1 without directly stating the role of BACH1 as a repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "BTB and CNC homolog 1 (Bach1) is a transcriptional repressor of heme oxygenase-1 (HO-1).", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"It plays an important role in the feedback regulation of HO-1 expression, which protects cells from various insults including oxidative stress and inflammatory cytokines.\"  \n**Analysis**: The context indicates that BACH1 regulates HO-1 expression (a protective gene). Since BACH1 deficiency enhances HO-1 expression (as shown by increased immunopositivity in Bach1-deficient mice), this implies BACH1 acts as a **repressor** of HO-1 under normal conditions.", "retries": 1}
{"idx": 270, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that Bach1 acts as a repressor, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.\"", "retries": 1}
{"idx": 271, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly acknowledges that while the context does not explicitly mention Clostridium botulinum, the answer is based on general scientific knowledge, which aligns with the gold standard. This is an acceptable explanation for the lack of direct context.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "BACKGROUND: Botulism is a serious neuroparalytic disease caused by toxins of Clostridium botulinum.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly mention the bacterium **Clostridium botulinum** as the cause of botulism. While the text discusses **botulinum toxin** and its detection, it does not identify the specific bacterium responsible for producing the toxin. The answer **Clostridium botulinum** is based on general scientific knowledge, not the provided context. \n\n**Supporting sentence:** *None* (The context does not contain the required information to answer the question).", "retries": 1}
{"idx": 272, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it introduces the context of the study rather than directly stating the genetic cause. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: \"Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.\"", "retries": 1}
{"idx": 273, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence mentions laboratory confirmation, which is indirectly related but not as directly relevant as the gold supporting sentence that clearly ties Clostridium botulinum to causing botulism.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease in animals is mainly caused by toxins produced by Clostridium botulinum strains belonging to group III, although outbreaks due to toxins produced by group I and II organisms have been recognized.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: \"the recovery of C. botulinum from sick animal specimens is consistent for laboratory confirmation.\"", "retries": 1}
{"idx": 274, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by linking nestin to neural precursor cells, aligning with the gold supporting sentence. Minor additional context (e.g., cultivation conditions) does not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "nestin", "gold_support": "Only a minority of stem cells expressed nestin, a marker for neural precursor cells.", "model_answer": "Answer: Nestin", "model_support": "Supporting sentence: \"Cultivation in serum-free medium supplemented with specific growth factors resulted in a markedly higher percentage of nestin-positive cells.\"  \n\n**Analysis**: While the context does not explicitly state that *nestin* is a marker for the subventricular zone, it directly links *nestin* to neuronal precursor cells (via \"nestin-positive cells\") under conditions that promote neural-like differentiation. This aligns with the broader scientific understanding that **nestin** is a well-established intermediate filament marker for neural progenitor cells, including those in the subventricular zone. The sentence provides the key evidence for nestin's association with neural precursor populations in the context.", "retries": 1}
{"idx": 275, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking alpha-synuclein to Lewy bodies through its interaction with synphilin-1, which is present in these structures.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"  \n**Analysis**: This sentence directly links alpha-synuclein to Lewy bodies through its interaction with synphilin-1, which is explicitly stated to be present in Lewy bodies. While the context does not explicitly declare alpha-synuclein as the *main* component, the subsequent mention of alpha-synuclein being \"recruited to synphilin-1A inclusion bodies\" (which resemble Lewy bodies) further reinforces its association with these structures. However, the most direct sentence supporting the answer is the one explicitly naming alpha-synuclein in relation to Lewy bodies.", "retries": 1}
{"idx": 276, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'Icatibant,' is incorrect and does not match the gold standard, 'ecallantide.' Furthermore, the supporting sentence provided by the model is entirely irrelevant to the gold answer, as it discusses external knowledge rather than utilizing the context provided. The model fails to identify the correct drug name from the given text, which explicitly mentions DX-88 as ecallantide.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "DX-88 (ecallantide), a 60-amino acid recombinant protein discovered through phage display technology, is a highly specific, potent inhibitor of human plasma kallikrein that has been used successfully in the treatment of patients experiencing acute HAE attacks.", "model_answer": "Answer: Icatibant", "model_support": "The provided context does not explicitly mention \"Icatibant\" or link \"DX-88\" to it. The answer \"Icatibant\" relies on external knowledge (DX-88 is the investigational name for Icatibant, a bradykinin B2 receptor antagonist used in HAE). However, **no sentence in the given context supports this connection**, as the text only refers to \"DX-88\" without naming the drug's full designation. \n\nIf the answer must strictly derive from the context, there is **no supporting sentence**. If external knowledge is allowed, the answer is inferred but not validated by the text.", "retries": 1}
{"idx": 277, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('semagacestat') but is present in the context as it correctly identifies LY450139 as a γ-secretase inhibitor. However, the supporting sentence is relevant but does not cover the gold answer, as it mentions LY450139 in relation to being a γ-secretase inhibitor without specifying its investigational name, semagacestat.\",\n  \"match\": false\n}", "gold_answer": "semagacestat", "gold_support": "The γ-secretase inhibitor LY450139 (semagacestat) lowers plasma Aβ(1-40) and Aβ(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms.", "model_answer": "Answer: LY450139 is an investigational name of a γ-secretase inhibitor.", "model_support": "Supporting sentence: \"9 dogs were treated with a single dose of the γ-secretase modulator E2012, the γ-secretase inhibitor LY450139, or vehicle with a dosing interval of 1 week.\"", "retries": 1}
{"idx": 278, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but focuses on genetic variants being 'different' rather than explicitly stating that cysteine mutations are the most common cause. It indirectly supports the answer with reasonable logic but is slightly less direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "cysteine", "gold_support": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease due to mutations involving loss or gain of a cysteine residue in the NOTCH3 gene.", "model_answer": "Answer: Cysteine", "model_support": "Supporting sentence: \"Moreover genetic variants different from loss or gain of a cysteine residue are identified and presented.\"  \n**Analysis**: The sentence implies that most mutations in CADASIL involve **loss or gain of a cysteine residue** (as these are explicitly noted as \"different\" from other variants), highlighting cysteine as the amino acid residue most frequently mutated in the disease.", "retries": 1}
{"idx": 279, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('p53'). However, the supporting sentence chosen by the model is less direct and includes information about the study's purpose rather than explicitly stating why p53 is called 'the guardian of the genome.' While relevant, it contains some redundancy and does not directly highlight the gene’s role in controlling apoptosis and cell cycle arrest. A more concise and direct supporting sentence would improve the score.\", \"match\": true}", "gold_answer": "di", "gold_support": "The p53 gene has been referred to as 'the guardian of the genome' because it controls apoptosis and cell cycle arrest.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The purpose of this study was to evaluate the association of p53 codon 72 genetic polymorphism and the p53 immunohistochemistry with Helicobacter pylori-associated gastroduodenal diseases, including gastric cancer.  \n\n**Note:** While the context does not explicitly use the term \"guardian of the genome,\" the mention of **p53** (a well-known tumor suppressor with this designation in scientific literature) supports the answer. The context focuses on p53's role in genetic polymorphism and disease association, aligning with its established function as the \"guardian of the genome.\"", "retries": 1}
{"idx": 280, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and supports the answer by explaining that direct factor Xa inhibitors target Factor Xa. However, it contains slight redundancy by discussing the broader class of inhibitors and their promise for therapeutic use, which is not directly necessary to justify the specific answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...  \n(Note: While the context does not explicitly name *betrixaban*, it defines the entire class of \"direct factor Xa inhibitors\" as targeting Factor Xa, which includes betrixaban as a member of this class.)", "retries": 1}
{"idx": 281, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is identical to the gold supporting sentence, making it perfectly aligned.\", \"match\": true}", "gold_answer": "p53", "gold_support": "This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'\"", "retries": 1}
{"idx": 282, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer 'Microautophagy' is incorrect and does not match the gold standard 'chaperone-mediated autophagy (CMA)'. The supporting sentence provided by the model does not logically support the answer, as it admits that no sentence in the context mentions the KFERQ motif or links it to microautophagy. Instead, the correct process associated with the KFERQ motif is clearly explained in the gold supporting sentence, which involves chaperone-mediated autophagy (CMA). Thus, both the answer and supporting sentence are incorrect and irrelevant.\", \"match\": false}", "gold_answer": "chaperone-mediated autophagy (CMA)", "gold_support": "Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes through the LAMP-2A (Lysosome-associated membrane protein type 2A) receptor.", "model_answer": "Answer: Microautophagy", "model_support": "The context provided does not explicitly mention the **KFERQ motif** or its association with any autophagy pathway. The question and answer pair appear to rely on external biological knowledge (e.g., KFERQ is a well-known motif for proteasomal degradation, not microautophagy). However, the context does describe **microautophagy** as \"direct engulfment of proteins into lysosomes\" but does not link this to the KFERQ motif. Thus, **no sentence in the provided context supports the answer** \"microautophagy\" for this specific question. \n\n**Note:** The answer \"microautophagy\" is likely based on general knowledge (e.g., KFERQ is a signal for proteasomal degradation, not autophagy), but the context does not address this motif or its role in autophagy pathways.", "retries": 1}
{"idx": 283, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('the transcribed strand'), though it uses slightly different phrasing ('The gene strand that is transcribed'). The supporting sentence provided by the model mentions Cockayne syndrome patients being defective in TCR, which is relevant but does not directly address the preferential repair of the transcribed strand. While the model correctly infers the answer from general biological knowledge, the supporting sentence lacks precision compared to the gold supporting sentence, which explicitly states the preferential repair of the transcribed strand over the non-transcribed strand.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "It has been previously shown that disruption of RAD26 in yeast strain W303-1B results in a strain that is deficient in transcription-coupled repair (TCR), the preferential repair of the transcribed strand of an expressed gene over the non-transcribed strand and the rest of the genome.", "model_answer": "Answer: The gene strand that is transcribed.", "model_support": "Supporting sentence: \"cells from Cockayne syndrome patients are defective in TCR.\"  \n**Note**: While the context does not explicitly state that TCR targets the transcribed gene strand, the term \"transcription-coupled repair\" inherently implies a relationship with transcription (i.e., the transcribed strand). This inference aligns with general biological knowledge, as TCR specifically repairs DNA damage on the transcribed strand of actively transcribed genes. However, the context lacks an explicit sentence confirming this. The closest reference is the mention of TCR in the context of Cockayne syndrome, which is a known disorder linked to TCR deficiency.", "retries": 1}
{"idx": 284, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'SERCA2a', is very close to the gold standard 'SERCA2', as SERCA2a is a specific isoform of the SERCA2 gene. The supporting sentence is relevant and supports the answer well, but it could be argued that the phrasing in the gold supporting sentence better captures the functional role of SERCA2a in calcium transport during diastole. Some redundancy is present, but overall, the logic is strong.\", \"match\": true}", "gold_answer": "SERCA2", "gold_support": "During diastole, muscle relaxation occurs as Ca2+ is again removed from cytosol, predominantly by accumulation into SR via the action of SERCA2a.", "model_answer": "Answer: SERCA2a", "model_support": "Supporting sentence: \"SERCA is mainly represented by the SERCA2a isoform in the heart.\"", "retries": 1}
{"idx": 285, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence could be more detailed to fully capture the information provided in the gold supporting sentence. However, it still logically supports the answer.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "The NF1 gene codes for a protein called \"neurofibromin.\" It possesses a region that shares a high homology with the family of GTPase-activating proteins, which are negative regulators of RAS function and thereby control cell growth and differentiation.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: \"The evidence points to the NF1 gene being a tumor-suppressor gene.\"", "retries": 1}
{"idx": 286, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by connecting MLL1 to the COMPASS family and H3K4 methylation. Minor extra details are present but do not detract from the strong logic.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Methylation of histone H3 lysine 4 (H3K4) in Saccharomyces cerevisiae is implemented by Set1/COMPASS, which was originally purified based on the similarity of yeast Set1 to human MLL1 and Drosophila melanogaster Trithorax (Trx).", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: \"all three complexes in Drosophila are H3K4 methyltransferases; however, dSet1/COMPASS is the major monoubiquitination-dependent H3K4 di- and trimethylase in Drosophila.\"  \n\nThis sentence establishes that the COMPASS family complexes, including those homologous to human MLL1/2 (Trx), methylate H3K4. Since MLL1 belongs to the COMPASS family and is functionally analogous to Trx in Drosophila, the histone residue methylated by MLL1 is H3K4.", "retries": 1}
{"idx": 287, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer includes both p16INK4a and p14ARF, which is close to the gold standard but not exact since the gold answer specifies only p16INK4. The supporting sentence highlights a lack of correlation between Bmi-1 and p16INK4a/p14ARF, which introduces some ambiguity. While it covers relevant context, it mixes in information that could be seen as contradictory to the idea of regulation. Logic is reasonable but could be more precise.\", \"match\": false}", "gold_answer": "p16INK4", "gold_support": "Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.", "model_answer": "Answer: p16INK4a and p14ARF", "model_support": "Supporting sentence: \"However, there was no correlation between expression of Bmi-1 and p16INK4a, p14ARF, or h-TERT.\"  \n\n**Note**: While the sentence explicitly states *no correlation* between Bmi-1 and p16INK4a/p14ARF, the question assumes a regulatory relationship (as implied by prior knowledge or the conclusion that Bmi-1's oncogenic role is not tied to inhibiting INK4a/ARF). The answer aligns with the context's focus on these proteins as potential targets, even if the specific data here does not confirm a direct regulatory link.", "retries": 1}
{"idx": 288, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Tarenflurbil,' does not match the gold standard, 'Semagacestat,' but is present in the context. The supporting sentence is relevant to Tarenflurbil but does not cover the gold answer, Semagacestat. The model seems to have confused the two drugs mentioned in the context, leading to an incorrect answer despite some relevance in the supporting sentence.\", \"match\": false}", "gold_answer": "Semagacestat", "gold_support": "The outcomes of the clinical trials of the γ-secretase inhibitor Semagacestat (LY-450139) and the γ-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the γ-secretase era.", "model_answer": "Answer: Tarenflurbil", "model_support": "Supporting sentence: \"The non-steroidal anti-inflammatory drug, Tarenflurbil, binds to AβPP and shifts the cleavage site from Aβ42 to Aβ38.\"  \n\n**Note:** The context does not explicitly mention \"LY450139\" as an investigational name for Tarenflurbil. However, based on the answer provided (Tarenflurbil), the supporting sentence refers to Tarenflurbil as the drug in question. If \"LY450139\" is a known investigational name for Tarenflurbil (not stated in the context), this would require external knowledge beyond the provided text.", "retries": 1}
{"idx": 289, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context, but it includes specific experimental details (e.g., genomic DNA confirmation) that are not necessary to directly support the synonym of Lubag disease. This makes it slightly more verbose than the gold supporting sentence, which succinctly conveys the connection between Lubag disease and X-linked dystonia-parkinsonism.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Despite recessive inheritance, X-linked dystonia-parkinsonism (Lubag disease) has also been described in women presenting with a late-onset isolated parkinsonian syndrome.", "model_answer": "Answer: X-linked dystonia-parkinsonism (XDP)", "model_support": "Supporting sentence: \"In a Filipino woman with suspected Parkinson disease, we confirmed the presence of all changes specific for X-linked dystonia-parkinsonism in genomic DNA.\"", "retries": 1}
{"idx": 290, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about antiparallel alpha-helices, but it focuses on the structure of R16 rather than directly stating that the heterodimer is antiparallel. It provides logical support but with slight redundancy and less direct relevance to the heterodimer itself.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Answer: Antiparallel.", "model_support": "Supporting sentence: \"R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.\"  \n\nThis sentence describes the structural arrangement of the spectrin repeat (R16), which includes antiparallel alpha-helices, implying the antiparallel orientation of the alpha- and beta-spectrin subunits in their heterodimeric assembly.", "retries": 1}
{"idx": 291, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('Xa') in essence, though it includes the word 'Factor,' which is slightly more verbose but still accurate. The supporting sentence is relevant and supports the answer by referencing betrixaban's anti-Xa activity through its pairing with a factor Xa decoy. However, the sentence is somewhat indirect and contains additional information about PRT4445 being a reversal agent, which is not necessary to justify the answer. This makes the reasoning slightly less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban has anti-Xa activity, as it is being paired with a factor Xa decoy (PRT4445) as a reversal agent.", "retries": 1}
{"idx": 292, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer '1,4-benzothiazepine' is very close to the gold standard 'benzothiazepine' but includes additional specificity (the '1,4-' prefix) that isn't strictly necessary based on the gold answer. The supporting sentence refers to diltiazem as a 1,5-benzothiazepine derivative, which does not directly confirm JTV519's classification as a 1,4-benzothiazepine. While it provides some context about benzothiazepines, it mixes relevant and irrelevant information by focusing on diltiazem rather than JTV519. Logic is reasonable but could be more concise and directly supportive.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Note:** The context does not explicitly state that JTV519 is a 1,4-benzothiazepine derivative. However, based on prior knowledge (as referenced in the example), JTV519 is a 1,4-benzothiazepine derivative. The provided context only mentions diltiazem as a 1,5-benzothiazepine derivative and does not clarify JTV519's chemical group. This discrepancy suggests the context may be incomplete or the answer relies on external knowledge.", "retries": 1}
{"idx": 293, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (ZFHX1B and Zfhx1b are equivalent in this context); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor differences in formatting (capitalization) do not detract from the correctness.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "Answer: Zfhx1b", "model_support": "Supporting sentence: \"Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome.\"", "retries": 1}
{"idx": 294, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer matches the gold standard but is present in the context only implicitly, relying on external knowledge. The supporting sentence does not cover the gold answer or provide logical reasoning about alpha-synuclein being the main component of Lewy bodies; instead, it discusses Parkinson's disease and its classification without directly addressing the composition of Lewy bodies.\",\n  \"match\": true\n}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein (AS) is the main component of Lewy bodies and its aggregation is a key event in the pathogenesis of PD.", "model_answer": "Answer: Alpha-synuclein (AS)", "model_support": "Supporting sentence: \"Parkinson disease (PD) is the most important movement disorder and about 50% of patients develop dementia over the time. PD belongs to the group of Lewy body disorders.\"  \n\n**Note**: While the context does not explicitly state the main component of Lewy bodies, it is well-established in biomedical literature that Lewy bodies are primarily composed of **alpha-synuclein (AS)** aggregates. However, the provided context does not directly mention this fact. The answer relies on external knowledge, as the text focuses on the relationship between AS/BS expression and PD/PDD rather than the composition of Lewy bodies.", "retries": 1}
{"idx": 295, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The gold answer specifies 7 TAp73 isoforms, while the model incorrectly states 1. However, the supporting sentence provided by the model is relevant to the context, as it mentions upregulation of specific isoforms including TAp73. The key issue is that the model's answer appears to be based on an incorrect assumption or lack of clarity in interpreting how many TAp73 isoforms exist, which is not explicitly detailed in the text but should align with the gold standard. The supporting sentence fails to directly address the number of TAp73 isoforms, making it insufficient for supporting the gold answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"TAp73, DeltaNp73 and DeltaN'p73 were significantly upregulated in tumors.\"  \n(Note: While the sentence lists three p73 isoforms (TAp73, DeltaNp73, and DeltaN'p73), the question specifically asks about **TAp73** isoforms. The context does not explicitly state how many **TAp73** isoforms exist, but the answer \"1\" may infer that TAp73 itself is a single isoform, distinct from DeltaNp73 and DeltaN'p73. However, the context does not directly address the number of TAp73 isoforms, so the answer might rely on external knowledge or an assumption not fully supported by the provided text.)", "retries": 1}
{"idx": 296, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Flumazenil' matches the gold standard, but the supporting sentence incorrectly states that no sentence in the context supports the answer. In fact, the context explicitly mentions flumazenil as a treatment for benzodiazepine intoxication. The supporting sentence fails to utilize this clear evidence from the text.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "Benzodiazepine intoxication treated with flumazenil (Anexate, RO 15-1788).", "model_answer": "Answer: Flumazenil", "model_support": "The context provided does not include any information about drugs, antidotes, benzodiazepine overdose, or Flumazenil. Therefore, **no sentence in the context supports the answer**. The answer \"Flumazenil\" is based on external medical knowledge, not the given text.", "retries": 1}
{"idx": 297, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, though it includes slightly more detail about the enzyme IFR than necessary. The mention of 'medicarpin biosynthesis' is helpful but not as direct as the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: Isoflavone reductase (IFR), the penultimate enzyme in **medicarpin biosynthesis**, is responsible for introducing one of two chiral centers in (-)-medicarpin.", "retries": 1}
{"idx": 298, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, correctly identifying the receptor as 'CGRP (calcitonin gene-related peptide) receptor.' However, the supporting sentence is somewhat redundant and verbose. While it acknowledges that the context does not explicitly provide the supporting information, it goes into unnecessary detail about what the context lacks instead of directly referencing the provided background sentence. The gold supporting sentence is more concise and directly relevant.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.", "model_answer": "Answer: CGRP (calcitonin gene-related peptide) receptor.", "model_support": "The context does not explicitly mention the specific receptor targeted by telcagepant. However, based on external knowledge, telcagepant is a **CGRP (calcitonin gene-related peptide) receptor antagonist**. This information is **not provided in the given context**, so no supporting sentence can be quoted from the text to confirm this. The context only discusses the drug's tolerability and adverse event profile, not its mechanism of action or target receptor. \n\n**Answer:** The context does not provide information about the receptor targeted by telcagepant.", "retries": 1}
{"idx": 299, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "The maintenance methylation of hemimethylated CpG sites by the DNA methyltransferase Dnmt1 is the molecular basis of the inheritance of DNA methylation patterns.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain.", "retries": 1}
{"idx": 300, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about posttranslational modifications, which are not necessary to directly support the answer. The logic is strong, but slightly more concise reasoning would improve it.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "Answer: α-Synuclein (AS)", "model_support": "Supporting sentence: \"Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS.\"", "retries": 1}
{"idx": 301, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer 'One' does not match the gold standard '7'. The supporting sentence is irrelevant and overly verbose, focusing on describing TAp73 alpha and Delta Np73 alpha without addressing the total number of TAp73 isoforms. It does not logically support the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: \"p73, the first p53 gene homologue, encodes an array of p73 proteins including p73 alpha full-length (TAp73 alpha) and amino-truncated isoforms (Delta Np73 alpha), two proteins with opposite biological functions.\"  \n\n**Analysis**: The sentence explicitly identifies **TAp73 alpha** as the full-length isoform of TAp73, while Delta Np73 alpha is a distinct, truncated isoform. Since the question asks specifically about **TAp73** isoforms, only **TAp73 alpha** is mentioned as a TAp73 isoform, confirming the answer \"One.\"", "retries": 1}
{"idx": 302, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning TCR and its focus on the transcribed strand, but it contains slight redundancy by introducing Cockayne syndrome gene products without directly emphasizing that TCR targets the transcribed strand of active genes.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 303, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard (ZFHX1B), though it includes additional information (SIP1) not explicitly required by the gold answer. The supporting sentence is relevant and covers the answer with logical reasoning, but it incorrectly states that the context does not mention the gene, whereas the gold supporting sentence clearly identifies ZFHX1B/SIP1 in the provided context. This introduces slight redundancy and an unnecessary claim about missing context.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Haploinsufficiency of a gene termed ZFHX1B (also known as SIP1) on chromosome 2 is responsible for this condition, and clinical genetic testing for MWS recently became available.", "model_answer": "Answer: The gene responsible for the development of Mowat-Wilson syndrome is the ZFHX1B (also known as SIP1) gene.", "model_support": "The context provided does not mention the specific gene responsible for Mowat-Wilson syndrome (ZFHX1B/SIP1). Therefore, **no supporting sentence** exists in the given context to validate the answer about the genetic cause of Mowat-Wilson syndrome. The answer relies on external knowledge rather than the text provided.", "retries": 1}
{"idx": 304, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"we quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on **CYP17A1 enzymatic activity**...\"", "retries": 1}
{"idx": 305, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 306, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly verbose and includes case-specific details that are not necessary for answering the question.\", \"match\": true}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are considered to be a continuum of a neurological sleep disorder associated with abnormal iron metabolism or deficiency.", "model_answer": "Answer: Iron deficiency", "model_support": "Supporting sentence: \"I describe a case of RLS and PLMD in a cystic fibrosis patient with iron deficiency from chronic hemoptysis. This is the first case that reports RLS and PLMD manifesting from iron deficiency caused by chronic hemoptysis in advanced cystic fibrosis lung disease.\"", "retries": 1}
{"idx": 307, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about the drug's function and development stage, which strengthens understanding without being overly verbose.\", \"match\": true}", "gold_answer": "semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "Answer: Semagacestat", "model_support": "Supporting sentence: Semagacestat (LY450139) is a novel γ-secretase inhibitor currently in late-stage development by Eli Lilly and Company as a potential treatment for Alzheimer's disease (AD).", "retries": 1}
{"idx": 308, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect and could be more concise. It discusses modulation of SERCA without directly stating it as the main calcium pump, while the gold supporting sentence explicitly defines its role in calcium homeostasis.\", \"match\": true}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "Answer: SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: \"Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.\"  \nThis sentence explicitly identifies **SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase)** as the calcium pump being modulated in the context, confirming its role as the main calcium pump of the sarcoplasmic reticulum.", "retries": 1}
{"idx": 309, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'SECIS element' matches the gold standard 'SECIS' with only minor variation in wording which does not affect correctness. The supporting sentence is relevant and supports the answer by discussing critical features of SECIS elements, but it is slightly less direct than the gold supporting sentence, which explicitly mentions the stem-loop and its presence in the 3' untranslated region. Slight redundancy exists in the model's supporting sentence but overall logic is sound.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Two functional SECIS elements were identified in the 3' untranslated region of the rat selenoprotein P mRNA, with predicted stem-loops and critical nucleotides similar to those in the SECIS elements in the type I iodothyronine 5' deiodinase (5'DI) and glutathione peroxidase selenoprotein mRNAs.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: \"Site-directed mutational analyses of three SECIS elements confirmed that conserved nucleotides in the loop and in unpaired regions of the stem are critical for activity.\"", "retries": 1}
{"idx": 310, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"", "retries": 1}
{"idx": 311, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Myelosuppression, predominantly neutropenia and leucopenia,' does not match the gold standard 'Cardiotoxicity,' but it is mentioned in the context as a significant toxicity (dose-limiting toxicity). However, it is not identified as the major adverse effect of adriamycin. The supporting sentence is relevant to the model's answer, discussing myelosuppression and other frequent toxicities, but it does not cover the gold answer (cardiotoxicity) or provide reasoning for cardiotoxicity being the major adverse effect.\", \"match\": false}", "gold_answer": "Cardiotoxicity", "gold_support": "Cardiotoxicity is a major adverse effect of the anthracycline antibiotics and can be acute or chronic; in the acute setting, electrocardiographic abnormalities may be seen, including ST-T elevations and arrhythmias, but chronic cardiotoxicity represents a serious adverse effect that may be lethal due to the development of irreversible, cumulative dose-dependent, congestive cardiomyopathy.", "model_answer": "Answer: Myelosuppression, predominantly neutropenia and leucopenia.", "model_support": "Supporting sentence: \"Myelosuppression, predominantly neutropenia and leucopenia, is the dose-limiting toxicity; in addition to this, mucositis, nausea, vomiting and alopecia are frequent, whereas hepatopathy, characterised by elevated bilirubin concentrations, occurs less frequently.\"", "retries": 1}
{"idx": 312, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and explains that the context does not explicitly mention DX-88 but still logically supports the conclusion that the drug in question is Ecallantide. Although the model's supporting sentence discusses the lack of explicit mention of DX-88, it correctly identifies Ecallantide as the answer based on the context, which includes the critical information linking DX-88 to Ecallantide in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.", "model_answer": "Answer: Ecallantide", "model_support": "The context provided does not mention \"DX-88\" or any investigational name for ecallantide. The answer \"Ecallantide\" is not supported by the given context, as the text only refers to the drug by its established name (ecallantide) and does not mention an investigational name like DX-88. This suggests a potential discrepancy between the question and the provided context.", "retries": 1}
{"idx": 313, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('JNK'). However, the supporting sentence is unnecessarily verbose and mentions that the context does not explicitly provide the information, which detracts from conciseness. Despite this, it indirectly acknowledges the relevance of the MAP kinase pathways, which includes JNK as referenced in the gold supporting sentence.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "The expressions of Bcl-2, Bax, caspase-3, extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal protein kinases (JNK), and p38 were evaluated by Western blot.", "model_answer": "Answer: c-Jun N-terminal kinase (JNK)", "model_support": "The context does not explicitly mention the specific MAP kinase that phosphorylates the transcription factor c-Jun. The provided text only references \"mitogen-activated protein kinase pathways\" in general without specifying c-Jun N-terminal kinase (JNK) or its role in phosphorylating c-Jun. Therefore, the answer cannot be directly supported by the given context.", "retries": 1}
{"idx": 314, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Na+-Ca2+ exchanger (NCX)' is equivalent to 'NCX'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although there is a minor difference in wording compared to the gold supporting sentence, the logic and relevance are strong.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "Using SEA0400, a potent and selective inhibitor of the Na+-Ca2+ exchanger (NCX), we examined whether NCX is involved in nitric oxide (NO)-induced disturbance of endoplasmic reticulum (ER) Ca2+ homeostasis followed by apoptosis in cultured rat microglia.", "model_answer": "Answer: Na+-Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: SEA0400, a specific inhibitor of the Na+-Ca2+ exchanger, attenuates sodium nitroprusside-induced apoptosis in cultured rat microglia.", "retries": 1}
{"idx": 315, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Nestin' matches the gold standard 'nestin', but the supporting sentence does not cover the gold answer. The model incorrectly states that the context does not mention Nestin, while the gold supporting sentence explicitly references it. Although the answer is correct, the supporting sentence fails to provide relevant support from the context.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "In the subventricular zone, this effect was exerted selectively on a precursor subpopulation expressing nestin but not neuronal or glial cell-specific proteins.", "model_answer": "Answer: Nestin", "model_support": "The answer \"Nestin\" is not supported by the provided context. The text does not mention any intermediate filament (IF) protein or Nestin specifically. The context discusses neurogenesis, NOS inhibitors, and effects on precursor cells but does not identify a marker protein like Nestin. \n\n**Note**: The answer \"Nestin\" may be derived from external knowledge (e.g., Nestin is a well-known marker for neural progenitor cells), but the given context does not include this information.", "retries": 1}
{"idx": 316, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly by correctly identifying PRDX2 as an 'antioxidant' enzyme. The supporting sentence is concise, directly relevant, and logically supports the classification of PRDX2 as an antioxidant enzyme by referencing its role in an antioxidant system. Minor extra details in the supporting sentence are acceptable as they enhance clarity without introducing irrelevance.\", \"match\": true}", "gold_answer": "antioxidant", "gold_support": "The aim of this study was to examine gonadotropin regulation of antioxidant enzyme sulfiredoxin (Srx) and peroxiredoxin 2 (PRDX2) expressions and modification during the ovulatory process in rats.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme.", "model_support": "Supporting sentence: \"Taken together, gonadotropin stimulation of Srx expression and PRDX2 modification in the ovary suggest the existence of an antioxidant system to maintain H₂O₂ production and elimination during the periovulatory period.\"  \n\nThis sentence implies that PRDX2 is part of an antioxidant system, thereby supporting the classification of PRDX2 as an antioxidant enzyme.", "retries": 1}
{"idx": 317, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, confirming that Microsporidia belong to the kingdom Fungi. The supporting sentence provides relevant information but includes slight redundancy by discussing external knowledge and over-explaining the lack of explicit support in the text. While it correctly identifies the relationship between Microsporidia and Fungi, it could be more concise and directly reference the phylogenetic analysis mentioned in the context.\",\n  \"match\": true\n}", "gold_answer": "Fungi", "gold_support": "Phylogenetic analysis indicates a relationship between the Microsporidia and the Fungi.", "model_answer": "Answer: Microsporidia belong to the kingdom Fungi.", "model_support": "The context does not explicitly state the kingdom to which microsporidia belong. However, the title of the study (\"New evidence on the relationship between Microsporidia and Fungi\") implies a focus on their potential evolutionary or genetic connection to fungi, which aligns with the widely accepted classification of microsporidia as belonging to the **kingdom Fungi** (based on external knowledge). Since the context does not directly name the kingdom, **no sentence in the provided text explicitly supports the answer**. \n\nIf the user insists on citing a sentence, the closest is:  \n**\"Microsporidia are a group of obligate intracellular eukaryotic parasites...\"**  \nThis confirms they are eukaryotes but does not specify their kingdom. The classification into Fungi is inferred from external biological knowledge, not the context provided.", "retries": 1}
{"idx": 318, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 319, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains the antiparallel nature of the subunit pairing through electrostatic interactions, which aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The spectrin heterodimer is formed by the antiparallel lateral association of an alpha and a beta subunit, each of which comprises largely a series of homologous triple-helical motifs.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: \"Together, these data support a model where complementary long range electrostatic interactions on the AB faces of the triple-helical motifs in the dimer nucleation site initiate the correct pairing of motifs, i.e. alpha21-beta1 and alpha20-beta2.\"  \n\nThis sentence implies that the alpha and beta subunits pair in a specific orientation (alpha21 with beta1 and alpha20 with beta2), which is consistent with an **antiparallel** arrangement (opposite directions of subunit alignment).", "retries": 1}
{"idx": 320, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer states that the question cannot be answered, which is incorrect since the context does mention the synonym 'X-linked dystonia-Parkinsonism.' The supporting sentence correctly identifies that no explicit synonym is provided but fails to recognize the gold answer present in the context. Therefore, while the supporting sentence is relevant, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "X-linked dystonia-Parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: None. The context does not mention \"lubag disease\" or its synonyms.", "retries": 1}
{"idx": 321, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Na+/Ca²⁺ exchanger (NCX)' is equivalent to 'NCX'). The supporting sentence is concise, directly relevant, and logically explains that SEA0400 inhibits NCX currents, which aligns with the gold supporting sentence. Minor additional details in the model's supporting sentence are acceptable as they do not detract from the clarity or accuracy of the explanation.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: \"The change of NCX current and the increase of [Ca2+]i during I/R can be blocked by SEA0400 in a dose-dependent manner...\"  \nThis sentence directly links SEA0400 to the inhibition of NCX (Na+/Ca²⁺ exchanger) currents, confirming its role as an inhibitor of this ion antiporter/exchanger.", "retries": 1}
{"idx": 322, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that [18F]altanserin is used for PET studies targeting the serotonin 5-HT2A receptor. No excessive details or irrelevant content are present.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 323, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentence provides relevant information about normal TSH and iodine organification, yet it fails to directly address or cover the gold answer ('thyroid'). Additionally, the inclusion of extra sentences adds verbosity without improving clarity or alignment with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter.", "model_answer": "Answer: Pendred syndrome is characterized by sensorineural hearing loss and goiter, but it does not typically involve abnormalities in thyroid hormone levels or TSH.", "model_support": "Supporting sentence: \"This implies that some pendrin mutations may involve direct stimulation of thyroid cell proliferation with no TSH hyperstimulation and no iodine organification defect.\"  \nAdditional supporting sentences:  \n1. \"She was seen at our hospital due to hearing loss at age 3 years, and subsequently developed goiter at age 10 years.\"  \n2. \"serum thyrotropin (TSH) levels and iodine organification [...] remained normal.\"  \n\nThese sentences confirm that Pendred syndrome is associated with sensorineural hearing loss and goiter, while thyroid hormone levels (TSH) and iodine organification are normal.", "retries": 1}
{"idx": 324, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning EWS/FLI1 as the fusion protein involved in the regulation of EYA3, which aligns with the context. However, it contains additional information ('Ewing sarcoma is an aggressive pediatric cancer...') that, while related to the broader topic, is not necessary for directly supporting the specific answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "Answer: EWS/FLI1", "model_support": "Supporting sentence: Ewing sarcoma is an aggressive pediatric cancer of the bone and soft tissue, in which patients whose tumors have a poor histologic response to initial chemotherapy have a poor overall prognosis. **We further show that EWS/FLI1 mediates upregulation of EYA3 via repression of miR-708...** (Note: The key phrase \"EWS/FLI1\" is explicitly mentioned as the fusion protein central to the molecular mechanism described in the context.)", "retries": 1}
{"idx": 325, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale is used as a stroke recognition tool, which aligns with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 326, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer. However, it includes additional details about the biosynthesis process that are not necessary to answer the question, leading to slight redundancy.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"One of the final steps of medicarpin biosynthesis, from vestitone to 7,2'-dihydroxy-4'-methoxyisoflavanol, is catalyzed by vestitone reductase.\"  \nThis sentence directly references **medicarpin** as the compound being synthesized in the pathway described, which aligns with the conclusion that it is the major phytoalexin in *Medicago sativa L.*.", "retries": 1}
{"idx": 327, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is equivalent to the gold standard 'stroke' in this context, as 'acute stroke' specifies the condition the ROSIER scale is designed for while remaining consistent with the gold answer. The supporting sentence is concise and directly relevant, clearly stating the purpose of the ROSIER scale in differentiating acute stroke in the ER. It logically supports the answer without unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 328, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is identical to the gold supporting sentence, ensuring perfect alignment.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.", "model_answer": "p53", "model_support": "Supporting sentence: \"Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.\"", "retries": 1}
{"idx": 329, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Rheumatoid Arthritis is more common in women') does not match the gold standard ('women'), though it is factually correct based on general knowledge outside the context. The supporting sentence discusses details from the context but fails to directly support the gold answer since it does not emphasize the higher prevalence in women. Instead, it focuses on disease characteristics and admits the context lacks prevalence data. Thus, while relevant, the supporting sentence does not logically cover the gold answer.\", \"match\": false}", "gold_answer": "women", "gold_support": "RESULTS: At baseline, men (n = 67) and women (n = 225) had similar disease activity and radiographic damage; men, however, had significantly worse erosion, while women had worse joint space narrowing.", "model_answer": "Answer: Rheumatoid Arthritis is more common in women.", "model_support": "The context does not provide information about the prevalence of Rheumatoid Arthritis (RA) between men and women. The study focuses on comparing disease characteristics and treatment responses in a DMARD-naive seropositive early RA cohort, noting that \"at baseline, men and women had similar disease activity and joint damage.\" However, no data on the overall incidence or prevalence of RA by gender is mentioned in the text. The answer \"Rheumatoid Arthritis is more common in women\" is based on general knowledge, not the provided context.", "retries": 1}
{"idx": 330, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but more specific than necessary ('hypothyroidism' would suffice to match 'thyroid'). The supporting sentence provides relevant information with specific details about TSH and free T4 levels, which are not required for a concise explanation. It mixes biochemical detail with the core concept of thyroid abnormalities, making it somewhat lengthy but still logically connected to the answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Hypothyroidism, characterized by raised TSH and low free T4 levels.", "model_support": "Supporting sentence: Thyroid function tests showed a raised TSH (42 mIU/l; normal range 0.5-4 mIU/l) with a low FT(4) concentration (10.21 pmol/l; normal range: 10.29-24.45 pmol/l).", "retries": 1}
{"idx": 331, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it relies on an indirect implication of Hsp70's upregulation rather than directly stating it as the gold supporting sentence does. The logic is sound but slightly less direct.\", \"match\": true}", "gold_answer": "Hsp70", "gold_support": "Inhibition of Hsp90 upregulated the expression of Hsp70 and Hsp70-bound Nox2, 5 and promoted degradation.", "model_answer": "Answer: Hsp70", "model_support": "Supporting sentence: \"Silencing Hsp70 prevented Hsp90 inhibitor-mediated degradation of Nox5.\"  \nThis indicates that Hsp70 plays a role in the degradation of Nox5 when Hsp90 is inhibited, implying its involvement (and likely upregulation) in response to Hsp90 inhibition.", "retries": 1}
{"idx": 332, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('peroxidase enzyme') does not match the gold standard ('antioxidant'), but the term 'antioxidant' is mentioned in the context. The supporting sentence provided by the model is incorrect because it claims no information about PRDX2 is included, while the context explicitly describes PRDX2 as an antioxidant enzyme. This results in a lack of logical support for the gold answer.\", \"match\": false}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, was the most upregulated while tribbles homolog 3 (TRB3), a pro-apoptotic protein, was the most downregulated, implying a beneficial effect of lithium on neuronal cells.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is a peroxidase enzyme.", "model_support": "The context does not mention **peroxiredoxin 2 (PRDX2)** or its classification as a peroxidase enzyme. The provided text focuses on lithium-modulated gene expression, including genes related to phosphoinositide metabolism and signaling pathways like the mitogen-activated protein kinase pathway, but **no information about PRDX2** is included. \n\n**Answer:** The context does not provide a supporting sentence for the claim that PRDX2 is a peroxidase enzyme.", "retries": 1}
{"idx": 333, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Inhibitor 1'). The supporting sentences provided are relevant and correctly explain the role of Inhibitor 1 as a potent PP1 inhibitor when phosphorylated. However, there is slight redundancy in citing two sentences when one concise sentence could suffice, hence a score of 4 instead of 5.\",\n  \"match\": true\n}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.", "model_answer": "Answer: Inhibitor 1 (I-1)", "model_support": "Supporting sentence: \"Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.\"  \nand  \n\"Nonphosphorylated I-1 is inactive, whereas phosphorylated I-1 is a potent PP1 inhibitor.\"  \n\nThese sentences directly identify Inhibitor 1 (I-1) as the main inhibitor of PP1, emphasizing its role when phosphorylated.", "retries": 1}
{"idx": 334, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and accurate but contains additional information about extracellular deposits of amyloid, which is not directly necessary to explain the main component of Lewy bodies. This makes it slightly more verbose than the gold supporting sentence, which is more concise and specific.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.", "retries": 1}
{"idx": 335, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke' and is correct in the context provided. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for stroke differentiation, but it includes slight redundancy by specifying 'acute stroke' instead of the more general 'stroke,' which aligns better with the gold answer. Overall, the logic is strong, but minor adjustments could make it more concise.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 336, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('FSHD'). The supporting sentence is concise, directly relevant, and provides clear reasoning by linking the FSHD-causing D4Z4 array to DUX4 production. It effectively supports the answer without unnecessary verbosity.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: Asymmetric bidirectional transcription from the **FSHD-causing D4Z4 array** modulates DUX4 production.", "retries": 1}
{"idx": 337, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically links 'Lubag' to 'XDP (X-linked Dystonia-Parkinsonism)' using information from the context. Minor additional details in the supporting sentence do not detract from the clarity or correctness of the reasoning.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Phenomenology of \"Lubag\" or X-linked dystonia-parkinsonism.", "model_answer": "Answer: XDP (X-linked Dystonia-Parkinsonism)", "model_support": "Supporting sentence: \"We present cinematographic material of 11 cases of Lubag carrying the XDP haplotypes who manifest with a wide spectrum of movement disorders...\"  \nThis sentence directly links \"Lubag\" to \"XDP haplotypes,\" establishing XDP (X-linked Dystonia-Parkinsonism) as the synonym for Lubag.", "retries": 1}
{"idx": 338, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the classification of Bach1 as a repressor. However, it includes slight redundancy by discussing ZnMP's effects, which are not necessary to directly answer the question.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a mammalian transcriptional repressor of HO-1.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"ZnMP produces profound post-transcriptional down-regulation of Bach1 protein levels and transcriptional up-regulation of HO-1.\"  \nThis indicates that Bach1 negatively regulates HO-1 (as its degradation leads to HO-1 up-regulation), classifying it as a **repressor** of HO-1.", "retries": 1}
{"idx": 339, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer logically, but it is slightly verbose and includes extra details about the mutation that are not necessary to directly answer the question.\", \"match\": true}", "gold_answer": "XK", "gold_support": "A spontaneous novel XK gene mutation in a patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK protein of 313 amino acids, compared with 444 amino acids in the normal XK protein.", "retries": 1}
{"idx": 340, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 341, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'Xa'). However, the supporting sentence provided by the model incorrectly states that there is no mention of betrixaban in the context, when in fact the gold supporting sentence shows that betrixaban is explicitly mentioned as a factor Xa inhibitor. The model's supporting sentence reflects a misunderstanding of the context, but the answer itself is correct.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or its mechanism of action. Therefore, there is no supporting sentence in the provided text to answer the question about which clotting factor is inhibited by betrixaban.", "retries": 1}
{"idx": 342, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly explains the synonym relationship between 'lubag' and 'X-linked dystonia-parkinsonism (XDP)' using logical reasoning. Minor additional context (e.g., 'in women') does not detract from the strong relevance and clarity.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-linked dystonia-parkinsonism (XDP) or \"lubag\" is an X-linked recessive disorder that afflicts Filipino men, and rarely, women.", "model_answer": "Answer: X-linked dystonia-parkinsonism (XDP)", "model_support": "Supporting sentence: Phenotypic and molecular analyses of X-linked dystonia-parkinsonism (\"lubag\") in women.  \nThis sentence explicitly states that \"lubag\" is a synonym for \"X-linked dystonia-parkinsonism (XDP)\" by enclosing the term \"lubag\" in quotation marks alongside its full name and abbreviation.", "retries": 1}
{"idx": 343, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less detailed than the gold supporting sentence. It mentions SERCA's role in fat storage but does not explicitly state that it is solely responsible for transporting cytosolic calcium into the ER lumen, which is key to the gold answer.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.", "model_answer": "Answer: SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: Seipin promotes adipose tissue fat storage through the ER Ca²⁺-ATPase SERCA.", "retries": 1}
{"idx": 344, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 correctly as a 'repressor.' The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It succinctly explains that BACH1 acts as a repressor by binding enhancers and antagonizing NRF2 until inactivated, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naive to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: \"the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.\"", "retries": 1}
{"idx": 345, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant but slightly less direct compared to the gold supporting sentence. The model's supporting sentence mentions debate about the position of microsporidia, which is true but introduces a minor element of ambiguity. The gold supporting sentence directly states the classification supported by phylogenomics, making it more concise and authoritative.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: \"the specific position of microsporidia within the fungal tree of life is still debated.\"  \n(Note: While the exact position is debated, the context explicitly places microsporidia within the **fungal tree of life**, which implies their classification under the **Fungi** kingdom.)", "retries": 1}
{"idx": 346, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns well with the gold standard by identifying the autoimmune nature of the response as the likely reason for narcolepsy post-vaccination. However, it omits specific details about the role of an environmental trigger and genetic susceptibility mentioned in the gold answer. The supporting sentence is relevant and covers the autoimmune aspect but lacks the detailed mechanism involving environmental triggers and genetic factors. Slight verbosity is present but does not detract significantly from the logic.\", \"match\": true}", "gold_answer": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "gold_support": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "model_answer": "The reason for the narcolepsy cases developed after H1N1 influenza vaccination is likely autoimmune, although supportive evidence is lacking.", "model_support": "Supporting sentence: \"The pathological explanation of this association and narcolepsy is likely to be autoimmune, although supportive evidence is lacking.\"", "retries": 1}
{"idx": 347, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it indirectly implies the connection to McLeod syndrome rather than stating it explicitly, which introduces slight ambiguity. While logical, it could be more direct in linking XK to McLeod syndrome as the gold supporting sentence does.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"We identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.\"  \n\n**Note:** While the context does not explicitly name the gene associated with McLeod syndrome, the XK gene is a well-established genetic cause of McLeod syndrome in real-world biomedical knowledge. The context indirectly supports this by identifying variants in the *XK* gene in psychiatric disorder subjects, aligning with its role in neuroacanthocytosis-related conditions like McLeod syndrome. However, the direct link to McLeod syndrome is not explicitly stated in the provided text.", "retries": 1}
{"idx": 348, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states the question cannot be answered, while the gold answer (NCX) is indeed present in the context. The supporting sentence is also incorrect because SEA0400 is mentioned in the context as an inhibitor of NCX(REV). Both the answer and supporting sentence fail to recognize the information provided in the text.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The question cannot be answered based on the provided context.  \n**Analysis**: The context discusses PPADS, KB-R7943, and SN-6 as inhibitors of the Na⁺/Ca²⁺ exchanger (NCX(REV)), but **SEA0400 is never mentioned** in the text. Therefore, there is no information in the context to determine which ion antiporter/exchanger SEA0400 inhibits.", "retries": 1}
{"idx": 349, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "\"Lubag\" or X-linked dystonia-parkinsonism (XDP) is a genetic syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism (XDP)", "model_support": "Supporting sentence: First case of X-linked dystonia-parkinsonism (\"Lubag\") to demonstrate a response to bilateral pallidal stimulation.", "retries": 1}
{"idx": 350, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The model incorrectly states that CENPA is localized at the inner kinetochore plate, which is actually the localization of CENPC as per the context. However, the correct localization of CENPA (centromeres) is present in the context. The supporting sentence discusses CENPC rather than CENPA and thus does not support the gold answer. While the answer is incorrect, it is based on information available in the context, hence a score of 2.\", \"match\": false}", "gold_answer": "centromeres", "gold_support": "CENPA is a member of the histone H3-like proteins and is thought to replace histone H3 in centromeric nucleosomes.", "model_answer": "Answer: At the inner kinetochore plate of active mammalian centromeres.", "model_support": "Supporting sentence: CENPC is a DNA-binding protein that is located at the inner kinetochore plate of active mammalian centromeres.  \n\n**Note**: The context explicitly describes the localization of **CENPC**, not **CENPA**. The answer provided (about CENPA) appears to be incorrect based on the given context. However, the supporting sentence quoted refers to **CENPC**, which is the only localization information present in the text.", "retries": 1}
{"idx": 351, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, and the supporting sentence is concise, directly relevant, and logically explains that Evolocumab targets proprotein convertase subtilisin/kexin type 9 (PCSK9). The information provided aligns perfectly with the gold supporting sentence without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab (AMG145) is a monoclonal antibody inhibiting the proprotein convertase subtilisin/kexin type 9 that binds to the liver LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Answer: Proprotein convertase subtilisin/kexin type 9 (PCSK9)", "model_support": "Supporting sentence: \"Evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9...\"", "retries": 1}
{"idx": 352, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context about alpha-synuclein's role in abnormal depositions, which aligns with its presence in Lewy bodies. However, it does not explicitly mention 'Lewy bodies,' making it slightly less precise than the gold supporting sentence, though the logic connecting alpha-synuclein to the question is still strong.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.\"  \n\n(Note: While the context does not explicitly mention \"Lewy bodies,\" alpha-synuclein is universally recognized as the main component of Lewy bodies in alpha-synucleinopathies like Parkinson's disease. The sentence above establishes alpha-synuclein as the central pathological feature of these disorders, which includes Lewy body formation.)", "retries": 1}
{"idx": 353, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('nuclear'). The supporting sentence provides relevant reasoning and correctly infers nuclear localization based on the enzyme's function as a DNA cytosine deaminase. However, it is somewhat verbose and indirect compared to the concise gold supporting sentence, which directly states that APOBEC3B is predominantly nuclear. The model's reliance on inference rather than explicit context leads to slight redundancy.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "Answer: Nuclear.", "model_support": "The context does not explicitly state whether APOBEC3B is predominantly cytoplasmic or nuclear. However, the answer \"Nuclear\" is inferred based on the enzyme's function as a **DNA cytosine deaminase**, which typically acts on DNA located in the nucleus. While the context does not directly quote the subcellular localization of APOBEC3B, the functional implication of its activity on DNA (e.g., causing C-to-T mutations in the genome) supports the conclusion that it operates in the nucleus. \n\n**Supporting sentence (indirect inference):**  \n\"DNA cytosine deaminase APOBEC3B is a probable source of these mutations.\"  \n*(This implies nuclear localization, as DNA deamination occurs in the nucleus.)*", "retries": 1}
{"idx": 354, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While it provides slightly more detail than the gold supporting sentence, the extra information does not detract from the clarity or accuracy of the response.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).", "retries": 1}
{"idx": 355, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not directly cover the gold answer, as it focuses on APOBEC3G's cytoplasmic localization rather than explicitly stating APOBEC3B's nuclear localization.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "The text does not explicitly state the subcellular localization of APOBEC3B. However, it mentions that APOBEC3G is predominantly cytoplasmic and that chimeric proteins between APOBEC3G and APOBEC3B were used to map localization determinants. Since the study focuses on differences in localization between APOBEC3G and APOBEC3B, it implies that APOBEC3B may have a different localization, but the specific localization (cytoplasmic or nuclear) of APOBEC3B is not directly stated. \n\nAnswer: The text does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear.", "model_support": "Supporting sentence: \"APOBEC3G limits the replication of human immunodeficiency virus type 1, other retroviruses, and retrotransposons. It localizes predominantly to the cytoplasm of cells...\"  \n(Note: The text explicitly describes APOBEC3G as cytoplasmic but does not provide direct information about the subcellular localization of APOBEC3B. The study's focus on differences between APOBEC3G and APOBEC3B implies APOBEC3B may have a distinct localization, but this is not confirmed in the context.)", "retries": 1}
{"idx": 356, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by identifying the NF1 gene as associated with neurofibromatosis type 1.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) gene is a tumor suppressor gene, and the NF1 gene product, neurofibromin, can downregulate the N-ras gene.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: \"Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.\"  \n\nThis sentence explicitly identifies the **NF1 gene** as the gene associated with **neurofibromatosis type 1**.", "retries": 1}
{"idx": 357, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'JNK (c-Jun N-terminal kinase)' matches the gold standard 'JNK'. However, the model's supporting sentence is missing and instead replaced by a statement explaining the lack of explicit support in the context. While this explanation is accurate, it does not provide the concise and relevant supporting sentence from the text as required. The gold supporting sentence demonstrates that the context indeed mentions JNK as one of the MAP kinases involved, which could have been used to support the answer more directly. Thus, the score reflects the correct answer but notes the absence of a proper supporting sentence.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "It also reduced the expressions of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and increases the expressions of reversion-inducing cysteine-rich protein with kazal motifs (RECK), as well as tissue inhibitor of metalloproteinase (TIMP) via inhibiting STAT3 by activating the mitogen-activated protein (MAP) kinases (the c-Jun N-terminal kinase (JNK), the p38 and extracellular signal-regulated kinase (ERK)) in A549 cells treated with RY10-4.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "The context provided does not explicitly mention JNK (c-Jun N-terminal kinase) or its role in phosphorylating c-jun. The text discusses the involvement of ERK and p38 pathways in the mechanism of RY10-4 but does not address JNK or c-jun. Therefore, **no supporting sentence** from the given context directly supports the answer \"JNK (c-Jun N-terminal kinase)\" for the question about which MAP kinase phosphorylates c-jun. The answer relies on general biochemical knowledge rather than the provided context.", "retries": 1}
{"idx": 358, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information and logically supports the answer by describing the interaction between the C terminus of the beta-chain and the N terminus of the alpha-chain, which implies an antiparallel arrangement. However, it is slightly more verbose than necessary and does not directly state 'antiparallel heterodimer,' which would have made it more concise and precise.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Answer: Antiparallel.", "model_support": "Supporting sentence: \"These assemble a tetramer via a mechanism that relies on the completion of a single repeat by association of the partial repeats located at the C terminus of the beta-chain (two helices) and at the N terminus of the alpha-chain (one helix).\"  \n\nThis sentence implies an antiparallel arrangement, as the C terminus of the beta-chain and the N terminus of the alpha-chain associate to form the tetramer, suggesting opposite directional alignment.", "retries": 1}
{"idx": 359, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about the importance of the Ca(2+)/calcineurin/NFAT pathway in lymphocyte activation, which indirectly supports the role of calcineurin in NFAT activation. However, it contains slight redundancy by discussing SCID syndrome and CRAC channels, which are not necessary for directly supporting the specific answer regarding calcineurin's role in NFAT activation.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: The importance of the Ca(2+)/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca(2+) entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes...", "retries": 1}
{"idx": 360, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'A repressor' matches the gold standard 'repressor', but the supporting sentence provided by the model is not optimal. It discusses Nrf2 as an activator rather than directly supporting BACH1's role as a repressor. While the context does explicitly identify BACH1 as a repressor in the first sentence, the model failed to use this concise information and instead provided a verbose and less relevant explanation about Nrf2. Logic is reasonable but could be more focused and concise.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: \"A central mechanism in cellular defence against oxidative or electrophilic stress is mediated by transcriptional induction of genes via the ARE (antioxidant-response element), a cis-acting sequence present in the regulatory regions of genes involved in the detoxification and elimination of reactive oxidants and electrophiles. The ARE binds different bZIP (basic-region leucine zipper) transcription factors, most notably Nrf2 (nuclear factor-erythroid 2-related factor 2) that functions as a transcriptional activator via heterodimerization with small Maf proteins.\" \n\n**Note:** While the above sentence describes Nrf2 as an activator, the specific identification of BACH1 as a repressor is explicitly stated in the first sentence of the context: **\"transcriptional repressor BACH1.\"** This is the critical supporting sentence for the answer. \n\n**Corrected Supporting Sentence:**  \n\"transcriptional repressor BACH1\" (first sentence of the context).", "retries": 1}
{"idx": 361, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer correctly identifies the ZFHX1B gene as responsible for Mowat-Wilson syndrome, which matches the gold standard. However, the supporting sentence is incorrect because it claims no sentence in the context supports the answer, whereas the context explicitly mentions a missense mutation in the ZFHX1B gene associated with the syndrome. This results in a failure to provide relevant support.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "A missense mutation in the ZFHX1B gene associated with an atypical Mowat-Wilson syndrome phenotype.", "model_answer": "Answer: The gene responsible for the development of Mowat-Wilson syndrome is the ZFHX1B (also known as SIP1) gene.", "model_support": "The context provided does not mention the **ZFHX1B (SIP1)** gene or any genetic basis for Mowat-Wilson syndrome. The text only describes clinical features (e.g., facial dysmorphism, congenital anomalies) but does not include information about the causative gene. Therefore, **no sentence in the context supports the answer** about the responsible gene.", "retries": 1}
{"idx": 362, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a 'repressor.' The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that NRF2 requires the inactivation of the transcriptional repressor BACH1 for heme oxygenase-1 induction. This aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: \"Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1.\"", "retries": 1}
{"idx": 363, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by focusing on patient response to methotrexate rather than explicitly stating it as the first JAK inhibitor. The logic is sound, but the gold supporting sentence is more concise and directly ties tofacitinib with its classification as a JAK inhibitor.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"Tofacitinib is an oral treatment option for RA patients who have inadequate response or intolerance to methotrexate.\"  \n\n(Note: While the context does not explicitly state that tofacitinib is a JAK inhibitor, the question assumes this classification based on external knowledge. The provided context supports that tofacitinib is approved for RA treatment, which aligns with its established role as a JAK inhibitor in clinical practice.)", "retries": 1}
{"idx": 364, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less detailed compared to the gold supporting sentence. It lacks mention of 'novel junctional epitope' and 'constitutively active receptor,' which provide more specific context in the gold sentence.\", \"match\": true}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 365, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence chosen by the model does not directly state that 'Imatinib targets Bcr-Abl,' which is critical for fully supporting the answer. Instead, the model's supporting sentence discusses patient eligibility, which is indirectly related but lacks explicit mention of Imatinib’s mechanism of action on Bcr-Abl. The gold supporting sentence more clearly and concisely supports the answer.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common.", "model_answer": "Answer: Bcr-Abl", "model_support": "Supporting sentence: \"Adults with chronic myelogenous leukemia or Philadelphia chromosome-positive acute leukemia were eligible.\"  \n**Analysis:** The context specifies that the trial targeted patients with **Bcr-Abl+ hematological malignancies** (as indicated in the title and patient eligibility criteria). While the text does not explicitly state that **imatinib targets Bcr-Abl**, the focus on Bcr-Abl+ diseases and the known clinical use of imatinib (Gleevec) for Bcr-Abl inhibition in CML (chronic myelogenous leukemia) provides contextual support for the answer. The **title** (\"Phase I trial [...] in patients with Bcr-Abl+ hematological malignancies\") further reinforces this connection. However, the most direct reference to the disease type is the eligibility criteria.", "retries": 1}
{"idx": 366, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'IL-17A' matches the gold standard 'interleukin-17A' as they are equivalent terms. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that secukinumab blocks IL-17A. There is no unnecessary verbosity or irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "interleukin-17A", "gold_support": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.", "model_answer": "Answer: IL-17A", "model_support": "Supporting sentence: \"Blockade of IL-17A by secukinumab does not appear to interfere with efficacy of influenza and meningococcal vaccinations...\"", "retries": 1}
{"idx": 367, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less detailed compared to the gold supporting sentence. It mentions the availability of LepChorionDB but does not include the additional context about it being a database with tools for identification, which would provide more comprehensive support.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: \"LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.\"", "retries": 1}
{"idx": 368, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is missing and does not match the gold standard. The supporting sentence states that the context does not mention the gene, which is factually incorrect as the gold supporting sentence explicitly mentions the NOTCH3 gene in the context provided. Both the answer and supporting sentence fail to address the question logically or accurately.\", \"match\": false}", "gold_answer": "NOTCH3 gene", "gold_support": "OBJECTIVE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease of the brain caused by mutations in the NOTCH3 gene.", "model_answer": "Answer: Not specified in the context.", "model_support": "Supporting sentence: The context does not mention or specify the gene involved in CADASIL.", "retries": 1}
{"idx": 369, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information and correctly highlights DNMT1's role in DNA methylation maintenance through its interaction with UHRF1 during the S phase. However, it includes additional details about other interactions (DNMT3a, DNMT3b, G9a) and UHRF2, which are not necessary to support the specific answer, making it slightly redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: \"Coimmunoprecipitation experiments demonstrate that both UHRF1 and UHRF2 interact with DNMT1, DNMT3a, DNMT3b and G9a.\"  \nAdditionally, the sentence: \"UHRF1 interacts with DNMT1 in an S phase-dependent manner in cells, UHRF2 does not.\"  \nThese sentences highlight DNMT1's role in DNA methylation maintenance through its interaction with UHRF1 during the S phase, which is critical for targeting DNMT1 to replication foci.", "retries": 1}
{"idx": 370, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('multiple'). The supporting sentence is relevant and supports the answer by mentioning 'three origins (O1, O2, O3),' which implies multiple origins. However, it contains slight redundancy by going into details about ortholog families, which is not directly necessary to support the answer.\",\n  \"match\": true\n}", "gold_answer": "multiple", "gold_support": "However, because some archaeal genomes contain multiple origins of replication, bias in gene dosage caused by delayed replication should be minimized and hence the substitution rate of genes should associate less with chromosome position.", "model_answer": "Answer: Multiple origins of replication.", "model_support": "Supporting sentence: \"Ortholog families were grouped by their consensus position and designated by their proximity to one of the three origins (O1, O2, O3).\"", "retries": 1}
{"idx": 371, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it mentions genetic defects in cell transporters generally without specifying MCT8.\", \"match\": false}", "gold_answer": "MCT8", "gold_support": "One, producing severe psychomotor defects in > 100 males from 26 families, is caused by mutations in the cell-membrane transporter of TH, MCT8;", "model_answer": "Answer: The thyroid hormone transporter is not specifically mentioned in the context; however, the text refers to genetic defects in hormone receptors, cell transporters, and deiodination as causes of reduced sensitivity to thyroid hormone. No specific transporter is named in this context.", "model_support": "Supporting sentence: \"Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination.\"  \n\n**Analysis**: The context explicitly states that genetic defects in *cell transporters* (alongside hormone receptors and deiodination) contribute to thyroid hormone resistance syndromes. However, **no specific transporter protein is named** in the text. The answer reflects this by acknowledging the general category (\"cell transporters\") mentioned in the context while clarifying that no specific transporter is identified.", "retries": 1}
{"idx": 372, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides accurate information about factor Xa inhibitors, but it is slightly verbose and includes general details about the drug class rather than focusing directly on betrixaban as the gold supporting sentence does. Despite this, the logic connecting the answer to the supporting sentence is strong.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin. These agents do not require cofactors and offer selective inhibition at a critical step of amplification in the coagulation cascade.  \n\n**Note**: While the context does not explicitly name *betrixaban*, it discusses \"oral direct factor Xa inhibitors\" as a class of drugs that inhibit **Factor Xa**. The answer is inferred based on the general description of the drug class in the context.", "retries": 1}
{"idx": 373, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'MEN1 gene', does not match the gold standard, 'aryl hydrocarbon receptor interacting protein'. However, the MEN1 gene is mentioned in the context and is relevant to endocrine tumors, though it is not specifically tied to familial isolated pituitary adenoma in the provided context. The supporting sentence discusses MEN1 gene alterations in parathyroid adenomas but does not directly support the gold answer regarding AIP's role in familial isolated pituitary adenoma.\", \"match\": false}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The aryl hydrocarbon receptor interacting protein (AIP) gene has a major role in the pathogenesis of familial isolated pituitary adenoma.", "model_answer": "Answer: MEN1 gene", "model_support": "Supporting sentence: \"MEN1 gene alterations occur in a substantial proportion of sporadic parathyroid adenomas.\"  \n\n**Note**: While the context focuses on parathyroid adenomas, the **MEN1 gene** is classically associated with **familial isolated pituitary adenoma** (a distinct clinical entity) due to its role in multiple endocrine neoplasia type 1 (MEN1). The context supports the relevance of the **MEN1 gene** in endocrine tumors, aligning with its known association with pituitary adenomas.", "retries": 1}
{"idx": 374, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.\"", "retries": 1}
{"idx": 375, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('NF1 gene' is equivalent to 'NF1'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by pointing out the mutation in the NF1 gene. Minor extra details about the specific mutation are acceptable as they do not detract from the clarity or relevance.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: \"Direct sequence analyses revealed a single base substitution in the splicing donor site of intron 6 (IVS6 888+1, G --> A) in one NF1 allele, resulting in an altered splice site (ss) in the mutated allele.\"", "retries": 1}
{"idx": 376, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The context explicitly lists betrixaban as a factor Xa inhibitor, making the model's answer correct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The answer \"Factor Xa\" is not supported by the provided context. The context does not mention **betrixaban** or its mechanism of action. It only discusses **dabigatran**, a direct thrombin inhibitor, and does not reference Factor Xa inhibition or betrixaban. \n\n**Note:** The question appears to be based on external knowledge (betrixaban is a Factor Xa inhibitor), but the provided context does not include this information.", "retries": 1}
{"idx": 377, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK') in meaning, though it is slightly more verbose by including 'c-Jun N-terminal kinase (JNK)' instead of just 'JNK.' The supporting sentence provides relevant context but contains some redundancy by introducing JNK as part of the MAPK family without directly stating its role in phosphorylating c-Jun. While the logic is clear and the information supports the answer, the explanation could have been more concise.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "JNK phosphorylates and regulates the activity of transcription factors other than c-Jun, including ATF2, Elk-1, p53 and c-Myc and non-transcription factors, such as members of the Bcl-2 family.", "model_answer": "Answer: c-Jun N-terminal kinase (JNK) phosphorylates the transcription factor c-jun.", "model_support": "Supporting sentence: \"c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase (MAPK) family...\"  \n(Implied by the nomenclature \"c-Jun N-terminal kinase,\" which directly indicates its role in phosphorylating the transcription factor c-Jun.)", "retries": 1}
{"idx": 378, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 379, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning medulloblastoma and a key feature (the role of p18Ink4c as a tumor suppressor). However, it does not include the specific detail that medulloblastoma is the most common malignant pediatric brain tumor, which makes it slightly less comprehensive than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "Answer: Medulloblastoma", "model_support": "Supporting sentence: The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.", "retries": 1}
{"idx": 380, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns well with the gold standard, though it includes additional descriptive details ('often involving the left hemisphere, and is frequently associated with male gender') that, while correct, are not strictly necessary to match the concise gold answer. The supporting sentence is relevant and logically supports the answer by referencing the frequent involvement of the male gender and left side in cerebral hemiatrophy, but it does not explicitly mention 'cerebral hemiatrophy,' which slightly reduces precision.\",\n  \"match\": true\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "Left hemisphere and male sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson Syndrome).", "model_answer": "Answer: Dyke-Davidoff-Masson syndrome is characterized by unilateral cerebral atrophy, often involving the left hemisphere, and is frequently associated with male gender.", "model_support": "Supporting sentence: We conclude that male gender and left side involvement are frequent in cerebral hemiatrophy disease.  \n\n(Note: While the context does not explicitly name \"Dyke-Davidoff-Masson syndrome,\" the described features—unilateral cerebral atrophy (left hemisphere predominance) and male predilection—align with this condition. The conclusion sentence directly supports the answer's characterization of the syndrome.)", "retries": 1}
{"idx": 381, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer. However, it includes some additional details about SMM, which are not directly necessary to justify AdoMet as the methyl donor, making it slightly verbose.\", \"match\": true}", "gold_answer": "S-adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "Answer: S-adenosylmethionine (AdoMet)", "model_support": "Supporting sentence: \"Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy).\"  \n\n**Note**: While the context does not explicitly mention \"histone methyltransferases,\" it identifies **S-adenosylmethionine (AdoMet)** as the precursor for **S-methylmethionine (SMM)**, which is described as a methyl donor in the SMM cycle. This aligns with general biochemical knowledge that **AdoMet** is the primary methyl donor for many methyltransferases, including histone methyltransferases. However, the direct mention of AdoMet as a methyl donor in the context is limited to its role in synthesizing SMM.", "retries": 1}
{"idx": 382, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acetylation' is very close to the gold standard 'acetylated lysines,' capturing the key biochemical process involved. However, it lacks the specific detail of 'lysines,' which is present in the gold answer. The supporting sentence provided by the model is technically correct but does not directly reference the gold supporting sentence from the text, leading to a slight mismatch. Despite this, the logic is sound and aligns with the context, though it draws on external knowledge rather than explicitly citing the given text.\", \"match\": false}", "gold_answer": "acetylated lysines", "gold_support": "Double bromodomain proteins bind to acetylated lysines in histones, bringing associated histone modification and nucleosome remodeling activity to chromatin.", "model_answer": "Answer: Acetylation", "model_support": "The context does not explicitly mention the specific histone modification (e.g., acetylation) recognized by the bromodomain. The provided text discusses the roles of bromodomain proteins in regulating chromatin status and gene expression but does not specify the histone modification (such as acetylation) that bromodomains recognize. Therefore, **no sentence in the context directly supports the answer \"acetylation.\"** The answer likely relies on external biochemical knowledge rather than the provided text.", "retries": 1}
{"idx": 383, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' referring to Factor Xa). The supporting sentence is relevant and aligns with the context, mentioning FXa inhibitors as part of the discussion. However, it introduces slight redundancy by elaborating on the lack of explicit mention in the text, which makes it less concise than ideal, even though the logic is sound.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Answer: FXa (Factor Xa)", "model_support": "Supporting sentence: The context does not explicitly mention betrixaban or its specific clotting factor target. However, based on external knowledge, betrixaban is a known inhibitor of FXa (Factor Xa). The provided context discusses anticoagulants targeting FXI, FXII, thrombin, FIXa, and platelet GPIV, but FXa is not listed. This discrepancy suggests the answer may rely on prior knowledge rather than the given context.", "retries": 1}
{"idx": 384, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes a detail that is slightly redundant (discussion of methylation at the 9 position). While logical and related to medicarpin, it does not directly state that medicarpin is the major phytoalexin in alfalfa as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\"  \nThis sentence directly references **medicarpin**, a compound central to the discussion of biosynthesis and stress responses in alfalfa, which aligns with its role as a phytoalexin. Additionally, the context explicitly states that IOMT is induced alongside other enzymes in **medicarpin biosynthesis**, reinforcing its significance.", "retries": 1}
{"idx": 385, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model incorrectly states that the context does not mention bortezomib, when in fact it is mentioned in the introduction as an effective treatment for multiple myeloma. Despite this error, the correct answer is still given, and the gold supporting sentence confirms the relevance of bortezomib to multiple myeloma. The evaluation would have been a 5 if the model's supporting sentence had correctly referenced the context.\", \"match\": true}", "gold_answer": "multiple myeloma", "gold_support": "INTRODUCTION: Over the past decade, the novel agents thalidomide, lenalidomide, and bortezomib have emerged as effective treatment in patients with multiple myeloma (MM).", "model_answer": "Answer: Multiple myeloma.", "model_support": "The answer is not supported by the provided context. The context discusses a phase II trial involving thalidomide, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma, but it does **not mention Velcade (bortezomib)** or its use for any disease. The answer \"Multiple myeloma\" is a general medical fact, but the context does not provide evidence for it.", "retries": 1}
{"idx": 386, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about the relative inhibition of 17,20-lyase versus 17-hydroxylase, which introduces slight redundancy. However, the logic connecting Orteronel to CYP17A1 remains clear and accurate.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"we quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on CYP17A1 enzymatic activity...\"  \n\nAdditionally, the sentence: \"Orteronel inhibited 17,20-lyase activity 5.4 times more potently than 17-hydroxylase activity in cell-free enzyme assays...\" further supports that CYP17A1 (which includes both 17,20-lyase and 17-hydroxylase activities) is the target enzyme.", "retries": 1}
{"idx": 387, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions 'Pendred syndrome' and related gene defects (e.g., PDS, NIS), which are relevant to the question but do not directly support the specific answer provided by the model. The model's answer focuses on iodine transport defects, which are not explicitly mentioned in the gold supporting sentence or answer. Additionally, the supporting sentence from the model incorrectly states that the context does not mention Pendred syndrome, when in fact it is mentioned indirectly. Thus, the answer is somewhat relevant but lacks alignment with the gold standard.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "Answer: Pendred syndrome is characterized by defects in the iodine transport, leading to congenital hypothyroidism and sensorineural hearing loss.", "model_support": "The provided context does **not** mention **Pendred syndrome** or explicitly link it to iodine transport defects. The answer given (about Pendred syndrome) is **not supported by the context**, as the text only discusses general categories of congenital hypothyroidism (thyroid dysgenesis, dyshormonogenesis, and iodothyronine transporter defects) without naming specific syndromes like Pendred. \n\n**Correct answer based on the context**:  \nThe context does not provide information about Pendred syndrome. It only mentions a third group of congenital hypothyroidism associated with **iodothyronine transporter defects** and severe neurological sequelae, but does not name this group as Pendred syndrome.", "retries": 1}
{"idx": 388, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but slightly less precise ('the transcribed strand' is more specific than 'the gene strand that is transcribed'). The supporting sentence provides relevant information about strand-specific repair but does not directly reference the transcribed strand or explicitly connect it to TCR. While the logic is reasonable, the supporting sentence could be more concise and directly tied to the gold answer.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "TCR can preferentially remove the bulky DNA lesions located at the transcribed strand of a transcriptional active gene more rapidly than those at the untranscribed strand or overall genomic DNA.", "model_answer": "Answer: The gene strand that is transcribed.", "model_support": "Supporting sentence: \"This strand-specific repair in a suitable restriction fragment is usually determined by alkaline gel electrophoresis followed by Southern blotting transfer and hybridization with an indirect end-labeled single-stranded probe.\"  \n\n**Note**: While the context does not explicitly state that transcription-coupled repair (TCR) targets the transcribed strand, the method described (strand-specific PCR) inherently implies that TCR is strand-specific, and the term \"transcription-coupled\" (TCR) itself is defined by its association with the transcription process (i.e., the transcribed strand). The broader scientific understanding of TCR is that it repairs the transcribed strand of DNA, which is not explicitly stated in the provided text. However, the question assumes this prior knowledge, and the supporting sentence is the one that introduces the concept of \"strand-specific repair\" in the context of TCR.", "retries": 1}
{"idx": 389, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and contains information about imatinib's mechanism in controlling a critical protein related to cell signaling, which aligns with BCR-ABL being the target. However, it does not explicitly mention BCR-ABL or provide as clear a connection to the tyrosine kinase as the gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling.\"  \n\n**Analysis**: While the sentence does not explicitly name *BCR-ABL*, the context explicitly associates **BCR-ABL mRNA** with chronic myeloid leukemia (CML) and its role as a biomarker for disease monitoring. Imatinib is the standard treatment for CML, and its mechanism of action is well-established in targeting the **BCR-ABL tyrosine kinase** (a fusion protein from the Philadelphia chromosome). The sentence implies that imatinib targets a tyrosine kinase pathway critical to CML pathogenesis, which aligns with the known role of BCR-ABL as the molecular target of imatinib. Thus, the context indirectly supports the answer by linking imatinib to CML and the BCR-ABL mRNA marker.", "retries": 1}
{"idx": 390, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is incorrect in stating that the context does not explicitly state the mode of inheritance, as the gold supporting sentence demonstrates that it does. The supporting sentence should have referenced the explicit mention of 'autosomal dominant inheritance pattern' from the context. Despite this flaw, the answer itself is correct.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "This family showed typical features of this syndrome with QT prolongation, torsades de pointes ventricular tachycardia, sudden death and an autosomal dominant inheritance pattern.", "model_answer": "Answer: Autosomal dominant", "model_support": "Supporting sentence: **The context does not explicitly state the mode of inheritance of Romano-Ward syndrome.**  \n**Note:** While the answer \"Autosomal dominant\" is factually correct for Romano-Ward long QT syndrome (a well-established clinical fact), the provided context does not include a sentence directly stating this. The context only describes the clinical presentation of the index case and treatment response, not the genetic inheritance pattern.", "retries": 1}
{"idx": 391, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer correctly identifies CaM kinase II as the kinase inhibited by KN-93, which matches the gold standard. However, the supporting sentence is incorrect and misleading because it claims that the context does not mention KN-93, when in fact the context explicitly states that KN-93 inhibits CaM kinase II. The supporting sentence fails to reference this key information and instead introduces confusion by discussing unrelated content. As a result, while the answer is correct, the supporting sentence does not adequately support it.\", \"match\": true}", "gold_answer": "CaM kinase II", "gold_support": "NE-induced MAP kinase and cPLA2 activation was also inhibited in cells treated with a CaM kinase II inhibitor, KN-93, or with CaM kinase II antisense oligonucleotide.", "model_answer": "Answer: Ca2+/calmodulin-dependent protein kinase II (CaM kinase II)", "model_support": "The context provided does not mention the small molecule **KN-93** or its inhibitory effects on any kinase. The question and answer appear to reference a different context (e.g., the earlier example involving JTV519 and CaMKII), but **KN-93 is not discussed in the current text**. \n\n**Answer:** The context does not provide information about which kinase is inhibited by KN-93.", "retries": 1}
{"idx": 392, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat indirect and does not explicitly mention CYP17A1 as the enzyme inhibited by Orteronel, unlike the concise and direct gold supporting sentence. While the logic connecting androgen suppression to CYP17A1 is reasonable, the supporting sentence contains slight redundancy in explaining the broader context of androgen suppression rather than focusing solely on the enzyme. This makes it less direct than ideal, warranting a score of 4.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Answer: CYP17A1 (cholesterol side-chain cleavage enzyme)", "model_support": "The context does not explicitly mention the enzyme inhibited by Orteronel (CYP17A1). However, the following sentence provides indirect support for the mechanism of action related to androgen suppression:  \n**\"Orteronel treatment suppresses androgen levels and causes shrinkage of androgen-dependent organs, such as the prostate gland.\"**  \n\nThis implies that Orteronel acts on the androgen synthesis pathway, which is consistent with its known mechanism of inhibiting CYP17A1 (a key enzyme in androgen production). However, the specific enzyme is not named in the provided context. The answer relies on external knowledge beyond the given text.", "retries": 1}
{"idx": 393, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and acknowledges that the context does not explicitly state the gene but correctly identifies 'XK' based on external knowledge, which aligns with the gold answer. While it explains the lack of direct support from the context, this does not detract from the logical correctness or relevance of the response.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene.", "model_answer": "Answer: XK", "model_support": "The context does not explicitly mention the gene associated with McLeod syndrome. However, based on medical knowledge, McLeod syndrome is caused by mutations in the **XK** gene. The context only states that the patient has the \"McLeod phenotype,\" which is a clinical feature of the syndrome, but it does not provide the genetic basis. Thus, no sentence in the provided context directly supports the answer \"XK.\" \n\n**Note:** The answer \"XK\" relies on external knowledge rather than the given context.", "retries": 1}
{"idx": 394, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 395, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Cortisol deficiency', does not match the gold standard, 'growth hormone'. However, cortisol deficiency is mentioned in the context as a related factor. The supporting sentence is relevant but does not cover the gold answer; it focuses on cortisol rather than growth hormone deficiency.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "We describe an 18-month-old boy with Costello syndrome (CS) with proven partial growth hormone (GH) deficiency and hypoglycemic episodes.", "model_answer": "Answer: Cortisol deficiency", "model_support": "Supporting sentence: The hypoglycemia is deemed to be due to cortisol deficiency.", "retries": 1}
{"idx": 396, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard, using a slightly different but acceptable synonym ('Small cell lung cancer' instead of 'small-cell lung cancer'). The supporting sentence is relevant and supports the answer by linking LES antibodies to SCLC cells, but it introduces additional details about P-type Ca2+ channels that are not strictly necessary to establish the association. This makes the sentence slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "Human small-cell lung cancer (SCLC) cells are believed to express the antigens responsible for the production of pathological antibodies in the Lambert-Eaton syndrome (LES), a Ca2+ channel disorder in which quantal transmitter release from the motor nerve terminal is impaired.", "model_answer": "Answer: Small cell lung cancer (SCLC)", "model_support": "Supporting sentence: \"the expression of P-type Ca2+ channels in the SCLC cells and the reactivity of LES IgG with these channels support the hypothesis that P-type Ca2+ channels in these cancer cells may trigger the autoantibody production in this disorder.\"  \n\nThis sentence explicitly links Lambert-Eaton syndrome (LES) antibodies to **small cell lung cancer (SCLC)** cells, establishing the association.", "retries": 1}
{"idx": 397, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'unilateral cerebral atrophy' is related to 'cerebral hemiatrophy,' it is more specific than the gold answer and does not fully align with the expected terminology. The supporting sentence provided by the model is incorrect as it claims no information in the context supports the answer, whereas the context explicitly mentions cerebral hemiatrophy as a characteristic feature in the gold supporting sentence. This results in a failure to logically support the gold answer.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "MRI brain revealed characteristic features diagnostic of congenital type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Increased intracranial pressure due to unilateral cerebral atrophy and ipsilateral enlargement of the lateral ventricle.", "model_support": "The context provided does not include any information about the characteristic features of Dyke-Davidoff-Masson syndrome, such as \"increased intracranial pressure due to unilateral cerebral atrophy and ipsilateral enlargement of the lateral ventricle.\" The context only describes clinical symptoms (seizures, hemiparesis, hemiatrophy, mental retardation) but does not mention anatomical or radiological findings. Therefore, **no sentence in the given context supports the provided answer**.", "retries": 1}
{"idx": 398, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'Xa' in meaning, though it is slightly more verbose. The supporting sentence provides relevant information and aligns with the context by referencing the anti-Xa activity of betrixaban, but it introduces additional details about a factor Xa decoy that are not necessary to answer the question directly. This makes the supporting sentence somewhat redundant, though it still logically supports the answer.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\" \n\nThis sentence implies that betrixaban, as a drug requiring a factor Xa-specific reversal agent, acts by inhibiting Factor Xa, aligning with its classification as a novel anticoagulant with anti-Xa activity.", "retries": 1}
{"idx": 399, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on APOBEC3G's cytoplasmic localization rather than explicitly stating APOBEC3B's nuclear localization.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "The text does not directly state the subcellular localization of APOBEC3B. However, it mentions that APOBEC3G is predominantly cytoplasmic and that chimeric proteins between APOBEC3G and APOBEC3B mapped a localization determinant to a region within the first 60 residues of each protein. This suggests that APOBEC3B may have a different localization than APOBEC3G, but the specific localization (cytoplasmic or nuclear) of APOBEC3B is not explicitly stated in the context provided.", "model_support": "Supporting sentence: \"APOBEC3G limits the replication of human immunodeficiency virus type 1, other retroviruses, and retrotransposons. It localizes predominantly to the cytoplasm of cells...\"  \n(Note: The context explicitly describes APOBEC3G as cytoplasmic but does not provide direct information about the subcellular localization of APOBEC3B. The chimeric protein analysis implies differences in localization determinants between APOBEC3G and APOBEC3B but does not confirm APOBEC3B's localization.)", "retries": 1}
{"idx": 400, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and accurate, as it mentions deletions in the ZEB2 gene, which aligns with the context of haploinsufficiency. However, it does not fully capture the broader explanation provided in the gold supporting sentence about the gene's mutations and their role in the syndrome, making it slightly less comprehensive.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: \"Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.\"", "retries": 1}
{"idx": 401, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (5-HT2A receptors vs. 5-HT2A). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that [18F]altanserin PET is used to quantify 5-HT2AR availability. Minor differences in phrasing do not detract from the strong logical reasoning.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.\"", "retries": 1}
{"idx": 402, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but is more verbose and less precise ('Stroke recognition in emergency room patients' vs. 'Stroke'). The supporting sentence provides relevant context about the development of the instrument but does not directly confirm the specific use for stroke recognition as clearly as the gold supporting sentence. It mixes logistic regression analysis and clinical reasoning without explicitly stating the purpose of the ROSIER scale, making it less concise and slightly off-target.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke recognition in emergency room patients.", "model_support": "Supporting sentence: We used logistic regression analysis and clinical reasoning to develop a stroke recognition instrument for application in this setting.  \n(Here, \"this setting\" refers to the emergency room [ER], as mentioned in the BACKGROUND section.)", "retries": 1}
{"idx": 403, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Na(+)/Ca(2+) exchanger (NCX)' matches the gold standard 'NCX', but the supporting sentence is incorrect and misleading. It claims that SEA0400 is not mentioned in the context, while SEA0400 is explicitly referenced in the gold supporting sentence as an inhibitor of NCX. The model supporting sentence introduces confusion by incorrectly stating that SEA0400 is absent from the text, which lowers the quality of reasoning.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400 (1 μM), a pharmacological inhibitor of NCX, significantly shortened the MAP duration (P < .01) and reduced dispersion (P < .05).", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "The question refers to \"SEA0400,\" but **this compound is not mentioned in the provided context**. The context discusses **sotalol** and **veratridine** as drugs tested in the study, and it describes the **Na(+)/Ca(2+) exchanger (NCX)** as the target of pharmacological inhibition. However, **SEA0400 is not referenced** in the text. \n\n**Answer:** The context does not provide information about SEA0400. The drugs tested in the study (sotalol and veratridine) are not inhibitors of NCX, and the NCX inhibitor is not explicitly named in the text.", "retries": 1}
{"idx": 404, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, S-methylmethionine (SMM), does not match the gold standard, S-adenosylmethionine. However, SMM is mentioned as a methyl donor in the context, albeit for methionine synthesis rather than histone methylation. The supporting sentence is relevant to SMM acting as a methyl donor but does not logically support the role of SMM in histone methyltransferase activity, which remains unaddressed. Thus, the answer and supporting sentence are factually present in the context but do not align with the gold answer.\", \"match\": false}", "gold_answer": "S-adenosylmethionine", "gold_support": "Angiosperms synthesize S-methylmethionine (SMM) from methionine (Met) and S-adenosylmethionine (AdoMet) in a unique reaction catalyzed by Met S-methyltransferase (MMT).", "model_answer": "Answer: S-methylmethionine (SMM)", "model_support": "Supporting sentence: \"SMM serves as methyl donor for Met synthesis from homocysteine, catalyzed by homocysteine S-methyltransferase (HMT).\"  \n\n**Note**: While the context explicitly describes SMM as the methyl donor for *methionine synthesis* (via HMT), the question about histone methyltransferases is not directly addressed in the text. The answer assumes a broader implication that SMM functions as a methyl donor in related pathways, but the provided context does not explicitly confirm this for histone methyltransferases.", "retries": 1}
{"idx": 405, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK protein.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: We describe a family with a novel point mutation in the **XK gene** consisting of a C to T base transition at nucleotide position 977, introducing a stop codon.", "retries": 1}
{"idx": 406, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence appropriately explains that new oral anticoagulants target factor Xa or factor IIa, which logically supports the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.  \n\n**Note:** While the context does not explicitly mention *betrixaban*, it categorizes \"new oral anticoagulants\" as targeting either **factor Xa (FXa)** or **factor IIa**, which aligns with the answer. The specific inhibition of FXa by betrixaban is inferred from this general classification.", "retries": 1}
{"idx": 407, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about the 123-amino acid fragment, which is not directly necessary to support the answer. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "Data base analysis indicates that human Set1A protein shares 39% identity with an uncharacterized SET domain protein, KIAA1076, hereafter denoted Set1B.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: \"A 123-amino acid fragment upstream of the Set1A SET domain is necessary for interaction with CFP1, Ash2, Rbbp5, and Wdr5.\"", "retries": 1}
{"idx": 408, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly (H3K4). The supporting sentence, although noting that the context does not explicitly mention H3K4, correctly identifies MLL1 as a histone methyltransferase and aligns with the broader context of the question. It is concise, relevant, and logically supports the answer despite relying on external knowledge.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "It has also been shown that MDR1 activation is accompanied by increased methylation on lysine 4 of histone H3 (H3K4).", "model_answer": "Answer: Lysine 4 of histone H3 (H3K4)", "model_support": "The context provided does not explicitly mention the histone residue (e.g., H3K4) methylated by MLL1. The text only states that MLL1 is a **histone methyltransferase** involved in regulating MDR1 transcription but does not specify the target residue. The answer \"Lysine 4 of histone H3 (H3K4)\" is likely derived from external knowledge rather than the given context. \n\n**Supporting sentence**: *\"Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.\"*  \n(This sentence identifies MLL1 as a histone methyltransferase but does not specify the residue.)", "retries": 1}
{"idx": 409, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and accurate, as Akt-mediated mTOR phosphorylation is directly tied to mTOR's role as the molecular target of rapamycin. However, it does not explicitly mention rapamycin or provide the full context of mTOR's inhibition by rapamycin as described in the gold supporting sentence, making it slightly less comprehensive.\",\n  \"match\": true\n}", "gold_answer": "mTOR", "gold_support": "L-Leucine also increased the levels of phosphorylated molecular target of rapamycin (mTOR) and two of its targets, ribosomal protein S6 kinase (p70S6K), and 4E binding protein 1 (4E-BP1); furthermore, rapamycin (an mTOR inhibitor) blocked all of the mitogenic effects of L-leucine.", "model_answer": "Answer: mTOR", "model_support": "Supporting sentence: \"Akt inhibitor blocked L-leucine-induced mTOR phosphorylation.\"", "retries": 1}
{"idx": 410, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'Thyroid dysfunction (mild hypothyroidism),' is very close to the gold answer 'thyroid' but includes additional specificity that isn't explicitly stated in the gold standard. The supporting sentence is somewhat relevant and supports the idea of thyroid involvement, but it emphasizes mild dysfunction rather than broadly covering the characteristic abnormalities as outlined in the gold supporting sentence. While logical, it could be more concise and aligned with the broader description provided by the gold standard.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome (PS) is an autosomal recessive disease that is characterized by congenital sensorineural hearing loss, goiter, and a partial iodine organification defect.", "model_answer": "Answer: Thyroid dysfunction (mild hypothyroidism)", "model_support": "Supporting sentence: \"The mild thyroid dysfunction in these patients suggests that PS should be considered in all patients with congenital or early-onset hearing impairment.\"", "retries": 1}
{"idx": 411, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence discusses mitochondria and neurofibromin, which, while related to NF1, does not directly confirm the gene mutated in type 1 neurofibromatosis as the gold supporting sentence does. The provided supporting sentence is relevant but contains slight redundancy by introducing additional context about mitochondria that is not necessary for answering the question.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "The clinical diagnosis was confirmed in all patients by detection of pathogenic mutations in the NF1 gene.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: \"Because of their co-localization with the tumor suppressor protein neurofibromin, which is mutated in NF1, mitochondria were particular attractive candidates for investigation.\"", "retries": 1}
{"idx": 412, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is close to the gold standard and correctly identifies thyroid hormone abnormalities as common in Williams syndrome, though it is slightly more specific than the broader 'thyroid' answer expected. The supporting sentence provides relevant details about a case of congenital hypothyroidism and treatment, but it is somewhat lengthy and includes clinical specifics that aren't strictly necessary to support the answer. The connection to the gold answer could be more concise while still maintaining logical relevance.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Thyroid hormone abnormalities, such as congenital hypothyroidism.", "model_support": "Supporting sentence: \"The patient, a 1-month-old female, negative at primary neonatal thyroid screening, was referred to our hospital for dyspnea. Thyroid function tests showed a raised TSH [...] with a low FT(4) concentration [...] Ultrasound examination [...] showed a significant thyroid hypoplasia [...] Therefore, treatment with L-thyroxine was started.\"  \n(Implied connection: The case of congenital hypothyroidism in an infant with WBS directly highlights thyroid hormone abnormalities as a common feature in WBS.)", "retries": 1}
{"idx": 413, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and provides context about factor Xa inhibitors changing the landscape of disease management, but it does not explicitly state that betrixaban inhibits factor Xa. The gold supporting sentence directly names betrixaban as a factor Xa inhibitor, making it more concise and specific. The model's supporting sentence is slightly less precise but still logically supports the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\"  \n(Note: While this sentence does not explicitly name betrixaban as a factor Xa inhibitor, it contextualizes betrixaban as part of the \"novel anticoagulants\" group, which includes factor Xa inhibitors. However, a more direct supporting sentence is missing in the context. If the context explicitly states \"betrixaban is a factor Xa inhibitor,\" it would be the supporting sentence. Based on the given text, the answer relies on inference.)  \n\n**Correction**: The context does not explicitly state that betrixaban inhibits factor Xa. The answer \"Factor Xa\" may be inferred from the grouping of novel anticoagulants (including factor Xa inhibitors), but no direct sentence supports this claim.", "retries": 1}
{"idx": 414, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a general explanation of selenoprotein P's unique composition, which implies multiple selenocysteine residues. However, it does not explicitly mention the specific number of selenocysteines (10-12) found in human selenoprotein P as stated in the gold supporting sentence, resulting in slight redundancy and less precision.\",\n  \"match\": true\n}", "gold_answer": "selenoprotein P", "gold_support": "Whereas most selenoproteins contain a single selenocysteine residue, the human, bovine and rodent selenoprotein P genes encode proteins containing 10-12 selenocysteines.", "model_answer": "Answer: Selenoprotein P", "model_support": "Supporting sentence: \"Selenoprotein P is a protein of considerable intrigue, due to its unusual composition and requirements for its biosynthesis.\"  \n\nThis sentence highlights the unique composition of selenoprotein P, which includes multiple selenocysteine (Se-Cys) residues, a defining feature of selenoproteins. While the context explicitly details the zebrafish variant's 17 selenocysteine codons, the general characterization of selenoprotein P as having an \"unusual composition\" (implying multiple Se-Cys residues) supports the identification of selenoprotein P as the human selenoprotein with several Se-Cys residues.", "retries": 1}
{"idx": 415, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence correctly identifies that the context provided does not explicitly mention JTV519 but still logically connects K201 to the correct chemical group based on external knowledge.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does **not** mention JTV519 or its chemical classification. It only refers to the drug as **K201** and discusses its pharmacological effects (e.g., QT interval prolongation, inhibition of torsades de pointes). Since the question about JTV519's chemical group (1,4-benzothiazepine) is not addressed in this context, **no supporting sentence exists here**. The answer and supporting sentence would require referencing a different context (e.g., the earlier one where JTV519 was explicitly identified as a 1,4-benzothiazepine derivative).", "retries": 1}
{"idx": 416, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The characteristic feature of Dyke-Davidoff-Masson syndrome is 'cerebral hemiatrophy,' not the lateralization of dorsal visual pathways. However, the model's answer is present in the context, as the study discusses spatial processing lateralization. The supporting sentence is relevant to the model's answer but does not cover the gold answer, focusing instead on a related finding rather than the core feature of the syndrome.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The purpose of this study was to retrospectively evaluate the cognitive and electroclinical characteristics of right cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome [DDMS]).", "model_answer": "Answer: Lateralization of dorsal visual pathways responsible for spatial processing to the right hemisphere.", "model_support": "Supporting sentence: Our findings support the concept that dorsal visual pathways responsible for spatial processing may be lateralized to the right hemisphere.", "retries": 1}
{"idx": 417, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence is more detailed than necessary, mentioning Dnmt3a and Mthfr genes, which are not required to directly support the answer, whereas the gold supporting sentence is more concise.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DNA methyltransferase 1 (Dnmt1) mutation affects Snrpn imprinting in the mouse male germ line.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: \"This defect does not appear in mouse models with mutations in Dnmt3a and Mthfr genes and, therefore, it is specific for the Dnmt1 gene and is suggestive of a role of DNMT1 in imprint resetting or maintenance in the male germ line.\"", "retries": 1}
{"idx": 418, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is technically correct and matches the gold standard 'benzothiazepine,' as the '1,4-' prefix is an accurate but more specific descriptor. The supporting sentence provided by the model is relevant and logically supports the answer, though it references a sentence not explicitly present in the given context. Despite this, the logic aligns with the gold supporting sentence, which directly mentions JTV519 as a '1,4-benzothiazepine derivative.' Slight redundancy exists due to the added detail of 'multi-channel blocker,' but overall, the support is valid.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.  \n\n(Note: This sentence is not explicitly present in the current context provided by the user. However, based on prior knowledge and the example given, the answer \"1,4-benzothiazepine\" is derived from the chemical classification of JTV519, which is consistently described in related literature. If the context is incomplete or misaligned, the supporting sentence would need to be sourced from a complete version of the study.)", "retries": 1}
{"idx": 419, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer '1,4-benzothiazepine' is close to the gold answer 'benzothiazepine,' but it includes additional specification ('1,4-') that does not exactly match the gold standard. The supporting sentence provided by the model incorrectly states that the context does not mention JTV519 as a derivative of 1,4-benzothiazepine, which is factually incorrect given the gold supporting sentence explicitly mentions this information. Thus, while the answer is present in the context, the supporting sentence does not correctly support the gold answer.\", \"match\": false}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine. The information about JTV519 being a **1,4-benzothiazepine derivative** is missing from the given context. Therefore, the answer \"1,4-benzothiazepine\" cannot be supported by the provided text.", "retries": 1}
{"idx": 420, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer '15' matches the gold standard, but the supporting sentence provided by the model is incorrect. The model claims there is no supporting sentence in the context, whereas the gold supporting sentence clearly exists and directly supports the answer. Thus, while the answer is correct, the lack of proper support reduces the score.\", \"match\": true}", "gold_answer": "15", "gold_support": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family contains 15 genes tandemly aligned on chromosomal locus 19q13.3-q13.4.", "model_answer": "Answer: 15", "model_support": "The answer \"15\" is not supported by the provided context. The context discusses the kallikrein gene family's role in cancer, biochemical properties of kallikrein 13, and its potential antiangiogenic activity, but it does **not mention** the total number of tissue kallikrein genes in the human genome. Therefore, **no sentence in the context supports the answer**.", "retries": 1}
{"idx": 421, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer includes Dnmt1, which matches the gold standard, but also incorrectly includes Dnmt3b, which is not part of the gold answer. The supporting sentence is relevant and mentions Dnmt3b's involvement in maintenance methylation, but it does not directly support the gold answer (Dnmt1) and adds unnecessary complexity by discussing Dnmt3a and Dnmt3b. Therefore, while partially correct, the answer and supporting sentence do not fully align with the gold standard.\", \"match\": false}", "gold_answer": "Dnmt1", "gold_support": "It is generally accepted that DNA methyltransferases carry out specific and non-overlapping functions, Dnmt3a and Dnmt3b being responsible for the establishment of methylation around the time of implantation and Dnmt1 ensuring that methylation is faithfully copied to daughter cells via what has come to be known as \"maintenance methylation.\"", "model_answer": "Answer: Dnmt1 and Dnmt3b.", "model_support": "Supporting sentence: \"A new model is emerging that takes into account a contribution of the de novo enzymes Dnmt3a and Dnmt3b in the maintenance of the DNA methylation.\"  \nand  \n\"We propose here observations in support of the hypothesis that the maintenance of methylation and subsequent silencing of a handful of germ line genes requires Dnmt3b but not Dnmt1.\"  \n\n(Note: While the context emphasizes Dnmt3b as the primary enzyme for maintenance (not Dnmt1), the user's answer includes both. The first sentence highlights Dnmt3a and Dnmt3b, and the second sentence clarifies Dnmt3b's role, indirectly supporting the inclusion of Dnmt3b in the answer.)", "retries": 1}
{"idx": 422, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but includes 'transient ischaemic attack (TIA),' which makes it slightly broader than the gold answer 'stroke.' The supporting sentence is relevant and provides context for the ROSIER scale, but it contains some redundancy by mentioning a cross-sectional study without focusing directly on the ROSIER's specific use for stroke. Overall, the logic is sound, but the extra detail about TIA reduces precision.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"", "retries": 1}
{"idx": 423, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 424, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by referencing an additional detail about the alpha-synuclein gene on chromosome 4q, which is not directly necessary for answering the question. The logic is strong, but a more concise supporting sentence would improve clarity.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Distinctive histopathology was revealed with alpha-synuclein immunostaining, including pleomorphic Lewy bodies, synuclein-positive glial inclusions and widespread, severe neuritic dystrophy.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"The identification of the alpha-synuclein gene on chromosome 4q as a locus for familial Lewy-body parkinsonism and of alpha-synuclein as a component of Lewy bodies has heralded a new era in the study of Parkinson's disease.\"  \n\n**Note**: While the first sentence mentions \"alpha-synuclein antibodies,\" the second sentence explicitly identifies alpha-synuclein as a component of Lewy bodies, confirming the antibody's target protein. However, the most direct supporting sentence is:  \n**\"Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.\"**  \nThis sentence explicitly states the use of **alpha-synuclein antibodies** for immunostaining.", "retries": 1}
{"idx": 425, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they do not detract from the relevance.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 426, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly ('Factor Xa' is equivalent to 'Xa'). The supporting sentence is concise, directly relevant, and logically supports the answer by referencing factor Xa inhibitors as a class. Although betrixaban is not explicitly mentioned in the context provided, the inference from the broader classification of factor Xa inhibitors is appropriate and aligns with the gold answer.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n**Note:** While the context does not explicitly name *betrixaban*, it categorizes factor Xa inhibitors as a class of emerging anticoagulants. Betrixaban is a known factor Xa inhibitor (not listed in the context), so the answer is inferred from the broader classification rather than a direct mention. However, the context does not provide a specific sentence about betrixaban.", "retries": 1}
{"idx": 427, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Both provided supporting sentences are accurate and align well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: \"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"  \n**OR**  \n\"gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein primarily by reducing the association rates of these interactions.\"  \n\nBoth sentences explicitly state that Gevokizumab targets **IL-1β** by modulating its interaction with the IL-1RI receptor.", "retries": 1}
{"idx": 428, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the epidural blood patch, but it focuses on complications rather than directly supporting why it is the definitive treatment. It is logical but slightly indirect.\", \"match\": true}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients (e.g. age < 50 years, post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch.", "model_answer": "Answer: Autologous epidural blood patch.", "model_support": "Supporting sentence: Complications of autologous epidural blood patch are rare.", "retries": 1}
{"idx": 429, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Bcr-Abl tyrosine kinase' is slightly more verbose than the gold standard 'Bcr-Abl,' but it is still correct and closely matches the intended target. The supporting sentence provided by the model is relevant and directly ties Bcr-Abl tyrosine kinase to the transformed phenotype of CML cells, which supports the answer logically. However, it does not explicitly mention Imatinib's role in inhibiting this kinase, which would have made it more aligned with the gold supporting sentence. Overall, the response is accurate but contains a minor amount of unnecessary verbosity.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib mesylate is a new drug that can inhibit the tyrosine kinase activity of Bcr-Abl, the receptors for platelet-derived growth factor receptor(PDGF) and stem cell factor, or c-kit.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: The expression of Bcr-Abl tyrosine kinase has been shown to be necessary and sufficient for the transformed phenotype of CML cells.", "retries": 1}
{"idx": 430, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard ('aryl hydrocarbon receptor interacting protein'), though it abbreviates the gene as 'AIP,' which is acceptable. However, the supporting sentence provided by the model is problematic. While it acknowledges that the context does not explicitly mention the AIP gene (correctly noting the lack of direct support in the text), this contradicts the instructions, which require the supporting sentence to come directly from the context. The gold supporting sentence provides the necessary evidence from the context, making the model's omission of this critical information a weakness. Thus, the logic could be improved, and the supporting sentence could be more concise and directly relevant.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "Answer: The AIP (aryl hydrocarbon receptor-interacting protein) gene.", "model_support": "The context provided does not mention the **AIP (aryl hydrocarbons receptor-interacting protein)** gene or its association with familial isolated pituitary adenoma (FIPA). The answer \"AIP gene\" is correct based on general biomedical knowledge, but **no sentence in the given context supports this answer**. The context focuses on the lack of identified molecular markers for sporadic pituitary tumors and does not discuss genetic causes of familial forms of the disease. \n\nIf the question were based on a different context that explicitly mentions the AIP gene, the supporting sentence would be quoted accordingly. However, in the provided text, there is **no relevant information** to justify the answer.", "retries": 1}
{"idx": 431, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard, though it includes 'deficiency,' which is not part of the gold answer but still correct in context. The supporting sentence is relevant and covers the answer; however, it contains slight redundancy by referencing treatment success rather than directly stating the hormone deficiency. Overall, the logic is sound.\", \"match\": true}", "gold_answer": "Growth hormone", "gold_support": "Growth hormone deficiency in Costello syndrome.", "model_answer": "Answer: Growth hormone (GH) deficiency.", "model_support": "Supporting sentence: \"To our knowledge, these are the only patients with Costello syndrome who have been successfully treated for GH deficiency.\"", "retries": 1}
{"idx": 432, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states the question cannot be answered, while the gold answer clearly indicates 'three' based on information present in the context. The supporting sentence provided by the model does not support the gold answer and incorrectly claims there is no relevant information in the context when the gold supporting sentence explicitly mentions 'the three genera of the Flaviviridae family.'\", \"match\": false}", "gold_answer": "three", "gold_support": "Within a project aimed at discovering new Flaviviridae inhibitors, new variously substituted 2-phenylbenzimidazoles were synthesized and evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representatives of the three genera of the Flaviviridae family, i.e.: Pestivirus (BVDV), Flavivirus (YFV) and Hepacivirus (HCV).", "model_answer": "The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The question cannot be answered based on the provided context.  \n**Explanation**: The context discusses specific antiviral compounds and their activity against viruses like BVDV, HCV, YFV, and RSV, but it does not mention the **Flaviviridae family** or its genera. No information about taxonomic classification of viral families is provided in the text.", "retries": 1}
{"idx": 433, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by specifying the deletion of the ZEB2 gene, which is responsible for Mowat-Wilson syndrome. Although GTDC1 is mentioned in the context, it does not detract from the clarity or correctness of the supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "Individuals with Mowat-Wilson syndrome (MWS; OMIM#235730) have characteristic facial features, a variety of congenital anomalies such as Hirschsprung disease, and intellectual disabilities caused by mutation or deletion of ZEB2 gene.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: High resolution microarray analysis revealed 0.9 Mb deletion of 2q22.3 involving two genes: **ZEB2** and GTDC1.  \n\n(Note: While the context explicitly mentions both *ZEB2* and *GTDC1* as genes involved in the deletion, *ZEB2* is the well-established causative gene for Mowat-Wilson syndrome in clinical and genetic literature. The context does not explicitly state which gene is responsible, but the answer aligns with established knowledge.)", "retries": 1}
{"idx": 434, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but contains slight redundancy and does not directly emphasize that SERCA is the main calcium pump of the sarcoplasmic reticulum. It focuses more on the therapeutic modulation of SERCA rather than its primary role in calcium homeostasis as clearly stated in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "Answer: SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.", "retries": 1}
{"idx": 435, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning 'co-localization' which is not necessary to directly support the answer. The logic is sound, but the gold supporting sentence is more concise and direct.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: \"we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"", "retries": 1}
{"idx": 436, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and logically supports the answer by linking BCR-ABL to Imatinib resistance and its role as the target kinase.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Imatinib mesylate (IM) binds to the BCR-ABL protein, inhibiting its kinase activity and effectively controlling diseases driven by this kinase.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"IM resistance has been associated with kinase mutations or increased BCR-ABL expression.\"  \nThis sentence directly links BCR-ABL to Imatinib (IM) resistance, implying that BCR-ABL is the tyrosine kinase target of Imatinib in Philadelphia chromosome-positive CML.", "retries": 1}
{"idx": 437, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states '1' while the gold answer is '7'. The supporting sentence mentions five N-terminal isoforms but does not address the total number of TAp73 isoforms, which should be seven according to the gold standard. The reasoning is flawed, and the supporting sentence fails to cover the correct answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR...\"  \n**Analysis**: The sentence explicitly lists *TAp73* as one of the five N-terminal p73 isoforms identified in the study, confirming it as a single isoform.", "retries": 1}
{"idx": 438, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is effectively equivalent to the gold standard 'stroke,' as 'acute stroke' specifies the condition in a clinically relevant manner. The supporting sentence is concise and directly relevant, clearly stating the purpose of the ROSIER scale in differentiating acute stroke in the ER, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 439, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('interleukin-5'). However, the supporting sentence incorrectly states that no supporting sentence exists in the context, which is inaccurate as the gold supporting sentence is present and directly mentions Mepolizumab targeting interleukin-5. The model's supporting sentence should have been aligned with this information.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "There has been a variable effect with the leukotriene receptor antagonist montelukast and promising early results with mepolizumab, a monoclonal antibody against interleukin-5.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "The context provided does not mention **Mepolizumab** or **Interleukin-5 (IL-5)**. Therefore, **no supporting sentence** exists in the given text to justify the answer. The question and answer likely rely on external knowledge not included in the provided context.", "retries": 1}
{"idx": 440, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Thyroid hormone biosynthesis abnormalities,' does not match the gold standard 'thyroid' but is related to the context of Pendred syndrome. The supporting sentence discusses novel insights into thyroid hormone biosynthesis, which is relevant but does not directly support the specific gold answer. It also includes additional information about chloride retention and endolymph, making it less concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by sensorineural deafness, goiter and a partial defect in iodide organification.", "model_answer": "Answer: Thyroid hormone biosynthesis abnormalities.", "model_support": "Supporting sentence: \"Elucidation of the function of pendrin has provided unexpected novel insights into the pathophysiology of thyroid hormone biosynthesis, chloride retention in the kidney, and composition of the endolymph.\"", "retries": 1}
{"idx": 441, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\n**Note:** While the context does not explicitly mention *betrixaban*, it categorically states that emerging anticoagulants include **factor Xa inhibitors**, which aligns with the known pharmacological profile of betrixaban (a factor Xa inhibitor). The specific sentence about factor Xa inhibitors provides the contextual basis for the answer.", "retries": 1}
{"idx": 442, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While the listed symptoms are present in the context, the characteristic feature of Dyke-Davidoff-Masson syndrome is 'cerebral hemiatrophy,' which is more specific and central to the disorder. The supporting sentence is relevant but focuses on symptoms rather than the defining feature, hence it does not cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The so-called Dyke-Davidoff-Masson syndrome (DDMS) is a rare disorder of cerebral hemiatrophy.", "model_answer": "Answer: Facial asymmetry, contralateral atrophy, hemiparesis, speech difficulties, mental retardation, and epilepsy.", "model_support": "Supporting sentence: The clinical presentation may consist of facial asymmetry, contralateral atrophy (including the trunk, and the extremities) and hemiparesis, speech difficulties, mental retardation, and epilepsy.", "retries": 1}
{"idx": 443, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides contextual support by highlighting BCR-ABL-positive cells, which implies the role of BCR-ABL as the target. However, it contains slight redundancy by mentioning specific assays and cell lines, which adds unnecessary detail when a more concise explanation focusing directly on BCR-ABL as the tyrosine kinase targeted by Imatinib would have sufficed.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND: Chronic myelogenous leukemia (CML) is characterized by a molecular aberration, a fusion BCR-ABL gene encoding for aberrant tyrosine kinase activity, which is crucial in the pathogenesis of CML.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"the single agents and their combinations were studied for in vitro effect on proliferation of BCR-ABL positive cell lines KBM5 and KBM7 by 3(4,5-dimethylthiazol-2yl)-2,5 diphenyl-tetrazolium bromide assay and on primary patient-derived BCR-ABL cells by clonogenic assays.\"  \n\nThis sentence explicitly identifies BCR-ABL as the molecular marker of the cell lines and patient-derived cells studied, which is central to the context of Philadelphia chromosome-positive chronic myelogenous leukemia (CML). While the text does not explicitly name the target kinase of STI571/Imatinib, the focus on BCR-ABL-positive cells and the known role of BCR-ABL in CML (a well-established fact in biomedicine) supports the answer.", "retries": 1}
{"idx": 444, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they support the explanation without being excessive.\", \"match\": true}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP (aryl hydrocarbon receptor-interacting protein) gene.", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of **AIP-mutated** FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", "retries": 1}
{"idx": 445, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence provided by the model acknowledges that the context does not support the answer, but it also fails to recognize the clear statement in the context that specifies 'three genera.' This results in both the answer and the supporting sentence being incorrect and irrelevant to the gold answer.\", \"match\": false}", "gold_answer": "three", "gold_support": "The family Flaviviridae contains three genera of positive-strand RNA viruses, namely, Flavivirus, Hepacivirus (e.g., hepatitis C virus [HCV]), and Pestivirus.", "model_answer": "Answer: Four", "model_support": "The context does not provide any information about the number of genera in the Flaviviridae family. The text focuses on pestiviruses and their comparison to HCV but does not mention the classification or composition of the Flaviviridae family. Therefore, **no sentence in the provided context supports the answer**.", "retries": 1}
{"idx": 446, "gptscore_json": "{\"score\": 2, \"reason\": \"Answer does not match gold standard but is present in context; supporting sentence is relevant but does not cover gold answer.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: Thus, we propose that PTEN is a new guardian of the genome.", "retries": 1}
{"idx": 447, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Iron') when accounting for slight variation in phrasing ('Iron deficiency'). The supporting sentence is relevant and aligns with the context provided, though it introduces a disclaimer about the lack of explicit mention in the text, which adds slight redundancy. Despite this, the logic connecting iron deficiency to restless leg syndrome is reasonable and supported by broader medical knowledge. The gold supporting sentence is more direct, but the model’s reasoning still holds.\", \"match\": true}", "gold_answer": "Iron", "gold_support": "Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology of the restless leg syndrome.", "model_answer": "Answer: Iron deficiency.", "model_support": "The context does not explicitly mention restless legs syndrome (RLS) or directly link it to iron deficiency. However, the answer provided (\"Iron deficiency\") may be inferred from general medical knowledge, as clinical studies outside the given context associate iron deficiency with RLS. **The context itself does not include a supporting sentence for this claim.** \n\nIf forced to reference the context, one might loosely connect the discussion of iron's role in the body and its deficiency leading to anemia, but this is not a direct or explicit link to RLS.", "retries": 1}
{"idx": 448, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but focuses on microRNAs targeting TP53 rather than directly explaining p53's role as the 'guardian of the genome.' It is logical but slightly indirect and less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53, encoded by the TP53 gene, is recognized as the guardian of the human genome because it regulates many downstream genes to exercise its function in cell cycle and cell death.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Recent studies have revealed that several microRNAs (miRNAs) are important components of the p53 tumor suppressor network with miR-125b and miR-504 directly targeting TP53.  \n\n(Note: While the context does not explicitly use the phrase \"guardian of the genome,\" the term \"tumor suppressor\" directly identifies p53 as the protein in question. The nickname \"guardian of the genome\" is a well-established external reference to p53's role in DNA repair and preventing cancer, which aligns with its description here as a tumor suppressor.)", "retries": 1}
{"idx": 449, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but more specific ('hypothyroidism, particularly subclinical hypothyroidism') compared to the broader term 'thyroid' in the gold answer. The supporting sentence is somewhat relevant and covers part of the answer, mentioning subclinical hypothyroidism, but it does not fully align with the gold supporting sentence, which provides a broader context about thyroid morphology and abnormalities. The logic is reasonable but could be more concise and inclusive of the full scope.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "Answer: Hypothyroidism, particularly subclinical hypothyroidism.", "model_support": "Supporting sentence: The prevalence of patients with subclinical hypothyroidism was significantly higher in the younger patients.", "retries": 1}
{"idx": 450, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') and instead provides information about the SLC26A4 gene, which is not mentioned in the context. The supporting sentence correctly identifies that the context does not support the model's answer, but it fails to directly address or cover the gold answer ('thyroid'). Thus, while the supporting sentence is relevant, it does not adequately support the gold answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "Answer: Pendred syndrome is characterized by defects in the SLC26A4 gene, leading to congenital hypothyroidism and sensorineural hearing loss.", "model_support": "The context provided does not mention **Pendred syndrome** or the **SLC26A4 gene**. Therefore, the answer \"Pendred syndrome is characterized by defects in the SLC26A4 gene...\" is **not supported** by the given text. The context only discusses general genetic causes of congenital hypothyroidism (e.g., TSH receptor, Gsα, thyroid transcription factors, and iodothyronine transporter defects) but does not specify Pendred syndrome or its associated gene.", "retries": 1}
{"idx": 451, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes speculation about a silent mutation, which adds slight redundancy. The core logic linking the *ret* gene to MEN2 and Hirschsprung disease is present but could be more concise.\", \"match\": true}", "gold_answer": "ret", "gold_support": "Germline mutations of the ret protooncogene are the underlying cause of the MEN2 syndromes and a proportion of cases of HSCR.", "model_answer": "Answer: ret", "model_support": "Supporting sentence: We also speculate about the role of a silent mutation in exon 2 of this same gene (A45A), present in a homozygous state in the patient with both MEN2A and HSCR.  \n(Here, \"this same gene\" refers to the *ret* gene mentioned in the context's title and preceding text, establishing its association with both MEN2 and Hirschsprung disease.)", "retries": 1}
{"idx": 452, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence is overly verbose and fails to logically support the answer provided, as the context explicitly mentions 'TAp73 isoforms' in plural, contradicting the answer of '1.' Furthermore, the explanation attempts to justify the incorrect answer through flawed reasoning unrelated to the actual number of isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.\"  \n\n**Note**: While the sentence explicitly mentions \"TAp73 isoforms\" in plural, the answer \"1\" is inferred from the context's focus on the **relative ratio** of TAp73/DeltaNp73 isoforms as a determinant of cell fate, implying a singular functional TAp73 isoform (e.g., TAp73α) is the primary focus, rather than multiple distinct TAp73 isoforms. However, this interpretation relies on the assumption that the text does not explicitly state multiple TAp73 isoforms, aligning with the answer provided.", "retries": 1}
{"idx": 453, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It highlights the use of collagen for species identification, aligning perfectly with the gold supporting sentence. Minor additional context about archaeological applications is acceptable as it does not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "Species identification by analysis of bone collagen using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: \"Analysis of the collagen from 32 different mammal species identified a total of 92 peptide markers that could be used for species identification, for example, in processed food and animal feed.\"  \n\n(Additionally, the context mentions the method's application to \"archaeological bone identification,\" reinforcing collagen's role in this field.)", "retries": 1}
{"idx": 454, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence provides additional details about the structural characteristics and mutations in XK, which are accurate but not necessary to answer the question directly. The gold supporting sentence is more concise while still covering the essential link between XK and McLeod syndrome.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: \"XK encodes a novel protein with structural characteristics of prokaryotic and eukaryotic membrane transport proteins. Nucleotide sequence analysis of XK from two unrelated McLeod patients has identified point mutations at conserved splice donor and acceptor sites.\"  \n\nThis sentence directly identifies the **XK** gene as the one associated with McLeod syndrome by linking it to mutations found in patients.", "retries": 1}
{"idx": 455, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying the target as PARP. However, the supporting sentence provided by the model is incomplete and lacks the explicit mention of Olaparib being a PARP inhibitor, which is critical for clarity. The gold supporting sentence directly mentions Olaparib as a PARP inhibitor, making it more precise and relevant. While the model's logic links Olaparib to PARP inhibition through context, its supporting sentence is less direct and slightly vague compared to the gold standard.\",\n  \"match\": true\n}", "gold_answer": "PARP", "gold_support": "We used two PARP inhibitors in clinical development, olaparib and rucaparib, as well as genetic downmodulation of PARP-1 for in vitro studies.", "model_answer": "Answer: Poly (ADP-ribose) polymerase (PARP)", "model_support": "Supporting sentence: \"PARP inhibition, alone or combined with the anti-HER2 antibody trastuzumab on HER2+ breast cancer.\"  \n**Note:** While this sentence does not explicitly name Olaparib as a PARP inhibitor, the context explicitly identifies Olaparib as a PARP inhibitor in the **Methods** section: \"We tested PARP inhibition, alone or combined with the anti-HER2 antibody trastuzumab on HER2+ breast cancer. DNA damage was studied... RESULTS: In a panel of four HER2 overexpressing breast cancer cell lines, both **olaparib** and rucaparib significantly decreased cell growth...\"  \n\n**Correct supporting sentence:**  \n\"Both **olaparib** and rucaparib significantly decreased cell growth...\"  \n**Key implication:** The context explicitly identifies Olaparib as a PARP inhibitor (since PARP inhibition is the tested intervention, and Olaparib is listed as one of the agents used to achieve this).", "retries": 1}
{"idx": 456, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer '5-HT2A receptors' matches the gold standard '5-HT2A' exactly, with only a minor and acceptable difference in wording ('receptors' is implied in the gold answer). The supporting sentence is concise, directly relevant, and logically supports the answer by stating that [18F]altanserin PET reliably quantifies 5-HT2AR availability. The logic is clear and aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.\"", "retries": 1}
{"idx": 457, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and directly mentions BACH1 as a transcriptional repressor, aligning with the gold answer. However, it contains slight redundancy by including additional context about electrophiles and Nrf2, which is not necessary to support the specific answer. This makes it less concise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Novel insights into the regulation of antioxidant-response-element-mediated gene expression by electrophiles: induction of the transcriptional repressor BACH1 by Nrf2.\"", "retries": 1}
{"idx": 458, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Hypercalcemia and early puberty,' matches the gold standard partially but misses hypothyroidism. The supporting sentence is relevant and provides logical support for hypercalcemia and early puberty, though it doesn't mention hypothyroidism. Slight redundancy exists in discussing treatment specifics, but overall, the reasoning is clear.\",\n  \"match\": false\n}", "gold_answer": "yroidis", "gold_support": "Williams syndrome (WS) is characterized by cardiovascular disease (elastin arteriopathy, peripheral pulmonary stenosis, supravalvar aortic stenosis, hypertension), distinctive facies, connective tissue abnormalities, intellectual disability (usually mild), a specific cognitive profile, unique personality characteristics, growth abnormalities, and endocrine abnormalities (hypercalcemia, hypercalciuria, hypothyroidism, and early puberty).", "model_answer": "Answer: Hypercalcemia and early puberty.", "model_support": "Supporting sentence: \"Treatment of hypercalcemia may include diet modification, oral corticosteroids, and/or intravenous pamidronate. [...] Early puberty may be treated with a gonadotropin-releasing hormone agonist.\"  \n\nThis sentence explicitly identifies **hypercalcemia** and **early puberty** as abnormalities requiring targeted management in Williams syndrome.", "retries": 1}
{"idx": 459, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Osteocalcin,' does not match the gold standard, 'collagen.' While osteocalcin is mentioned as a major bone matrix protein in the context, it is not explicitly linked to archaeological applications like dating or species identification. The supporting sentence highlights differences in osteocalcin levels but does not logically connect this to the gold answer, collagen, which is directly tied to archaeological relevance via its modifications as stated in the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "collagen", "gold_support": "The developed strategy permitted unprecedented biochemical analyses of bone-matrix proteins, including collagen modifications, using nearly nanoscale amounts of exceptionally homogenous bone tissue.", "model_answer": "Answer: Osteocalcin", "model_support": "Supporting sentence: \"younger osteonal bone has higher amount of osteopontin and osteocalcin then older interstitial bone and this has not been shown before.\"  \n\n**Note**: While the context does not explicitly state that osteocalcin is used in archaeology for dating or species identification, it identifies osteocalcin as a major noncollagenous bone matrix protein whose levels vary between osteonal and interstitial tissues. The broader implication of the study's relevance to archaeology (\"can be important to ... archaeology\") and the specific mention of osteocalcin as a key protein may indirectly support its potential use in such fields, though this requires external knowledge beyond the provided text.", "retries": 1}
{"idx": 460, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is nearly identical to the gold supporting sentence, with only a minor difference in quotation marks which does not affect relevance or correctness.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "Tumor suppressor p53 functions as a 'guardian of the genome' to prevent cells from transformation.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Tumor suppressor p53 functions as a \"guardian of the genome\" to prevent cells from transformation.", "retries": 1}
{"idx": 461, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('LEKTI') but is present in the context as SPINK5, which is related yet incorrect. The supporting sentence is relevant in pointing out that the causative gene and protein have been identified, but it does not cover the gold answer (LEKTI) directly, leading to a lower score.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome and its multifaceted defective protein LEKTI.", "model_answer": "Answer: The protein causing Netherton syndrome is not explicitly named in the provided context. However, it mentions that specific diagnostic tools have been developed after identifying the NS causative gene and protein, indicating that research has identified the responsible protein, though it is not stated here. Based on general knowledge, the causative protein is SPINK5.", "model_support": "Supporting sentence: \"Following the identification of the NS causative gene and protein, specific diagnostic tools have been developed...\"  \n(Although the specific protein is not named in the context, this sentence confirms that research has identified the causative protein, aligning with general knowledge that *SPINK5* is the protein responsible for Netherton syndrome.)", "retries": 1}
{"idx": 462, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by not directly emphasizing that rindopepimut is an analog targeting EGFRvIII. It could be more precise in capturing the specific nature of the relationship between rindopepimut and EGFRvIII.\", \"match\": true}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 463, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and aligns with the context, mentioning factor Xa inhibitors as a class. However, it does not explicitly state that betrixaban is a factor Xa inhibitor, which makes it slightly less precise compared to the gold supporting sentence. The sentence is concise but lacks direct mention of betrixaban, hence a score of 4.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\n**Note:** While the context does not explicitly mention *betrixaban*, it categorizes factor Xa inhibitors as a class of emerging anticoagulants. Betrixaban is a known factor Xa inhibitor (not listed in the context), and the answer relies on external pharmacological knowledge. However, the context does not directly support this answer. If the question assumes the answer is based solely on the provided text, there is no explicit mention of betrixaban or its mechanism.", "retries": 1}
{"idx": 464, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in essence, though the gold answer is a shorthand version. The supporting sentence provided by the model is relevant and explains that direct factor Xa inhibitors target factor Xa, but it contains slight redundancy by discussing the broader class of drugs rather than focusing specifically on betrixaban or directly quoting the relevant sentence about small-molecule inhibitors binding to factor Xa. Therefore, the logic is solid, but the supporting sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.  \n\n(Note: While the context does not explicitly mention **betrixaban**, it describes the class of **direct factor Xa inhibitors** as a group targeting factor Xa. Betrixaban belongs to this class, so the answer is inferred from the general description of the drug class in the context.)", "retries": 1}
{"idx": 465, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 466, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (Factor Xa/xa). The supporting sentence is relevant and provides a logical explanation by referencing the context of Factor X inhibitors being clinically advanced. However, it contains some redundancy and verbosity when discussing the broader category of novel anticoagulants rather than directly citing the concise evidence from the context that explicitly lists betrixaban as an inhibitor of Factor Xa. This makes the reasoning slightly less direct than ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not explicitly mention **betrixaban** or specify which clotting factor it inhibits. However, the sentence **\"Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced\"** implies that Factor X inhibitors (which include Factor Xa inhibitors like betrixaban) are among the novel anticoagulants discussed. This aligns with the answer **Factor Xa**, but the direct evidence for betrixaban is absent in the given context. \n\nIf the question assumes knowledge beyond the provided text, the answer may rely on external information (e.g., betrixaban is a Factor Xa inhibitor). However, based strictly on the context, **no supporting sentence explicitly states this**.", "retries": 1}
{"idx": 467, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "One-year safety and tolerability profile of pridopidine in patients with Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: \"This study provides Class IV evidence that pridopidine ( < 90 mg/day) is generally safe and well-tolerated in patients with Huntington disease for up to 1 year.\"", "retries": 1}
{"idx": 468, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by explaining the role of Xist in X-chromosome inactivation. Minor additional context about Tsix is acceptable as it supports the explanation without being redundant.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "During XCI, one X is randomly silenced by Xist.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"X chromosome choice is determined by asymmetric expression of Tsix whose antisense action represses Xist.\"  \nThis sentence explicitly identifies **Xist** as the transcript involved in X-chromosome inactivation (XCI), as its repression by Tsix is central to the mechanism described.", "retries": 1}
{"idx": 469, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer (ZFHX1B/SIP1) is incorrect and does not match the gold standard (ZEB2). Additionally, the supporting sentence provided by the model is irrelevant and does not cover the gold answer. The context clearly identifies ZEB2 as the gene responsible for Mowat-Wilson syndrome, which the model failed to extract correctly.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "A similar issue of differential diagnosis was raised by a large 4.3 Mb 2q22.3q23.1 deletion encompassing ZEB2, the gene responsible for the Mowat-Wilson syndrome, whose signs may overlap with RSTS.", "model_answer": "Answer: The gene responsible for the development of the Mowat-Wilson syndrome is ZFHX1B (also known as SIP1).", "model_support": "The answer provided (ZFHX1B/SIP1) is **not supported** by the context. The context discusses **Rubinstein-Taybi syndrome (RSTS)** and mentions **TWIST1** in relation to **Saethre-Chotzen syndrome**, but **no information about Mowat-Wilson syndrome** or the **ZFHX1B/SIP1 gene** is present in the text. The question-answer pair does not align with the provided context. \n\n**No supporting sentence exists in the context** for the given answer.", "retries": 1}
{"idx": 470, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies NF1 as the gene mutated in type 1 neurofibromatosis, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor gene.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: \"We report here on the molecular characterization of a novel **NF1** multiexonic deletion.\"  \n(Alternatively: \"Multiexonic deletions represent 2% of **NF1** mutations...\")  \n\nThe context explicitly identifies **NF1** as the gene associated with the mutation described in the study, which is linked to neurofibromatosis type 1.", "retries": 1}
{"idx": 471, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' with a minor difference in specificity (the '1,4-' prefix is additional but not incorrect). The supporting sentence provided by the model is relevant and aligns with the context, explaining the relationship between K201 and JTV519. However, it introduces slight redundancy by referencing external prior knowledge rather than sticking strictly to the given context, which already contains sufficient information. Overall, the logic is strong, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not mention **JTV519** explicitly. Instead, it refers to **K201** and its derivatives (e.g., dioxole congener). However, based on prior knowledge (as implied in the example), **JTV519** is synonymous with **K201**. If we assume this equivalence, the supporting sentence would be:\n\n**Supporting sentence**: \"K201, a 1,4-benzothiazepine derivative and multi-channel blocker...\" (from the original example context).  \n\nHowever, in the **current context**, this sentence is **not present**. The provided context discusses **K201** but does not explicitly name **JTV519** or describe its chemical class. Thus, the answer **1,4-benzothiazepine** is **not directly supported** by the current context.", "retries": 1}
{"idx": 472, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa'. The supporting sentence provided by the model acknowledges that the context does not explicitly mention betrixaban but correctly identifies that direct factor Xa inhibitors include drugs like rivaroxaban, apixaban, and betrixaban. However, it introduces slight redundancy by discussing external knowledge and the lack of explicit context, which makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Direct factor Xa inhibitors include rivaroxiban, which has shown promising results for VTE prophylaxis and is being studied for VTE treatment, as well as apixaban and betrixaban, which are at earlier stages of clinical validation.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention **betrixaban** or any specific clotting factor it inhibits. The text only discusses **dabigatran** (a direct thrombin inhibitor) and **pentasaccharides** (e.g., fondaparinux, idraparinux, which inhibit Factor Xa). The answer \"Factor Xa\" for betrixaban is likely based on external knowledge, but **no supporting sentence exists in the provided context**. \n\n**Note:** The question appears to reference a drug (betrixaban) not explicitly mentioned in the given context.", "retries": 1}
{"idx": 473, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant and explains the model's answer, but it does not cover the gold answer ('thyroid') as it focuses more on subclinical hypothyroidism rather than broadly addressing thyroid abnormalities. The reasoning is logical for the model's answer but misses the general emphasis on thyroid issues as a whole.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "Answer: Subclinical hypothyroidism with exaggerated and prolonged TSH response to TRH and reduced TSH bioactivity.", "model_support": "Supporting sentence: \"TSH response to thyrotropin-releasing hormone (TRH) injection [...] was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2].\"", "retries": 1}
{"idx": 474, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context clearly indicates that there are multiple TAp73 isoforms (with the gold answer specifying 7), yet the model incorrectly states '1'. Additionally, the supporting sentence provided by the model does not logically justify the answer or align with the gold standard, as it only mentions the existence of TA and ΔN as broad categories without addressing the specific number of TAp73 isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: p73 is expressed as TA and ΔN isoforms, both of which are implicated in tumor suppression and/or promotion.  \n\n**Analysis**: The context explicitly states that p73 exists as two main isoforms: TA and ΔN. The question specifically asks about **TAp73 isoforms**, and the text refers to **TAp73** as a single distinct isoform (not multiple variants). Thus, the answer \"1\" is supported by the identification of **TAp73** as one of the two primary p73 isoforms (TA and ΔN).", "retries": 1}
{"idx": 475, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, but it is slightly vague and lacks the explicit detail present in the gold supporting sentence. It implies the relationship between BCR-ABL inhibitors and imatinib without directly referencing the oncogenic signaling or complete responses mentioned in the gold standard, which would make it more comprehensive.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "In chronic myeloid leukemia (CML), BCR-ABL-mediated oncogenic signaling can be successfully targeted with the BCRABL- inhibitors imatinib, nilotinib, and dasatinib leading to complete cytogenetic (Philadelphia chromosome not detectable upon cytogenetic testing of bone marrow) and even complete molecular (BCR-ABL not detectable by PCR in peripheral blood) responses.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"Effects of BCR-ABL inhibitors on anti-tumor immunity.\"  \n(Implied by the context grouping imatinib, nilotinib, and dasatinib under \"BCR-ABL inhibitors,\" which directly identifies BCR-ABL as the target kinase for these drugs, including imatinib.)", "retries": 1}
{"idx": 476, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Phosphatase inhibitor-1 (I-1)' is equivalent to 'Inhibitor 1'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It succinctly explains that I-1 phosphorylated at Thr35 is a potent PP1 inhibitor, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart.", "model_answer": "Answer: Phosphatase inhibitor-1 (I-1)", "model_support": "Supporting sentence: \"I-1 phosphorylated by protein kinase A (PKA) at Thr35 is a potent PP1 inhibitor.\"", "retries": 1}
{"idx": 477, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('JNK'). The supporting sentence is relevant and provides a logical explanation linking JNK to c-Jun phosphorylation, which aligns with the gold supporting sentence. However, it includes slightly more detail than necessary (mentioning AP-1 activation), making it somewhat redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "In parallel with these immunosuppressive phenomena, DHA attenuated post-stroke oxidative stress, c-Jun N-terminal kinase (JNK) phosphorylation, c-Jun phosphorylation and activating protein-1 (AP-1) activation but further elevated ischemia-induced NF-E2-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) expression.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: \"DHA treatment also had an immunosuppressive effect in lipopolysaccharide/interferon-γ-stimulated glial cultures by attenuating JNK phosphorylation, c-Jun phosphorylation and AP-1 activation...\"  \nThis sentence explicitly links **JNK phosphorylation** with **c-Jun phosphorylation**, confirming JNK as the MAP kinase responsible for phosphorylating c-Jun.", "retries": 1}
{"idx": 478, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('NCX') in essence, as 'Na+/Ca²⁺ exchanger (NCX)' is a valid elaboration. The supporting sentence is relevant and provides logical reasoning by linking NCX1 to retinal cell death and SEA0400's effects, but it does not explicitly state that SEA0400 is a selective NCX inhibitor, which would have made it more direct and concise. Instead, it implies this relationship through context, making it slightly less precise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: \"A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.\"  \n**Note:** While the context does not explicitly state that SEA0400 directly inhibits NCX, the experimental findings (e.g., SEA0400 reducing NMDA/OGD-induced damage, which is linked to NCX1 activity) and the conclusion that NCX1 \"may play a role\" in retinal cell death imply a functional relationship. The first sentence establishes NCX1's relevance, and SEA0400's protective effects are interpreted as targeting NCX1. However, a more direct link (e.g., \"SEA0400 inhibits NCX\") is absent in the text.", "retries": 1}
{"idx": 479, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly indirect. The chosen sentence mentions the interaction between synphilin-1 and alpha-synuclein and its presence in Lewy bodies, which implies alpha-synuclein's importance but does not explicitly state it as the 'main component.' A more direct sentence exists in the context that explicitly states alpha-synuclein as the main component.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"  \n\n**Note:** While the context does not explicitly state that alpha-synuclein is the *main* component of Lewy bodies, it directly links alpha-synuclein to Lewy bodies through its interaction with synphilin-1, which is present in Lewy bodies. Additionally, the later sentence about inclusion bodies \"resembling Lewy bodies by their ability to recruit alpha-synuclein\" further reinforces alpha-synuclein's role in their composition. However, the most direct sentence explicitly mentioning alpha-synuclein's presence in Lewy bodies is the one quoted above.", "retries": 1}
{"idx": 480, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about the database's function without being overly verbose.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "Answer: mpMoRFsDB", "model_support": "Supporting sentence: mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins.", "retries": 1}
{"idx": 481, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: Dephosphorylated PLN inhibits SERCA2a.", "retries": 1}
{"idx": 482, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model’s supporting sentence effectively explains the aggregation of alpha-synuclein as a critical step in Lewy body formation, logically connecting it to the main component.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation.  \n(Here, \"its\" refers to **alpha-synuclein**, as the preceding text explicitly discusses alpha-synuclein aggregation as a key pathological feature of Lewy bodies.)", "retries": 1}
{"idx": 483, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' vs. 'xa'). The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning by correctly inferring from the context that betrixaban belongs to the class of Factor Xa inhibitors. Although the model notes the lack of explicit mention in the provided text, it accurately uses logical inference based on the context to support the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not explicitly mention which clotting factor is inhibited by betrixaban. However, the answer **Factor Xa** is inferred based on general pharmacological knowledge of NOACs (e.g., rivaroxaban, apixaban, and endoxaban are Factor Xa inhibitors). Since the context groups betrixaban with these drugs, the inference is made. **No direct supporting sentence is present in the provided context.** \n\nIf the question assumes the answer is **Factor Xa**, the reasoning is based on external knowledge, not the text.", "retries": 1}
{"idx": 484, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose compared to the concise gold supporting sentence. The logic is clear and supports the answer well, though it includes additional details about the database's functionality rather than directly focusing on its definition.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "Answer: mpMoRFsDB", "model_support": "Supporting sentence: \"mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins.\"", "retries": 1}
{"idx": 485, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions '10 nm filaments,' which directly answers the question about the average diameter of intermediate filaments.\", \"match\": true}", "gold_answer": "10 nm", "gold_support": "Scanning tunneling microscope (STM) and transmission electron microscope (TEM) micrographs showed that acidic keratins and basic keratins can assemble into dimers and further into 10 nm filamentsin vitro.", "model_answer": "Answer: 10 nm", "model_support": "Supporting sentence: \"One of the explicit features of plant keratin intermediate filaments is a 24-25 nm periodic structural repeat along the axis of both the **10 nm filaments** and protofilaments.\"  \n\n(Note: The sentence explicitly refers to the \"10 nm filaments\" as the structural unit of intermediate filaments, which directly answers the question about their average diameter.)", "retries": 1}
{"idx": 486, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate contextual information about zfhx1b being linked to Mowat-Wilson syndrome. However, it contains slight redundancy by mentioning 'zinc finger homeobox gene' instead of focusing solely on the causative role of zfhx1b, as the gold supporting sentence does. This makes it slightly less concise than ideal, though the logic remains strong.\", \"match\": true}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "Answer: zfhx1b (also known as ZFHX1B or SIP1)", "model_support": "Supporting sentence: \"Intrahepatic biliary anomalies in a patient with Mowat-Wilson syndrome uncover a role for the zinc finger homeobox gene zfhx1b in vertebrate biliary development.\"  \n(Implied connection: The context links zfhx1b to the pathogenesis of Mowat-Wilson syndrome through its role in biliary anomalies, aligning with the known genetic basis of the syndrome.)", "retries": 1}
{"idx": 487, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more verbose than necessary. The supporting sentence provides relevant information, including the regulation of developmental genes in embryonic stem cells, which aligns with the gold answer. However, it combines two sentences and includes additional details that, while related, make it less concise than the gold supporting sentence. The logic is reasonable but could be streamlined.\",\n  \"match\": true\n}", "gold_answer": "development", "gold_support": "The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs).", "model_answer": "Answer: Gene regulation, particularly of developmental genes in embryonic stem cells.", "model_support": "Supporting sentence: \"We explored this by examining histone methylation in mouse embryonic stem (ES) cells across 56 large HCNE-rich loci.\"  \n**and**  \n\"We propose that bivalent domains silence developmental genes in ES cells while keeping them poised for activation.\"  \n\nThese sentences establish that conserved noncoding elements (HCNEs) are associated with bivalent chromatin domains, which regulate developmental genes in embryonic stem cells.", "retries": 1}
{"idx": 488, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and implies the correct reasoning by connecting SEA0400 to its role in inhibiting NCX, but it is somewhat indirect and lacks explicit mention of NCX compared to the gold supporting sentence. This results in a minor reduction in clarity and directness.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Sodium-calcium exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400.  \n(Implied connection: Since the context states that SNP's effects are mediated via NCX, and SEA0400 blocks these effects, it follows that SEA0400 inhibits NCX.)", "retries": 1}
{"idx": 489, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and acknowledges that the current context does not provide the necessary information to derive the answer, which aligns with the instructions. Although it references external knowledge, it correctly identifies the lack of relevant content in the provided context.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "BACKGROUND: A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does **not** mention the chemical group (e.g., 1,4-benzothiazepine) to which JTV519 belongs. The question and answer (1,4-benzothiazepine) are based on **external knowledge** (from the prior context in the example), not the current context. \n\n**Supporting sentence**: *None* (the current context does not specify JTV519’s chemical classification).", "retries": 1}
{"idx": 490, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they do not detract from the core information.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.\"", "retries": 1}
{"idx": 491, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('AF' or 'Atrial fibrillation'). However, the supporting sentence, while relevant to atrial fibrillation, does not explicitly state that AF is the most prevalent form of arrhythmia worldwide, which is a key part of the question. Instead, it focuses on an experimental finding related to AF. The gold supporting sentence directly addresses the prevalence, making it more aligned with the question. The model's supporting sentence is slightly less precise but still relevant.\",\n  \"match\": true\n}", "gold_answer": "AF", "gold_support": "Atrial fibrillation (AF) is associated with increased morbidity and is in addition the most prevalent cardiac arrhythmia.", "model_answer": "Answer: Atrial fibrillation (AF)", "model_support": "Supporting sentence: The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.  \n\n**Note:** While the context does not explicitly state that atrial fibrillation (AF) is the *most prevalent* form of arrhythmia globally, the focus of the study on AF and its treatment implies its clinical significance. However, this sentence directly references AF as the arrhythmia under investigation, aligning with the answer provided. For a definitive answer about prevalence, external knowledge (e.g., AF being the most common arrhythmia worldwide) would be required, as the context does not address this explicitly.", "retries": 1}
{"idx": 492, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional information about Cockayne syndrome gene products and stalled RNA polymerase, which is not directly necessary to support the answer. This makes it slightly more verbose than the gold supporting sentence, which is more concise and directly addresses the transcribed strand.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 493, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD' is equivalent to 'Facioscapulohumeral muscular dystrophy (FSHD)'). The supporting sentence is relevant and supports the answer by emphasizing DUX4's role in FSHD pathogenesis. However, it is slightly less direct than the gold supporting sentence, which specifically mentions the recapitulation of FSHD in zebrafish development. The model's sentence is accurate but more general.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"These results strongly support the current hypothesis for a role of DUX4 in FSHD pathogenesis.\"", "retries": 1}
{"idx": 494, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.", "retries": 1}
{"idx": 495, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard ('the transcribed strand'), though it uses slightly different phrasing ('the gene strand that is being transcribed'). The supporting sentence is relevant and connects TCR to transcription, but it focuses on the stalled RNA polymerase as a signal rather than explicitly stating that TCR targets the transcribed strand. While logical, this makes the reasoning less direct compared to the gold supporting sentence, which explicitly mentions the preferential repair of the transcribed strand.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Among these is a process called transcription-coupled repair (TCR) that catalyzes the removal of DNA lesions from the transcribed strand of expressed genes, often resulting in a preferential bias of damage clearance from this strand relative to its non-transcribed counterpart.", "model_answer": "Answer: The gene strand that is being transcribed.", "model_support": "Supporting sentence: \"It is also believed that the signal for TCR is the stalled RNA polymerase that results when DNA damage prevents its translocation during transcription elongation.\"  \nThis sentence directly connects TCR to the transcription process, implying that the repair targets the gene strand being transcribed (as RNA polymerase is actively transcribing it).", "retries": 1}
{"idx": 496, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it includes 'Factor' which is not strictly necessary but still correct. The supporting sentence provides relevant information about betrixaban’s anti-Xa activity, but it introduces additional details about PRT4445 that are not directly needed to support the answer. This makes the supporting sentence slightly more verbose than necessary, hence a score of 4.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \nThis implies that betrixaban has anti-Xa activity, as PRT4445 is described as a factor Xa decoy specifically for anticoagulants targeting Factor Xa.", "retries": 1}
{"idx": 497, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence is concise, acknowledges the lack of explicit information in the context, and correctly references general knowledge about betrixaban as a Factor Xa inhibitor. This approach aligns well with the gold supporting sentence, which confirms betrixaban as an inhibitor of factor Xa.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not explicitly state which clotting factor is inhibited by betrixaban. However, based on general pharmacological knowledge (not derived from the provided text), betrixaban is a Factor Xa inhibitor. Since the context does not include this specific detail, there is **no supporting sentence** in the given text to answer the question. \n\n**Answer:** The context does not provide information about the clotting factor inhibited by betrixaban.", "retries": 1}
{"idx": 498, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly verbose and less direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "Answer: Dermatitis herpetiformis.", "model_support": "Supporting sentence: \"These findings may relate to the fact, that dermatitis herpetiformis is associated with gluten sensitive enteropathy, coeliac disease, which is characterised by IgA type autoantibodies to a closely related enzyme, tissue transglutaminase.\"", "retries": 1}
{"idx": 499, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly links DUX4 production to FSHD through the D4Z4 array, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.\"  \n\nThis sentence explicitly links the D4Z4 array (associated with DUX4 expression) to **FSHD** (Facioscapulohumeral muscular dystrophy), establishing the disease context.", "retries": 1}
{"idx": 500, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, but it is slightly less direct compared to the gold supporting sentence. While it implies the regulatory role of phospholamban over SERCA2a, it does not explicitly state its role in calcium cycling or contractility, which are key elements in the gold supporting sentence. Thus, there is minor redundancy and less precision in conveying the full significance of phospholamban.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban has been suggested to be a key regulator of cardiac sarcoplasmic reticulum (SR) Ca cycling and contractility and a potential therapeutic target in restoring the depressed Ca cycling in failing hearts.", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: \"The findings suggest that important species-dependent differences in phospholamban regulation of SERCA2a occur.\"  \n\nThis sentence explicitly identifies phospholamban as the regulatory molecule for SERCA2a, aligning with the conclusion that phospholamban modulates SERCA2a function in cardiac muscle.", "retries": 1}
{"idx": 501, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by specifying that TBC1D7 is part of the functional TSC1-TSC2-TBC1D7 complex upstream of mTORC1. Minor additional details about its function do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "Answer: TBC1D7", "model_support": "Supporting sentence: We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.", "retries": 1}
{"idx": 502, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, while not a direct quote from the context, logically connects APP isoforms to alpha-synuclein deposition in DLB, which indirectly supports alpha-synuclein as the main component of Lewy bodies. It is concise and relevant.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\n**Note:** While the context does not explicitly state that alpha-synuclein is the main component of Lewy bodies, it does reference alpha-synuclein deposition in the context of DLB pathogenesis, which aligns with the known role of alpha-synuclein in Lewy body formation. The direct statement about the main component of Lewy bodies is not present in the provided text.", "retries": 1}
{"idx": 503, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('medulloblastoma'). However, the supporting sentence provided by the model is unnecessarily verbose and questions the availability of a supporting sentence in the context, despite the context explicitly stating that medulloblastoma is the most common malignant pediatric brain tumor. The gold supporting sentence directly provides this information concisely, whereas the model’s supporting explanation adds unnecessary doubt and complexity.\", \"match\": true}", "gold_answer": "medulloblastoma", "gold_support": "Mouse models have increased our understanding of the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor that often forms in the cerebellum.", "model_answer": "Answer: Medulloblastoma", "model_support": "The context does not explicitly state that medulloblastoma is the most common type of pediatric cerebellar tumor. While the study focuses on medulloblastoma (MB) as the subject of investigation, it does not provide comparative data or prevalence information about MB relative to other pediatric cerebellar tumors. The context only describes the use of MEMRI for detecting and monitoring MB in a mouse model, without addressing its frequency or commonality in pediatric populations. \n\n**Answer:** The context does not contain a supporting sentence for the claim that medulloblastoma is the most common type of pediatric cerebellar tumor. The provided information focuses on the application of MEMRI for MB detection but does not discuss its prevalence.", "retries": 1}
{"idx": 504, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'). However, the supporting sentence is somewhat indirect and introduces additional information about PRT4445, which is not necessary to answer the question. While it logically supports the conclusion that betrixaban inhibits Factor Xa, it is less concise than the gold supporting sentence. The gold supporting sentence directly states that betrixaban is a 'direct factor Xa inhibitor,' making it more straightforward.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban has anti-Xa activity, as its potential reversal agent (PRT4445) targets Factor Xa. While the context does not explicitly state that betrixaban directly inhibits Factor Xa, the association with a Factor Xa-specific reversal agent strongly supports this conclusion.", "retries": 1}
{"idx": 505, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke', differing only in specificity. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for acute stroke differentiation, but it is slightly more verbose than necessary compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 506, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and correctly identifies flumazenil as a benzodiazepine antagonist, which supports its use as an antidote. However, it focuses slightly more on hepatic encephalopathy rather than explicitly mentioning its established role in benzodiazepine overdose, making it less direct than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is the first benzodiazepine antagonist which can be used in humans and is a well established for treatment of benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: For the first time a causal treatment of hepatic encephalopathy may be possible by the **benzodiazepine antagonist flumazenil**.  \n\n(While the context primarily discusses flumazenil's role in hepatic encephalopathy, the explicit classification of flumazenil as a **benzodiazepine antagonist** directly supports its use as an antidote in benzodiazepine overdose.)", "retries": 1}
{"idx": 507, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes unnecessary details about the study period and patient recruitment, which slightly detracts from direct relevance to the question. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"This was a prospective cohort study in an urban academic emergency department (ED) over a 7-month period. Patients over 18 years of age with suspected stroke were recruited between June 2011 and December 2011.\"  \n\n**Analysis**: The sentence explicitly states that the ROSIER scale was evaluated in patients with suspected stroke, confirming its use for diagnosing or identifying stroke cases.", "retries": 1}
{"idx": 508, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('xa' corresponds to 'factor Xa'). The supporting sentence provided by the model is incorrect because it states no supporting sentence exists, while the context explicitly mentions that betrixaban targets factor Xa. Despite this, the model's answer is still correct, and the context does contain a relevant sentence, which justifies a score of 4.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Most are small synthetic molecules that target factor IIa (e.g., dabigatran etexilate, AZD-0837) or factor Xa (e.g., rivaroxaban, apixaban, betrixaban, DU176b, idrabiotaparinux).", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action (e.g., inhibition of clotting factors). Therefore, **no supporting sentence** exists in the given text to justify the claim that \"betrixaban inhibits factor Xa.\" The context focuses on vitamin K antagonists and other unspecified anticoagulants but does not reference betrixaban.", "retries": 1}
{"idx": 509, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('The GBA gene') does not match the gold standard ('glucocerebrosidase'), but it is related since GBA is the gene encoding glucocerebrosidase. The supporting sentence acknowledges that the context doesn't explicitly mention the gene name, and the answer relies on external knowledge rather than direct evidence from the text. However, the supporting sentence itself does not clearly connect to the gold answer (glucocerebrosidase) and focuses more on justifying the use of external knowledge rather than citing relevant information from the context.\",\n  \"match\": false\n}", "gold_answer": "glucocerebrosidase", "gold_support": "A 26-year-old Bedouin with moderate thrombocytopenia and enlarged spleen and liver was diagnosed as having type I Gaucher disease based on the presence of Gaucher cells in the bone marrow biopsy and enzymatic determination of glucocerebrosidase activity.", "model_answer": "Answer: The GBA gene.", "model_support": "Supporting sentence: The context does not explicitly mention the gene name. However, the question assumes prior knowledge that Gaucher disease is caused by mutations in the **GBA** gene (encoding glucocerebrosidase), which is a well-established fact in biomedicine. While the provided context describes a specific mutation (259T) in the cDNA, it does not name the gene (GBA) directly. The answer relies on external knowledge rather than a direct quote from the context. \n\n**Note**: The context does not include the gene name (\"GBA\") explicitly, so no sentence in the provided text directly supports the answer. The answer is inferred from general knowledge of Gaucher disease.", "retries": 1}
{"idx": 510, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Fifth lumbar vertebra,' does not match the gold standard 'Lumbosacral,' but it is mentioned in the context. The supporting sentence is relevant and accurate, describing an abnormality in the fifth lumbar vertebra, but it does not directly cover the gold answer, which refers to the lumbosacral region as a whole. Thus, while the answer is present in the context, the supporting sentence fails to fully align with the gold standard.\", \"match\": false}", "gold_answer": "Lumbosacral", "gold_support": "Lumbosacral transitional vertebra causing Bertolotti's syndrome: a case report and review of the literature.", "model_answer": "Answer: Fifth lumbar vertebra", "model_support": "Supporting sentence: Radiographic investigation revealed an anomalous enlargement of the left transverse process of the fifth lumbar vertebra forming a pseudarthrosis with the infrajacent ala of the sacrum.", "retries": 1}
{"idx": 511, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it states 'parallel heterodimers' while the gold answer clearly indicates 'antiparallel.' The supporting sentence provided by the model does not logically support the incorrect answer; instead, it describes interactions between specific repeats but fails to address the orientation (parallel or antiparallel) of the dimers. Furthermore, the explanation given in the model's supporting sentence incorrectly infers parallel orientation without evidence. The gold supporting sentence explicitly states that spectrin subunits form antiparallel dimers, making the model's response both inaccurate and unsupported.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Spectrins comprise α- and β-subunits made up predominantly of a series of homologous repeating units of about 106 amino acids; the α- and β-chains form antiparallel dimers by lateral association, and tetramers through head-to-head contacts between the dimers.", "model_answer": "Answer: Parallel heterodimers.", "model_support": "Supporting sentence: \"the first two paired repeats (βIR1 with αIR21, and βIR2 with αRI20) at one end of the erythroid spectrin (αIβI) dimer are necessary and sufficient to unite the chains.\"  \nThis sentence describes the pairing of α and β subunits in the erythroid spectrin dimer, where βIR1 interacts with αIR21 and βIR2 interacts with αRI20, indicating a **parallel** orientation (same directionality of subunit repeats).", "retries": 1}
{"idx": 512, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions 'all TAp73' isoforms, which might suggest there is more than one, but the model incorrectly infers only one isoform exists. The logic used to arrive at the answer is flawed, and the supporting sentence does not adequately cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.  \n**Analysis**: The sentence implies that \"all TAp73\" refers to a single isoform (since it is grouped with DeltaNp73 as distinct categories), supporting the answer that only **1** TAp73 isoform has been identified in humans.", "retries": 1}
{"idx": 513, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence provided by the model is relevant and correctly identifies that betrixaban is not specifically mentioned in the context, but it indirectly supports the answer by referencing the category of Factor Xa inhibitors. However, the supporting sentence could be slightly more direct in pointing out that betrixaban belongs to this class as per the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, **no sentence in the context supports the answer \"Factor Xa\"** for the question about betrixaban. The text focuses on dabigatran and rivaroxaban (which inhibit thrombin and Factor Xa, respectively) but does not discuss betrixaban.", "retries": 1}
{"idx": 514, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the function of calsequestrin as a calcium-binding protein in the SR, but it includes additional information about its role in frog cardiac muscle contraction, which makes it slightly more verbose than necessary. The core logic is sound, but the extra details reduce conciseness.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin is a calcium-binding protein known to sequester calcium accumulated in the sarcoplasmic reticulum (SR) of muscle cells during relaxation.", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: \"the identification of a calsequestrin isoform very similar to mammalian cardiac calsequestrin that is confined to specialized regions of frog cardiac SR lends support to the idea that frog cardiac SR has the ability to store Ca²⁺ and thus function in some capacity in frog cardiac muscle contraction.\"  \n\nThis sentence explicitly links calsequestrin to its role as the calcium-binding protein in the sarcoplasmic reticulum (SR) by highlighting its function in Ca²⁺ storage, a key property of calsequestrin.", "retries": 1}
{"idx": 515, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by discussing OPG's role in inhibiting RANKL rather than directly focusing on Denosumab's binding to RANKL. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Denosumab (AMG 162), a fully human monoclonal antibody to RANKL, shares the pharmacologic attributes of OPG but has a significantly longer half-life that allows less frequent administration.", "model_answer": "Answer: RANKL", "model_support": "Supporting sentence: RANKL stimulates osteoclast formation, function and survival, and each of these effects is inhibited by OPG.  \n**Note**: While the context does not explicitly mention Denosumab (Prolia), the mechanism of action of Denosumab (targeting RANKL) is inferred from the described role of RANKL as the ligand that OPG inhibits. The sentence above establishes RANKL as the critical ligand involved in osteoclast regulation, which aligns with Denosumab's known target.", "retries": 1}
{"idx": 516, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'AIP gene' matches the gold standard conceptually, as 'aryl hydrocarbon receptor interacting protein' is the full name of the AIP gene. However, the supporting sentence contains relevant but somewhat redundant information about the phenotype and disease characteristics, which are not directly necessary to support the answer. It could be more concise by focusing on the discovery or role of AIP mutations in FIPA.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The discovery of heterozygous, loss-of-function germline mutations in the gene encoding the aryl hydrocarbon receptor interacting protein (AIP) in 2006 has subsequently enabled the identification of a mutation in this gene in 20% of FIPA families and 20% of childhood-onset simplex soma- totroph adenomas.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: \"The exact mechanism by which the lack of AIP leads to pituitary adenomas is not clear. AIP mutations cause a low penetrance autosomal dominant disease with often a distinct phenotype characterized by young-onset, aggressive, large GH, mixed GH and PRL or PRL-secreting adenomas.\"", "retries": 1}
{"idx": 517, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'EGFR' matches the gold standard 'epidermal growth factor receptor (EGFR) gene' in essence, as it correctly identifies the gene in question. The supporting sentence is concise and directly relevant, highlighting the EGFR gene as central to the detection of mutations associated with drug responses, aligning logically with the gold standard reasoning.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the responses to the tyrosine kinase inhibitors gefitinib and erlotinib in patients with non-small-cell lung cancer (NSCLC).", "model_answer": "Answer: EGFR", "model_support": "Supporting sentence: Simple polymerase chain reaction for the detection of mutations and deletions in the **epidermal growth factor receptor gene**...  \n\nThis sentence explicitly identifies the **EGFR gene** as the target of the study, which is directly relevant to the question about mutations determining response to EGFR-targeting drugs like erlotinib and gefitinib.", "retries": 1}
{"idx": 518, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, identifying BACH1 as a repressor. The supporting sentence is relevant and supports the answer by describing Bach1's role as a transcriptional repressor indirectly through its genetic ablation effects. However, it does not explicitly mention that Bach1 represses the HO-1 gene, which makes it slightly less direct compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice.", "retries": 1}
{"idx": 519, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer (10 nm). It mentions the increase in diameter with temperature but fails to provide the specific value mentioned in the gold supporting sentence.\", \"match\": false}", "gold_answer": "10 nm", "gold_support": "Negative staining showed that supernatants from the centrifugation assays contained protofilaments, protofibrils and short particles (less than 300 nm), but pellets contained long filaments (greater than 1 micron) with an average diameter of 10 nm.", "model_answer": "Answer: The average diameter of intermediate filaments was not directly provided in the context.", "model_support": "Supporting sentence: \"As the temperature increased, both the average diameter and average length of particles in the supernatant increased.\"  \n**Note**: The context does not provide a specific numerical value for the average diameter of intermediate filaments. It only states that the average diameter increased with temperature, but no direct measurement is given.", "retries": 1}
{"idx": 520, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Atrial fibrillation', matches the gold standard ('af') in meaning, but the supporting sentence is incorrect. The context does not support the model's claim that AF is the most prevalent arrhythmia worldwide, as it focuses on AF in athletes rather than global prevalence. However, the gold supporting sentence directly confirms AF as the most common arrhythmia affecting the population, which the model failed to utilize.\", \"match\": true}", "gold_answer": "af", "gold_support": "Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting up to 1-1.5% of the population.", "model_answer": "Answer: Atrial fibrillation", "model_support": "The answer \"Atrial fibrillation\" is not supported by the provided context. The context discusses **atrial fibrillation (AF)** in athletes and its association with physical activity, but it does **not explicitly state** that AF is the most prevalent form of arrhythmia worldwide. The text focuses on AF's occurrence in athletes and its clinical implications, not global prevalence rates of arrhythmias. Therefore, **no sentence in the context supports the claim** that AF is the most prevalent arrhythmia.", "retries": 1}
{"idx": 521, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model correctly identifies the chemical group of JTV519 as 1,4-benzothiazepine, and while the provided context does not explicitly contain the supporting sentence, the inference aligns perfectly with the gold standard.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The context provided does not explicitly mention the chemical group of JTV519 (e.g., 1,4-benzothiazepine). However, based on prior knowledge from the example context, the answer is inferred. If strictly relying on the current context, no supporting sentence is present. \n\n**Note:** The current context does not include the sentence specifying JTV519 as a 1,4-benzothiazepine derivative. The answer \"1,4-benzothiazepine\" is derived from the example context, not the provided text.", "retries": 1}
{"idx": 522, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer includes 'Tofacitinib,' which matches the gold standard, but it also lists additional JAK inhibitors ('Baricitinib' and 'Upadacitinib') that are not mentioned in the context. The supporting sentence correctly notes that the context does not explicitly name these inhibitors, but this makes the support weak because the model answer goes beyond the provided information. While 'Tofacitinib' is correct and present in the context, the extra drugs reduce accuracy and relevance.\", \"match\": false}", "gold_answer": "tofacitinib", "gold_support": "After two decades of research and development activity focussed on orally active kinase inhibitors, the first such drug (the JAK inhibitor Xeljanz, tofacitinib) was approved by the FDA in November 2012 for the treatment of rheumatoid arthritis (RA).", "model_answer": "Answer: Tofacitinib, Baricitinib, and Upadacitinib are JAK inhibitors approved for the treatment of rheumatoid arthritis.", "model_support": "The context does not explicitly name any specific JAK inhibitors (e.g., tofacitinib, baricitinib, upadacitinib) as approved for treating rheumatoid arthritis. While it discusses the development and clinical progress of JAK inhibitors in autoimmune diseases, it does not provide the names of approved drugs. Therefore, **no sentence in the context directly supports the answer** provided. The answer relies on external knowledge rather than the given text.", "retries": 1}
{"idx": 523, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 524, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence provided by the model acknowledges that the context does not explicitly mention the clotting factor but correctly identifies betrixaban as a Factor Xa inhibitor based on general knowledge. However, it is slightly verbose and includes an explanation about the lack of explicit support in the text, which adds unnecessary length. A more concise statement would improve the response.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "The provided context does not explicitly mention which clotting factor is inhibited by betrixaban. However, based on general knowledge, betrixaban is a Factor Xa inhibitor. The context does not include a sentence specifying this mechanism, so the answer cannot be directly supported by the given text. \n\n**Note**: If the answer \"Factor Xa\" is derived from external knowledge (not the provided context), the context lacks the supporting sentence. If the context were complete, it might include a line such as: \"Betrixaban is a direct Factor Xa inhibitor,\" but this is not present here.", "retries": 1}
{"idx": 525, "gptscore_json": "{\"score\": 1, \"reason\": \"The answer provided by the model (1) does not match the gold standard (7). The supporting sentence is irrelevant and does not logically support the gold answer. It discusses the function of TAp73 and ΔNp73 but does not address the number of TAp73 isoforms identified in humans. The reasoning is flawed, and the supporting sentence fails to provide any relevant evidence for the correct answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: TAp73 has similar activity as p53 and functions as a tumor suppressor whereas ΔNp73 has both pro- and anti-survival functions.  \n**Analysis**: The sentence explicitly distinguishes **TAp73** as a single isoform (contrasted with ΔNp73), confirming that only one TAp73 isoform is identified in the context.", "retries": 1}
{"idx": 526, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 527, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it includes additional information about the comparison with ubiquitin, which is not necessary to directly support the answer. This makes it slightly verbose compared to the gold supporting sentence, which is more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: \"alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles.\"", "retries": 1}
{"idx": 528, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('hypertrophic cardiomyopathy'), but the supporting sentence is incorrect because it states that the context does not provide support for the answer. In reality, the context explicitly mentions hypertrophic cardiomyopathy as the most common cause of death. The supporting sentence fails to reference this key evidence, making it irrelevant to the gold answer.\", \"match\": true}", "gold_answer": "hypertrophic cardiomyopathy", "gold_support": "The most common cause of death was hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).", "model_answer": "Answer: The most common cause of sudden cardiac death in young athletes is hypertrophic cardiomyopathy.", "model_support": "The context does not explicitly mention the most common cause of sudden cardiac death in young athletes (e.g., hypertrophic cardiomyopathy). The provided text only states that the \"cardiac causes of death\" were comparable to previous reports but does not specify which condition is most common. Therefore, **no sentence in the context supports the answer** \"hypertrophic cardiomyopathy.\" The answer relies on external knowledge, not the given text.", "retries": 1}
{"idx": 529, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for the role of calcineurin in NFAT activation, with a clear reference to the Ca(2+)/calcineurin/NFAT pathway. However, it includes additional context about SCID syndrome, which, while related, introduces slight redundancy and verbosity not strictly necessary to directly support the answer.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: \"The importance of the Ca(2+)/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca(2+) entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes...\"  \n\nThis sentence explicitly identifies **calcineurin** as part of the **Ca²+/calcineurin/NFAT signalling pathway**, which is central to NFAT activation.", "retries": 1}
{"idx": 530, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by referencing the specific study on [18F]altanserin as a 5-HT2A receptor PET ligand. Minor extra details are acceptable and do not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.\"", "retries": 1}
{"idx": 531, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by identifying Bach1 as a transcriptional repressor. Minor additional context provided does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.\"  \n\nThis sentence explicitly identifies Bach1 as a **transcriptional repressor**. Additional context supports this by showing that Bach1 binds to the NA site in the HS-40 enhancer and its activity is inversely correlated with alpha-globin gene expression (e.g., SA treatment increases Bach1 binding and reduces alpha-globin, while hemin disrupts Bach1 binding and restores expression).", "retries": 1}
{"idx": 532, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a general description of alpha-synuclein's role in abnormal depositions, which indirectly supports the answer. However, it is slightly less direct than the gold supporting sentence, as it does not explicitly mention Lewy bodies or their connection to alpha-synuclein in Parkinson's disease or Lewy body dementia.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\n(Note: While the context does not explicitly mention \"Lewy bodies,\" it defines alpha-synucleinopathies as disorders characterized by alpha-synuclein deposition, which is the defining feature of Lewy bodies in neurodegenerative diseases like Parkinson's disease. The answer is inferred from the general description of alpha-synuclein's role in these pathologies.)", "retries": 1}
{"idx": 533, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard (beta-Trcp), but the supporting sentence does not logically support the gold answer. The chosen sentence discusses Tyk2 stabilizing IFNAR1 independently of beta-Trcp, which could mislead one to think beta-Trcp is irrelevant, contradicting the gold supporting sentence. While the answer is correct, the supporting sentence fails to directly justify it and instead introduces confusion.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: beta-Trcp (beta-transducin repeat-containing protein)", "model_support": "Supporting sentence: \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"  \n\n(Note: While the context does not explicitly state that **beta-Trcp** is the E3 ligase mediating ubiquitination, the sentence above is the only mention of **beta-Trcp** in the context. However, this sentence actually implies that **beta-Trcp is not** the E3 ligase involved, as Tyk2's stabilization of IFNAR1 occurs independently of **beta-Trcp** binding. This suggests a potential inconsistency between the answer and the provided context. If the intended answer is **beta-Trcp**, the context may lack direct evidence to support it.)", "retries": 1}
{"idx": 534, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a fully humanized monoclonal antibody (IgG1/κ) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "Supporting sentence: Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex on the eosinophil cell surface, thereby inhibiting IL-5 signalling.", "retries": 1}
{"idx": 535, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by referencing p53, which is central to the context provided.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Note:** While the context does not explicitly use the term \"guardian of the genome,\" the entire passage focuses on the function and regulation of the **p53** tumor suppressor protein, which is widely recognized in biomedical literature as \"the guardian of the genome.\" The supporting sentence identifies p53 as the subject of the study, confirming its relevance to the question.", "retries": 1}
{"idx": 536, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The gold answer 'Thyroid' refers to thyroid hormone abnormalities implied by the presence of thyroid goiter in 46.5% of cases. However, the model incorrectly states that there are no hormone abnormalities, which is inconsistent with the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on normal hormone analysis without addressing the clinical finding of thyroid goiter.\", \"match\": false}", "gold_answer": "Thyroid", "gold_support": "Thyroid goiter was found in 46.5% of cases.", "model_answer": "Answer: Pendred syndrome is not characterized by hormone abnormalities.", "model_support": "Supporting sentence: Hormone analysis was normal and perchlorate test negative in all cases.", "retries": 1}
{"idx": 537, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the co-administration of L-dopa with a peripheral decarboxylase inhibitor (PDI), which includes benserazide. Although the term 'benserazide' is not explicitly mentioned in the supporting sentence, the explanation about PDI provides sufficient and accurate context.\",\n  \"match\": true\n}", "gold_answer": "L-dopa", "gold_support": "In a cross-sectional study blood was obtained, 2 h after dosing, from 104 patients with idiopathic parkinsonism, divided into four groups: no L-dopa treatment (group 1), L-dopa alone (group 2), L-dopa + benserazide (Madopar) (group 3) and L-dopa + carbidopa (Sinemet) (group 4).", "model_answer": "Answer: L-dopa (levodopa)", "model_support": "Supporting sentence: \"The effect of levodopa (L-dopa), alone or in combination with a peripheral decarboxylase inhibitor (PDI), on plasma levels...\"  \n(Note: While the context does not explicitly name *benserazide*, it refers to a **peripheral decarboxylase inhibitor (PDI)**, which is a class of drugs that includes benserazide. The sentence establishes that L-dopa is co-administered with PDI, aligning with the known clinical use of benserazide as a PDI paired with L-dopa.)", "retries": 1}
{"idx": 538, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' is equivalent to 'XK'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly linking McLeod syndrome to a mutation in the XK gene.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod syndrome resulting from a novel XK mutation.\"", "retries": 1}
{"idx": 539, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Ser129' matches the gold standard 'serine 129' exactly, as both refer to the same residue. The supporting sentence is concise, directly relevant, and provides clear reasoning by mentioning that Ser129 is phosphorylated in vivo, which aligns logically with the context of Lewy bodies. Minor additional details (e.g., Gprk2 enhancing toxicity) do not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "serine 129", "gold_support": "Alpha-synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies.", "model_answer": "Answer: Ser129", "model_support": "Supporting sentence: The G protein-coupled receptor kinase 2 (Gprk2) phosphorylates Ser129 in vivo and enhances alpha-synuclein toxicity.", "retries": 1}
{"idx": 540, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'xa'), though it could be slightly more concise by omitting 'Factor'. The supporting sentence is relevant and explains the mechanism of action of direct factor Xa inhibitors, which includes betrixaban. However, it contains slight redundancy by discussing the broader class of drugs rather than directly focusing on betrixaban or being as concise as the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.  \n\n(Note: While the context does not explicitly mention *betrixaban*, it describes the mechanism of action of the entire class of direct factor Xa inhibitors, which includes betrixaban. The answer is inferred from the class-specific mechanism described in the context.)", "retries": 1}
{"idx": 541, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and provides logical support but contains slight redundancy by describing the consequences of p53 impairment instead of directly stating it as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: When p53 function is impaired, its ability to preserve genomic integrity is compromised.", "retries": 1}
{"idx": 542, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning by referencing that APOBEC3B appeared predominantly nuclear in the context of L1 inhibition. Although the model notes that no direct context was provided, this aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "Answer: Nuclear.", "model_support": "The context does not explicitly mention the subcellular localization (nuclear or cytoplasmic) of APOBEC3B. Therefore, **there is no supporting sentence in the provided context** that directly answers the question about whether APOBEC3B is predominantly nuclear or cytoplasmic. The answer \"Nuclear\" likely relies on external knowledge or assumptions about APOBEC3 family proteins, which are typically nuclear in function (e.g., acting on DNA in the nucleus), but this is not stated in the given text.", "retries": 1}
{"idx": 543, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "selenoprotein P", "gold_support": "Molecular cloning of cDNA encoding a bovine selenoprotein P-like protein containing 12 selenocysteines and a (His-Pro) rich domain insertion, and its regional expression.", "model_answer": "Answer: Selenoprotein P", "model_support": "Supporting sentence: The coding nucleotide sequence of its cDNA insert displayed high homology to rat and human selenoprotein P cDNA but contained 12 rather than 10 TGAs (12 rather than 10 selenocysteines in deduced amino acids)...", "retries": 1}
{"idx": 544, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa', albeit with slight verbosity by including the word 'Factor'. The supporting sentence is relevant and provides logical reasoning that betrixaban inhibits Factor Xa by referencing its anti-Xa activity. However, it contains some redundancy by discussing PRT4445, which is not necessary to directly support the answer. A more concise sentence could have been extracted from the context.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis implies that betrixaban is an anticoagulant with anti-Xa activity, thereby inhibiting Factor Xa.", "retries": 1}
{"idx": 545, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it focuses slightly more on the inability of the inhibitors to cure CML rather than directly stating that BCR-ABL is the target of Imatinib. The logic is sound, but there's a minor level of indirectness compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "CML is induced by the BCR-ABL oncogene, whose gene product is a BCR-ABL tyrosine kinase.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"However, the inability of BCR-ABL kinase inhibitors to completely kill leukemia stem cells (LSCs) indicates that these kinase inhibitors are unlikely to cure CML.\"  \n\nThis sentence explicitly identifies **BCR-ABL** as the tyrosine kinase targeted by kinase inhibitors in CML, which includes Imatinib (Gleevec).", "retries": 1}
{"idx": 546, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence correctly identifies that betrixaban is a Factor Xa inhibitor based on the context, but it introduces unnecessary commentary about the lack of support in the context and adds details not directly required to justify the answer. This makes the supporting sentence slightly verbose, hence a score of 4.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, **no sentence in the given context supports the answer \"Factor Xa\"** for the question about betrixaban. The context only discusses **dabigatran**, a direct thrombin inhibitor, but not betrixaban (which is a Factor Xa inhibitor). \n\nThis indicates a mismatch between the question and the context provided.", "retries": 1}
{"idx": 547, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and aligns with the gold standard, indicating that Rheumatoid Arthritis is more common in women. However, the supporting sentence focuses on specific risk factors for Colombian women with RA (e.g., early onset, polyautoimmunity) rather than directly addressing the prevalence of RA in women versus men. While the information provided in the supporting sentence is relevant to gender differences in RA, it does not explicitly confirm the higher prevalence of RA in women, which is the key point in the gold supporting sentence. The logic is reasonable but could be more concise and directly tied to prevalence.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Answer: Rheumatoid Arthritis is more common in women.", "model_support": "Supporting sentence: \"Colombian women with RA are more at risk of having an early age at onset and developing polyautoimmunity and abdominal obesity, and they perform more household duties than their male counterparts.\"  \n\n**Note**: While the context does not explicitly state that RA is more common in women, the phrasing \"Colombian women with RA are more at risk...\" implies a higher proportion of women in the studied population with RA, which could indirectly suggest a higher prevalence. However, this is an inference rather than a direct statement about overall prevalence. The context focuses on gender differences in *manifestations* and *risk factors* rather than *prevalence rates*.", "retries": 1}
{"idx": 548, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer, but contains some redundancy by referencing a broader context rather than directly citing the specific trial or PBT2's role in Alzheimer's disease. The logic is strong, but the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "Answer: Alzheimer's disease", "model_support": "Supporting sentence: \"Drug development based on the metals hypothesis of Alzheimer's disease.\"  \n**Analysis**: While the sentence directly mentioning PBT2 is \"PBT2 is a once per day, orally bioavailable, second generation 8-OH quinoline derivative of clioquinol,\" the broader context explicitly frames the discussion around Alzheimer's disease. The entire paragraph focuses on drug development targeting metal-related abnormalities in Alzheimer's, and PBT2 is introduced as part of this therapeutic approach. Thus, the overarching context (\"Drug development based on the metals hypothesis of Alzheimer's disease\") establishes the disorder for which PBT2 has been tested.", "retries": 1}
{"idx": 549, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('xa' referring to Factor Xa), but the supporting sentence does not cover the gold answer. The context provided by the model discusses other anticoagulants and does not directly reference betrixaban or its specific target (FXa). While the model correctly identifies FXa as the target, it fails to provide a relevant supporting sentence from the given text that connects betrixaban to FXa inhibition.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Answer: FXa (Factor Xa)", "model_support": "The context provided does not mention **betrixaban** or its specific target clotting factor. Therefore, **no supporting sentence** exists in the given text to confirm that betrixaban inhibits FXa (Factor Xa). The answer \"FXa\" would require external knowledge, as the context focuses on other anticoagulants (e.g., inhibitors of FXI, FXII, thrombin, FIXa) and does not reference betrixaban.", "retries": 1}
{"idx": 550, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('memory loss') but is present in the context. The supporting sentence is relevant to the study's methodology but does not cover the gold answer or logically support it, as it focuses on the questionnaire design rather than the reported symptoms.\", \"match\": false}", "gold_answer": "memory loss", "gold_support": "The strongest associations were for mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8), night sweats (OR 9.9, 95% CI 6.5-15.2), general fatigue (OR 9.6, 95% CI 8.3-11.1) and sexual dysfunction (OR 4.6, 95%CI 3.2-6.6).", "model_answer": "Answer: The context does not mention specific memory problems reported in Gulf War syndrome.", "model_support": "Supporting sentence: \"This study was the first to use a questionnaire which did not focus specifically on the veterans' symptoms themselves.\"  \n\n**Analysis**: The context explicitly states that the questionnaire used in the study did not focus on veterans' symptoms, including specific issues like memory problems. Therefore, the study does not provide details about memory-related symptoms in Gulf War syndrome.", "retries": 1}
{"idx": 551, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides context about factor Xa inhibitors, including betrixaban implicitly. However, it contains some redundancy by discussing the success of other drugs without directly naming betrixaban, which slightly dilutes the focus on the specific question.\", \"match\": true}", "gold_answer": "xa", "gold_support": "EXPERT OPINION: A large body of Phase II and Phase III data is now available for FXa inhibitors such as rivaroxaban, apixaban, edoxaban and betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Significant success has recently been reported with compounds such as rivaroxaban, apixaban and edoxaban in the treatment and prevention of venous thromboembolism (VTE) and more recently in the prevention of stroke in atrial fibrillation (AF).\"  \n(Note: While \"betrixaban\" is not explicitly mentioned, the context establishes that the class of drugs discussed (including rivaroxaban, apixaban, edoxaban) are **factor Xa inhibitors**, implying betrixaban, as a similar compound, also inhibits factor Xa.)", "retries": 1}
{"idx": 552, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, but it does not explicitly mention the KFERQ motif, which is a key part of the question. While it supports the answer by discussing CMA, it lacks the specificity of the gold supporting sentence. The reasoning is logical but slightly less precise compared to the ideal.\",\n  \"match\": true\n}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.", "model_answer": "Answer: Chaperone-mediated autophagy (CMA)", "model_support": "Supporting sentence: Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.  \n\n**Note:** While the context does not explicitly mention the KFERQ motif, the question assumes general knowledge that the KFERQ motif is associated with **chaperone-mediated autophagy (CMA)**, which is the pathway discussed in the context. The supporting sentence highlights the relevance of CMA in the study, aligning with the known role of the KFERQ motif in targeting proteins for CMA.", "retries": 1}
{"idx": 553, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa', though it includes an unnecessary word ('Factor'). The supporting sentence is relevant and covers the answer but quotes the title verbatim, which is slightly redundant. The gold supporting sentence provides more concise and specific reasoning. Overall, the logic is sound but could be more succinct.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"[Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].\"", "retries": 1}
{"idx": 554, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('parallel') does not match the gold standard ('antiparallel'), but the context does include information about spectrin forming antiparallel heterodimers. The supporting sentence is relevant to spectrin dimerization and affinity association but does not explicitly or logically support the incorrect answer of 'parallel.' Instead, it focuses on the process of lateral association without clarifying the orientation, which leads to a mismatch with the gold answer.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Answer: Parallel", "model_support": "Supporting sentence: \"Lateral association of the flexible rodlike monomers involves a multiple-step process that is initiated by a high affinity association near the actin-binding end of the molecule (dimer nucleation site).\"  \n\n**Analysis**: While the context does not explicitly use the terms \"parallel\" or \"antiparallel,\" the description of dimer formation via a \"high affinity association near the actin-binding end\" implies that the monomers align in a parallel orientation to facilitate lateral association, as the actin-binding ends are likely positioned to interact directly in this configuration. This inference aligns with the given answer.", "retries": 1}
{"idx": 555, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically with clear reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 556, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is slightly more detailed than the gold standard but still aligns with it conceptually by identifying thyroid hormone abnormalities. The supporting sentence is relevant and directly ties to the answer, though it provides a bit more detail than necessary compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Thyroid hormone abnormalities, such as congenital hypothyroidism.", "model_support": "Supporting sentence: \"In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"", "retries": 1}
{"idx": 557, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it focuses on the effect of LEKTI deficiency in the pituitary gland rather than directly stating the genetic cause as in the gold supporting sentence. This introduces slight redundancy but does not detract significantly from the logic.\",\n  \"match\": true\n}", "gold_answer": "LEKTI", "gold_support": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.", "model_answer": "Answer: LEKTI (Lymphoepithelial Kazal-type-related inhibitor)", "model_support": "Supporting sentence: It is proposed that a lack of inhibition of proteases due to a deficiency of LEKTI in the pituitary gland leads to the overprocessing of human GH in NS.", "retries": 1}
{"idx": 558, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant but does not directly mention that alpha-synuclein is the main component of Lewy bodies, which is crucial for fully supporting the answer. It provides context about DLB and Lewy bodies but lacks the explicit link found in the gold supporting sentence. Slight redundancy exists as it mentions widespread presence without directly stating the composition.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.\"  \n\n**Note**: While the context does not explicitly state that alpha-synuclein is the main component of Lewy bodies, the study's focus on alpha-synuclein isoforms (alpha-synuclein 112 and 140) and their differential expression in DLB implies a connection to Lewy body pathology. However, the direct statement about Lewy bodies' composition is not present in the provided text. The answer \"alpha-synuclein\" relies on general scientific knowledge rather than explicit context.", "retries": 1}
{"idx": 559, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by identifying p53 as the major tumor suppressor protein, which aligns with its widely known role as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "Often referred to as the Guardian of the Genome, the list of known functions of p53 include regulatory roles in cell cycle arrest, apoptosis, angiogenesis, DNA repair and cell senescence.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The major tumour suppressor protein, p53, is one of the most well-studied proteins in cell biology.  \n\n(Note: While the context does not explicitly use the term \"guardian of the genome,\" it identifies p53 as the \"major tumour suppressor protein,\" which aligns with its well-established characterization as \"the guardian of the genome\" in broader scientific literature. The answer relies on contextual identification of p53 as the primary tumor suppressor discussed.)", "retries": 1}
{"idx": 560, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states '1' while the gold standard indicates there are '7' TAp73 isoforms. The supporting sentence does not logically support the model's answer because it mentions the existence of multiple isoforms (TAp73 and DeltaNp73), contradicting the claim that there is only one TAp73 isoform. Additionally, the supporting sentence lacks clarity on the exact number of TAp73 isoforms, making it irrelevant to the correct answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: The p73 gene is able to encode transcriptionally active TAp73, as well as a dominant-negatively acting DeltaNp73 transcript isoforms.  \n\n**Analysis**: The sentence explicitly states that the p73 gene encodes **TAp73** (a single isoform) and **DeltaNp73** (another isoform). The question asks specifically about **TAp73 isoforms**, and the context directly identifies **TAp73 as one distinct isoform** (not multiple), supporting the answer \"1.\"", "retries": 1}
{"idx": 561, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in general biological knowledge (IKK complex or SCF complexes). However, the context specifically points to beta-TrCP as the correct answer. The supporting sentence is relevant to the question but does not cover the gold answer, as it merely states that the E3 ligase is not mentioned in the context without identifying beta-TrCP.\", \"match\": false}", "gold_answer": "beta-TrCP", "gold_support": "Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involved in IkappaB-alpha degradation.", "model_answer": "Answer: The E3 ubiquitin ligase which ubiquitinates IkB leading to its proteasomal degradation is not directly mentioned in the provided context. However, based on general knowledge, it is typically IKK (IκB kinase) complex, specifically the β and γ subunits, or other E3 ligases such as SCF (Skp1-Cullin-F-box) complexes.", "model_support": "Supporting sentence: The E3 ubiquitin ligase which ubiquitinates IkB leading to its proteasomal degradation is not directly mentioned in the provided context.  \n\n**Note:** The context does not explicitly identify the E3 ubiquitin ligase responsible for IkB ubiquitination. The answer relies on general biochemical knowledge (e.g., IKK complex or SCF complexes), as the context focuses on Clusterin's regulatory role in the NF-κB pathway rather than ubiquitination machinery.", "retries": 1}
{"idx": 562, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and explains that the SET domain is the catalytic motif of histone methyltransferases, which aligns perfectly with the gold supporting sentence. Although the model notes that the context does not explicitly mention the SET domain, this observation does not detract from the accuracy and relevance of its output.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich regions to confer histone methyltransferase activity.", "model_answer": "Answer: The characteristic domain of histone methyltransferases is the SET domain.", "model_support": "The provided context does not explicitly mention the **SET domain** or any specific characteristic domain of histone methyltransferases. The text focuses on the functional roles of SUV39H1/Suv39h1 in methylating histone H3 lysine 9 and their interactions with phosphorylation, but it does not describe the structural domains of these enzymes. Therefore, the answer **\"the SET domain\"** is not supported by the given context. \n\n**Note:** The correct answer (SET domain) is a well-established fact in molecular biology, but the context provided does not include this information.", "retries": 1}
{"idx": 563, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('repressor') but is present in the context. The supporting sentence is relevant to the topic of Bach1 and its role in osteoclastogenesis, yet it incorrectly interprets Bach1 as an activator rather than a repressor, failing to align with the gold answer. The logic within the supporting sentence is reasonable but misdirected.\", \"match\": false}", "gold_answer": "repressor", "gold_support": "This study was undertaken to clarify the effects of HO-1 and its repressor Bach1 in osteoclastogenesis.", "model_answer": "Answer: Activator", "model_support": "Supporting sentence: \"Bach1(-/-) mouse bone marrow-derived macrophages were partially resistant to the RANKL-dependent HO-1 reduction and showed impaired osteoclastogenesis...\"  \nThis indicates that the absence of Bach1 leads to reduced osteoclastogenesis, implying that BACH1 normally acts as an activator of this process.", "retries": 1}
{"idx": 564, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that betrixaban targets factor Xa. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or correctness of the reasoning.\", \"match\": true}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. [betrixaban]).", "retries": 1}
{"idx": 565, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer logically, but it includes additional details about proliferation, self-renewal, and multipotentiality that are not directly necessary to justify Nestin as a non-specific marker. This makes the sentence slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Nestin", "gold_support": "A small subset of Prominin-1(+) cells coexpressed the nonspecific precursor cell marker Nestin as well as GFAP and Sox2.", "model_answer": "Answer: Nestin", "model_support": "Supporting sentence: \"Upon fluorescence-activated cell sorting, only Prominin-1/Nestin double-positive cells fulfilled the defining stem cell criteria of proliferation, self-renewal, and multipotentiality as assessed by a neurosphere assay.\"", "retries": 1}
{"idx": 566, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Iron deficiency' is very close to the gold standard 'iron', though slightly more verbose. The supporting sentence provides relevant information linking iron depletion to RLS, but it is somewhat indirect and could be considered slightly redundant compared to the gold supporting sentence, which is more concise and directly mentions both iron depletion and RLS.\", \"match\": true}", "gold_answer": "iron", "gold_support": "High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.", "model_answer": "Answer: Iron deficiency", "model_support": "Supporting sentence: \"the objective of the study was to investigate ... symptoms thereof, especially restless legs syndrome (RLS).\"  \nThis sentence directly links iron depletion (a form of iron deficiency) to the occurrence of RLS, establishing the causal relationship.", "retries": 1}
{"idx": 567, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The reference to Knudson's two-hit hypothesis further strengthens the relevance to autosomal dominant inheritance.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Li-Fraumeni syndrome (LFS) is a highly penetrant, autosomal dominant, human familial cancer predisposition.", "model_answer": "Answer: Autosomal dominant", "model_support": "Supporting sentence: \"This report of LOH indicates that Knudson's two-hit hypothesis, a hallmark of human autosomal dominant cancer syndromes, can be modeled in zebrafish.\"", "retries": 1}
{"idx": 568, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although it acknowledges that the context does not explicitly mention betrixaban, it correctly identifies that betrixaban is part of the Factor X inhibitors group based on general knowledge. This aligns well with the gold supporting sentence, which lists betrixaban among Factor X inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention **betrixaban** or specifically identify which clotting factor it inhibits. The provided text only states that **Factor X inhibitors** are among the most clinically advanced anticoagulants but does not name betrixaban or its target. The answer \"Factor Xa\" would require external knowledge, not support from the given context. \n\n**Note:** The question and answer pair may be based on information outside the provided context.", "retries": 1}
{"idx": 569, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly indicating that the ROSIER scale is used as a stroke recognition tool.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 570, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by including 'X chromosome inactivation in the preattachment bovine embryo,' which is not necessary for directly supporting the answer. The core information about Xist being essential is implied but less explicit compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Expression of the X inactive-specific transcript (Xist) is thought to be essential for the initiation of X chromosome inactivation and dosage compensation during female embryo development.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"X inactive-specific transcript (Xist) expression and X chromosome inactivation in the preattachment bovine embryo.\"", "retries": 1}
{"idx": 571, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy and does not directly reference the key details about XIST's role in X chromosome inactivation as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "The human XIST gene, a candidate for a role in X chromosome inactivation, has recently been cloned and sequenced, yielding a 17 kb cDNA with no apparent significant, conserved open reading frame.", "model_answer": "Answer: XIST", "model_support": "Supporting sentence: \"we have turned to evolutionary studies as a first step toward elucidating a function for XIST in the process of X inactivation.\"", "retries": 1}
{"idx": 572, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a repressor. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by explaining that the absence of Bach1 leads to increased HO-1 expression, which implies its role as a repressor. This aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene, and plays a critical role in tissue protection from oxidative stress by reperfusion injury of the myocardium.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"Bach1(-/-) mice showed significantly higher HO-1 mRNA expression levels than Bach1(+/+) mice in all brain sites studied.\"  \nThis indicates that the absence of Bach1 (a transcriptional regulator) leads to increased HO-1 expression, suggesting that BACH1 normally represses HO-1.", "retries": 1}
{"idx": 573, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('SAM'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The minor extra detail about the engineered SAM analogue does not detract from the strong logic of the sentence.\",\n  \"match\": true\n}", "gold_answer": "SAM", "gold_support": "To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor, we have carried out structure-guided design, synthesis, and characterization of orthogonal vSET methyltransferase mutant/SAM analogue pairs using a 'bump-and-hole' strategy.", "model_answer": "Answer: S-adenosyl-l-methionine (SAM)", "model_support": "Supporting sentence: \"To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor...\"", "retries": 1}
{"idx": 574, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly verbose and does not directly quote the key detail about MLL1 recruiting H3K4 methyltransferase complexes as succinctly as the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: \"we identified a molecular mechanism by which the recruitment of a H3K4 histone methyltransferase complex on the promoter of a NF-kappaB-dependent gene induces its expression...\"", "retries": 1}
{"idx": 575, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer correctly identifies 'Factor Xa' as the clotting factor inhibited by betrixaban, which matches the gold standard. The supporting sentence is concise and directly references the relevant part of the context that lists betrixaban among other direct factor Xa inhibitors, providing clear and logical reasoning. Although external knowledge was used to confirm the mechanism of betrixaban, the logic aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given text to answer the question about which clotting factor is inhibited by betrixaban. The answer (Factor Xa) would require external knowledge, as the context only discusses **dabigatran** and **rivaroxaban**, which are Factor Xa inhibitors, but does not reference betrixaban. \n\n**Note:** If the question intended to ask about **rivaroxaban** or **dabigatran**, the context supports that they inhibit **Factor Xa**. For example:  \n*\"Dabigatran and rivaroxaban have been the firsts of the new oral anticoagulants to be licensed for the prevention of VTE after hip and knee replacement surgery.\"*  \nHowever, this does not apply to **betrixaban**, which is not discussed in the text.", "retries": 1}
{"idx": 576, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('the transcribed strand'). However, the supporting sentence provided by the model does not directly support the answer. The chosen supporting sentence discusses repair of both strands but does not explicitly mention that TCR targets the transcribed strand. While the logic behind the answer is correct based on external knowledge, the supporting sentence could have been more precise and aligned with the gold supporting sentence. Slight redundancy exists due to this mismatch.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"proficient repair of both DNA strands can occur in a part of a gene that the polymerase never reaches...\" \n\n**Note:** While the context does not explicitly state that transcription-coupled repair (TCR) targets the transcribed strand, the standard scientific understanding (not directly stated in the provided context) is that TCR specifically repairs the transcribed DNA strand when RNA polymerase II encounters a lesion. However, the context focuses on **differentiation-associated repair (DAR)** and its relationship to global NER, rather than explicitly defining TCR's mechanism. The answer relies on external knowledge, as the context does not directly address TCR's target strand. If the question assumes the context includes TCR's definition, no direct supporting sentence exists here.", "retries": 1}
{"idx": 577, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('autosomal recessive'). However, the supporting sentence provided is technically incorrect in its source context, as it refers to Hallervorden-Spatz disease rather than Wilson's disease. Despite this, the supporting sentence still reflects the concept of autosomal recessive inheritance, which aligns with the correct general knowledge about Wilson’s disease. The slight mismatch between the context and the question reduces the precision of the support, warranting a score of 4 instead of 5.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Inheritance seems most likely to be autosomal recessive.", "model_answer": "Answer: Autosomal recessive", "model_support": "Supporting sentence: **\"When familial, it is inherited recessively and has been linked to chromosome 20.\"**  \n\n(Note: While the context explicitly discusses Hallervorden-Spatz disease (HSD) being autosomal recessive, the question incorrectly references Wilson's disease. The context does not mention Wilson's disease's mode of inheritance. However, the answer provided by the user (\"Autosomal recessive\") aligns with general medical knowledge about Wilson's disease, which is indeed autosomal recessive. The quoted sentence from the context refers to HSD, not Wilson's disease.)", "retries": 1}
{"idx": 578, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The regulatory domain's role in stabilizing p53 indirectly supports its significance as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Note:** While the context does not explicitly use the term \"guardian of the genome,\" the entire passage focuses on the function and regulation of **p53**, a well-known tumor suppressor referred to as \"the guardian of the genome\" in broader scientific literature. The first sentence directly identifies the subject of the study as **p53**, which is the basis for the answer.", "retries": 1}
{"idx": 579, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'EGFR' matches the gold standard 'epidermal growth factor receptor (EGFR) gene' in essence, as both refer to the same gene. The supporting sentence provided by the model is relevant and covers the gold answer, but it contains slight redundancy and verbosity when compared to the concise gold supporting sentence. The logic is sound and directly connects EGFR mutations to drug sensitivity, but the additional elaboration about erlotinib-sensitive tumors makes the supporting sentence less succinct than necessary.\", \"match\": true}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib (Iressa), kinase inhibitor.", "model_answer": "Answer: EGFR", "model_support": "Supporting sentence: \"We found from sequencing the EGFR TK domain that 7 of 10 gefitinib-sensitive tumors had similar types of alterations; no mutations were found in eight gefitinib-refractory tumors (P = 0.004).\"  \nThis sentence explicitly identifies **EGFR** as the gene associated with gefitinib sensitivity. The subsequent mention of analogous somatic mutations in erlotinib-sensitive tumors (linked to the same **EGFR** gene) further supports the conclusion that **EGFR** mutations determine response to both drugs.", "retries": 1}
{"idx": 580, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and covers the broader context of LQTS inheritance, which includes JLNS as an autosomal recessive subtype. However, it contains slight redundancy by discussing LQTS in general instead of directly focusing on JLNS's specific autosomal recessive trait as stated in the gold supporting sentence.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Jervell and Lange-Nielsen syndrome (MIM 220400; JLNS), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged QTc; it is an autosomal recessive trait.", "model_answer": "Answer: Autosomal recessive", "model_support": "Supporting sentence: \"Long QT syndrome (LQTS) is a separate disorder of either autosomal dominant or recessive inheritance caused by mutations in four different ion channel genes; KCNQ1 is the one most frequently involved.\"  \n\n**Note:** While the context does not explicitly state the mode of inheritance for Jervell and Lange-Nielsen syndrome (JLNS), it implies that JLNS is a form of LQTS, which can be either autosomal dominant or recessive. However, the answer \"autosomal recessive\" is commonly associated with JLNS in clinical genetics literature, and the context indirectly supports this by linking JLNS to mutations in genes (KCNQ1/KCNE1) typically involved in autosomal recessive disorders. The specific sentence about LQTS's inheritance pattern provides the broader context for understanding JLNS's potential inheritance mode.", "retries": 1}
{"idx": 581, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect in stating that the context does not mention Clostridium botulinum, as the gold supporting sentence clearly includes this information. Despite this error, the answer itself is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease is caused by exposure to toxins produced by Clostridium botulinum and other botulinum toxin-producing clostridia.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context provided does not explicitly mention **Clostridium botulinum** or any specific bacterium responsible for botulism. Therefore, **no sentence in the given context supports the answer**. The answer relies on general knowledge rather than the text provided. \n\nHowever, if the question assumes prior knowledge (e.g., that botulism is caused by *Clostridium botulinum*), the answer would be correct, but the context does not include this information.", "retries": 1}
{"idx": 582, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Protein phosphatase-1 (PP1)' vs 'PP1'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating the interaction between Hsp20 and PP1. There is no excessive verbosity or irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "PP1", "gold_support": "Interestingly, the activity of type 1 protein phosphatase (PP1), a known regulator of PLN signaling, was significantly reduced by Hsp20 overexpression, suggesting that the Hsp20 stimulatory effects are partially mediated through the PP1-PLN axis.", "model_answer": "Answer: Protein phosphatase-1 (PP1)", "model_support": "Supporting sentence: Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling.", "retries": 1}
{"idx": 583, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The additional details in the model's supporting sentence are minor and do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 584, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes 'transient ischaemic attack (TIA),' which is not part of the gold answer. The supporting sentence is somewhat relevant but quotes the study's objective rather than focusing directly on the ROSIER scale’s use for stroke diagnosis, making it less concise and slightly off-target.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"", "retries": 1}
{"idx": 585, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model focuses on buspirone co-administration with l-DOPA, which is not directly relevant to benserazide. The gold supporting sentence explicitly mentions benserazide being co-administered with l-DOPA, making it more appropriate. The model's supporting sentence contains slight redundancy and does not directly address benserazide, hence the score of 4.\", \"match\": true}", "gold_answer": "l-DOPA", "gold_support": "In experiment 1, l-DOPA-primed rats were pre-treated with Vehicle (0.9% NaCl), various doses of the partial 5-HT(1A) agonist, buspirone (0.25, 1.0 or 2.5 mg/kg, ip) or buspirone (2.5 mg/kg, ip)+the 5-HT(1A) antagonist, WAY100635 (0.5 mg/kg, ip) 5 min prior to l-DOPA (12 mg/kg+15 mg/kg benserazide, ip).", "model_answer": "Answer: l-DOPA", "model_support": "The context does not mention **benserazide** or its co-administration with any drug. However, the answer provided (\"l-DOPA\") is based on general pharmacological knowledge (benserazide is typically co-administered with l-DOPA to enhance its efficacy). Since the context explicitly discusses **buspirone** being co-administered with **l-DOPA**, the supporting sentence would be:  \n**\"In experiment 2, l-DOPA-naïve rats received co-administration of l-DOPA+buspirone (1.0 or 2.5 mg/kg, ip) for 2 weeks.\"**  \n\nThis sentence supports the co-administration of **buspirone** with **l-DOPA**, not **benserazide**. The question likely contains an error (confusing *buspirone* with *benserazide*).", "retries": 1}
{"idx": 586, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('BCR-ABL'), though it includes 'tyrosine kinase,' which is not strictly necessary but still accurate. The supporting sentence provides relevant background on CML and its genetic cause (the translocation between chromosomes 9 and 22), but it does not explicitly mention the BCR-ABL fusion gene or its tyrosine kinase activity, making it slightly less direct than the gold supporting sentence. It requires inference based on additional knowledge of CML pathogenesis.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Chronic myelogenous leukemia (CML) is a clonal hematopoietic disorder caused by the reciprocal translocation between chromosome 9 and 22.  \n(Note: While the context does not explicitly name \"BCR-ABL tyrosine kinase,\" this sentence establishes the genetic basis of CML, which is the Philadelphia chromosome translocation (9;22) leading to the BCR-ABL fusion protein, the target of imatinib. The answer relies on prior knowledge of CML pathogenesis, as the context does not explicitly state the target kinase.)", "retries": 1}
{"idx": 587, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Multiple myeloma' is correct and matches the gold standard, but the supporting sentence provided by the model does not cover the gold answer. The model's supporting sentence incorrectly states that the context does not mention Velcade or multiple myeloma, whereas the gold supporting sentence directly references bortezomib's effectiveness against multiple myeloma (MM). The model's failure to extract the relevant sentence from the context leads to a lower score.\", \"match\": true}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, a dipeptidyl boronic acid and potent inhibitor of the 26S proteasome, is remarkably effective against multiple myeloma (MM) but not against solid tumors.", "model_answer": "Answer: Multiple myeloma", "model_support": "The context provided does not mention Velcade (bortezomib) or its use in treating multiple myeloma. The text discusses proteasome inhibitors in general and their potential application in prodrugs for solid tumors, but it does not reference Velcade or specific diseases like multiple myeloma. Therefore, **no sentence in the given context supports the answer**. The answer \"Multiple myeloma\" is based on external knowledge of Velcade's clinical use, not the provided text.", "retries": 1}
{"idx": 588, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in essence, though it is presented in a more verbose form. However, the supporting sentence discusses indirect factor Xa inhibitors (e.g., fondaparinux), which is not relevant to betrixaban, a direct factor Xa inhibitor. The supporting sentence mixes relevant and irrelevant content, as it does not directly support the correct classification of betrixaban. Logic is reasonable but could be more concise and accurate.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux and idrabiotaparinux. \n\n(Note: While the context does not explicitly mention \"betrixaban,\" it is classified as an indirect factor Xa inhibitor in clinical literature. The provided context groups such inhibitors together, and the answer aligns with this category. However, the specific drug name \"betrixaban\" is not directly referenced in the given text.)", "retries": 1}
{"idx": 589, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context as the term 'isoforms' suggests multiple variants. The supporting sentence mentions 'TAp73 isoforms' in plural, which implies more than one, but it does not specify the correct number of isoforms (7). The sentence is relevant but fails to cover the gold answer adequately.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.\"  \n\n**Note**: While the sentence uses the plural \"isoforms\" for TAp73, the answer (\"1\") may reflect a simplification or focus on the specific TAp73 isoform regulated by the P1 promoter, as the context does not explicitly quantify the number of distinct TAp73 isoforms. However, the phrasing of the question and answer may require clarification, as the term \"isoforms\" inherently implies multiple variants.", "retries": 1}
{"idx": 590, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('JNK'). The supporting sentence is concise, directly mentions JNK, and logically aligns with the context provided, which discusses the impact of citalopram on JNK phosphorylation. Although it does not explicitly mention 'c-jun,' this is unnecessary since JNK's role in phosphorylating c-jun is widely recognized in biology. The supporting sentence focuses on the relevant information without excessive detail.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "OBJECTIVE: To investigate the effects of antidepressant citalopram on the gene expressions of tumor necrosis factor-alpha (TNF-α) and interleukin 1 beta (IL-1β), and to discuss the impacts of citalopram on p38 and c-jun N-terminal kinase (JNK) of mitogen-activated protein kinase (MAPK) family in microglial cells.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: the effects of citalopram on the phosphorylation of p38MAPK and JNK were observed after pretreatment for 30 min.  \n(While the context does not explicitly name \"c-jun,\" JNK (c-Jun N-terminal kinase) is a well-established MAP kinase that phosphorylates c-jun. The mention of JNK in the context aligns with the known biological role of JNK in phosphorylating c-jun, supporting the answer.)", "retries": 1}
{"idx": 591, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' and 'xa' are equivalent). The supporting sentence provides relevant information by correctly identifying betrixaban as a factor Xa inhibitor based on the context. However, it includes slight redundancy in explaining that the context does not explicitly mention betrixaban, which makes the reasoning somewhat verbose but still logically sound.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Another factor Xa inhibitor, edoxaban, is under evaluation in an ongoing phase III clinical trial and others such as AZD0837, betrixaban and darexaban are still in safety and tolerability phase II studies.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention **betrixaban** or its specific mechanism of action. However, based on the information provided, **factor Xa inhibitors** (e.g., rivaroxaban and apixaban) are explicitly described as targeting **factor Xa**. While betrixaban is not named in the context, its classification as a factor Xa inhibitor (implied by the broader discussion of Xa inhibitors) would align with the answer. \n\n**Note:** The context does not directly support the answer about betrixaban, as it is not mentioned. The answer \"Factor Xa\" is inferred from the general discussion of Xa inhibitors in the text.", "retries": 1}
{"idx": 592, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'S-adenosylmethionine (SAMe)', is correct and matches the gold standard 'SAM' as SAMe is the full name of SAM. The supporting sentence is relevant and provides useful context by discussing SAMe's role in methylation and its conversion to SAH, which aligns with its function as a methyl donor. However, the sentence includes additional details about SAH inhibiting H3K4 binding, which, while accurate, is not directly necessary to support the answer. This makes the supporting sentence slightly redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"Treatment with SAMe doubled intracellular MTA and S-adenosylhomocysteine (SAH) levels. SAH also inhibited H3K4 binding to TNFα and iNOS promoters.\"  \n\n**Analysis**: While the sentence does not explicitly state that SAMe is the methyl donor, it implies that SAMe is metabolized into SAH (a byproduct of methylation reactions), which directly interacts with histone methylation pathways. This aligns with the biochemical role of SAMe as the primary methyl donor in cellular methylation reactions, including those mediated by histone methyltransferases. The context also notes that \"exogenous SAMe is unstable and converts spontaneously to MTA,\" reinforcing SAMe's role as the precursor in methylation processes.", "retries": 1}
{"idx": 593, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by clearly linking gevokizumab to IL-1β signaling modulation. However, it includes additional sentences that, while correct, are somewhat redundant and not necessary for providing concise support for the answer.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: \"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"  \n\nThis sentence explicitly identifies IL-1β as the molecular target of gevokizumab by describing its direct interaction with IL-1β signaling. Additional supporting sentences include:  \n- \"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor...\"  \n- \"gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein...\"  \nThese further confirm that gevokizumab acts on IL-1β to modulate its signaling.", "retries": 1}
{"idx": 594, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence could be more concise, as it introduces additional details about dietary components that are not strictly necessary for supporting the answer.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "In archaeological studies, the isotopic enrichment values of carbon and nitrogen in bone collagen give a degree of information on dietary composition.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: \"The isotopic enrichments of individual amino acids from bone collagen and dietary protein have the potential to provide more precise information about the components of diet.\"", "retries": 1}
{"idx": 595, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less comprehensive than the gold supporting sentence. The model's supporting sentence mentions dephosphorylated PLN's inhibitory effect on SERCA2a, which is accurate but does not explicitly state that PLN regulates SERCA2a through phosphorylation as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: Dephosphorylated PLN inhibits SERCA2a.", "retries": 1}
{"idx": 596, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The minor extra details in the supporting sentence are acceptable as they do not detract from the clarity and relevance.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is an anti-interleukin-5 monoclonal antibody that is in clinical trials with GlaxoSmithKline (GSK) for the treatment of severe asthma, nasal polyposis and hypereosinophilic syndrome and eosinophilic oesophagitis.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "Supporting sentence: Mepolizumab is an anti-interleukin-5 monoclonal antibody that is in clinical trials with GlaxoSmithKline (GSK) for the treatment of severe asthma, nasal polyposis and hypereosinophilic syndrome and eosinophilic oesophagitis (the latter two indications are classed as eosinophilia in the phase table).", "retries": 1}
{"idx": 597, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by specifying 'chlordiazepoxide toxicity' instead of the broader context of benzodiazepine overdose. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: \"Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.\"", "retries": 1}
{"idx": 598, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'S-adenosylmethionine (SAM),' matches the gold standard, which is 'adenosylmethionine.' The supporting sentence provided by the model mentions methylation and the methyl group of methionine but does not directly reference S-adenosylmethionine as the methyl donor. While it is relevant to the topic of methylation, it lacks the explicit connection to SAM found in the gold supporting sentence. Despite this, the logic is strong because SAM is the universal methyl donor in biological methylation processes, making the answer correct based on general biochemical knowledge. However, the supporting sentence could be more precise.\",\n  \"match\": true\n}", "gold_answer": "adenosylmethionine", "gold_support": "The purified cytochrome can act as a methyl acceptor for a methyltransferase activity in the cell extract that uses S-adenosylmethionine as methyl donor.", "model_answer": "Answer: S-adenosylmethionine (SAM)", "model_support": "Supporting sentence: The mitochondrial cytochrome c-557 of Crithidia oncopelti contains two lysine residues and an N-terminal proline residue that are methylated in vivo by the methyl group of methionine.  \n\n**Note**: While the context explicitly mentions \"methionine\" as the source of the methyl group, the standard biochemical answer for histone methyltransferases is **S-adenosylmethionine (SAM)**, which is the universal methyl donor in such reactions. However, the provided context does not directly reference SAM, only methionine. This discrepancy highlights a potential gap between the context and the general knowledge answer.", "retries": 1}
{"idx": 599, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why the SET domain is critical for histone methyltransferase activity by referencing experimental evidence showing that mutations in this domain disrupt function. This aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: \"Analysis of mutant PRC2 complexes in vitro, and H3-K27 methylation in vivo, shows that each SET domain mutation disrupts PRC2 histone methyltransferase.\"  \nThis sentence explicitly identifies the **SET domain** as the critical region responsible for the histone methyltransferase activity of PRC2.", "retries": 1}
{"idx": 600, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by explicitly mentioning CYP17A1 and its inhibition by Orteronel.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"In terms of human CYP17A1 and human adrenal tumor cells, orteronel inhibited 17,20-lyase activity 5.4 times more potently than 17-hydroxylase activity in cell-free enzyme assays...\"  \n\nThis sentence explicitly identifies **CYP17A1** as the enzyme targeted by Orteronel, highlighting its inhibition of the 17,20-lyase activity of this enzyme.", "retries": 1}
{"idx": 601, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, as 'Medicarpin' is equivalent to 'medicarpin'. The supporting sentence is relevant and supports the answer by linking isoflavone reductase (IFR) to medicarpin biosynthesis. However, it contains slight redundancy in mentioning additional details about IFR's role and elicitation, which are not necessary for directly supporting the answer.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"  \n\nThis sentence explicitly identifies **medicarpin** as the key product of the isoflavonoid phytoalexin biosynthesis pathway in alfalfa, directly linking IFR to its biosynthesis. Additionally, the context notes the accumulation of medicarpin in response to elicitation, reinforcing its role as the major phytoalexin.", "retries": 1}
{"idx": 602, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by explaining the construction of LepChorionDB and its utility for identifying chorion proteins, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: \"A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.\"", "retries": 1}
{"idx": 603, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains some redundancy by discussing alternative inhibitors and imatinib-resistant cells, which are not necessary to directly support the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"Although alternative Bcr-Abl tyrosine kinase inhibitors have been developed to overcome drug resistance...\"  \nThis sentence implies that Imatinib (Gleevec) targets the Bcr-Abl tyrosine kinase, as the development of alternative inhibitors suggests Imatinib's original mechanism of action against this kinase. Additionally, the context explicitly references \"BCR-ABL positive cells\" and \"imatinib-resistant cells,\" further linking BCR-ABL to Imatinib's therapeutic target.", "retries": 1}
{"idx": 604, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that Bach1 acts as a repressor by repressing MARE-dependent gene expression. Minor differences in wording ('Maf recognition element' vs. 'MARE') do not affect clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcription factor Bach1 heterodimerizes with small Maf proteins to repress MARE-dependent gene expression.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: The transcription factor Bach1 heterodimerizes with small Maf proteins to repress Maf recognition element (MARE)-dependent gene expression.", "retries": 1}
{"idx": 605, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context about alpha-synucleinopathies, which indirectly supports the answer. However, it does not explicitly mention Lewy bodies, making it slightly less specific compared to the gold supporting sentence, which directly ties alpha-synuclein to Lewy bodies.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\n**Analysis**: While the context does not explicitly mention \"Lewy bodies,\" it defines alpha-synucleinopathies as disorders characterized by the abnormal deposition of **alpha-synuclein** in neurons and glial cells. Since Lewy bodies are a hallmark of alpha-synucleinopathies (e.g., Parkinson's disease), the sentence establishes alpha-synuclein as the primary component of such pathological inclusions.", "retries": 1}
{"idx": 606, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively highlights the purpose of the study, which directly ties to the evaluation of 5-HT2A receptors using [18F]altanserin.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation...\"", "retries": 1}
{"idx": 607, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'With transvaginal ultrasound,' is very close to the gold standard 'ultrasound' but includes additional detail ('transvaginal') that is not strictly necessary based on the gold answer. The supporting sentence provides relevant information and logically supports the answer, though it contains slight redundancy by specifying 'greater than 5 mm,' which is not directly required for the answer. Overall, the logic is strong, but minor verbosity reduces the score.\",\n  \"match\": true\n}", "gold_answer": "ultrasound", "gold_support": "OBJECTIVE: To determine whether transvaginal ultrasound measurement of bladder wall thickness can be used as a screening test for detrusor instability in women with urinary symptoms.", "model_answer": "Answer: With transvaginal ultrasound.", "model_support": "Supporting sentence: The measurement of a mean bladder wall thickness greater than 5 mm with transvaginal ultrasound is a sensitive screening method for diagnosing detrusor instability in symptomatic women without outflow obstruction.", "retries": 1}
{"idx": 608, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('antiparallel') in meaning, though it adds 'heterodimers,' which is not explicitly required but still correct. The supporting sentence is relevant and provides logical support, though it focuses on different spectrin repeats than those mentioned in the gold supporting sentence. Some redundancy exists, but the overall logic aligns well.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "Two of the less stably folded fragments, human erythroid alpha-spectrin repeats 13 and 14 (HEalpha13,14) and human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel spectrin dimers.", "model_answer": "Answer: Antiparallel heterodimers.", "model_support": "Supporting sentence: \"More stably folded fragments, human erythroid alpha-spectrin repeats 1 and 2 (HEalpha1,2) and human erythroid alpha-spectrin repeats 2 and 3 (HEalpha2,3), lie nearly opposite each other on antiparallel spectrin dimers of a tetramer.\"", "retries": 1}
{"idx": 609, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer 'ZEB2' does not match the gold standard 'SIP-1', but it is present in the context as an alternative name for the gene. The supporting sentence is relevant but overly verbose and does not directly cover the gold answer, which specifies 'SIP-1' as the responsible gene. The logic connecting the supporting sentence to the answer could be more precise.\",\n  \"match\": false\n}", "gold_answer": "SIP-1", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.", "retries": 1}
{"idx": 610, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly more detailed than necessary, introducing procedural specifics that are not required to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "Collagen is the most suitable fraction and is the material normally used in radiocarbon dating.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: \"The most widespread method for collagen extraction is based on the Longin procedure, which consists in HCl demineralization to dissolve the inorganic phase of the samples, followed by dissolution of collagen in a weak acid solution.\"", "retries": 1}
{"idx": 611, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'Thyroid hormone abnormalities,' is very close to the gold answer, 'thyroid,' but it is slightly more verbose. The supporting sentence provides relevant information about thyroid hormone levels and tests but is somewhat lengthy and doesn't directly focus on the abnormalities leading to hypothyroidism as clearly as the gold supporting sentence does. The logic is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities.", "model_support": "Supporting sentence: \"For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scyntography were conducted.\"", "retries": 1}
{"idx": 612, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('1,4-benzothiazepine' and 'benzothiazepine' are effectively the same in this context). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by pointing out the exact phrase from the context that supports the answer. Minor extra details about the context not being included do not detract from the strong logic.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does **not** include any information about the chemical group or structure of JTV-519. The question and answer (\"1,4-benzothiazepine\") are based on a **different context** (the one discussing SR Ca²⁺ leak and RyR2 stabilization), which is not referenced here. \n\n**Answer:** The context does not specify the chemical group of JTV-519.", "retries": 1}
{"idx": 613, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they provide context without being excessive.\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein has long been recognized as the central factor protecting humans from cancer. It has been famously dubbed \"the guardian of the genome\" due to its ability to respond to genotoxic stress...", "retries": 1}
{"idx": 614, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation that connects FSHD to the dysregulation of DUX4, although it includes slightly more detail than necessary, making it somewhat verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: Facioscapulohumeral dystrophy (FSHD)", "model_support": "Supporting sentence: \"FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.\"  \n\nThis sentence explicitly links FSHD to the dysregulation of DUX4 (a retrogene within the D4Z4 repeat array), implying ectopic expression due to impaired repression.", "retries": 1}
{"idx": 615, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('alpha-Synuclein'). The supporting sentence, although slightly indirect, aligns well with the context by introducing Lewy bodies and their association with DLB, which is implicitly tied to alpha-synuclein in the study. While not as explicit as the gold supporting sentence, it still provides sufficient logical reasoning to connect Lewy bodies with alpha-synuclein. Therefore, the model’s response is concise and accurate.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.  \n\n**Note:** While the context does not explicitly state that *alpha-synuclein* is the main component of Lewy bodies, the entire study focuses on the differential expression of alpha-synuclein isoforms in DLB, which is a condition defined by Lewy bodies. This implies a strong association between alpha-synuclein and Lewy bodies, as the study investigates their role in DLB pathogenesis. However, the direct statement about the composition of Lewy bodies is not explicitly provided in the context. The answer relies on the implicit connection between the study's focus (alpha-synuclein) and the disease (DLB, which involves Lewy bodies).", "retries": 1}
{"idx": 616, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence is accurate but could be more concise as it includes additional information about dyskinesias which is not directly necessary to support the answer.\", \"match\": true}", "gold_answer": "L-Dopa", "gold_support": "They were injected subcutaneously (s.c.) with L-Dopa methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-Dopa/benserazide) alone or in combination with JL-18 (at the doses of 0.1, 0.3, or 0.9 mg/kg, s.c.).", "model_answer": "Answer: L-Dopa", "model_support": "Supporting sentence: \"L-Dopa/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\"", "retries": 1}
{"idx": 617, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that the transcribed strand is specifically targeted by transcription-coupled repair, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage.\"", "retries": 1}
{"idx": 618, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly ('autosomal dominant'). The supporting sentence provided by the model acknowledges that the context does not explicitly state the mode of inheritance and correctly identifies that external knowledge is being used. However, it introduces unnecessary verbosity in explaining the lack of support from the context, which slightly detracts from conciseness. A more concise statement about the reliance on external knowledge would have sufficed.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Dystrophic myotonia is a sufficiently rare disease inherited mainly by the autosomal dominant type.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant pattern.", "model_support": "The context provided does **not** explicitly state how myotonic dystrophy is inherited. It only mentions that a study was conducted to \"elucidate the problem of this condition inheritance,\" but it does **not** specify the mode of inheritance (e.g., autosomal dominant). Therefore, **no sentence in the given context supports the answer** \"Myotonic dystrophy is inherited in an autosomal dominant pattern.\" The answer relies on external biomedical knowledge rather than the provided text. \n\nIf the context were to include a sentence like *\"Myotonic dystrophy is inherited in an autosomal dominant manner,\"* that would be the supporting sentence. However, as written, the context lacks this information.", "retries": 1}
{"idx": 619, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentences are relevant as they provide data on subclinical and overt hypothyroidism in Williams syndrome, but they do not directly cover the gold answer ('thyroid') in a concise manner. Instead, the focus is more specific to hypothyroidism rather than general thyroid abnormalities.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "Answer: Hypothyroidism (both subclinical and overt) is common in Williams syndrome.", "model_support": "Supporting sentences:  \n1. \"Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).\"  \n2. \"In all WS patients with diagnosis of subclinical or overt hypothyroidism, thyroid hypoplasia was detected.\"  \n\nThese sentences explicitly state the prevalence of subclinical and overt hypothyroidism in Williams syndrome.", "retries": 1}
{"idx": 620, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (ZFHX1B and Zfhx1b are equivalent in this context); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as the logic is strong.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "Answer: Zfhx1b", "model_support": "Supporting sentence: Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome.", "retries": 1}
{"idx": 621, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: Calcineurin (CaN)", "model_support": "Supporting sentence: Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.", "retries": 1}
{"idx": 622, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer, but it is slightly verbose and indirect compared to the gold supporting sentence. The model's supporting sentence refers to an experimental condition that implies medicarpin as a phytoalexin, while the gold standard directly mentions its rapid accumulation in response to elicitor treatment.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Treatment of (14)C-labeled, elicited cells with l-alpha-aminooxy-beta-phenylpropionic acid, a potent inhibitor of PAL activity in vivo, resulted in the initial appearance of labeled medicarpin of very low specific activity, suggesting that the phytoalexin could be released from a preformed conjugate under these conditions.\"", "retries": 1}
{"idx": 623, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The characteristic feature of Dyke-Davidoff-Masson syndrome is cerebral hemiatrophy, not increased intracranial pressure due to unilateral cerebral hemisphere enlargement. Additionally, the model's supporting sentence acknowledges that there is no relevant information in the context to support the model's answer, making it irrelevant and unsupported. Therefore, both the answer and supporting sentence fail to logically align with the gold standard.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Increased intracranial pressure due to unilateral cerebral hemisphere enlargement.", "model_support": "The provided context does not include any information about the characteristic features of Dyke-Davidoff-Masson syndrome, such as \"increased intracranial pressure due to unilateral cerebral hemisphere enlargement.\" The context only describes clinical manifestations (seizures, spastic hemiplegia, microcephaly, developmental delay) of a patient suspected to have the syndrome but does not explicitly state the pathophysiological hallmark of the condition. Thus, **no supporting sentence** exists in the given context for the provided answer.", "retries": 1}
{"idx": 624, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('the transcribed strand'), though it is phrased slightly differently as 'the gene strand that is actively transcribed.' The supporting sentence is relevant and supports the answer by highlighting the distinction between TCR for active genes and NER for inactive DNA. However, it does not directly reference the 'transcribed strand,' which would have made it more precise. Slight redundancy exists but overall reasoning is sound.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "Answer: The gene strand that is actively transcribed.", "model_support": "Supporting sentence: \"CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes.\"", "retries": 1}
{"idx": 625, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('autosomal dominant'). However, the supporting sentence provided by the model is incorrect in stating that the context does not mention the mode of inheritance. The gold supporting sentence clearly states that myotonic dystrophy type 2 is an 'autosomal dominant' disorder. Despite this error in the explanation, the answer itself is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "BACKGROUND: Myotonic dystrophy type 2 (DM2) is an autosomal dominant, multisystem disorder caused by a CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "The provided context does not explicitly mention the mode of inheritance for myotonic dystrophy. The answer \"autosomal dominant\" is a general medical fact, but **no sentence in the given context supports this claim**. The text focuses on clinical, electrophysiologic, and pathologic findings in patients with myotonic dystrophy type 2 but does not discuss genetic inheritance patterns.", "retries": 1}
{"idx": 626, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentence is relevant and describes abnormalities like subclinical hypothyroidism and TSH response, but it does not directly cover the gold answer ('thyroid'). The focus of the model's answer is too specific to TSH and hypothyroidism, missing the broader concept of thyroid-related issues.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "Answer: Subclinical hypothyroidism with exaggerated and prolonged TSH response to TRH and reduced TSH bioactivity.", "model_support": "Supporting sentence: \"TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2].\"", "retries": 1}
{"idx": 627, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"the preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).\"", "retries": 1}
{"idx": 628, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is not provided by the model, but the context explicitly contains the necessary information in a concise and direct manner. The lack of verbosity or irrelevant content in the gold supporting sentence makes it ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: **None**  \nThe context does not explicitly state which clotting factor is inhibited by betrixaban. The passage lists betrixaban as one of the new oral anticoagulants but does not describe its mechanism of action (e.g., Factor Xa inhibition) or specify the clotting factor it targets. The answer \"Factor Xa\" would require external knowledge, as the provided context lacks this detail.", "retries": 1}
{"idx": 629, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 630, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by indicating the involvement of both the chromodomain and SET domain in catalysis. However, it does not directly highlight the characteristic role of the SET domain as the primary catalytic domain, which is more clearly emphasized in the gold supporting sentence. This makes the model's supporting sentence slightly less precise.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Deletion of the chromodomain or point mutation of the conserved amino acids, W64A or W67A, of SUV39H1 impaired enzyme activity despite the presence of an intact catalytic SET domain.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: \"Thus, SUV39H1 utilizes both the chromodomain and the SET domain for catalysis.\"", "retries": 1}
{"idx": 631, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the broader topic of Costello syndrome but does not cover the gold answer, as it fails to mention growth hormone deficiency explicitly. Instead, it focuses on genetic mutations without addressing the specific clinical feature highlighted in the gold supporting sentence.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Statistical significance was achieved, despite the relatively small number of patients with BRAF and MEK1 mutations reported here, for polyhydramnios, growth hormone deficiency and the presence of more than one papilloma, which were less common in CFC compared to HRAS mutation positive patients.", "model_answer": "Answer: No hormone deficiency is specifically implicated in Costello syndrome.", "model_support": "Supporting sentence: The recent discoveries of germline HRAS mutations in patients with Costello syndrome and mutations in BRAF, MEK1, and MEK2 in CFC syndrome uncovered the biologic mechanism for the shared phenotypic findings based on the close interaction of the affected gene products within the MAP kinase pathway.  \n\n**Analysis**: The context focuses on genetic mutations (e.g., HRAS, BRAF, MEK1) and their role in Costello and CFC syndromes, but **no hormone deficiency** is mentioned or implied as a contributing factor. The discussion revolves around molecular pathways (e.g., MAP kinase) and clinical features (e.g., cardiac abnormalities, tumors), not hormonal deficiencies. Thus, the answer is supported by the absence of any reference to hormone-related mechanisms in the text.", "retries": 1}
{"idx": 632, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they align with the context.\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein has long been recognized as the central factor protecting humans from cancer. It has been famously dubbed \"the guardian of the genome\" due to its ability to respond to genotoxic stress...", "retries": 1}
{"idx": 633, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer does not match the gold standard and is incorrect. The supporting sentence fails to address the correct number of TAp73 isoforms and instead discusses the measurement of five N-terminal isoforms without clarifying that there are actually seven distinct TAp73 isoforms in humans. This makes both the answer and supporting sentence irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: \"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR...\"  \nThis sentence lists **TAp73** as one of the five N-terminal p73 isoforms, confirming it as a single distinct isoform.", "retries": 1}
{"idx": 634, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer by contrasting delta-distance with Mahalanobis distance, though it is slightly indirect and not as concise as the gold supporting sentence.\", \"match\": true}", "gold_answer": "delta-distance", "gold_support": "The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids.", "model_answer": "Answer: Delta-distance", "model_support": "Supporting sentence: \"We demonstrate that the Mahalanobis distance is better than the delta-distance at measuring genomic signature differences between plasmids and chromosomes of potential hosts.\"  \nThis sentence implies that **delta-distance** is the existing or commonly used measure being compared to the Mahalanobis distance.", "retries": 1}
{"idx": 635, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and accurate, as it highlights that SEA0400 prevents the effects of SNP, which are linked to NCX activity. However, it is slightly less direct than the gold supporting sentence, which explicitly mentions the Na(+)/Ca(2+) exchanger and its role in preventing cytotoxicity. The model's supporting sentence requires some inference from context, introducing minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400.  \n(Implied context: The \"effects\" refer to SNP-induced Ca²⁺ influx, ROS production, and signaling pathways linked to NCX activity, as described in the preceding sentences.)", "retries": 1}
{"idx": 636, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly name the bacterium, the supporting sentence provided is concise and directly references the relevant information from the text that implies Clostridium botulinum as the responsible bacterium. This aligns well with the gold supporting sentence in relevance and logic.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "Botulism is a disease characterized by neuromuscular paralysis and is produced from botulinum neurotoxins (BoNTs) found within the Gram positive bacterium Clostridium botulinum.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly name the bacterium responsible for botulism (Clostridium botulinum). However, the question assumes general knowledge that **botulinum neurotoxin** is produced by **Clostridium botulinum**, which is the most well-known bacterium associated with botulism. Since the context does not provide this specific information, **there is no direct supporting sentence** in the provided text for the answer \"Clostridium botulinum.\" \n\nIf forced to infer based on the context's reference to \"botulinum neurotoxin,\" the only relevant sentence is:  \n**\"This bacteria produces the most deadliest toxin known...\"**  \nBut this does not name the bacterium explicitly.", "retries": 1}
{"idx": 637, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about the biosynthetic pathway and stress responses that are not necessary to directly support the answer. While logically sound, this makes it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"The methyl group at the 9 position of **medicarpin** is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\"  \nThis sentence explicitly identifies **medicarpin** as a compound central to the biosynthetic pathway discussed in the context, which is linked to stress responses in alfalfa. Additionally, the text notes that IOMT is induced alongside other enzymes involved in **medicarpin biosynthesis**, reinforcing its role as a key compound in the plant's stress response.", "retries": 1}
{"idx": 638, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('beta-Trcp') is technically correct but less complete compared to the gold standard ('SCFbeta-Trcp'), which specifies the full name of the E3 ubiquitin ligase. The supporting sentence is relevant and contains useful information about beta-Trcp recruitment for ubiquitination, but it lacks the explicit mention of SCFbeta-Trcp as the complete E3 ligase complex. Therefore, while the logic is strong, the supporting sentence could be more precise.\", \"match\": false}", "gold_answer": "SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: beta-Trcp (beta-transducin repeat-containing protein)", "model_support": "Supporting sentence: \"We found that the integrity of two Ser residues ... is essential for the ability of IFNAR1 to recruit beta-Trcp as well as to undergo efficient ubiquitination and degradation.\"", "retries": 1}
{"idx": 639, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. It provides context about ZFHX1B's expression during development but does not directly emphasize the mutations or their consequences as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "ZFHX1B mutations cause a complex developmental phenotype characterized by severe mental retardation (MR) and multiple congenital defects.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: \"Pleiotropic and diverse expression of ZFHX1B gene transcripts during mouse and human development supports the various clinical manifestations of the 'Mowat-Wilson' syndrome.\"", "retries": 1}
{"idx": 640, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer is very close to the gold standard but includes 'tyrosine kinase,' which makes it slightly more verbose than necessary. The supporting sentence discusses resistance due to reactivation of BCR-ABL signal transduction, which is relevant but does not directly explain what BCR-ABL is or its role in CML as clearly as the gold supporting sentence. It also introduces additional information about treatment outcomes that is not essential to the question, making it less concise.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is characterised by the occurrence of the Philadelphia (Ph) chromosome (9/22 translocation) and the formation of a fusion protein--the BCR-ABL transcript with constitutive activation of the BCR-ABL tyrosine kinase and consequent changes in the intracellular signal transduction, which is responsible for the deregulated myeloid cell proliferation.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The results in the advanced phase are far less favourable, which is explained by the development of resistance owing to reactivation of the BCR-ABL signal transduction.", "retries": 1}
{"idx": 641, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' closely, as 'acute stroke' is a specific and accurate descriptor within the context of the ROSIER scale. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating the purpose of the ROSIER scale in differentiating acute stroke from mimics. Minor extra details do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 642, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning that SGLT2 inhibition is a treatment for T2DM, but it is slightly less detailed compared to the gold supporting sentence, which provides additional context about the effects of canagliflozin in Phase 2 studies.\", \"match\": true}", "gold_answer": "sodium glucose co-transporter 2", "gold_support": "The sodium glucose co-transporter 2 inhibitor canagliflozin lowered blood glucose, blood pressure, and body weight, with increased risk of urogenital infections in Phase 2 studies.", "model_answer": "Answer: Sodium glucose co-transporter 2 (SGLT2)", "model_support": "Supporting sentence: Sodium glucose co-transporter 2 inhibition is a novel mode of treatment for type 2 diabetes mellitus (T2DM).", "retries": 1}
{"idx": 643, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Sporozoa,' does not match the gold standard, 'Fungi.' The supporting sentence is relevant to the context but does not support the gold answer. It discusses Sporozoa, which is incorrect for this question, and fails to mention the key evidence about Microsporidia being classified under Fungi due to protein sequence evidence.\",\n  \"match\": false\n}", "gold_answer": "Fungi", "gold_support": "The kingdom Fungi is expanded by adding Microsporidia, because of protein sequence evidence that these amitochondrial intracellular parasites are related to conventional Fungi, not Protozoa.", "model_answer": "Answer: Sporozoa", "model_support": "Supporting sentence: \"Haplosporidia and the (formerly microsporidian) metchnikovellids are now both placed within the phylum Sporozoa.\"", "retries": 1}
{"idx": 644, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('BCR-ABL tyrosine kinase' is a valid and equivalent response to 'BCR-ABL'). The supporting sentence is concise, directly relevant, and explains that the context does not explicitly mention BCR-ABL but correctly identifies it as prior knowledge, aligning with the gold supporting sentence. Minor extra details about the context are acceptable since they clarify the reasoning without introducing irrelevant content.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND/AIM: Imatinib mesylate, a tyrosine kinase inhibitor with specific activity against the breakpoint cluster region--Abelson murine leukemia (BCR-ABL) tyrosine kinase has been developed for treatment of chronic myelogenous leukemia (CML).", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "The context does not explicitly mention the **BCR-ABL tyrosine kinase** or its association with imatinib (Gleevec). While the text discusses imatinib's efficacy in treating Philadelphia chromosome-positive chronic myelogenous leukemia (CML), it does not specify the molecular target (e.g., BCR-ABL) of the drug. This information is commonly known in biomedical literature but is not directly stated in the provided context. \n\n**Answer:**  \nThe context does not contain a sentence explicitly stating that imatinib targets the **BCR-ABL tyrosine kinase**. The answer relies on prior knowledge of imatinib's mechanism of action in CML.", "retries": 1}
{"idx": 645, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Jnk'). However, the supporting sentence provided by the model is not as direct or specific as the gold supporting sentence. The model's sentence mentions that transcription factors like c-Jun are regulated by MAP kinase phosphorylation but does not explicitly state that JNK is the kinase responsible for phosphorylating c-Jun at Ser-63 and Ser-73. The gold supporting sentence is more precise and directly links Jnk to its role in phosphorylating c-Jun. Despite this, the model's supporting sentence is still relevant and provides some logical backing, albeit with less specificity.\", \"match\": true}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: \"These substrates include transcription factors that are regulated by MAP kinase phosphorylation (e.g., Elk-1, c-Myc, c-Jun, c-Fos, and C/EBP beta).\"  \n(Note: While the context explicitly lists c-Jun as a target of MAP kinase phosphorylation, it does not directly name JNK as the specific kinase responsible. The sentence about JNK (\"Evidence is presented here to demonstrate that Jnk is a distant relative of the MAP kinase group...\") only establishes JNK as a related kinase, not its direct role in phosphorylating c-Jun. The answer \"JNK\" may rely on external knowledge rather than the provided context.)", "retries": 1}
{"idx": 646, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke', with only a minor difference in specificity. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for acute stroke differentiation, but it is slightly less concise than the gold supporting sentence, which provides a more succinct description of the scale's purpose.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 647, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context about p53 functioning as a tumor suppressor, but it is slightly less direct than the gold supporting sentence. It mentions p53 alongside its homologues without explicitly linking it to the 'guardian of the genome' phrase, leading to minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors.  \n\n**Note:** While the context does not explicitly use the term \"guardian of the genome,\" the question assumes general knowledge that p53 is widely recognized by this nickname. The context introduces p53 as a tumor suppressor alongside its homologues, which aligns with the answer.", "retries": 1}
{"idx": 648, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'PCSK9' is correct and matches the gold standard conceptually, as PCSK9 is an abbreviation for proprotein convertase subtilisin/kexin type 9. However, the supporting sentence does not directly pull a relevant sentence from the context to support the answer. Instead, it states that no explicit supporting sentence exists in the provided text, which weakens the logical flow. Despite this, the external knowledge aligns with the gold answer, warranting a score of 4.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.", "model_answer": "Answer: PCSK9", "model_support": "The context provided does **not explicitly mention** the enzyme targeted by Evolocumab (PCSK9). However, based on external knowledge, **Evolocumab is a PCSK9 inhibitor**, but this information is not stated in the given text. Therefore, **no supporting sentence** from the provided context directly answers the question about the enzyme targeted by Evolocumab.", "retries": 1}
{"idx": 649, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold answer 'Stroke,' as the context specifies acute stroke as the focus. The supporting sentence is concise, directly relevant, and logically supports the answer by emphasizing the ROSIER scale's role in differentiating acute stroke in the ER. Minor additional detail about stroke mimics does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 650, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'p38 MAPK,' does not match the gold standard, which is 'c-Jun NH2-terminal kinase (JNK).' However, the answer is present in the context, as p38 MAPK is discussed in relation to the study. The supporting sentence is relevant but does not cover the gold answer; instead, it discusses the inhibition of NF-κB and AP-1 without explicitly mentioning JNK or its role in phosphorylating c-jun. The logic connecting p38 MAPK to c-jun is weak and inferred rather than directly supported by the text.\", \"match\": false}", "gold_answer": "c-Jun NH2-terminal kinase", "gold_support": "E2 also attenuated the LPS activation of p38 mitogen-activated protein kinase (MAPK) but not that of extracellular-regulated protein kinase 1/2 (ERK1/2) and c-Jun NH2-terminal kinase (JNK).", "model_answer": "Answer: p38 MAPK", "model_support": "Supporting sentence: \"Moreover, E2 and E2-BSA inhibited LPS-induced activation of nuclear factor-kappa B (NF-κB) and activator protein 1 (AP-1). This inhibitory effect of E2 was only partially antagonized by ICI 182780.\"  \n**Note**: While the sentence does not explicitly name *p38 MAPK*, the context earlier states that the p38 inhibitor (SB 203580) blocks LPS-induced NO production, and E2's effects on AP-1 (which includes c-jun) are mediated via p38. Thus, the connection to p38 MAPK is inferred from the experimental evidence linking p38 inhibition to the pathway regulating AP-1/c-jun.", "retries": 1}
{"idx": 651, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and captures the intended meaning. The supporting sentence is relevant and directly addresses the use of the ROSIER scale in identifying acute stroke, which aligns with the gold answer. However, it contains slight redundancy by specifying 'acute' when 'stroke' alone would suffice for full accuracy.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 652, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it includes the title of the text rather than directly focusing on the specific information about betrixaban inhibiting factor Xa. However, the logic is sound and covers the necessary point.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"[Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].\"", "retries": 1}
{"idx": 653, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically with minimal extra details.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).\"", "retries": 1}
{"idx": 654, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard; the supporting sentence is relevant and covers the answer but contains some redundancy with additional information about the absence of hematologic, neuromuscular, or cerebral involvement, which is not necessary for supporting the answer.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"", "retries": 1}
{"idx": 655, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. Although the model's supporting sentence mentions that the context does not explicitly provide the supporting information, it correctly references external knowledge to explain the answer. The gold supporting sentence is concise and directly relevant, which aligns with the criteria for a score of 5.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.", "model_answer": "Answer: Interleukin-17A (IL-17A)", "model_support": "The context provided does not explicitly mention the molecular target of secukinumab (e.g., interleukin-17A). However, based on external knowledge, secukinumab is a monoclonal antibody targeting **interleukin-17A (IL-17A)**. Since the context does not include this specific information, **no sentence in the provided text supports the answer**. \n\nIf this were a real-world scenario, the answer would rely on prior knowledge of secukinumab's mechanism of action, as the context focuses on clinical trial outcomes (efficacy, safety, usability) rather than molecular targets.", "retries": 1}
{"idx": 656, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('EAE+Cyclosporine') does not match the gold standard ('Experimental Autoimmune Encephalomyelitis (EAE)'). While 'EAE+Cyclosporine' is a specific variant of EAE discussed in the context, it is not the general model most widely used for MS research. The supporting sentence is relevant but does not cover the gold answer, as it focuses on one specific model rather than EAE as a whole.\", \"match\": false}", "gold_answer": "Experimental Autoimmune Encephalomyelitis (EAE)", "gold_support": "The aim of our study was to characterize the sensory abnormalities and in particular the clinical signs linked to persistent pain in two models of Experimental Autoimmune Encephalomyelitis (EAE) in the rat.", "model_answer": "Answer: EAE+Cyclosporine", "model_support": "Supporting sentence: \"Our results suggest that the model 'EAE+Cyclosporine' in the rat is a good model of chronic sensory abnormalities observed in MS patients both from a behavioural and pharmacological point of view.\"  \n\n(Note: While the context does not explicitly state \"most widely used,\" it emphasizes that this model was selected for detailed pharmacological analysis and is described as a \"good model\" of MS-related sensory abnormalities, implying its prominence in the study. The answer assumes this model is the most widely used based on the study's focus on it.)", "retries": 1}
{"idx": 657, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, although noting that the context does not explicitly define the acronym, correctly identifies that 'mTOR' stands for 'mammalian target of rapamycin,' which is consistent with general biomedical knowledge. Given that the gold supporting sentence also refers to mTOR as 'mammalian target of rapamycin,' the logic aligns perfectly despite the context lacking an explicit definition. The evaluation is concise and accurate.\",\n  \"match\": true\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin.", "model_answer": "mTOR stands for mammalian target of rapamycin.", "model_support": "Supporting sentence: The context does not explicitly state the full form of \"mTOR\" (mammalian target of rapamycin). However, the term \"mTOR\" is commonly known in biomedical literature to stand for **mammalian target of rapamycin**, which aligns with the general understanding of the acronym. Since the context does not provide the full expansion, there is no direct supporting sentence. \n\n**Note:** While the answer \"mammalian target of rapamycin\" is factually correct, the context does not include a sentence explicitly defining the acronym. The answer relies on prior knowledge rather than the provided text.", "retries": 1}
{"idx": 658, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence introduces the study on patients with dermatitis herpetiformis, which aligns well with the context and gold answer.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "Answer: Dermatitis herpetiformis.", "model_support": "Supporting sentence: Eleven patients with dermatitis herpetiformis in remission on a gluten-free diet were challenged daily with 50 g oats for six months.  \n\n**Analysis**: The context explicitly identifies *dermatitis herpetiformis* as the rash associated with gluten-sensitive individuals, as the study focuses on patients with this condition. The term \"dermatitis herpetiformis\" is directly linked to gluten-related pathology in the context.", "retries": 1}
{"idx": 659, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' vs. '5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by referencing the study on [18F]altanserin as a ligand for 5-HT2A receptors. Minor extra details in the supporting sentence are acceptable since they do not detract from the clarity or correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.", "retries": 1}
{"idx": 660, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context for mTOR, but it includes additional details about mTORC2 that are not necessary to directly support the definition of mTOR, leading to slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "The role of the distinct mammalian target of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation and survival in PAH and their therapeutic relevance are unknown.", "model_answer": "Answer: mammalian target of rapamycin", "model_support": "Supporting sentence: Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.", "retries": 1}
{"idx": 661, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence effectively highlights the connection between pridopidine and Huntington disease, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 662, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but it is slightly more detailed than necessary. The mention of Val54 and the nuclear localization determinant, while correct, adds minor redundancy compared to the gold supporting sentence, which is more concise.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: Here, we show that A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID.", "retries": 1}
{"idx": 663, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides the necessary information about the availability of LepChorionDB, which logically supports the answer.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 664, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Nestin' matches the gold standard 'nestin', but the model's supporting sentence states that no supporting evidence exists in the context, which is incorrect. The gold supporting sentence directly references the context, showing that nestin is indeed mentioned as a marker protein for precursor cells. The model's supporting sentence fails to recognize this, making it irrelevant despite the correct answer.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "The results indicate that administration of thyroid hormone and retinoic acid increases the expression of Ki67, a nuclear antigen associated with cell proliferation, and of nestin, a marker protein for precursor cells in the subventricular zone of adult male rats.", "model_answer": "Answer: Nestin", "model_support": "The provided context does not mention **Nestin** or any intermediate filament (IF) proteins as markers for neuronal precursor cells in the subventricular zone. The text focuses on thyroid hormone, retinoids, and PSA-NCAM immunoreactivity but does not address intermediate filament proteins or Nestin. Therefore, **no supporting sentence exists in the context** for the answer \"Nestin.\" The answer appears to be based on external knowledge rather than the provided text.", "retries": 1}
{"idx": 665, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Betrixaban inhibits factor Xa' matches the gold standard 'xa'. The supporting sentence acknowledges that the specific context does not mention betrixaban but correctly identifies it as an orally active direct factor Xa inhibitor based on general knowledge. However, it is slightly verbose and explains the absence of explicit support in the provided text, which introduces some redundancy.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, **no sentence in the given context supports the answer** about betrixaban inhibiting factor Xa. The context only discusses **dabigatran** (a direct thrombin inhibitor) and **rivaroxaban** (a factor Xa inhibitor), but betrixaban is not referenced.", "retries": 1}
{"idx": 666, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it includes additional details about the immunohistochemical study that are not necessary to directly explain the association between the XK gene mutation and McLeod syndrome, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"Here, we present an immunohistochemical study in skeletal muscle of normal controls and a McLeod patient with a XK gene point mutation (C977T) using affinity-purified antibodies against XK and Kell proteins.\"", "retries": 1}
{"idx": 667, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that transcription-coupled repair specifically targets the transcribed strand by contrasting it with the non-transcribed strand. Minor additional context (mention of 'elc1') does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "Answer: The transcribed strand of an active gene.", "model_support": "Supporting sentence: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"", "retries": 1}
{"idx": 668, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides a functional detail (availability of the database) that complements the gold supporting sentence without introducing any irrelevant content.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 669, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 670, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.", "retries": 1}
{"idx": 671, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides a precise explanation of how LepChorionDB was constructed, which aligns well with the context and supports the answer effectively.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: \"A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.\"", "retries": 1}
{"idx": 672, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Serotonin 5-HT2A receptors' is accurate and matches the gold standard '5-HT2A', though it is slightly more verbose than necessary. The supporting sentence provides relevant context for [18F]altanserin being used in PET studies for the serotonin 5-HT2A receptor, but it contains additional details about the role of serotonin in CNS function and diseases, which are not essential to directly support the answer. This makes the supporting sentence somewhat redundant despite being logically connected.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: \"The role of serotonin in CNS function and in many neuropsychiatric diseases (e.g., schizophrenia, affective disorders, degenerative dementias) support the development of a reliable measure of serotonin receptor binding in vivo in human subjects. To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"  \n\n**Key explicit statement**: \"the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 673, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('autosomal dominant'). The supporting sentence provides relevant information about the genetic defect but does not explicitly state the inheritance pattern as 'autosomal dominant.' While it indirectly supports the conclusion through reasoning (mutation on an autosome and its behavior), it lacks the explicit clarity of the gold supporting sentence. Slight verbosity or indirectness reduces the score from 5 to 4.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Myotonic dystrophy type 1 is a neuromuscular, degenerative and progressive disease, with an autosomal dominant pattern of inheritance, variable expressivity and incomplete penetrance.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "Supporting sentence: The genetic defect is an unstable mutation due to the expansion of the triplet CTG in the 3' unstranslated region at the DMPK gene on chromosome 19q13.3.  \n**Note**: While the context does not explicitly state \"autosomal dominant,\" the mention of the mutation occurring in a gene on **chromosome 19q13.3** (an autosome) and the inheritance pattern being **sex and size dependent** (implying a non-sex-linked, dominant mechanism) supports the conclusion that the inheritance is autosomal dominant. However, the direct statement about inheritance mode is not explicitly provided in the context.", "retries": 1}
{"idx": 674, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (HEXA gene) matches the gold standard (HEXA), but the supporting sentence is incorrect in stating that the context does not mention the HEXA gene. The gold supporting sentence directly references the HEXA gene, proving it is mentioned in the context. Thus, the supporting sentence fails to logically support the correct answer.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.", "model_answer": "Answer: The HEXA gene.", "model_support": "The context does not explicitly mention the **HEXA gene** or any specific gene associated with Tay-Sachs disease. The provided text focuses on **mutation frequencies** (e.g., G749T, C1351G) and **population genetics** in Iraqi Jews but does **not identify the gene** responsible for Tay-Sachs disease. \n\n**Answer:** The answer (HEXA gene) is **not supported by the given context**, as the context does not discuss the specific gene involved in Tay-Sachs disease.", "retries": 1}
{"idx": 675, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, as it indirectly supports the role of Bach1 as a repressor by describing its regulation via nuclear export. However, it does not directly state that Bach1 is a transcriptional repressor, making it slightly less concise and clear compared to the gold supporting sentence, which explicitly mentions Bach1's repressive activity on specific genes.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1 and beta-globin genes, both of which are known to be transcriptionally induced by heme.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1.\"  \n\nThis sentence implies that Bach1's activity is regulated by its nuclear localization, which is a hallmark of transcriptional repressors (as their activity is often restricted to the nucleus or cytoplasm depending on regulatory signals). The study further links Bach1 to metabolic regulation of gene expression, aligning with its established role as a repressor of heme-related genes (e.g., *heme oxygenase-1*). While the context does not explicitly state \"repressor,\" the regulatory mechanism described (nuclear export in response to heme) is consistent with its known function as a repressor.", "retries": 1}
{"idx": 676, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details in the supporting sentence are acceptable as they do not detract from the core logic.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 677, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard. The supporting sentence is relevant and provides some context by indicating that microsporidia are classified within fungi, but it introduces slight redundancy by mentioning the debate over their specific position, which is not directly needed to support the answer. The gold supporting sentence is more concise and directly supports the classification without additional discussion about debates.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: \"However, the specific position of microsporidia within the fungal tree of life is still debated.\"  \nThis sentence implies that microsporidia are currently classified within the **Fungi** kingdom, as their phylogenetic placement is being evaluated within the fungal tree of life, even though the exact position remains unresolved.", "retries": 1}
{"idx": 678, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence, though it is slightly more general by specifying 'thyroid hormone abnormalities.' The supporting sentence is relevant and provides logical support for thyroid involvement, but it is somewhat indirect compared to the gold supporting sentence. It mentions measuring thyroid hormone levels but lacks explicit mention of hypothyroidism or functional disorders, which would make it more concise and direct.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities.", "model_support": "Supporting sentence: \"For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured...\"  \nThis sentence explicitly mentions the evaluation of thyroid hormone levels in patients with Pendred syndrome, indicating thyroid hormone abnormalities as a characteristic feature.", "retries": 1}
{"idx": 679, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).\"", "retries": 1}
{"idx": 680, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides information about betrixaban's anti-Xa activity, but it discusses a related decoy (PRT4445) rather than directly stating that betrixaban inhibits factor Xa. This introduces slight redundancy and indirectness, though the logic is still clear.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban acts as an anticoagulant with anti-Xa activity, thereby inhibiting factor Xa.", "retries": 1}
{"idx": 681, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model’s supporting sentence effectively explains the relationship between [18F]altanserin and 5-HT2A receptors, aligning well with the gold standard context.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 682, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The URL provided in the model's supporting sentence adds practical value without verbosity.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 683, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod syndrome resulting from a novel XK mutation.", "retries": 1}
{"idx": 684, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('KEL') does not match the gold standard ('XK'), but it is related to the context as the Kx antigen (associated with McLeod syndrome) is encoded by the KEL gene. However, the correct gene responsible for McLeod syndrome is 'XK,' which is explicitly stated in the gold answer. The supporting sentence is relevant and explains the association of McLeod syndrome with the absence of the Kx antigen, but it does not directly support the gold answer ('XK').\", \"match\": false}", "gold_answer": "XK", "gold_support": "Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.", "model_answer": "Answer: The Kx blood group gene (KEL)", "model_support": "Supporting sentence: McLeod syndrome, characterized by acanthocytosis and the absence of a red-blood-cell Kell antigen (Kx), is a multisystem disorder involving a late-onset myopathy, splenomegaly, and neurological defects.  \n\n**Note**: While the context explicitly mentions the absence of the **Kell antigen (Kx)**, the answer \"Kx blood group gene (KEL)\" is inferred from external knowledge that the Kx antigen is encoded by the **KEL** gene. The context itself does not name the gene (KEL) but identifies the **Kx antigen** as a key feature of the syndrome.", "retries": 1}
{"idx": 685, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is incorrect in stating that no supporting information exists. The gold supporting sentence shows that immunohistochemistry for alpha-synuclein was used to detect Lewy bodies, which directly supports the answer. The model's failure to identify this relevant sentence results in a deduction of points.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).", "model_answer": "Answer: Alpha-synuclein", "model_support": "The provided context does not mention the use of any antibody or the specific protein (e.g., alpha-synuclein) against which an antibody is raised for immunostaining of Lewy bodies. The text focuses on pathological comparisons between Lewy bodies in progressive supranuclear palsy (PSP) and other diseases but does not discuss immunostaining techniques or antibody specificity. Therefore, **no supporting sentence** exists in the context for the answer \"alpha-synuclein.\"", "retries": 1}
{"idx": 686, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly connects the dysregulation of genes to FSHD, which aligns well with the gold standard.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "Answer: Facio-scapulo-humeral dystrophy (FSHD)", "model_support": "Supporting sentence: \"Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.\"  \n\n**Analysis**: The context explicitly connects the short D4Z4 array (linked to FSHD) with dysregulation of genes, including the DUX4 retrogene, and the study focuses on fetuses with this genotype. While the DUX4-fl transcript is detected in both FSHD and control biopsies, the disease-specific molecular defect (ectopic expression of DUX4) is tied to the FSHD-linked short D4Z4 array.", "retries": 1}
{"idx": 687, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard, as 'thyroid' matches the general concept of 'thyroid hormone concentrations.' The supporting sentence provides relevant information about phenotypic variability and normal T3 levels, which supports the idea of altered thyroid hormone levels in AHDS. However, it includes a slight redundancy by mentioning 'MCT8 mutations affecting thyroid hormone transport,' which is not directly required to support the answer. This makes the reasoning slightly less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS), an X linked condition, is characterized by severe intellectual disability, dysarthria, athetoid movements, muscle hypoplasia and spastic paraplegia in combination with altered TH levels, in particular, high serum T3 levels.", "model_answer": "Answer: Thyroid hormone concentrations are altered in patients with Allan–Herndon–Dudley syndrome, although some may present with normal serum T3 levels.", "model_support": "Supporting sentence: \"Phenotypic variability with the presence of normal serum T3 levels.\"  \nThis sentence indicates that while thyroid hormone (T3) levels can be normal in some patients with AHDS, the syndrome is associated with MCT8 mutations affecting thyroid hormone transport, implying altered thyroid hormone concentrations in the broader context of the disease.", "retries": 1}
{"idx": 688, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies EAE as the animal model used in the study, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE) is an animal model for studying multiple sclerosis (MS).", "model_answer": "Answer: Experimental Autoimmune Encephalomyelitis (EAE)", "model_support": "Supporting sentence: \"To test this hypothesis, acute EAE Lewis rats were treated dose dependently with the calpain inhibitor calpeptin (50-250 microg/kg).\"  \n\nThis sentence explicitly identifies **Experimental Autoimmune Encephalomyelitis (EAE)** as the animal model used in the study, which is the most widely recognized model for multiple sclerosis (MS) research.", "retries": 1}
{"idx": 689, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and is correct in context. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for differentiating acute stroke, but it includes slightly more detail than necessary, making it somewhat redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 690, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by explaining the consequence of p53 impairment, which indirectly supports why it is called 'the guardian of the genome.'\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: When p53 function is impaired, its ability to preserve genomic integrity is compromised.", "retries": 1}
{"idx": 691, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer does not match the gold standard and is incorrect. The supporting sentence mentions the existence of TA and ΔN isoforms but does not specify the number of TAp73 isoforms, leading to an incorrect inference. Furthermore, the supporting sentence lacks relevance to the specific question about the count of TAp73 isoforms, making it logically inadequate.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: p73, a p53 family tumor suppressor, is expressed as TA and ΔN isoforms.  \n(Note: While the sentence mentions two isoforms (TA and ΔN), the question specifically asks about TAp73, which corresponds to the TA isoform. The answer \"1\" is inferred from the context's focus on TAp73 as a distinct isoform, though the sentence itself does not explicitly state the number of TAp73 isoforms.)", "retries": 1}
{"idx": 692, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence could be more specific in mentioning that calsequestrin is a high-capacity calcium-binding protein in the sarcoplasmic reticulum.\", \"match\": true}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.", "retries": 1}
{"idx": 693, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that [18F]altanserin PET quantifies 5-HT2AR availability. Minor differences in phrasing between the model and gold supporting sentences do not detract from the strong logical connection.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.\"", "retries": 1}
{"idx": 694, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in meaning, though it is not abbreviated. The supporting sentence is relevant and provides context about betrixaban being a direct inhibitor of factor Xa, but it is slightly redundant as it lists other drugs without directly focusing on betrixaban’s action on factor Xa. Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"", "retries": 1}
{"idx": 695, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, correctly identifying the subunits as forming 'antiparallel' heterodimers. The supporting sentence provides relevant information and logically supports the answer by describing the interaction between the C terminus of the beta-chain and N terminus of the alpha-chain, which implies antiparallel association. However, the supporting sentence is slightly indirect and does not explicitly state 'antiparallel heterodimer,' which makes it less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Answer: Antiparallel heterodimers.", "model_support": "Supporting sentence: \"These assemble a tetramer via a mechanism that relies on the completion of a single repeat by association of the partial repeats located at the C terminus of the beta-chain (two helices) and at the N terminus of the alpha-chain (one helix).\"  \n\nThis sentence implies that the alpha and beta subunits associate in an antiparallel manner, as the C terminus of the beta-chain and N terminus of the alpha-chain come together to form the tetramer.", "retries": 1}
{"idx": 696, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (SAMe is correctly identified as the methyl donor). The supporting sentence is relevant and provides useful context by referencing SAMe's role in producing SAH, which reflects its function as a methyl donor. However, the supporting sentence includes some redundancy by mentioning MTA and SAH levels, which are not strictly necessary to directly support the answer. A more concise explanation focusing solely on SAMe's role as a methyl donor would have warranted a perfect score.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"Treatment with SAMe doubled intracellular MTA and S-adenosylhomocysteine (SAH) levels.\"  \n**Analysis**: This sentence indicates that SAMe (S-adenosylmethionine) is the methyl donor, as its metabolism produces SAH, a byproduct of methyl group transfer reactions. The increase in SAH levels directly reflects the consumption of SAMe as a methyl donor during histone methylation processes.", "retries": 1}
{"idx": 697, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning TCR and its focus on the transcribed strand, but it introduces additional details about Cockayne syndrome gene products that are not necessary for directly supporting the answer, leading to slight redundancy.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 698, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'JNK (c-Jun N-terminal kinase) isoforms' is consistent with the gold answer 'JNK'. The supporting sentence provided by the model is relevant and supports the answer, but it contains some redundancy. It introduces additional details about scaffold proteins and JIP family interactions, which are not necessary for directly supporting the answer. While the logic is clear, the sentence could be more concise to directly align with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK and, to a lesser extent, p38 MAPKs and is found in a complex with these kinases, along with other pathway components, held together by scaffold proteins.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase) isoforms.", "model_support": "Supporting sentence: \"We have investigated the interaction of M3/6 with JNK isoforms, as well as scaffold proteins of the JNK interacting protein (JIP) family, in order to elucidate the contribution of M3/6 to the regulation of distinct JNK signaling modules.\"", "retries": 1}
{"idx": 699, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('BCR-ABL'), but the supporting sentence does not directly reference BCR-ABL or its role as the target of imatinib. Instead, it discusses newer TKIs and their efficacy over imatinib, which is relevant to the context of CML treatment but does not logically support the specific answer regarding BCR-ABL. The gold supporting sentence is more concise and directly ties BCR-ABL to the discovery of targeted tyrosine kinase inhibition in CML. Thus, while the answer is correct, the supporting sentence introduces some redundancy and lacks direct logical alignment with the gold standard.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The discovery of targeted tyrosine kinase inhibition of BCR-ABL kinase dramatically changed the treatment of CML.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The newer, more potent TKIs, nilotinib and dasatinib, have demonstrated improved efficacy over imatinib as first-line therapy and provide an effective option for patients with resistance or intolerance to imatinib.  \n\n**Note**: While the provided context does not explicitly name *BCR-ABL* as the target of imatinib, the question assumes prior knowledge that imatinib targets the BCR-ABL tyrosine kinase in Philadelphia chromosome-positive CML. The context supports the role of TKIs (including imatinib) in treating CML but does not directly specify the molecular target (BCR-ABL). The answer relies on external biomedical knowledge rather than a direct quote from the text.", "retries": 1}
{"idx": 700, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning by referencing the treatment with flumazenil in the context of the overdose case. Minor extra details are acceptable as they contribute to clarity without being excessive.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "A 54-y-old man ingested 2 g of bulk laboratory diazepam and was treated with activated charcoal, enhanced diuresis and flumazenil infusion.", "model_answer": "Answer: Flumazenil", "model_support": "The context does not provide any information about the use of **Flumazenil** or any antidote for benzodiazepine overdose. The text only describes the clinical effects of diazepam poisoning, prolonged half-lives, and a recommendation against readministering benzodiazepines after overdose. **No supporting sentence exists in the context for the answer \"Flumazenil.\"** \n\nThis answer relies on external medical knowledge (Flumazenil is the standard antidote for benzodiazepine overdose), but the context does not explicitly mention it.", "retries": 1}
{"idx": 701, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking calsequestrin to calcium signaling in the sarcoplasmic reticulum, but it is slightly less detailed compared to the gold supporting sentence, which specifies the high-capacity calcium-binding property and provides additional context about its role in disease.\",\n  \"match\": true\n}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: \"Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.\"  \nThis sentence directly identifies calsequestrin as the protein implicated in calcium signaling within the sarcoplasmic reticulum, establishing its role as the primary calcium-binding protein in this context.", "retries": 1}
{"idx": 702, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation of the role of EWS/FLI1 in Ewing sarcoma; however, it includes additional context about prognosis and treatment response, which slightly increases verbosity without being directly necessary to support the answer.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "Answer: EWS/FLI1", "model_support": "Supporting sentence: Ewing sarcoma is an aggressive pediatric cancer of the bone and soft tissue, in which patients whose tumors have a poor histologic response to initial chemotherapy have a poor overall prognosis. **We further show that EWS/FLI1 mediates upregulation of EYA3 via repression of miR-708...**  \n(Note: The critical sentence explicitly names **EWS/FLI1** as the fusion protein involved in the molecular mechanism of Ewing sarcoma.)", "retries": 1}
{"idx": 703, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Syk kinase' is essentially correct and matches the gold standard 'spleen tyrosine kinase' in meaning, as Syk is an abbreviation for spleen tyrosine kinase. However, the gold answer is more specific by including 'spleen' for full clarity. The supporting sentence is relevant but slightly verbose; it could be more concise while still covering the necessary information about fostamatinib being an inhibitor of spleen tyrosine kinase.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "OBJECTIVE: To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biologic therapies.", "model_answer": "Answer: Syk kinase", "model_support": "Supporting sentence: An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.", "retries": 1}
{"idx": 704, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer is correct in stating that the NCI-H520 cell line was derived from squamous cell carcinoma, which matches the gold standard. However, the supporting sentence provided by the model does not directly support the answer because it incorrectly claims that the context does not mention NCI-H520. In fact, the gold supporting sentence shows that the context does refer to NCI-H520 as a squamous cell carcinoma cell line. Therefore, while the answer is correct, the reasoning in the supporting sentence is flawed.\", \"match\": true}", "gold_answer": "squamous cell carcinoma", "gold_support": "Functional studies in A549 bronchioalveolar carcinoma and NCI-H520 squamous cell carcinoma cells revealed that Msi1 was enriched in spheroid cultures of tumor cells and in the CD133+ cell population.", "model_answer": "Answer: The NCI-H520 cell-line was derived from a human lung squamous cell carcinoma.", "model_support": "The provided context does **not** mention the NCI-H520 cell line or its derivation. The answer and supporting sentence quoted by the user are **not supported by the given context**. The context discusses Msi1 expression in lung cancer subtypes (including squamous cell carcinomas) but does not reference the NCI-H520 cell line.", "retries": 1}
{"idx": 705, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Calsequestrin' matches the gold standard 'CASQ' conceptually, as CASQ refers to calsequestrin. However, the supporting sentence is slightly less precise than the gold supporting sentence. While it correctly identifies calsequestrin as a key protein related to calcium signaling, it does not explicitly mention its role as the main calcium-binding protein in the sarcoplasmic reticulum or its high-capacity binding properties, which are central to the gold supporting sentence. The logic is sound but could be more detailed and direct.\", \"match\": true}", "gold_answer": "CASQ", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: \"Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.\"  \n(Alternatively: \"the arrhythmogenic CASQ2(D307H) mutation impairs SR Ca2+ storing and release functions...\" — since CASQ2 encodes calsequestrin, the main calcium-binding protein of the SR.)  \n\n**Note**: While the first sentence explicitly names *calsequestrin*, the second sentence provides context about its role in SR calcium handling. However, the most direct answer is supported by the first sentence.", "retries": 1}
{"idx": 706, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer, but contains additional details about the conditions treated, making it slightly more verbose than necessary.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 707, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about p53's role in response to genomic stress, which logically supports its designation as 'the guardian of the genome.' However, it includes additional details about cell cycle arrest and apoptosis that, while correct, are not necessary to directly support the specific nickname of 'guardian of the genome,' making it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "model_answer": "Answer: p53", "model_support": "Supporting sentence: In response to genomic stresses, p53 causes cell cycle arrest to allow time for genomic damage to be repaired before cell division or induces apoptosis to eliminate irreparably damaged cells.  \n\nThis sentence highlights p53's critical role in maintaining genomic integrity through cell cycle regulation and apoptosis, which is why it is widely referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 708, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The characteristic feature of Dyke-Davidoff-Masson syndrome is cerebral hemiatrophy, not increased intracranial pressure or unilateral cerebral hemisphere enlargement. Additionally, the supporting sentence is irrelevant because it correctly states that the context does not support the model's answer, further highlighting the mismatch. The model fails to capture the correct information from the context.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Increased intracranial pressure due to unilateral cerebral hemisphere enlargement.", "model_support": "The provided context does not include any information about the characteristic feature of Dyke-Davidoff-Masson syndrome (e.g., increased intracranial pressure or unilateral cerebral hemisphere enlargement). The context only describes clinical symptoms (seizures, spastic hemiplegia, microcephaly, developmental delay) but does not mention pathophysiological mechanisms or diagnostic features. Thus, **no supporting sentence exists in the context** to justify the answer about intracranial pressure or cerebral hemisphere enlargement.", "retries": 1}
{"idx": 709, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly, correctly identifying 'the transcribed strand' as the target of transcription-coupled repair (TCR). However, the supporting sentence provided by the model is not ideal. While it mentions repair within active genes, it does not directly address TCR or its specificity to the transcribed strand. The gold supporting sentence explicitly states that TCR is targeted to the transcribed strand, making it more relevant and precise. The model's supporting sentence is related but lacks the clarity and directness of the gold standard.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"Within active genes, however, both DNA strands continue to be proficiently repaired.\"  \n\n**Note**: While the context explicitly states that both DNA strands are repaired in active genes, it does not directly specify that transcription-coupled repair (TCR) targets the transcribed strand. The answer \"the transcribed strand\" is based on general knowledge of TCR (which repairs the transcribed strand), but the provided context does not include a sentence explicitly confirming this. However, if forced to quote a sentence from the context that indirectly supports the idea of strand-specific repair, the above sentence is the closest, as it contrasts global repair (both strands) with TCR (which is implied to be distinct).", "retries": 1}
{"idx": 710, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by introducing APP isoforms which are not necessary to directly support the answer. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\n**Note:** While the context does not explicitly state the main component of Lewy bodies, it implies that **alpha-synuclein deposition** is a key pathological feature of DLB, which aligns with the established scientific understanding that alpha-synuclein is the primary component of Lewy bodies. The sentence above indirectly supports this by linking APP isoforms to alpha-synuclein pathology in DLB.", "retries": 1}
{"idx": 711, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the relationship between Bmi-1 and p16Ink4a, covering the answer effectively with minor extra details that do not detract from the clarity.\", \"match\": true}", "gold_answer": "p16Ink4", "gold_support": "In the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferation.", "model_answer": "Answer: p16Ink4a", "model_support": "Supporting sentence: \"This conserved requirement for Bmi-1 to promote self-renewal and to repress p16Ink4a expression suggests that a common mechanism regulates the self-renewal and postnatal persistence of diverse types of stem cell.\"", "retries": 1}
{"idx": 712, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Light-harvesting complex II (LHCII),' is essentially correct and matches the gold standard in meaning, though it uses a slightly different phrasing ('Light-harvesting complex II' vs. 'Light-harvesting pigment-protein complex of Photosystem II'). The supporting sentence provided by the model is relevant but does not directly state that LHCII is the most abundant membrane protein on Earth—it focuses instead on a detail about neoxanthin isomerization. This makes the supporting sentence less effective in fully covering the gold answer compared to the gold supporting sentence, which explicitly states LHCII's abundance. However, the logical connection between LHCII and its biological importance is implied, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "Light-harvesting pigment-protein complex of Photosystem II", "gold_support": "Light-harvesting pigment-protein complex of Photosystem II (LHCII) is the largest photosynthetic antenna complex of plants and the most abundant membrane protein in the biosphere.", "model_answer": "Answer: Light-harvesting complex II (LHCII)", "model_support": "Supporting sentence: \"We show that illumination of the isolated LHCII leads to isomerization of the protein-bound neoxanthin...\"  \n(Note: While the context does not explicitly state that LHCII is the most abundant membrane protein on Earth, the focus on LHCII's central role in photoprotection and its detailed characterization in the study implies its biological significance. However, the direct claim about abundance is not explicitly supported by the provided text. The answer may rely on external knowledge rather than the context.)", "retries": 1}
{"idx": 713, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about the complex's function are acceptable as they do not detract from the core relevance.\", \"match\": true}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "Answer: TBC1D7", "model_support": "Supporting sentence: \"We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.\"", "retries": 1}
{"idx": 714, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it mentions the title of the context rather than directly focusing on the specific information about betrixaban inhibiting factor Xa. The logic is solid, but the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].", "retries": 1}
{"idx": 715, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the study investigates metabolic changes in patients with Huntington disease before and after pridopidine treatment.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: \"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"", "retries": 1}
{"idx": 716, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about the biosynthesis of medicarpin, but it includes additional details about the IOMT enzyme that are not necessary to directly support the answer, leading to slight verbosity.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"the isoflavone-O-methyltransferase (IOMT), which is induced along with other enzymes involved in medicarpin biosynthesis, methylates the A-ring 7-hydroxyl group of daidzein in vitro...\"  \nThis sentence directly ties the IOMT enzyme (involved in stress response pathways) to the biosynthesis of **medicarpin**, implicating it as a key compound produced during alfalfa's stress response.", "retries": 1}
{"idx": 717, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and covers the answer, but it is slightly redundant as it includes a broader context about the pharmacologic characteristics of all factor Xa inhibitors rather than focusing specifically on betrixaban. Despite this, the logic is clear and accurate.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"", "retries": 1}
{"idx": 718, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and provides context about the emergence of factor Xa inhibitors, which includes betrixaban. However, it does not explicitly state that betrixaban is a factor Xa inhibitor, leading to slight ambiguity. While logical support is present, a more direct quote from the context would improve clarity.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\"  \n\n**Note:** While this sentence does not explicitly name betrixaban as a factor Xa inhibitor, it establishes the context that betrixaban belongs to the category of \"novel anticoagulants\" alongside direct thrombin and factor Xa inhibitors. The answer \"Factor Xa\" is inferred based on the classification of betrixaban as a novel anticoagulant in the same group as factor Xa inhibitors, though the context does not explicitly state this. For a more direct quote, the text would need to explicitly identify betrixaban as a factor Xa inhibitor.", "retries": 1}
{"idx": 719, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard. The supporting sentence is relevant and indirectly supports the conclusion that MALAT-1 is upregulated by describing its functional role in cancer cell migration when silenced. However, it lacks direct mention of 'upregulation' and is slightly less concise and explicit compared to the gold supporting sentence, which directly states that MALAT-1 is upregulated. Minor verbosity and indirectness reduce the score from 5 to 4.\", \"match\": true}", "gold_answer": "upregulated", "gold_support": "Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.", "model_answer": "Answer: Upregulated", "model_support": "Supporting sentence: \"SiRNA-mediated MALAT-1 silencing impaired in vitro bladder cancer cell migration.\"  \n**Analysis**: While this sentence does not explicitly state whether MALAT-1 is upregulated, the fact that silencing MALAT-1 (i.e., reducing its expression) impairs cancer cell migration implies that MALAT-1 is likely overexpressed in bladder cancer to promote metastasis. This inference aligns with the conclusion that MALAT-1 plays a pro-metastatic role, suggesting its upregulation in cancer. However, a more direct statement (e.g., \"MALAT-1 was found to be upregulated in bladder cancer tissues\") would be stronger evidence. The provided context lacks such a direct sentence, but the experimental focus on silencing MALAT-1 to study its effects indirectly supports the assumption of its upregulation.", "retries": 1}
{"idx": 720, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking DNMT1 to its role in DNA methylation during homologous recombination. However, it contains slight redundancy by introducing details about gene silencing and double-strand breaks, which are not directly necessary to justify the answer.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DMAP1 is a potent activator of DNMT1 methylation in vitro, suggesting that DMAP1 is a co-repressor that supports the maintenance and de novo action of DNMT1.", "model_answer": "Answer: DNA methyltransferase 1 (DNMT1)", "model_support": "Supporting sentence: Correction of double strand DNA breaks proceeds in an error-free pathway of homologous recombination (HR), which can result in gene silencing of half of the DNA molecules caused by action by DNA methyltransferase 1 (DNMT1).", "retries": 1}
{"idx": 721, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'p53' matches the gold standard, but the supporting sentence incorrectly states that the context does not mention p53 or the term 'guardian of the genome.' In fact, the context explicitly refers to p53 as 'the guardian of the genome,' which directly supports the gold answer. The supporting sentence is relevant but fails to cover the gold answer correctly.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The oncogenic potential of iPSCs is further underscored by the findings that the critical tumor suppressor p53, known as the guardian of the genome, suppresses induced pluripotency.", "model_answer": "Answer: p53", "model_support": "The context does not mention the tumor suppressor \"p53\" or the term \"guardian of the genome.\" The provided text focuses on induced pluripotent stem cells (iPSCs), their genomic stability, and challenges in reprogramming technology, but it does not reference specific tumor suppressors or their roles. \n\n**Answer:** The context does not contain the required information to answer the question.", "retries": 1}
{"idx": 722, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and states that the context does not provide the information, whereas the gold answer (beta-TrCP) is explicitly mentioned in the context. The supporting sentence is irrelevant to the gold answer, focusing on Tyk2 without identifying the E3 ubiquitin ligase responsible for IFNAR1 degradation.\", \"match\": false}", "gold_answer": "beta-TrCP", "gold_support": "IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis.", "model_answer": "Answer: The question does not provide information about the specific E3 ubiquitin ligase involved in the ubiquitination and degradation of IFNAR1.", "model_support": "Supporting sentence: \"In the present study, we show that catalytic activation of Tyk2 is not essential for IFNAR1 internalization, but is required for ligand-induced IFNAR1 serine phosphorylation, ubiquitination and efficient lysosomal proteolysis.\"  \n\n**Analysis**: The context explicitly states that Tyk2 is required for IFNAR1 ubiquitination and proteolysis but does **not** identify the specific E3 ubiquitin ligase responsible for this process. The text focuses on Tyk2's role in signaling events (phosphorylation, ubiquitination) but does not mention an E3 ligase by name.", "retries": 1}
{"idx": 723, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and directly addresses PD-1 blockade, aligning with the gold answer. However, it does not explicitly mention CT-011's role as an anti-PD-1 antibody, which makes it slightly less precise compared to the gold supporting sentence. The reasoning is sound but contains minor omissions.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "Answer: PD-1 (Programmed Death-1)", "model_support": "Supporting sentence: \"We examined the effect of PD-1 blockade on T-cell response to DC/tumor fusions ex vivo.\"  \nThis sentence directly references targeting the **PD-1** protein through blockade, which aligns with the answer that both MK-3475 and CT-011 target PD-1. While the context explicitly mentions **CT-011** (not MK-3475), the experimental focus on **PD-1 blockade** and the conclusion that **CT-011 enhances T-cell responses** (likely via PD-1 inhibition) support the answer.", "retries": 1}
{"idx": 724, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is relevant but does not directly state that TCR targets the transcribed strand; instead, it provides a broader statement about transcription domains being more accessible for repair. While logical and related, it is less precise compared to the gold supporting sentence which explicitly mentions TCR targeting the transcribed strand.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"Our findings support the general view that the genomic domains within which transcription is active are more accessible than the bulk of the genome to the recognition and repair of lesions through the global pathway and that TCR is superimposed upon that pathway of NER.\"  \n\n**Note**: While the context does not explicitly state that TCR targets the *transcribed strand*, it implies that TCR operates in regions of active transcription (i.e., where the transcribed strand is being processed by RNA polymerase). This aligns with prior biological knowledge that TCR specifically repairs the transcribed DNA strand, which is consistent with the answer provided. However, the context does not directly name the \"transcribed strand\" as the target.", "retries": 1}
{"idx": 725, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and supports the answer, but contains slight redundancy by describing the analysis performed rather than directly stating the susceptibility gene for MEN 2. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "RET", "gold_support": "The susceptibility gene for MEN 2 is the RET proto-oncogene.", "model_answer": "Answer: RET", "model_support": "Supporting sentence: \"Systematic analysis for germline mutations of the RET proto-oncogene was performed in a series of 67 patients with apparently sporadic MTC to determine whether they were true sporadic cases or unsuspected de novo MEN 2 cases.\" \n\nThis sentence explicitly links the *RET* proto-oncogene to Multiple Endocrine Neoplasia 2 (MEN2). While the context does not mention Hirschsprung disease, the question combines known clinical associations (RET mutations are also implicated in Hirschsprung disease) with the context's focus on RET in MEN2.", "retries": 1}
{"idx": 726, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer '7' is incorrect and does not match the gold standard 'three.' The supporting sentence acknowledges that the context does not provide information about the number of genera, but it fails to extract the relevant information from the provided context. The gold supporting sentence clearly indicates 'two of the three genera of the Flaviviridae family,' which directly supports the gold answer. Therefore, the model's answer and supporting sentence are irrelevant and do not logically support the correct answer.\",\n  \"match\": false\n}", "gold_answer": "three", "gold_support": "Compounds were tested in cell-based assays against viruses representative of: i) two of the three genera of the Flaviviridae family, i.e.", "model_answer": "Answer: 7", "model_support": "The context does not provide any information about the number of genera in the Flaviviridae family. The text only mentions \"Flaviviridae\" in the context of an anti-Flaviviridae project and references Yellow Fever Virus (a Flavivirus) but does not discuss taxonomic classification or the number of genera within the family. \n\n**Answer:** The context does not contain a supporting sentence for the answer \"7.\"", "retries": 1}
{"idx": 727, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'SERCA2a' is correct in the context of the heart, but it does not fully match the gold answer 'SERCA,' which refers to the general calcium pump without specifying the isoform. The supporting sentence is relevant and supports the answer well, but it contains slight redundancy by emphasizing the heart-specific isoform rather than the general function of SERCA as described in the gold supporting sentence.\", \"match\": false}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "Answer: SERCA2a", "model_support": "Supporting sentence: \"SERCA is mainly represented by the SERCA2a isoform in the heart.\"", "retries": 1}
{"idx": 728, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and supports the answer by referencing anti-Xa activity, but it includes information about a factor Xa decoy (PRT4445) which is not necessary to justify the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \nThis indicates that betrixaban acts as an anticoagulant with anti-Xa activity, implying it inhibits factor Xa.", "retries": 1}
{"idx": 729, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('FSHD' and 'Facioscapulohumeral muscular dystrophy (FSHD)' are equivalent). The supporting sentence is concise, directly relevant, and logically explains that DUX4 contributes to the dysregulation seen in FSHD, aligning well with the gold supporting sentence. Minor additional details in the model's supporting sentence do not detract from its clarity or relevance.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: DUX4 and its target genes contribute to the global dysregulation of gene expression observed in FSHD.", "retries": 1}
{"idx": 730, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect and less concise than the gold supporting sentence. The model's supporting sentence discusses expert suggestions and peer administration rather than directly stating naloxone's pharmacological action as an opioid antagonist, which is more aligned with the gold standard.\", \"match\": true}", "gold_answer": "naloxone", "gold_support": "Naloxone hydrochloride, an injectable opioid antagonist which reverses the respiratory depression, sedation and hypotension associated with opioids, has long been used to treat opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: Experts have suggested that, as part of a comprehensive overdose prevention strategy, naloxone should be provided to heroin users for peer administration after an overdose.", "retries": 1}
{"idx": 731, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Epidermal growth factor (EGFR)') does not match the gold standard ('EGFRvIII'). While 'EGFR' is related to the context and mentioned indirectly, it misinterprets the specific target of Rindopepimut, which is EGFRvIII. The supporting sentence discusses why EGFRvIII is a therapeutic target but does not logically support the model's incorrect answer. Therefore, the answer is not correct, though the supporting sentence is relevant to the broader topic.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "The epidermal growth factor receptor variant III (EGFRvIII) is a naturally occurring mutant of EGFR and is expressed on approximately 20% to 30% of GBMs.", "model_answer": "Answer: Epidermal growth factor (EGFR)", "model_support": "Supporting sentence: As it is not expressed on normal cells, it is an ideal therapeutic target.  \n**Note**: The context does not explicitly state that Rindopepimut is an analog of a growth factor. The answer \"Epidermal growth factor (EGFR)\" appears to be a misinterpretation, as the context refers to **EGFRvIII** (a variant of the **EGFR receptor**, not the growth factor itself). The correct answer would be **epidermal growth factor (EGF)**, which binds to the EGFR receptor, but this is not stated in the provided context. The context only identifies EGFRvIII as the target of Rindopepimut.", "retries": 1}
{"idx": 732, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by linking the MR CLEAN study to acute ischemic stroke treatment.\",\n  \"match\": true\n}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: \"A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.\"", "retries": 1}
{"idx": 733, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer is correct and aligns with the gold standard in meaning, though it includes 'gene,' which makes it slightly more specific than the gold answer. The supporting sentence references the glucocerebrosidase gene but focuses on a methodological detail (internal polymorphism and microsatellite markers) rather than directly stating that mutations in this gene cause Gaucher disease. While relevant, it introduces some redundancy and does not cover the core reasoning as concisely as the gold supporting sentence.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase.", "model_answer": "Answer: glucocerebrosidase gene", "model_support": "Supporting sentence: \"...using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers.\"", "retries": 1}
{"idx": 734, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.", "retries": 1}
{"idx": 735, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is less direct and somewhat vague compared to the gold supporting sentence. While it hints at PLN's regulatory role by mentioning 'additional regulatory proteins associated with PLN,' it does not explicitly state that PLN is the main regulatory molecule of SERCA2A, as clearly articulated in the gold supporting sentence. The model's supporting sentence could be more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: \"Recent studies identified additional regulatory proteins, associated with PLN, that control SR Ca-transport.\"  \n**Note:** While the sentence does not explicitly name PLN as the \"main regulatory molecule\" of SERCA2A, the broader context explicitly identifies **phospholamban (PLN)** as the central regulatory molecule of SERCA2A in the title (\"Phospholamban interactome in cardiac contractility and survival\") and throughout the discussion of SR Ca-cycling regulation. A more direct supporting sentence is:  \n**\"Regulation of SR Ca-cycling by the PLN/SERCA interactome...\"** (implying PLN is the primary regulator of SERCA2A).  \n\nHowever, the most precise supporting sentence from the context is:  \n**\"Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend.\"**  \nThis explicitly frames PLN as the central regulatory molecule in the context of SERCA2A function.", "retries": 1}
{"idx": 736, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly redundant as it mentions 'Dysregulation of the Mammalian Target of Rapamycin' which is not directly necessary to explain what mTOR stands for, though it is relevant to the context. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "mammalian Target of Rapamycin", "gold_support": "One class of agents that are highly effective in the prevention of in-stent restenosis is the mammalian Target of Rapamycin (mTOR) inhibitors.", "model_answer": "mTOR stands for Mammalian Target of Rapamycin.", "model_support": "Supporting sentence: Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes Mellitus.", "retries": 1}
{"idx": 737, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the context does not provide the information, whereas the gold answer (10 nm) can indeed be derived from the context. The supporting sentence is also flawed because it incorrectly claims that the context lacks the relevant information, while the gold supporting sentence directly provides it. Both the answer and the supporting sentence are therefore inaccurate and fail to support the gold answer.\", \"match\": false}", "gold_answer": "10 nm", "gold_support": "Ultrastructurally, rhabdoid cells showed paranuclear aggregates and whorls of intermediate filaments with a 9-10 nm diameter.", "model_answer": "The context does not provide information about the average diameter of intermediate filaments.", "model_support": "Supporting sentence: The context does not provide information about the average diameter of intermediate filaments.", "retries": 1}
{"idx": 738, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence, while relevant and mentioning both GPi and VIM as targets, does not directly emphasize the improvement seen specifically with GPi stimulation. The gold supporting sentence is more precise in highlighting the effectiveness of GPi for dystonia treatment. The model's supporting sentence contains slight redundancy by including VIM without clarifying its ineffectiveness in this context.\",\n  \"match\": true\n}", "gold_answer": "globus pallidus internus", "gold_support": "After bilateral stimulation of the GPi, the patient showed a clear and stable improvement of the painful dystonic syndrome within hours.", "model_answer": "Answer: Globus pallidus internus (GPi)", "model_support": "Supporting sentence: \"a bilateral stereotactic electrode placement targeting the ventral intermediate thalamic nucleus (VIM) and the globus pallidus internus (GPi) was performed.\"  \n\n(Note: While the context explicitly mentions both VIM and GPi as targets, the question focuses on the nucleus *used for treatment* of dystonia. The answer \"globus pallidus internus (GPi)\" is supported by the fact that GPi is a well-established target for deep brain stimulation in dystonia, even though the specific case described here did not show improvement with VIM or combined stimulation. The direct reference to GPi in the context confirms its inclusion as a targeted nucleus.)", "retries": 1}
{"idx": 739, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is relevant but does not directly cover the gold answer as it focuses on serotypes C and D affecting animals rather than explicitly stating that Clostridium botulinum produces the botulinum neurotoxins responsible for botulism. The gold supporting sentence is more precise in linking the bacterium to the disease. The model relies on external knowledge rather than the specific context provided.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: **Two BoNT serotypes, C and D, while rarely associated with human infection, are responsible for deadly botulism outbreaks afflicting animals.**  \n(Note: While the context does not explicitly name *Clostridium botulinum*, the term \"botulinum neurotoxin\" (BoNT) is directly linked to *Clostridium botulinum* in general scientific knowledge. However, the provided context does not include the bacterium's name. The answer relies on external knowledge rather than a direct quote from the text.)", "retries": 1}
{"idx": 740, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is slightly more specific than the gold standard 'benzothiazepine,' but it does not contradict the gold answer and could be considered correct. The supporting sentence explains that the classification isn't directly mentioned in the provided context but relies on external knowledge, which aligns with the gold supporting sentence. However, the supporting sentence is somewhat verbose and includes unnecessary details about what is missing from the context rather than focusing solely on the key information. This reduces clarity and conciseness.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The context does not explicitly state the chemical group of JTV519 (K201). However, based on prior knowledge and the example provided earlier, the answer is **1,4-benzothiazepine**, as confirmed in the initial context. The current context focuses on the drug's mechanism of action (e.g., suppressing Ca²⁺ release, interacting with RyR2) but does not mention its chemical classification. Thus, the supporting sentence is **not present** in the provided context. \n\n**Note:** The answer relies on external knowledge (from the example context) rather than the current text.", "retries": 1}
{"idx": 741, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the model's answer but does not cover the gold answer, which refers to 'more than 30 loci' identified through GWAS rather than the specific list of genes provided by the model.\", \"match\": false}", "gold_answer": "more than 30", "gold_support": "Large genome-wide association studies (GWAS) have identified more than 30 loci involved in RA pathogenesis.", "model_answer": "Answer: 8 genes (PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4)", "model_support": "Supporting sentence: \"The most relevant non-HLA gene single nucleotide polymorphisms (SNPs) associated with RA include PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4.\"", "retries": 1}
{"idx": 742, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('FSHD'). The supporting sentence is relevant and supports the connection between DUX4 and FSHD, though it includes additional context about 'barely detectable' expression that slightly complicates the explanation. This makes it less concise than the ideal supporting sentence but still logically ties DUX4 to FSHD.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"A DUX4 transcript derived from the last repeat unit in a contracted array is associated with pathogenesis but it is unclear how.\"  \n\n**Note**: While the sentence explicitly mentions \"pathogenesis,\" the context (title and discussion of FSHD) clearly links DUX4 to **Facioscapulohumeral muscular dystrophy (FSHD)**. A more direct supporting sentence is:  \n\"Importantly, the disease-linked DUX4 RNA isoform was detected by RT-PCR in FSHD myoblast and myotube preparations only at extremely low levels.\"  \nThis sentence explicitly ties DUX4 to FSHD, though the low-level detection contrasts with the \"ectopic\" (abnormal) expression implied in the conclusion:  \n\"Our model could explain why DUX4's inappropriate expression was barely detectable in myoblasts and myotubes but nonetheless linked to FSHD.\"  \n\n**Final Answer**:  \nSupporting sentence: \"Our model could explain why DUX4's inappropriate expression was barely detectable in myoblasts and myotubes but nonetheless linked to FSHD.\"", "retries": 1}
{"idx": 743, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Immunoaffinity enrichment' is very close to the gold answer 'immunoaffinity purification,' with only a slight difference in wording that does not affect the meaning. The supporting sentence is relevant and covers the answer, but it is slightly less specific than the gold supporting sentence, as it does not mention the use of antibodies or the specific context of methyl peptides. Minor redundancy exists, but the logic is strong overall.\", \"match\": true}", "gold_answer": "immunoaffinity purification", "gold_support": "These antibodies were used to perform immunoaffinity purification of methyl peptides followed by LC-MS/MS analysis to identify and quantify arginine and lysine methylation sites in several model studies.", "model_answer": "Answer: Immunoaffinity enrichment", "model_support": "Supporting sentence: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.", "retries": 1}
{"idx": 744, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant, as it correctly notes that the context does not explicitly specify the E3 ubiquitin ligase, yet it fails to cover the gold answer (beta-Trcp). This leads to a lower score since the gold supporting sentence directly mentions beta-Trcp as responsible for IFNAR1 degradation.\",\n  \"match\": false\n}", "gold_answer": "beta-Trcp", "gold_support": "Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.", "model_answer": "The context does not specify the E3 ubiquitin ligase involved in the ubiquitination and degradation of IFNAR1.", "model_support": "Supporting sentence: The context does not specify the E3 ubiquitin ligase involved in the ubiquitination and degradation of IFNAR1.  \n**Explanation**: The provided context describes the phosphorylation events (by CK1α and PERK) that lead to ubiquitination and degradation of IFNAR1 but does not explicitly name or reference any specific E3 ubiquitin ligase responsible for this process.", "retries": 1}
{"idx": 745, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Kinase', is correct but too general and does not match the specificity of the gold answer, 'nonreceptor tyrosine kinase'. The supporting sentence mentions ABL kinase inhibitors but does not explicitly describe ABL1 as a nonreceptor tyrosine kinase, thus failing to cover the gold answer with sufficient detail or precision.\", \"match\": false}", "gold_answer": "nonreceptor tyrosine kinase", "gold_support": "The Abelson (ABL) family of nonreceptor tyrosine kinases, ABL1 and ABL2, transduces diverse extracellular signals to protein networks that control proliferation, survival, migration and invasion.", "model_answer": "Answer: Kinase", "model_support": "Supporting sentence: The demonstration that small-molecule ABL kinase inhibitors could effectively treat chronic myeloid leukaemia opened the door to the era of targeted cancer therapies.", "retries": 1}
{"idx": 746, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('NCX' is equivalent to 'Sodium-calcium exchanger (NCX)'). The supporting sentence is relevant and covers the answer well, but it contains slight redundancy by repeating 'SEA0400' and could be more concise. Overall, the logic is clear and supports the answer effectively.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The effects of 2-[4-[(2,5-difluorophenyl) methoxy]phenoxy]-5-ethoxyaniline (SEA0400), a newly synthesized Na(+)-Ca(2+) exchanger (NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea-pig ventricular myocytes and compared with those of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea (KB-R7943).", "model_answer": "Answer: Sodium-calcium exchanger (NCX)", "model_support": "Supporting sentence: Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents.", "retries": 1}
{"idx": 747, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The chosen supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating that alpha-synuclein antibodies are used for immunostaining. While an alternative supporting sentence was provided, the selected one is strong and free of excessive content.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In addition, CLBs and dystrophic neurites were identified immunohistochemically with antibodies specific for alpha-synuclein and ubiquitin; plaques and tangles were identified by staining with thioflavine S.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"recent advances in immunostaining of alpha-synuclein have suggested the possible importance of cortical Lewy bodies (CLBs) in the brains of demented patients with PD.\"  \nOR  \n\"CLBs detected by alpha-synuclein antibodies in patients with PD are a more sensitive and specific correlate of dementia...\"  \n\nBoth sentences explicitly state that the antibody used for immunostaining targets **alpha-synuclein**.", "retries": 1}
{"idx": 748, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'NACP/alpha-synuclein,' is very close to the gold standard 'alpha-synuclein' and is correct in the context provided. The supporting sentence is relevant and supports the answer, but it is slightly verbose and could be more concise. It introduces additional details like 'immunogold electron microscopy,' which, while relevant, are not strictly necessary to justify the answer. Overall, the logic is sound, but slight redundancy lowers the score.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as alpha-synuclein) is a presynaptic terminal molecule that abnormally accumulates in the plaques of Alzheimer's disease (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffuse Lewy body disease, and Parkinson's disease.", "model_answer": "Answer: NACP/alpha-synuclein", "model_support": "Supporting sentence: \"studies of the subcellular localization of NACP/alpha-synuclein within LB-bearing neurons were performed by immunogold electron microscopy.\"  \n\nThis sentence explicitly identifies **NACP/alpha-synuclein** as the target protein for the antibody used in the immunostaining experiments. Additionally, later sentences referencing \"anti-NAC immunoreactivity\" (where NAC is a fragment of NACP/alpha-synuclein) further confirm the antibody's specificity.", "retries": 1}
{"idx": 749, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard but is present in the context rather than being supported by the model's own supporting sentence. The model's supporting sentence incorrectly claims that the context does not provide information about the number of tissue kallikrein genes, whereas the context explicitly mentions '15 genes tandemly arranged.' Thus, the supporting sentence fails to cover the gold answer and contains an incorrect statement.\", \"match\": true}", "gold_answer": "15", "gold_support": "The tissue kallikrein gene family consists of 15 genes tandemly arranged on human chromosome 19q13.4.", "model_answer": "Answer: 15", "model_support": "The context does not provide information about the number of tissue kallikrein genes in the human genome. The answer \"15\" is not supported by the provided text, which focuses on the epigenetic regulation of kallikrein genes in cancer but does not mention their total count.", "retries": 1}
{"idx": 750, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains some redundancy by mentioning the specific concentration of SEA0400 (0.3 microM), which is not necessary to support the answer. The gold supporting sentence is more concise while still providing clear and logical reasoning.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400 is a selective inhibitor of the Na(+)/Ca(2+) exchanger having equal potencies to suppress both the forward and reverse mode operation of the Na(+)/Ca(2+) exchanger.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger", "model_support": "Supporting sentence: Partial blockade of Na(+)/Ca(2+) exchanger was induced by superfusion of the cells with SEA0400 at a concentration of 0.3 microM.", "retries": 1}
{"idx": 751, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer 'Factor Xa' matches the gold standard 'xa' exactly. The supporting sentence is concise, directly relevant, and logically explains that direct factor Xa inhibitors target factor Xa, which covers the answer effectively. Minor extra details about the class of inhibitors are acceptable as they do not detract from the clarity or correctness of the reasoning.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...\"  \n\n**Note:** While the context does not explicitly mention *betrixaban*, it categorically describes the mechanism of action for the entire class of direct factor Xa inhibitors (e.g., apixaban, rivaroxaban). Since betrixaban is a known direct factor Xa inhibitor (not listed in the provided context), the answer is inferred from the class description.", "retries": 1}
{"idx": 752, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by quoting the title of the context rather than directly focusing on the role of Xist in X-chromosome inactivation.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The transcriptional silencing of one of the female X-chromosomes is a finely regulated process that requires accumulation in cis of the long non-coding RNA X-inactive-specific transcript (Xist) followed by a series of epigenetic modifications.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: X-inactivation: quantitative predictions of protein interactions in the Xist network.", "retries": 1}
{"idx": 753, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer logically, but it indirectly derives the repressive function of BACH1 by describing how heme counteracts it, rather than directly stating that BACH1 acts as a repressor. This creates slight redundancy compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the enhancers of heme oxygenase-1 (HO-1) gene (Hmox-1) by forming heterodimers with the small Maf proteins such as MafK.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"Heme induces expression of Hmox-1 in part by inhibiting the binding of Bach1 to the enhancers and inducing the nuclear export of Bach1.\"  \nThis indicates that Bach1 normally represses Hmox-1 transcription by binding to enhancers, and heme counteracts this repression.", "retries": 1}
{"idx": 754, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional information about survival and remodeling that is not necessary to directly support the answer, leading to slight redundancy.\", \"match\": true}", "gold_answer": "phospholamban", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: \"regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.\"  \nThis sentence explicitly links phospholamban (PLN) to SERCA2A regulation through the \"PLN/SERCA interactome,\" establishing PLN as the central regulatory molecule for SERCA2A function.", "retries": 1}
{"idx": 755, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence provides relevant information about factor Xa inhibition being a target for anticoagulation, which supports the answer. However, it does not explicitly mention betrixaban as one of the drugs that inhibits factor Xa, making it slightly less precise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.  \n\n**Note**: While the context does not explicitly mention *betrixaban*, it defines the class of \"direct factor Xa inhibitors\" as targeting **factor Xa**, which is the basis for the answer. The question assumes knowledge that betrixaban belongs to this class.", "retries": 1}
{"idx": 756, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Abl kinase', does not fully match the gold standard 'bcr-abl', although it is related and present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on imatinib being a small-molecule inhibitor without specifying that the target is the bcr-abl fusion gene product.\", \"match\": false}", "gold_answer": "bcr-abl", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia chromosome, which is associated with a balanced translocation involving chromosomes 9 and 22 to produce a fusion gene (bcr-abl) that gives rise to a constitutively activated Abl tyrosine kinase.", "model_answer": "Answer: Abl kinase", "model_support": "Supporting sentence: \"This kinase led to the discovery of several small-molecule inhibitors, imatinib being the first and most successful of these.\"  \n(Implied context: The \"this kinase\" refers to Abl kinase, which is the target of imatinib, as stated in the preceding sentence: \"Novel Abl kinase inhibitors in chronic myeloid leukemia...\")", "retries": 1}
{"idx": 757, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (5-HT(2A) receptors is equivalent to 5-HT2A in this context). The supporting sentence is relevant and supports the answer by concluding that studies of these receptors can be conducted reliably with [18F]altanserin. However, it contains slight redundancy by discussing the time frame and reliability, which are not necessary for directly supporting the answer.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.", "model_answer": "Answer: 5-HT(2A) receptors", "model_support": "Supporting sentence: It is concluded that 5-HT(2A) receptor studies can be conducted within 2 h of [18F]altanserin infusion, yielding reliable results.", "retries": 1}
{"idx": 758, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer by referencing medulloblastoma as a tumor suppressor context, but it does not explicitly mention that it is the most common pediatric cerebellar tumor, leading to slight ambiguity. It also contains minor redundancy by focusing on p18Ink4c without directly tying it to the prevalence aspect of medulloblastoma.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "Answer: Medulloblastoma", "model_support": "Supporting sentence: The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.  \n\n**Note:** While the context does not explicitly state that medulloblastoma is the *most common* pediatric cerebellar tumor, the entire discussion focuses on medulloblastoma (MB) as the subject of the research, implying its significance in the context of pediatric cerebellar tumors. However, strictly speaking, the context does not provide a direct statement about its prevalence.", "retries": 1}
{"idx": 759, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer. However, the model's supporting sentence includes an additional sentence which, while relevant, introduces slight redundancy. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: \"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"  \n\n**Additional supporting sentence**: \"gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein...\"  \n\nThese sentences explicitly state that Gevokizumab targets **IL-1β** by interfering with its binding to the IL-1RI receptor.", "retries": 1}
{"idx": 760, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by summarizing the broader findings instead of directly focusing on the specific inhibition of CYP17A1. The logic is sound, but the gold supporting sentence is more concise and directly tied to the enzyme inhibition.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"In summary, orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity...\"", "retries": 1}
{"idx": 761, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically with clear reasoning.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "The spleen tyrosine kinase (Syk) inhibitor R406 is orally administered as the prodrug R788.", "model_answer": "Answer: Spleen tyrosine kinase (Syk)", "model_support": "Supporting sentence: Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkey.", "retries": 1}
{"idx": 762, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying 'zfhx1b' as the causative gene. The supporting sentence is relevant and supports the answer by linking the gene to Mowat-Wilson syndrome and its associated biliary anomalies. However, it contains slight redundancy by introducing details about biliary atresia, which are not necessary for directly supporting the answer. The gold supporting sentence is more concise and directly ties the gene to the syndrome without additional context.\",\n  \"match\": true\n}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "Answer: zfhx1b (also known as ZFHX1B or SIP1)", "model_support": "Supporting sentence: \"We identified a patient with Mowat-Wilson syndrome who also developed cholestasis and histopathologic features consistent with biliary atresia, suggesting that mutations involving zfhx1b may lead to biliary developmental anomalies or injury to the biliary tract.\"  \n\n(Note: The context contains a typo: \"zfhz1b\" should be \"zfhx1b,\" which is the correct gene name.)", "retries": 1}
{"idx": 763, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' as it specifies the same chemical group with additional detail (1,4-), which is acceptable. The supporting sentence is concise, directly relevant, and logically supports the answer by linking JTV519 to the 1,4-benzothiazepine class.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107.  \n\n**Note**: While the context explicitly refers to **S107** (not JTV519), the chemical group **1,4-benzothiazepine** is directly mentioned in the context. The question may contain an error (confusing JTV519 with S107), but the answer aligns with the example and the chemical class described in the context.", "retries": 1}
{"idx": 764, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'). The supporting sentence is relevant and provides a general classification of factor Xa inhibitors, though it does not explicitly mention betrixaban by name. There is slight redundancy in discussing 'these drugs' without direct specificity, but the logic connecting the context to the answer is sound.\", \"match\": true}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Multiple new oral anticoagulants have been developed as potential replacements for VKAs for stroke prevention in AF. Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. [these drugs]).  \n\n**Note:** While the context explicitly names dabigatran etexilate as a thrombin inhibitor, it refers to factor Xa inhibitors (e.g., \"these drugs\") without specifying their names. Betrixaban is a known factor Xa inhibitor, but it is not directly mentioned in the provided context. The answer \"Factor Xa\" is inferred based on the general classification of drugs targeting factor Xa in the context.", "retries": 1}
{"idx": 765, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer by describing the study involving tofacitinib. However, it contains slight redundancy by including extra details about the study design (e.g., '6 dosages,' 'stable background regimen of methotrexate'), which are not essential to directly support the answer. The gold supporting sentence is more concise while still covering the necessary information.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"To compare the efficacy, safety, and tolerability of 6 dosages of oral tofacitinib (CP-690,550) with placebo for the treatment of active rheumatoid arthritis (RA) in patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.\"  \n\n(Note: While the context does not explicitly state that tofacitinib is a JAK inhibitor, the drug is widely recognized in clinical literature as a JAK inhibitor. The sentence identifies the drug under investigation, which is the basis for the answer.)", "retries": 1}
{"idx": 766, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'S-adenosylmethionine (SAMe),' is technically correct and aligns with the gold standard 'SAM' as SAMe is the full name of SAM. However, the supporting sentence, while relevant and logical, contains slight redundancy by elaborating on SAMe’s metabolites and pharmacologic effects, which are not strictly necessary to support the answer. This makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"S-adenosylmethionine (SAMe) inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation.\"  \nThis sentence indirectly supports the answer by establishing SAMe's role in histone methylation regulation, a process requiring methyl donors like SAMe. While the context does not explicitly state SAMe is the methyl donor, it is well-established in biochemical contexts that SAMe serves as the primary methyl donor for methyltransferases, including histone methyltransferases. The conclusion further aligns with this by noting the pharmacologic effects of SAMe are mediated through its metabolites (MTA and SAH), which are derived from SAMe.", "retries": 1}
{"idx": 767, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Some archaeal genomes contain multiple origins of replication' is close to the gold standard 'Multiple' but is more verbose. The supporting sentence is relevant and aligns with the gold supporting sentence, though it could be slightly more concise. Overall, the model provides a correct and logical response with minor verbosity.\", \"match\": true}", "gold_answer": "Multiple", "gold_support": "Multiple origins of replication in archaea.", "model_answer": "Answer: Some archaeal genomes contain multiple origins of replication.", "model_support": "Supporting sentence: These are the first reports of archaea having multiple origins.", "retries": 1}
{"idx": 768, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by not directly emphasizing that rindopepimut targets a specific epitope of EGFRvIII. The logic is clear but could be more precise.\", \"match\": true}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 769, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in meaning, despite a minor difference in formatting (capitalization and spelling). The supporting sentence is relevant but contains slight redundancy by listing all the inhibitors instead of focusing solely on betrixaban. It still logically supports the answer, though it could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"", "retries": 1}
{"idx": 770, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' is effectively equivalent to 'XK'). The supporting sentence provided by the model is relevant and covers the answer, as it mentions a specific XK mutation linked to McLeod syndrome. However, it includes extra details about symptoms that are not necessary for supporting the answer, making it slightly more verbose than the gold supporting sentence, which directly explains the causal relationship between XK mutations and McLeod syndrome.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"A novel XK splice site mutation (IVS1-1G>A) has been identified in a McLeod patient who has developed hematologic, neuromuscular, and neurologic symptoms.\"", "retries": 1}
{"idx": 771, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but includes additional details about cyclophilin D that slightly increase verbosity without being necessary to support the answer.\", \"match\": true}", "gold_answer": "experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.", "model_answer": "Answer: Experimental autoimmune encephalomyelitis (EAE)", "model_support": "Supporting sentence: In a murine disease model, experimental autoimmune encephalomyelitis (EAE) mice lacking cyclophilin D (CyPD), a key regulator of the mitochondrial permeability transition pore (PTP), developed EAE, but unlike WT mice, they partially recovered.", "retries": 1}
{"idx": 772, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard, as '5-HT2A receptors' is equivalent to '5-HT2A'. However, the supporting sentence, while relevant and providing useful context about the involvement of 5-HT2A receptors in aggression and impulsivity, does not explicitly mention [18F]altanserin or its use in evaluating these receptors. The gold supporting sentence directly ties [18F]altanserin PET imaging to the measurement of 5-HT2A receptor binding, making it more precise. The model's supporting sentence contains slight redundancy by discussing serotonergic systems broadly without focusing on the specific method ([18F]altanserin).\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "We investigated 94 healthy individuals (60 men, mean age 47.0±18.7, range 23-86) to determine if trait aggression and trait impulsivity were related to frontal cortex 5-HT2A receptor binding (5-HT2AR) as measured with [18F]-altanserin PET imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"Numerous studies indicate that the serotonergic (5-HT) transmitter system is involved in the regulation of impulsive aggression and there is from post-mortem, in vivo imaging and genetic studies evidence that the 5-HT2A receptor may be involved.\"  \n\n(Note: While the context does not explicitly mention [18F]altanserin, the question assumes knowledge that [18F]altanserin is a radioligand used to evaluate 5-HT2A receptors in vivo, as implied by the focus on 5-HT2A receptor research in the context.)", "retries": 1}
{"idx": 773, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('nuclear'), but the supporting sentence is somewhat misleading. While it correctly states that the context does not explicitly focus on subcellular localization, it gives the impression that no information exists in the text, whereas the gold supporting sentence directly provides this detail ('APOBEC3B appeared predominantly nuclear'). The logic is reasonable but could be more precise and concise by pointing out the relevant sentence in the text.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "Answer: Nuclear.", "model_support": "The context does not provide any explicit information about the subcellular localization (cytoplasmic or nuclear) of the APOBEC3B protein. The text focuses on its functional role in inhibiting L1 retrotransposition but does not describe its cellular compartment. Therefore, **no supporting sentence** in the provided context directly addresses whether APOBEC3B is predominantly cytoplasmic or nuclear. The answer \"Nuclear\" likely relies on external knowledge rather than the given text.", "retries": 1}
{"idx": 774, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard, correctly identifying 'naloxone' as the medication. However, the supporting sentence is somewhat lengthy and focuses on cost rather than directly supporting the use of naloxone for opioid overdose management. While it does mention naloxone, the reasoning could be more concise and directly tied to the context of its therapeutic use.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: \"Cost of materials for administering naloxone 0.4 mg i.v. was $12.30/patient, compared with $10.70/patient for naloxone 0.8 mg s.q.\"  \n\nThis sentence explicitly mentions **naloxone** as the medication administered in the study for managing suspected opioid overdose, confirming its use in the context.", "retries": 1}
{"idx": 775, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence provides relevant context and correctly explains that betrixaban is inferred to inhibit Factor Xa based on its classification with other anticoagulants like apixaban and rivaroxaban. However, it unnecessarily states that the context does not explicitly mention the mechanism, which introduces slight redundancy. Despite this, the logic connecting the answer to the context is strong.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The context does not explicitly state which clotting factor is inhibited by betrixaban. The provided text lists betrixaban as one of the new oral anticoagulants but does not specify its mechanism of action or target clotting factor. The answer \"Factor Xa\" is inferred from general knowledge of anticoagulants, but the context lacks a direct quote supporting this. \n\n**Note**: The answer \"Factor Xa\" is not supported by the provided context, which does not mention betrixaban's specific target. The context only lists betrixaban as part of a group of new oral anticoagulants without detailing their mechanisms.", "retries": 1}
{"idx": 776, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context as Pendred syndrome is indeed associated with thyroid-related abnormalities like goiter. However, the supporting sentence incorrectly claims that the context does not mention thyroid abnormalities when it clearly references 'diffuse thyroid enlargement (goiter)' in the provided background information. The supporting sentence fails to cover the gold answer and adds incorrect reasoning.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).", "model_answer": "Answer: Pendred syndrome is characterized by abnormalities in thyroid hormone function, specifically goiter and congenital hypothyroidism.", "model_support": "The context provided does not mention hormone abnormalities or thyroid-related issues (e.g., goiter, hypothyroidism) associated with Pendred syndrome. The text focuses solely on genetic mutations in the **PDS gene** (chloride-iodide transport protein) and their role in **hearing loss variability**, without addressing hormonal characteristics. \n\n**Answer:** The context does not provide information about hormone abnormalities in Pendred syndrome.", "retries": 1}
{"idx": 777, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer 'BCR-ABL tyrosine kinase' is very close to the gold standard 'BCR-ABL,' but it adds extra detail ('tyrosine kinase') not present in the gold answer, which slightly deviates from the exact match. The supporting sentence discusses the translocation that leads to the creation of the BCR-ABL fusion gene but does not explicitly mention the BCR-ABL protein or its role as a tyrosine kinase, which is key to justifying the answer. The logic is reasonable but could be more directly aligned with the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Chronic myelogenous leukemia (CML) is a clonal hematopoietic disorder caused by the reciprocal translocation between chromosome 9 and 22.  \n\n**Note:** While the context does not explicitly name the BCR-ABL tyrosine kinase, the reciprocal translocation between chromosomes 9 and 22 is well-established in medical literature as the genetic event responsible for creating the BCR-ABL fusion protein, which is the target of imatinib. However, the context provided does not include the explicit mention of \"BCR-ABL,\" so the answer relies on prior knowledge rather than a direct quote from the text.", "retries": 1}
{"idx": 778, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct in a general sense, as thyroid hormone concentrations are indeed altered in Allan-Herndon-Dudley syndrome. However, it does not match the gold standard 'thyroid' exactly, which is more concise and specific to the question. The supporting sentence provided by the model discusses the general importance of thyroid hormones but does not directly address the altered concentrations or provide information about the syndrome itself. While relevant, the supporting sentence lacks specificity and does not logically cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "With the discovery of monocarboxylate transporter 8 (MCT8) as a specific thyroid hormone transporter and the finding that mutations in this transporter lead to a syndrome of severe psychomotor retardation and elevated serum 3,3',5-tri-iodothyronine levels known as the Allan-Herndon-Dudley syndrome, the interest in this area of research has greatly increased.", "model_answer": "Answer: Thyroid hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome.", "model_support": "Supporting sentence: \"Thyroid hormone is a pleiotropic hormone with widespread biological actions. For instance, adequate levels of thyroid hormone are critical for the development of different tissues such as the central nervous system, but are also essential for the regulation of metabolic processes throughout life.\"  \n\n**Note:** While the context does not explicitly mention *Allan–Herndon–Dudley syndrome*, it provides foundational information about thyroid hormone's critical role in biological processes and the necessity of transporters (like MCT8) for its uptake. The answer relies on external knowledge that the syndrome is caused by MCT8 mutations, which align with the context's discussion of thyroid hormone transporters and their genetic variations. However, the direct link to the syndrome is not stated in the provided text.", "retries": 1}
{"idx": 779, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazipine' is very close to the gold standard 'benzothiazepine,' with only a minor difference in spelling or formatting (e.g., 'zipine' vs. 'zepine'). The supporting sentence is relevant and directly mentions JTV-519 as a 1,4-benzothiazipine derivative, aligning well with the gold supporting sentence. However, there is slight redundancy in the model's supporting sentence because it repeats the phrase 'Reversal of P-glycoprotein mediated multidrug resistance,' which adds verbosity without enhancing clarity. Overall, the logic is strong, but the redundancy slightly reduces the score.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively.", "model_answer": "Answer: 1,4-benzothiazipine", "model_support": "Supporting sentence: Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519.", "retries": 1}
{"idx": 780, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable, but none are present here.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 781, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer 'Factor Xa' is correct and matches the gold standard ('xa'). However, the supporting sentence is somewhat indirect and does not explicitly state that betrixaban inhibits Factor Xa. Instead, it discusses a reversal agent for anticoagulants with anti-Xa activity, which requires an inference to connect back to betrixaban's function. The logic is reasonable but could be more concise and direct.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"The availability of an effective reversal agent would be very attractive for the management of associated bleeding, bleeding due to trauma, or the need for emergent surgery for all anticoagulants with anti-Xa activity.\" \n\nThis sentence implies that betrixaban is an anticoagulant with anti-Xa activity, thereby inhibiting Factor Xa.", "retries": 1}
{"idx": 782, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While the model's supporting sentence refers to experimental results, it still clearly supports the answer without introducing excessive or irrelevant details.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "Answer: The transcribed strand of an active gene.", "model_support": "Supporting sentence: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"", "retries": 1}
{"idx": 783, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard (which is '0'), but it is correct in stating that the context does not explicitly provide the information asked for. The supporting sentence is relevant to explaining the lack of specific data on off-label drug trials in neonates, but it does not directly support the gold answer of '0'. It focuses on the absence of explicit information rather than addressing the count of clinical trials implied by the gold supporting sentence.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "Answer: The context does not provide information on the number of clinical trials for off-label drugs in neonates cited in the literature.", "model_support": "Supporting sentence: The context does not provide information on the number of clinical trials for off-label drugs in neonates cited in the literature.  \n**Analysis:** The context discusses Paediatric Investigation Plans (PIPs) and their outcomes related to drug development for pain in children, but it does not mention clinical trials for **off-label drugs in neonates**. The focus is on new drug development, not existing drugs used off-label or neonatal-specific trials.", "retries": 1}
{"idx": 784, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence aligns well with the gold supporting sentence without unnecessary verbosity.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Therefore, while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"while p53 can be rightly defined as the guardian of the genome\"", "retries": 1}
{"idx": 785, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning APP isoforms, which is not directly necessary to support the answer. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\nAlthough the context does not explicitly state the main component of Lewy bodies, it implies a connection between alpha-synuclein deposition and DLB pathology, which aligns with the widely accepted scientific understanding that alpha-synuclein is the primary component of Lewy bodies. The sentence above is the only direct reference to alpha-synuclein in the context.", "retries": 1}
{"idx": 786, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard (1:5000) but is within a reasonable estimate based on general knowledge of Edwards syndrome incidence. However, the supporting sentence incorrectly states that the context does not provide the incidence, when in fact the context explicitly mentions 'The incidence of Edwards syndrome is 1:5000 of live-born.' This results in a failure to cover the gold answer properly.\", \"match\": false}", "gold_answer": "1:5000", "gold_support": "The incidence of Edwards syndrome is 1:5000 of live-born.", "model_answer": "Answer: The incidence of Edwards syndrome (trisomy 18) in the European population is approximately 1 in 6,000 to 1 in 8,000 live births.", "model_support": "The context does not explicitly provide the incidence rate of Edwards syndrome (trisomy 18) in the European population. The text only states that **\"oesophageal atresia is a congenital defect... with an incidence of 1:3000-3500 of live-born\"** and that **\"associated anomalies including genetic disorders occur in 50% of patients\"**, but it does not specify the incidence of Edwards syndrome itself. The answer provided (1 in 6,000–8,000) is not supported by the context given.", "retries": 1}
{"idx": 787, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly ('Stroke' and 'stroke' are equivalent in this context). The supporting sentence provides relevant information about the ROSIER scale being used for patients with suspected stroke, but it is slightly verbose and includes details not directly necessary to support the answer (e.g., the time period of recruitment). The gold supporting sentence is more concise while still covering the essential purpose of the ROSIER scale.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"Patients over 18 years of age with suspected stroke were recruited between June 2011 and December 2011. ROSIER scale assessment was performed in the ED triage area.\"", "retries": 1}
{"idx": 788, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'BCR-ABL tyrosine kinase' is very close to the gold standard 'Bcr-Abl', though it could be more concise. The supporting sentence provided by the model is somewhat relevant but does not explicitly cover the gold answer or provide clear reasoning about the BCR-ABL fusion protein being the target of imatinib. Instead, it discusses targeted therapy in general terms without directly linking it to the specific genetic lesion or tyrosine kinase activity described in the gold supporting sentence. Thus, while the logic is reasonable, the supporting sentence lacks specificity and mixes general context with the necessary information.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "As a consequence of this translocation, a BCR-ABL fusion gene is formed on the 22q- derivative (traditionally known as the Philadelphia chromosome) and the deregulated tyrosine kinase activity of the protein encoded by this gene has been shown to be both necessary and sufficient for initiation and maintenance of the disease.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Chronic myeloid leukemia (CML) is the first human malignancy for which the promise of targeted therapy has come true.  \n**Note:** While the context does not explicitly name \"BCR-ABL tyrosine kinase,\" the mention of the **t(9;22) chromosomal translocation** (implied by the term \"Philadelphia chromosome positive\") is the foundational genetic lesion in CML that leads to the **BCR-ABL fusion protein** (a tyrosine kinase). This connection is standard knowledge in oncology, but the provided context does not directly state the target of imatinib. If the question assumes prior knowledge, the answer is correct, but the context lacks an explicit supporting sentence.", "retries": 1}
{"idx": 789, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('fungi') but is present in the context as microsporidia are indeed eukaryotes. However, the question specifically asks for the kingdom under the current classification scheme, which is 'fungi.' The supporting sentence is relevant but does not cover the gold answer, instead focusing on the general characteristic of microsporidia being eukaryotic pathogens.\", \"match\": false}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Eukaryota (or Eukarya)", "model_support": "Supporting sentence: Microsporidia are obligate intracellular, eukaryotic pathogens that infect a wide range of animals from nematodes to humans, and in some cases, protists.", "retries": 1}
{"idx": 790, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but contains slight redundancy by introducing dasatinib's efficacy against mutations rather than directly stating that imatinib targets BCR-ABL. However, the logic connecting imatinib to BCR-ABL is still clear.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Dasatinib is a dual Abl/Src tyrosine kinase inhibitor (TKI) designed as a prototypic short-acting BCR-ABL-targeted TKI that inhibits BCR-ABL with greater potency compared with imatinib, nilotinib, bosutinib, and ponatinib and has been shown to have potential immunomodulatory effects.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"Dasatinib demonstrates efficacy against most BCR-ABL mutations arising during imatinib therapy...\"  \nThis sentence implies that Imatinib (Gleevec) targets the BCR-ABL tyrosine kinase, as dasatinib is effective against mutations in this kinase that develop during imatinib treatment.", "retries": 1}
{"idx": 791, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard, 'p53'. However, PTEN is mentioned in the context as a 'new guardian of the genome,' which explains its presence in the model's answer. The supporting sentence directly references this phrase but fails to cover the gold answer, as it does not mention p53 or its role as the original 'guardian of the genome.'\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: PTEN: a new guardian of the genome.", "retries": 1}
{"idx": 792, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "Rigel Pharmaceuticals Inc is developing fostamatinib, a prodrug of the spleen tyrosine kinase (Syk) inhibitor R-406, for the potential treatment of autoimmune diseases such as rheumatoid arthritis (RA), idiopathic thrombocytopenic purpura (ITP) and B-cell lymphomas.", "model_answer": "Answer: Syk", "model_support": "Supporting sentence: Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.", "retries": 1}
{"idx": 793, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' with only a minor difference in specificity. The supporting sentence is relevant and supports the answer well, but it contains slight redundancy by specifying 'acute stroke' while 'stroke' would suffice. Overall, the logic is strong, and the information is accurate.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 794, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to Factor Xa). However, the supporting sentence is somewhat redundant in pointing out the lack of explicit mention of betrixaban in the context, which is unnecessary given that the gold supporting sentence provides sufficient evidence by listing betrixaban among orally active direct factor Xa inhibitors. The reasoning could have been more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given text to confirm that betrixaban inhibits Factor Xa. The context only discusses **dabigatran** (a direct thrombin inhibitor) and **rivaroxaban** (a Factor Xa inhibitor), but betrixaban is not referenced. \n\nIf the answer were based on external knowledge (e.g., betrixaban is a Factor Xa inhibitor), the context does not support this claim.", "retries": 1}
{"idx": 795, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by emphasizing the importance of ZFHX1B in diagnosing Mowat-Wilson syndrome.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: In conclusion, molecular genetic analysis of ZFHX1B is important for a definite diagnosis of MWS which has a wide phenotypic spectrum of congenital anomalies.", "retries": 1}
{"idx": 796, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by identifying Fanconi anemia as the disease in question. Minor extra details in the reasoning are acceptable as they do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "Fanconi anemia (FA) is characterized at the cellular level by a high frequency of spontaneous chromosomal aberrations; crosslinking agents cause an abnormal increase in the frequency of chromosomal damage, and semiconservative DNA synthesis is severely inhibited.", "model_answer": "Answer: Fanconi anemia", "model_support": "Supporting sentence: \"Effect of hydroxyurea and normal plasma on DNA synthesis in lymphocytes from Fanconi anemia patients.\"  \nThis sentence explicitly identifies the disease as **Fanconi anemia** (FA), which is known for sensitivity to DNA crosslinking agents and chromosomal instability. While the context does not explicitly mention \"chromosomal aberrations,\" the reference to FA aligns with the clinical definition of the disease, which is characterized by hypersensitivity to DNA crosslinking agents and genomic instability.", "retries": 1}
{"idx": 797, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('stroke'). The supporting sentence is relevant and aligns with the context, but it contains slight redundancy by referencing two potential sentences instead of focusing on the most direct one. The chosen sentence from the title provides accurate support, though the second option introduces minor unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.\"  \n**OR**  \n\"Patients over 18 years of age with suspected stroke were recruited...\"  \n\nThe title explicitly names the disorder (stroke) associated with the ROSIER scale, while the methods section confirms its use in patients with suspected stroke.", "retries": 1}
{"idx": 798, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by mentioning medicarpin biosynthesis and its role in producing (-)-medicarpin, aligning with the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: Isoflavone reductase (IFR), the penultimate enzyme in **medicarpin biosynthesis**, is responsible for introducing one of two chiral centers in (-)-medicarpin.", "retries": 1}
{"idx": 799, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a direct link between the ZEB2 gene and Mowat-Wilson syndrome, but it contains slight redundancy by mentioning the title of the study rather than focusing solely on the key information. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: \"Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.\"  \n\nThis sentence directly links the ZEB2 gene to Mowat-Wilson syndrome, establishing its role in the condition. Additionally, the context further supports this by stating that mutations in the ZEB2 gene (nonsense, frameshift, splice site, or deletions) were identified in patients with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 800, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the supporting sentence is not present in the context, this reflects accurate acknowledgment of the lack of direct support within the text. The gold supporting sentence indeed confirms the relevance of H3K36me3 to RNA splicing, aligning perfectly with the model's answer.\",\n  \"match\": true\n}", "gold_answer": "H3K36me3", "gold_support": "Moreover, recent observations indicate that chromatin structure, transcription and splicing are functionally intertwined, and that modified nucleosomes with trimethylation of lysine 36 in histone subunit 3 (H3K36me3) are enriched at internal exons and the downstream flanking intronic regions of highly expressed genes.", "model_answer": "Answer: H3K36me3", "model_support": "The context does not mention **H3K36me3** or any specific histone trimethylation associated with RNA splicing. The provided text focuses on **nucleosome positioning** at exons and its independence from factors like histone modification status, but it does not discuss specific histone marks (e.g., H3K36me3) or their role in splicing. Therefore, **no supporting sentence exists in the given context** for the answer \"H3K36me3.\" \n\nThis suggests the answer may be derived from external knowledge not included in the provided text.", "retries": 1}
{"idx": 801, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly supports the answer by identifying BACH1 as a transcriptional repressor. The logic is strong and free of unnecessary details.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"the transcriptional repressor BACH1\"  \n(From the first sentence of the context: *\"Novel insights into the regulation of antioxidant-response-element-mediated gene expression by electrophiles: induction of the transcriptional repressor BACH1 by Nrf2.\"*)", "retries": 1}
{"idx": 802, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The connection between BCR-ABL and imatinib is well-supported.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib induces a durable response in most patients with Philadelphia chromosome-positive chronic myeloid leukemia, but it is currently unclear whether imatinib reduces the leukemic stem cell (LSC) burden, which may be an important step toward enabling safe discontinuation of therapy.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.\"  \n\nThis sentence implicitly identifies BCR-ABL as the target of imatinib, as the study focuses on BCR-ABL transcript levels and their response to imatinib therapy.", "retries": 1}
{"idx": 803, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in meaning, though it is not abbreviated. The supporting sentence is relevant and mentions betrixaban as one of the direct inhibitors of factor Xa, but it is somewhat redundant as it lists all four inhibitors instead of focusing concisely on betrixaban. Despite this, the logic connecting the answer to the supporting sentence is strong.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].", "retries": 1}
{"idx": 804, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for calsequestrin's role in calcium regulation, but it does not explicitly state that calsequestrin is the 'low-affinity, high-capacity calcium binding protein,' which is a key detail in the gold supporting sentence. While logical and supportive, the model's sentence is slightly less precise compared to the gold standard.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen of terminal cisternae (TC) of the sarcoplasmic reticulum (SR).", "model_answer": "Answer: Calsequestrin (CS)", "model_support": "Supporting sentence: \"The physiological role of CS in controlling calcium release from the SR depends on both its intrinsic properties and its localization.\"  \n(While the sentence does not explicitly state \"main calcium binding protein,\" the context focuses on **calsequestrin (CS)** as the central protein discussed in relation to calcium regulation in the sarcoplasmic reticulum, implying its role as the primary calcium-binding protein.)  \n\n**Note**: The direct identification of CS as the \"main calcium-binding protein\" is inferred from the context's focus on its physiological role in calcium release and targeting to the SR, even though the exact phrase is not explicitly stated.", "retries": 1}
{"idx": 805, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'SECIS element' is correct and matches the gold standard 'SECIS'. However, the supporting sentence provided by the model does not directly support the answer using the context given, as it states that the context does not explicitly mention the SECIS element. In contrast, the gold supporting sentence succinctly identifies the stem-loop structure in the 3' UTR RNA as the SECIS element, offering direct support. The model's supporting sentence is accurate in noting the lack of explicit mention in the text but could be seen as slightly redundant or verbose when contrasted with the more concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "In mammals, this requires a dedicated machinery comprising a stem-loop structure in the 3' UTR RNA (the SECIS element) and the specific SECIS Binding Protein 2.", "model_answer": "Answer: SECIS element", "model_support": "The context does not explicitly mention the term \"SECIS element\" or any specific stem-loop structure in the 3' end of selenoprotein-encoding genes. The provided text focuses on **SECIS-binding protein 2 (SBP2)** and its role in selenoprotein synthesis but does not name or describe the SECIS element (the stem-loop structure). Therefore, **no sentence in the given context directly supports the answer \"SECIS element.\"** The answer relies on external knowledge of selenoprotein biology rather than the provided text.", "retries": 1}
{"idx": 806, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by referencing the category of factor Xa inhibitors, which aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\n**Note**: While the context does not explicitly mention *betrixaban*, the classification of anticoagulants into factor Xa inhibitors and IIa inhibitors (thrombin inhibitors) implies that betrixaban, as a newer anticoagulant, likely falls into the factor Xa inhibitor category. This inference aligns with the broader context of drug development targeting these pathways. However, the context does not directly name betrixaban or confirm its mechanism.", "retries": 1}
{"idx": 807, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'BCR-ABL tyrosine kinase,' is essentially correct and matches the gold standard 'Bcr-Abl' in meaning, though it is slightly more verbose. The supporting sentence provided by the model does not directly mention Bcr-Abl or provide clear reasoning for the answer, instead discussing imatinib's limitations in a general sense. While this is related to the context of CML and imatinib, it lacks the specificity and direct relevance of the gold supporting sentence. Thus, the answer is strong, but the supporting sentence contains some redundancy and misses key details.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) is caused by Bcr-Abl, a constitutively active tyrosine kinase that is the result of a reciprocal translocation between chromosomes 9 and 22 and cytogenetically evident as the Philadelphia chromosome.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The reasons imatinib may not be able to eradicate the disease are discussed, and potential strategies to achieve disease elimination are presented.  \n**Note:** While the context does not explicitly name the BCR-ABL tyrosine kinase, the question assumes prior knowledge that imatinib targets BCR-ABL in Philadelphia chromosome-positive CML. The context indirectly supports this by discussing imatinib's limitations in eradicating leukemic stem cells, which are driven by the BCR-ABL fusion protein (a well-established fact in CML biology). However, the specific kinase is not named in the provided text.", "retries": 1}
{"idx": 808, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence by specifying 'thyroid hormone concentrations,' which is correct but slightly more verbose. The supporting sentence is relevant and mentions the 'thyroid profile,' which aligns with the gold supporting sentence. However, it does not explicitly state that the thyroid hormone profile is 'altered' or 'typical,' leading to slight redundancy and less precision compared to the gold standard.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "This syndrome is characterized by axial hypotonia, severe mental retardation, dysarthria, athetoid movements, spastic paraplegia, and a typical thyroid hormone profile.", "model_answer": "Answer: Thyroid hormone concentrations are altered.", "model_support": "Supporting sentence: \"Allan-Herndon-Dudley syndrome should be suspected in males with the typical neurological and thyroid profile, even in cases with normal brain myelination.\"  \n\nThis sentence explicitly mentions the \"thyroid profile,\" indicating altered thyroid hormone concentrations in patients with the syndrome.", "retries": 1}
{"idx": 809, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: \"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.\"", "retries": 1}
{"idx": 810, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa') in essence, as 'Factor Xa' is a valid representation of the same concept. The supporting sentence is relevant and supports the answer by explaining that direct factor Xa inhibitors target factor Xa, but it is slightly verbose and could be more concise. It does not directly mention betrixaban, which makes it less specific than the gold supporting sentence, but the reasoning is still logical and accurate.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.  \n\n**Note**: While the context does not explicitly name *betrixaban*, it defines the class of \"direct factor Xa inhibitors\" as targeting factor Xa. Since betrixaban is a known member of this class (not mentioned in the provided text), the answer is inferred from the general description of the drug class in the context.", "retries": 1}
{"idx": 811, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but fails to cover the gold answer, as it focuses on the absence of an explicit name rather than identifying beta-Trcp from the provided context.\", \"match\": false}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: The E3 ubiquitin ligase is not explicitly named in the context provided.", "model_support": "Supporting sentence: \"The E3 ubiquitin ligase is not explicitly named in the context provided.\"  \n(Note: The context does not identify the specific E3 ubiquitin ligase responsible for IFNAR1 ubiquitination and degradation. While it discusses phosphorylation and ubiquitin acceptor sites, it does not name the E3 ligase directly.)", "retries": 1}
{"idx": 812, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'), as betrixaban is indeed a factor Xa inhibitor. However, the supporting sentence provided by the model incorrectly states that there is no supporting information in the context, while the gold supporting sentence clearly identifies betrixaban as an orally active direct factor Xa inhibitor. The model's supporting sentence should have been more precise and referenced the relevant part of the context to fully support the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given text to confirm that betrixaban inhibits factor Xa. The answer cannot be validated based on the provided context.", "retries": 1}
{"idx": 813, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' in meaning, and the supporting sentence is concise, directly relevant, and provides clear reasoning for the answer by stating that the ROSIER scale differentiates acute stroke from mimics. The minor difference in wording ('acute stroke' vs. 'stroke') does not detract from the correctness or relevance.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 814, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model supporting sentence introduces inflammatory bowel disease treatment instead of focusing solely on rheumatoid arthritis as the question asks, yet it still correctly identifies tofacitinib as the JAK inhibitor.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib is an oral janus kinase (JAK) inhibitor that inhibits JAK family kinase members, in particular JAK1 and JAK3, achieving a broad limitation of inflammation by interfering with several cytokine receptors.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment.  \n(Note: While the context focuses on inflammatory bowel disease, the sentence explicitly identifies **tofacitinib** as the JAK inhibitor, which is also approved for rheumatoid arthritis in broader medical knowledge. The context does not directly mention rheumatoid arthritis, but the question assumes prior knowledge that tofacitinib is a JAK inhibitor approved for RA.)", "retries": 1}
{"idx": 815, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context for the ROSIER scale's use in stroke assessment, but it is slightly less detailed compared to the gold supporting sentence, which explicitly mentions the purpose of risk-stratifying patients with suspected stroke.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.", "retries": 1}
{"idx": 816, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it mentions 'various p73 isoforms' without specifying the number. The lack of numerical detail and failure to directly address the question reduces the score.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The context does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: The role of various p73 isoforms in tumorigenesis has been controversial.  \n**Analysis**: The context mentions \"various p73 isoforms\" but does not specify the exact number of TAp73 isoforms identified in humans. The term \"various\" indicates multiple isoforms exist, but no numerical value is provided.", "retries": 1}
{"idx": 817, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes more specific details (e.g., increased thyroid volume, thyroglobulin levels, and radioiodine discharge) rather than simply stating 'thyroid.' While these details are correct and relevant, they go beyond the concise nature of the gold answer. The supporting sentence provides relevant evidence from the context but is somewhat lengthy and could be more concise to directly support the gold answer. Overall, the logic is reasonable, but the response could benefit from brevity.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "Answer: Thyroid function abnormalities, including increased thyroid volume, higher serum thyroglobulin levels, and greater radioiodine discharge after perchlorate.", "model_support": "Supporting sentence: \"Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.\"", "retries": 1}
{"idx": 818, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is missing and instead notes that there is no supporting sentence in the context, which weakens the response. Ideally, the model should have identified the relevant sentence from the context, as it does provide implicit support for the co-administration of benserazide with L-DOPA. The logic is correct but slightly incomplete due to the lack of a concise supporting sentence.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "Co-administration of benserazide (i.t.), a DOPA decarboxylase inhibitor, abolished the antinociceptive effect of L-DOPA.", "model_answer": "Answer: L-DOPA", "model_support": "The context does not mention benserazide or its co-administration with any drug. Therefore, **there is no supporting sentence in the provided context** for the answer \"L-DOPA.\" The answer relies on external knowledge (benserazide is typically co-administered with L-DOPA to prevent peripheral decarboxylation), but the context itself does not address this.", "retries": 1}
{"idx": 819, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is less direct and slightly more verbose than the gold supporting sentence. It introduces additional context about APP isoforms which, while related, is not necessary to support the answer.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\nThis sentence explicitly links **alpha-synuclein deposition** to **dementia with Lewy bodies (DLB)**, implying that alpha-synuclein is a central pathological component of Lewy bodies. While the context does not explicitly state \"alpha-synuclein is the main component of Lewy bodies,\" the focus on its deposition in DLB (a disease characterized by Lewy bodies) directly supports the answer.", "retries": 1}
{"idx": 820, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context for the RET gene mutation, specifically mentioning the Tyr791Phe mutation in the RET proto-oncogene. However, it does not directly mention the specific diseases (MEN2 and Hirschsprung disease) that are central to the question, making it slightly less comprehensive than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR).", "model_answer": "Answer: RET", "model_support": "Supporting sentence: \"the aim of this study was to evaluate genotype-phenotype correlations of the frequently discussed Tyr791Phe mutation in exon 13 of the RET proto-oncogene.\"", "retries": 1}
{"idx": 821, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Intellectual impairment,' does not match the gold standard, 'craniosynostosis,' but it is mentioned in the context. The supporting sentence is relevant to the model's answer but does not cover the gold answer or provide logical support for it. The gold answer is specifically about craniosynostosis being a key feature of Goldberg-Shprintzen syndrome, which the model fails to capture.\",\n  \"match\": false\n}", "gold_answer": "craniosynostosis", "gold_support": "The Shprintzen-Goldberg syndrome (SGS) is a disorder of unknown cause comprising craniosynostosis, a marfanoid habitus and skeletal, neurological, cardiovascular, and connective-tissue anomalies.", "model_answer": "Answer: Intellectual impairment", "model_support": "Supporting sentence: The degree of reported intellectual impairment ranges from mild to severe.", "retries": 1}
{"idx": 822, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'XIST/Xist RNA,' closely matches the gold standard 'XIST,' though it includes an extra reference to 'Xist RNA' which is not strictly necessary. The supporting sentence is relevant and provides logical support for the answer, but it contains slight redundancy by mentioning 'chromosomal RNA' alongside XIST/Xist RNA, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XIST", "gold_support": "X chromosome inactivation begins when a novel chromosomal RNA (cRNA) from the imprinted mouse Xist or human XIST locus coats or \"paints\" one X chromosome in cis and initiates a cascade of chromosome remodeling events.", "model_answer": "Answer: XIST/Xist RNA", "model_support": "Supporting sentence: \"The cell biology of a novel chromosomal RNA: chromosome painting by XIST/Xist RNA initiates a remodeling cascade.\"", "retries": 1}
{"idx": 823, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'RANK (Receptor activator of nuclear factor κB),' does not match the gold standard 'RANKL.' However, the answer is present in the context as RANK is related to RANKL. The supporting sentence is relevant but does not directly cover the gold answer; it discusses RANKL's role in mammary gland development rather than denosumab binding to RANKL. Therefore, the answer and supporting sentence do not fully align with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "RANKL", "gold_support": "Whether the factor has the same role in humans is of clinical interest because an inhibitor for RANKL, denosumab, is already used for the treatment of bone disease and might benefit breast cancer patients.", "model_answer": "Answer: RANK (Receptor activator of nuclear factor κB)", "model_support": "Supporting sentence: Receptor activator of nuclear factor κB ligand (RANKL) has been identified as a pivotal paracrine mediator of progesterone function in mouse mammary gland development and mammary carcinogenesis.", "retries": 1}
{"idx": 824, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is very close to the gold standard, specifying 'hypothyroidism' and linking it to 'thyroid hypoplasia,' which aligns well with the context. The supporting sentence directly references a case of congenital hypothyroidism due to thyroid hypoplasia in Williams syndrome, logically supporting the answer. However, the supporting sentence could be slightly more concise, as it repeats some details that are not strictly necessary for supporting the answer.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Hypothyroidism, due to thyroid hypoplasia.", "model_support": "Supporting sentence: \"In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"", "retries": 1}
{"idx": 825, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Obstructive apnea,' does not match the gold standard, 'craniosynostosis,' but is present in the context as an additional feature of the syndrome. The supporting sentence mentions several features, including obstructive apnea, but it does not directly support the gold answer. It lacks focus on craniosynostosis, which is central to the question.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome.", "model_answer": "Answer: Obstructive apnea", "model_support": "Supporting sentence: Additional common findings include other craniofacial anomalies, hypotonia, obstructive apnea, foot deformity, and congenital weakness of the abdominal wall.", "retries": 1}
{"idx": 826, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model correctly identifies 'Fungi' as the answer based on external biological knowledge, and the gold supporting sentence confirms this classification explicitly from the context.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Microsporidia are ubiquitous fungi with genomes that have undergone a strong reduction to the extreme cases of Encephalitozoon cuniculi and Encephalitozoon intestinalis.", "model_answer": "Answer: Fungi", "model_support": "The context does not explicitly mention the kingdom to which microsporidia belong. The provided text focuses on genetic variability analysis in *Encephalitozoon intestinalis* and related species but does not discuss their taxonomic classification (e.g., kingdom). The answer \"Fungi\" is based on external biological knowledge, not the given context. **No supporting sentence is present in the context for this question.**", "retries": 1}
{"idx": 827, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is slightly more general. The supporting sentence provides relevant information and connects thyroid hormone involvement to the syndrome, though it does not explicitly mention MCT8 or its mutation as the cause of altered thyroid hormone function. It mixes some details (e.g., LT4 administration effects) that are tangential to the core answer. While the logic is reasonable, it could be more concise and directly tied to the role of MCT8 in thyroid hormone transport.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Recently, the monocarboxylate transporter 8 (MCT8) was identified as a thyroid hormone transporter, and MCT8 mutations have been associated with Allan-Herndon-Dudley syndrome, an X linked condition characterized by severe mental retardation, dysarthria, athetoid movements, muscle hypoplasia, and spastic paraplegia.", "model_answer": "Answer: Thyroid hormone concentrations are altered.", "model_support": "Supporting sentence: \"While LT4 administration suppressed thyrotropin (TSH) secretion, no significant changes in thyroid hormone values or clinical symptoms were observed.\"  \n\n**Analysis**: The context discusses a patient with an MCT8 mutation and notes that thyroid hormone (LT4) administration did not alter thyroid hormone values, implying that the mutation may disrupt thyroid hormone transport or utilization rather than directly altering circulating concentrations. However, the conclusion highlights \"thyroid hormone function tests\" as characteristic findings, indirectly supporting that thyroid hormone-related parameters (e.g., TSH suppression) are involved, even if specific concentrations remain unchanged. The answer focuses on the broader implication of thyroid hormone involvement in the syndrome.", "retries": 1}
{"idx": 828, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking medicarpin to stress-induced biosynthesis, which aligns with its role as a phytoalexin. However, it contains slight redundancy in discussing IOMT induction without directly referencing medicarpin's status as the major phytoalexin, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"IOMT is induced along with other enzymes involved in medicarpin biosynthesis.\"  \nThis sentence implies that medicarpin is a key compound synthesized in response to stress (as IOMT is elicitor-inducible), aligning with the role of phytoalexins in plant defense. While the term \"phytoalexin\" is not explicitly used, the context links medicarpin to stress-induced biosynthesis pathways, which is characteristic of phytoalexins.", "retries": 1}
{"idx": 829, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer by explaining the consequence of the HEXA mutation, but it does not directly reference the presence of two mutated HEXA alleles as explicitly as the gold supporting sentence. It contains slight redundancy in discussing the enzyme deficiency rather than focusing solely on the gene mutation.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.", "model_answer": "Answer: The HEXA gene.", "model_support": "Supporting sentence: The exon 5 mutated allele with the premature translation termination resulted in severe deficiency of Hex A.  \n(While the context does not explicitly name the *HEXA* gene, the reference to \"Hex A\" (hexosaminidase A) deficiency directly implicates the *HEXA* gene, as Tay-Sachs disease is caused by mutations in this gene. The clinical context and enzyme deficiency align with the known genetic basis of Tay-Sachs.)", "retries": 1}
{"idx": 830, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard but the supporting sentence does not cover the gold answer. The model incorrectly states that there is no supporting sentence in the context, while the gold supporting sentence directly links DX-88 to ecallantide. The model's supporting sentence fails to acknowledge the presence of relevant information in the context.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product.", "model_answer": "Answer: Ecallantide", "model_support": "The context does not mention \"DX-88\" or provide any information linking it to ecallantide. Therefore, **there is no supporting sentence** in the provided context to answer the question about DX-88 being an investigational name for ecallantide. The context exclusively refers to the drug as \"ecallantide\" and does not include the name \"DX-88.\"", "retries": 1}
{"idx": 831, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' exactly, as 'acute stroke' is a precise descriptor within the context of the ROSIER scale. The supporting sentence is concise, directly relevant, and logically explains the use of the ROSIER scale for differentiating acute stroke in the ER, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 832, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking DUX4 to FSHD pathogenesis, but it is slightly less direct compared to the gold supporting sentence. The chosen sentence is accurate but could be more concise in directly referencing the experimental recapitulation of FSHD phenotypes.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"These results strongly support the current hypothesis for a role of DUX4 in FSHD pathogenesis.\"  \n\nAdditionally, the context explicitly states: \"FSHD is an autosomal dominant disease linked to chromosome 4q35,\" and the experimental findings demonstrate that DUX4 misexpression recapitulates FSHD phenotypes in zebrafish. However, the most direct sentence linking DUX4 to FSHD is the one cited above.", "retries": 1}
{"idx": 833, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'gene expression,' does not match the gold standard 'development,' but it is a plausible inference based on general knowledge of conserved noncoding elements. The supporting sentence mentions targeting functional regions but does not explicitly connect to the regulation of development as described in the gold supporting sentence. Hence, while relevant, the supporting sentence fails to cover the gold answer directly.\", \"match\": false}", "gold_answer": "development", "gold_support": "Organization of conserved elements near key developmental regulators in vertebrate genomes.", "model_answer": "Answer: Gene expression.", "model_support": "Supporting sentence: Sequence conservation has traditionally been used as a means to target functional regions of complex genomes.  \n\n**Note:** While the context does not explicitly state that conserved noncoding elements regulate *gene expression*, the phrase \"functional regions of complex genomes\" implies roles in regulatory processes (e.g., gene expression). However, the answer \"gene expression\" is inferred from general knowledge rather than being directly stated in the provided context. If the question assumes prior knowledge, the supporting sentence is the one about targeting functional regions.", "retries": 1}
{"idx": 834, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The correct gene responsible for Mowat-Wilson syndrome is ZEB2, not ZFHX1B (also known as SALL1). Additionally, the supporting sentence admits that there is no relevant information in the context to justify the answer, making it irrelevant and incorrect. The model fails to provide logical support from the given context.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "A case of Mowat-Wilson syndrome caused by a truncating mutation within exon 8 of the ZEB2 gene.", "model_answer": "Answer: The ZFHX1B (also known as SALL1) gene.", "model_support": "The context provided does not mention the specific gene responsible for Mowat-Wilson syndrome. Therefore, there is **no supporting sentence** in the given context to justify the answer \"ZFHX1B (also known as SALL1).\" The answer appears to be based on external knowledge not included in the provided text.", "retries": 1}
{"idx": 835, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' and 'xa' are equivalent in this context). However, the supporting sentence is incorrect in stating that no supporting sentence exists in the context. The gold supporting sentence shows that relevant information was indeed present in the context ('direct factor Xa inhibitors'). Despite this error, the answer is correct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its target clotting factor. Therefore, **no supporting sentence** exists in the given context to answer the question about betrixaban's mechanism of action. The answer \"Factor Xa\" cannot be validated based on the provided text.", "retries": 1}
{"idx": 836, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The mention of 'negative control' aligns well with the gold standard's description of repression, and the additional context provided strengthens the explanation without being overly verbose.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a member of the basic leucine zipper transcription factor family, and the Bach1/small Maf heterodimer specifically represses transcriptional activity directed by the Maf recognition element (MARE).", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Bach1 regulates the oxidation state through the negative control of HO-1 expression prior to terminal keratinocyte differentiation.\"  \nThis sentence explicitly states that BACH1 exerts a **negative control** (i.e., repression) over HO-1 expression, confirming its role as a **repressor**. Additionally, the context notes that **Bach1 overexpression abolished HO-1 induction**, further supporting its repressive function.", "retries": 1}
{"idx": 837, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'E3 ligase activity' is slightly less precise than the gold standard 'E3 ubiquitin ligase activity,' missing the specific mention of 'ubiquitin.' However, it still reflects the correct enzymatic activity. The supporting sentence is relevant and mentions the E3 ligase activity, but includes additional context about BRCT phosphoprotein binding that is not directly necessary to support the answer. This makes it slightly redundant but still logically connected.\", \"match\": true}", "gold_answer": "E3 ubiquitin ligase activity", "gold_support": "The BRCA1 protein displays E3 ubiquitin ligase activity, and this enzymatic function is thought to be required for tumor suppression.", "model_answer": "Answer: E3 ligase activity", "model_support": "Supporting sentence: \"BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.\"  \nThis sentence explicitly identifies **E3 ligase activity** as an enzymatic function of BRCA1, even though it clarifies that this activity is not required for tumor suppression.", "retries": 1}
{"idx": 838, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it contains slight redundancy by mentioning the unusual case of non-small-cell lung cancer, which is not necessary for directly supporting the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "LEMS is generally associated with small cell lung cancer occurring in three percent of cases.", "model_answer": "Answer: Small-cell lung cancer", "model_support": "Supporting sentence: \"the case that we report shows the unusual association of LEMS with non small-cell lung cancer and highlights the difficulties associated in the management of this condition.\"  \nThis implies that **small-cell lung cancer** is the more commonly associated type, as the case of non-small-cell lung cancer is described as \"unusual.\"", "retries": 1}
{"idx": 839, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard conceptually by identifying 'thyroid' as the relevant hormone abnormality in Williams syndrome, albeit with more specificity ('congenital hypothyroidism due to thyroid hypoplasia'). The supporting sentence is concise and directly relevant, but it introduces slight redundancy by restating details like 'congenital hypothyroidism due to thyroid hypoplasia,' which could be streamlined. However, the logic connecting the answer to the supporting sentence is strong.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia is a frequent characteristic of WBS and abnormalities of thyroid function are common in patients with this feature.", "model_answer": "Answer: Thyroid hormone abnormalities, specifically congenital hypothyroidism due to thyroid hypoplasia.", "model_support": "Supporting sentence: \"Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.\"  \n\nAdditional supporting details:  \n- \"The patient [...] showed a raised TSH [...] with a low FT(4) concentration,\" indicating hypothyroidism.  \n- \"Ultrasound examination [...] showed a significant thyroid hypoplasia,\" confirming structural abnormalities.  \n- The conclusion emphasizes the need for thyroid evaluation in Williams syndrome, linking hypothyroidism to thyroid hypoplasia.", "retries": 1}
{"idx": 840, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides some logical support by referring to the involvement of XK gene variants in psychiatric disorders, but it is less direct compared to the gold supporting sentence. It does not explicitly mention that XK is responsible for MLS, leading to slight verbosity and indirectness.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"the presence of a pathogenic mutation or a potentially functional variant in mood disorder or schizophrenia subjects suggests that neuroacanthocytosis-related-genes might be involved in the pathogenesis of these psychiatric disorders.\" \n\n**Note:** While the context does not explicitly state that the *XK* gene is associated with McLeod syndrome, it is widely established in medical literature that mutations in the *XK* gene are the primary cause of McLeod syndrome. The context supports this by analyzing *XK* gene variants in the context of neuroacanthocytosis-related disorders, which include McLeod syndrome. The direct mention of *XK* gene variants aligns with this association. \n\n**Clarified supporting sentence (more precise):** \"one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.\"", "retries": 1}
{"idx": 841, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, DNMT1, does not match the gold standard in terms of correct contextual support. While DNMT1 is indeed the maintenance DNA methyltransferase mentioned in the gold supporting sentence, the model supporting sentence incorrectly states that DNMT1 is 'not supported' by the context. The context explicitly differentiates DNMT1 from DNMT3A and DNMT3B, noting DNMT1 as the 'maintenance enzyme.' Therefore, although the answer (DNMT1) matches the gold standard, the supporting sentence fails to cover the gold answer appropriately and contains inaccuracies.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases.", "model_answer": "Answer: DNMT1", "model_support": "The answer **DNMT1** is **not supported** by the provided context. The context discusses **DNMT3A** and **DNMT3B** as enzymes involved in **de novo DNA methylation** and **5-hydroxymethylcytosine dehydroxymethylation**, but it does **not mention DNMT1** or its role in **maintenance methylation**. \n\nSince the context does not include information about DNMT1, there is **no supporting sentence** in the provided text for the answer \"DNMT1.\"", "retries": 1}
{"idx": 842, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. It does not explicitly mention 'guardian of the genome,' which makes it less precise despite being logically connected to the correct answer.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.  \n\n(Note: While the exact phrase \"guardian of the genome\" is not explicitly stated in the context, the text directly identifies **p53** as the tumor suppressor gene discussed, which is widely recognized in scientific literature as \"the guardian of the genome\" due to its role in maintaining genomic stability. The context supports the answer by explicitly naming **p53** as the tumor suppressor in question.)", "retries": 1}
{"idx": 843, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The context provided does not explicitly state the number of TAp73 isoforms identified in humans, and the supporting sentence refers to two N-terminal isoforms (TAp73 and ΔNp73), which is unrelated to the specific question about TAp73 isoforms. While the supporting sentence is relevant to the broader context of p73 isoforms, it does not cover the gold answer or provide logical support for the correct number of TAp73 isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 2", "model_support": "Supporting sentence: \"we investigated the expression and subcellular distribution of two N-terminal isoforms, TAp73 and ΔNp73, in medulloblastoma cells using immunofluorescence microscopy.\"  \n\n(Note: While the sentence explicitly mentions two p73 isoforms (TAp73 and ΔNp73), the question about TAp73 isoforms may be ambiguous. However, the answer \"2\" likely refers to the two N-terminal p73 isoforms studied, including TAp73, as the context does not specify further subdivisions of TAp73 itself.)", "retries": 1}
{"idx": 844, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa' and 'Factor Xa' are effectively equivalent in this context). The supporting sentence is relevant and supports the answer by logically connecting betrixaban to its anti-Xa activity. However, it contains slight redundancy because the mention of PRT4445 as a reversal agent is not necessary to directly support the answer. A more concise explanation could have been drawn from the title itself.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \nThis implies that betrixaban has anti-Xa activity, as PRT4445 (a factor Xa decoy) is being evaluated as a reversal agent for anticoagulants targeting Factor Xa.", "retries": 1}
{"idx": 845, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).", "retries": 1}
{"idx": 846, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'CRISPR-Cas system (or CRISPR-mediated RNA silencing),' is slightly more detailed than the gold answer 'CRISPR-Cas,' but it still aligns closely with the gold standard and provides an accurate response. The supporting sentence is relevant and captures the essence of the CRISPR-Cas system as an adaptive prokaryotic immune mechanism; however, it is somewhat lengthy and includes additional details about CRISPRs and Cas proteins that are not strictly necessary to support the answer. This makes it slightly redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "CRISPR-Cas", "gold_support": "Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders.", "model_answer": "Answer: CRISPR-Cas system (or CRISPR-mediated RNA silencing)", "model_support": "Supporting sentence: \"This adaptive prokaryotic immune system arises from the clustered regularly interspaced short palindromic repeats (CRISPRs) found in prokaryotic genomes, which harbor short invader-derived sequences, and the CRISPR-associated (Cas) protein-coding genes.\"  \n\n**Note:** While the exact term \"CRISPR-Cas system\" is not explicitly stated in the context, the description of an adaptive prokaryotic immune system involving CRISPRs and Cas proteins (which cleave target RNAs via psiRNAs) directly corresponds to the CRISPR-Cas system. The sentence above establishes the foundational mechanism analogous to RNAi in prokaryotes.", "retries": 1}
{"idx": 847, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is slightly more verbose ('Stroke recognition in emergency room settings' vs. 'stroke'). The supporting sentence is relevant but includes extra details about logistic regression and clinical reasoning that are not necessary to directly support the answer. It mixes some contextual information with the core fact, making it less concise than ideal.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke recognition in emergency room settings.", "model_support": "Supporting sentence: \"We used logistic regression analysis and clinical reasoning to develop a stroke recognition instrument for application in this setting.\"  \n(Here, \"this setting\" refers to the emergency room (ER) for patients with suspected acute stroke, as described in the BACKGROUND section.)", "retries": 1}
{"idx": 848, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('xa'), but the supporting sentence does not correctly reference the gold supporting sentence. The context provided by the model incorrectly states that betrixaban is not mentioned, while the gold supporting sentence clearly indicates that betrixaban belongs to the class of direct factor Xa inhibitors. The supporting sentence is relevant but does not adequately cover the gold answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does **not mention betrixaban** or its target clotting factor. The text discusses **TTP889** as a direct oral **factor IXa inhibitor**, but there is no information about **betrixaban** or its mechanism of action. Therefore, the answer **\"Factor Xa\"** is **not supported by the given context**. \n\n**Correction:** The question and answer pair are **inconsistent** with the provided context. The context does not contain the necessary information to determine which clotting factor is inhibited by betrixaban.", "retries": 1}
{"idx": 849, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes extra details about tissue-specific expression that are not necessary to answer the question. While logical, it is slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "15", "gold_support": "The human kallikrein gene family consists of 15 serine proteases.", "model_answer": "Answer: 15", "model_support": "Supporting sentence: \"KLK1, 4, 5, 6, 7, 8, 10, 11, 13 and 14 are expressed in both cerebral cortex and hippocampus. KLK9 is expressed in cortex but not hippocampus, whereas KLK2, 3, 12 and 15 are not expressed in either tissue.\"  \n\nThis sentence lists 15 distinct kallikrein genes (KLK1–15) by explicitly naming all members of the family, even though some are not expressed in specific tissues.", "retries": 1}
{"idx": 850, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they provide context without being excessive.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet.", "model_answer": "Answer: Dermatitis herpetiformis.", "model_support": "Supporting sentence: These results confirm that most children with **dermatitis herpetiformis** have jejunal villous atrophy, though they rarely have gastrointestinal symptoms.", "retries": 1}
{"idx": 851, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: Calcineurin (CaN)", "model_support": "Supporting sentence: Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.", "retries": 1}
{"idx": 852, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly links alpha-synuclein to Lewy bodies. However, it introduces synphilin-1, which adds slight redundancy not present in the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"  \n\nThis sentence directly links alpha-synuclein to Lewy bodies, supporting the conclusion that alpha-synuclein is a key component. Additionally, the context later notes that alpha-synuclein is recruited to synphilin-1A inclusion bodies, reinforcing its role in Lewy body formation.", "retries": 1}
{"idx": 853, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('JNK'), and the supporting sentence is relevant and supports the conclusion that JNK is affected. However, the supporting sentence provided by the model is slightly less direct compared to the gold supporting sentence, as it does not explicitly mention the down-regulation of JNK phosphatases like M3/6. The model’s sentence still logically links the activation of JNK to the down-regulation of its phosphatases, but with minor redundancy in emphasizing H₂O₂ plus PDTC, which makes it slightly less concise than the gold standard.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase) is affected by DUSP8 activation.", "model_support": "Supporting sentence: These results suggest that JNK activation by H₂O₂ plus PDTC resulted from the down-regulation of JNK phosphatases.  \n\n**Note:** While the context does not explicitly mention *DUSP8*, it discusses the down-regulation of a JNK phosphatase (M3/6/hVH-5) and its role in JNK activation. If DUSP8 is considered a JNK phosphatase (as in broader literature), the above sentence indirectly supports the conclusion that JNK is affected by DUSP8 activation (via phosphatase regulation). However, the context does not name DUSP8 directly.", "retries": 1}
{"idx": 854, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about calcineurin's role in NFAT signaling, but it is slightly verbose and less direct compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed of catalytic and regulatory subunits.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: Recent studies have demonstrated the vital nature of calcium/calcineurin/NFAT signaling in cardiovascular and skeletal muscle development in vertebrates.", "retries": 1}
{"idx": 855, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence introduces additional disorders (e.g., DMD, CYBB) not directly necessary for explaining the association between XK and McLeod syndrome, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: \"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\"", "retries": 1}
{"idx": 856, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly indirect and does not explicitly state that alpha-synuclein is the main component of Lewy bodies. The phrase 'alpha-synuclein deposition in dementia with Lewy bodies' implies the connection but lacks the clarity and directness of the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\n**Note:** While the context does not explicitly state that alpha-synuclein is the main component of Lewy bodies, the phrase \"alpha-synuclein deposition in dementia with Lewy bodies (DLB)\" implies a direct association between alpha-synuclein and Lewy bodies, which is consistent with established knowledge (not explicitly stated in the provided context).", "retries": 1}
{"idx": 857, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence refers to the absence of 'all TAp73' isoforms without specifying the number, which leads to an incorrect inference of '1'. However, the supporting sentence is relevant as it discusses TAp73 isoforms indirectly, though it fails to cover the gold answer of '7'.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 1", "model_support": "Supporting sentence: Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.  \n\n**Note**: While the context explicitly states \"all TAp73 and DeltaNp73 isoforms\" are absent in the knockout mice, it does **not** specify the number of TAp73 isoforms in humans. The answer \"1\" may be inferred from the phrasing \"all TAp73\" (implying a single isoform), but this is not explicitly stated in the text. The context only confirms the presence of *both* TAp73 and DeltaNp73 isoforms, not their count.", "retries": 1}
{"idx": 858, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (FSHD), though it is slightly more verbose by including the full name of the disease. The supporting sentence is relevant and covers the answer well, but it contains some additional details not strictly necessary to support the answer, making it somewhat redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "SUMMARY: Recent studies have provided a plausible disease mechanism for FSHD in which FSHD results from inappropriate expression of the germline transcription factor DUX4.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: In the majority of cases, FSHD is caused by contraction of the D4Z4 repeat array (FSHD1). This results in local chromatin relaxation and stable expression of the DUX4 retrogene in skeletal muscle, but only when a polymorphic DUX4 polyadenylation signal is present.", "retries": 1}
{"idx": 859, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the classification of microsporidia within the fungi. However, it introduces additional details about zygomycetes being a phylum in the kingdom Fungi, which slightly increases verbosity without being directly necessary for the answer.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.  \n(zygomycetes are a phylum within the kingdom Fungi, establishing microsporidia's classification under Fungi.)", "retries": 1}
{"idx": 860, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke', with only minor additional specification that does not detract from correctness. The supporting sentence is relevant and supports the answer logically, but it contains slight redundancy by emphasizing effectiveness rather than directly stating the purpose of the scale. Overall, it aligns well with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: *The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.*", "retries": 1}
{"idx": 861, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. Although the model notes that no supporting sentence is available from the context, the gold supporting sentence confirms that the answer 'autosomal dominant' is explicitly stated in the context provided. Therefore, the answer is fully correct and aligns perfectly with the gold standard.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context provided does not explicitly mention the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD). The answer \"autosomal dominant\" is based on general medical knowledge rather than the information presented in the given text. Therefore, **no supporting sentence** from the context is available to justify this answer.", "retries": 1}
{"idx": 862, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the development of a stroke recognition instrument but does not explicitly mention the ROSIER scale, leading to slight redundancy and less precision compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"We used logistic regression analysis and clinical reasoning to develop a stroke recognition instrument for application in this setting.\"  \n\n(Note: While the term \"ROSIER scale\" is not explicitly mentioned in the context, the described instrument is explicitly developed for **stroke recognition**, aligning with the answer \"Stroke.\")", "retries": 1}
{"idx": 863, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. It mentions additional details like phosphorylation and force, which are not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "CaM kinase II", "gold_support": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM).", "model_answer": "Answer: CaM kinase II", "model_support": "Supporting sentence: \"the effect of a CaM kinase II inhibitor (KN-93) on CaM kinase II activation, phosphorylation of myosin regulatory light chains (MLC(20)), and force.\"", "retries": 1}
{"idx": 864, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a correct explanation that alpha-synuclein is involved in abnormal depositions, which aligns with the gold answer. However, it is slightly more general and does not specifically mention Lewy bodies or their main component, making it less precise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.", "retries": 1}
{"idx": 865, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by specifying 'acute' stroke. The gold answer is more concise as it simply states 'stroke,' which is sufficient. The supporting sentence provides logical support but could be slightly more direct.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 866, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'Papulovesicular rash,' is very close to the gold standard but focuses on a symptom rather than the condition itself ('Dermatitis herpetiformis'). The supporting sentence provides relevant information about the rash and its association with gluten sensitivity, but it does not fully cover the gold answer, which specifies the disease name. The logic is reasonable, but the response could be more precise by naming the condition.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "Answer: Papulovesicular rash", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 867, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' and 'xa' are equivalent in this context). The supporting sentence provided by the model acknowledges that the context does not explicitly mention the target but correctly infers it based on general knowledge of anticoagulants. The gold supporting sentence confirms this inference, making the model's logic clear, concise, and accurate.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "The provided context does not explicitly mention the clotting factor inhibited by betrixaban. However, based on general knowledge of anticoagulants (e.g., rivaroxaban and apixaban are Factor Xa inhibitors), the answer **Factor Xa** may be inferred. However, **no supporting sentence** in the given context directly states this. \n\nIf the question assumes prior knowledge (not the context), the answer would rely on external information rather than the provided text. The context only discusses betrixaban's clinical trials and development without specifying its pharmacological target.", "retries": 1}
{"idx": 868, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer correctly identifies 'Xist' as the transcript responsible for X-chromosome inactivation, matching the gold answer. The supporting sentence provided by the model is relevant and references Xist in the context of experimental manipulation, which indirectly supports its role in XCI. However, it introduces additional details about histone hypoacetylation that are not directly necessary to explain Xist's role, making it slightly verbose compared to the more concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "Ectopic expression of the X-inactive-specific transcript (Xist) gene from an autosome imposed the same synchronous replication pattern.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"We used mutations and chemical inhibition affecting different epigenetic marks as well as inducible Xist expression and we demonstrate that histone hypoacetylation has a key role in controlling Xi replication.\"  \n\n(Note: While the context does not explicitly name *Xist* as the transcript responsible for X-chromosome inactivation (XCI), it references *Xist* in the experimental methods (\"inducible Xist expression\"), which is widely recognized in the field as the non-coding RNA central to XCI. The answer relies on prior knowledge of *Xist*'s role in XCI, but the context only explicitly mentions *Xist* in the context of experimental manipulation.)", "retries": 1}
{"idx": 869, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence aligns perfectly with the gold supporting sentence, providing a strong and accurate rationale.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.  \n\n**Note:** While the context does not explicitly name *betrixaban*, it categorically states that new oral anticoagulants (including FXa inhibitors like betrixaban) target either **factor Xa (FXa)** or **factor IIa**. This general statement supports the inference that betrixaban, as an FXa inhibitor, targets **factor Xa**.", "retries": 1}
{"idx": 870, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively highlights the focus on non-synonymous mutations, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "non-synonymous", "gold_support": "We identified 101 single-nucleotide variants (SNVs) including 77 non-synonymous SNVs (67 missense and 10 nonsense mutations) and 11 INDELs causing frameshifts.", "model_answer": "Answer: Non-synonymous.", "model_support": "Supporting sentence: We used whole-exome sequencing to identify novel non-synonymous somatic mutations in squamous cell lung cancer.", "retries": 1}
{"idx": 871, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Bcr-Abl tyrosine kinase' is very close to the gold standard 'BCR-ABL', differing only in formatting and inclusion of 'tyrosine kinase,' which is implied by context. The supporting sentence is relevant and supports the answer by discussing the re-establishment of the Bcr-Abl pathway in imatinib-resistant patients, but it contains slight redundancy and does not directly state that BCR-ABL is the target of imatinib as clearly as the gold supporting sentence. Overall, the logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia cells contain a BCR-ABL oncoprotein with an enhanced tyrosine kinase activity, which is considered to be the principal 'cause' of the leukemia.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: \"In patients with chronic myeloid leukaemia who develop resistance to imatinib, the Bcr-Abl signaling pathway is often re-established.\"  \n\nThis sentence implies that Bcr-Abl is the signaling pathway central to the disease and the target of imatinib, as resistance to imatinib is associated with its reactivation. While the context does not explicitly state that imatinib directly targets Bcr-Abl, the re-establishment of the Bcr-Abl pathway in resistant patients strongly supports its role as the primary target of imatinib in Philadelphia chromosome-positive CML.", "retries": 1}
{"idx": 872, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'human kallikrein 5 (hK5),' does not match the gold standard 'LEKTI.' However, the supporting sentence is relevant as it discusses the role of hK5 in the molecular cascades leading to Netherton syndrome. The supporting sentence does not cover the gold answer, which refers to SPINK5 and LEKTI-1 mutations causing the syndrome.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome is caused by loss-of-function mutations in SPINK5 encoding the Kazal-type inhibitor LEKTI-1 leading to dysregulation of proteolytic cascades involving several kallikreins.", "model_answer": "Answer: human kallikrein 5 (hK5)", "model_support": "Supporting sentence: \"human kallikrein 5 (hK5), a serine protease (trypsin-like) that plays a central role in the initiation of the molecular cascades leading to the Netherton syndrome phenotype.\"", "retries": 1}
{"idx": 873, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is slightly more verbose and less direct ('Stroke recognition in emergency room patients' vs. 'stroke'). The supporting sentence provides relevant information but is somewhat indirect and does not explicitly mention the ROSIER scale or fully align with the concise logic of the gold supporting sentence. Logic is reasonable but could be more focused.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke recognition in emergency room patients.", "model_support": "Supporting sentence: \"We used logistic regression analysis and clinical reasoning to develop a stroke recognition instrument for application in this setting.\"  \n(Note: The context does not explicitly mention the \"ROSIER scale,\" but the described instrument is for **stroke recognition in emergency room patients**. The answer provided by the user may refer to an external tool not named in the context.)", "retries": 1}
{"idx": 874, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('interleukin-5' vs. 'IL-5'), which is acceptable as they are commonly used interchangeably in biomedical contexts. The supporting sentence, while accurate, refers to external knowledge rather than directly citing the provided context. However, it does provide a logical explanation of IL-5's role and acknowledges the lack of explicit mention in the text. The gold supporting sentence is more concise and directly sourced from the context, making the model's response slightly less optimal but still strong.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Subjects received infusions of either mepolizumab, an anti-interleukin-5 monoclonal antibody (29 subjects), or placebo (32) at monthly intervals for 1 year.", "model_answer": "Answer: IL-5", "model_support": "The context provided does not explicitly mention the molecular target of Mepolizumab (e.g., IL-5). However, based on external biomedical knowledge, Mepolizumab is a monoclonal antibody that targets **interleukin-5 (IL-5)**, a cytokine involved in eosinophil activation and survival. While the context does not include this detail, the answer relies on prior knowledge rather than direct textual support from the provided passage. \n\nIf the question assumes the context includes this information, it would be an error, as the text does not state the specific molecular target of Mepolizumab.", "retries": 1}
{"idx": 875, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly, as both mention 'SERCA' or its full form 'sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase.' The supporting sentence is relevant and covers the answer by referencing SERCA in the context of modulation, but it contains slight redundancy by mentioning quercetin derivatives instead of directly focusing on SERCA's role as the main calcium pump. Despite this, the logic connecting the answer to the supporting sentence is strong.\",\n  \"match\": true\n}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "Answer: SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: Modulation of rabbit muscle sarcoplasmic reticulum Ca(2+)-ATPase activity by novel quercetin derivatives.  \n(Implies that the sarcoplasmic reticulum Ca²⁺-ATPase (SERCA) is the primary calcium pump being studied, as it is explicitly named in the context.)", "retries": 1}
{"idx": 876, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer provided ('RANK') does not match the gold standard ('RANKL'), but 'RANK' is mentioned in the context as a related term. The supporting sentence mentions both RANK and RANKL, but it does not directly support the incorrect answer with clarity or specificity. It mixes relevant information (mentioning RANKL) with less relevant content (focusing on RANK), making it somewhat unclear and not fully aligned with the gold answer.\", \"match\": false}", "gold_answer": "RANKL", "gold_support": "Initials studies have demonstrated that targeting RANK/ RANKL signaling with the fully human monoclonal antibody denosumab prevented skeletal complications in patients with MM and other cancers with bone metastases.", "model_answer": "Answer: RANK (receptor activator of nuclear factor-kappaB)", "model_support": "Supporting sentence: \"Recent advances in the pathobiology of MM-related bone disease and other cancer-related bone metastases have led to the identification of novel therapeutic targets, such as receptor activator of nuclear factor-kappaB (RANK); its ligand (RANKL); and a decoy receptor, osteoprotegerin...\"  \n\n**Note**: While the context explicitly lists **RANKL** (the ligand of RANK) as a therapeutic target, the answer provided by the user (\"RANK\") is **incorrect** based on standard pharmacological knowledge (Denosumab targets **RANKL**, not RANK itself). However, since the user's answer is \"RANK,\" the supporting sentence is the one that mentions RANK and RANKL as targets, even though the correct answer should be **RANKL**.", "retries": 1}
{"idx": 877, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 878, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'ABL (or BCR-ABL)' is very close to the gold standard 'BCR-ABL' and effectively conveys the same target enzyme. The supporting sentence provides relevant information about imatinib's limited effect on SRC kinases, indirectly pointing to BCR-ABL as the primary target in CML. However, it includes some redundant reasoning by discussing the comparison between CML and Ph+ ALL, which slightly detracts from conciseness. Overall, the logic is sound but could be more direct.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is triggered by constitutively activated BCR-ABL and SRC family tyrosine kinases.", "model_answer": "Answer: ABL (or BCR-ABL)", "model_support": "Supporting sentence: \"imatinib has few inhibitory effects on SRC tyrosine kinase with response rate of Ph+ ALL lower and relapse more frequent and quicker compared with CML.\"  \nThis implies that imatinib's primary target in CML (where it is highly effective) is not SRC but rather the BCR-ABL fusion protein, which is the hallmark of CML and a known target of imatinib. While the context does not explicitly name ABL/BCR-ABL, the comparison between CML and Ph+ ALL (where imatinib is less effective) aligns with the well-established role of imatinib in targeting BCR-ABL in CML.", "retries": 1}
{"idx": 879, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "H3K36Me3", "gold_support": "We also observe that the histone modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3), exhibits different patterns around the cleavage sites of genes using multiple polyadenylation sites from those of genes using a single polyadenylation site.", "model_answer": "Answer: H3K36Me3", "model_support": "Supporting sentence: Surprisingly, the H3K36Me3 levels are comparable among the alternative polyadenylation sites themselves.", "retries": 1}
{"idx": 880, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, but the supporting sentence is somewhat convoluted and includes unnecessary information about the lack of direct mention in the context. While it correctly identifies that the classification is derived from another context, it spends excessive effort explaining what is missing rather than directly focusing on the relevant sentence from the context. The logic is reasonable but could be more concise.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does **not mention JTV519** (K201) or its chemical classification. Instead, it discusses **K201** and its derivatives (e.g., the dioxole congener) as inhibitors of RyR1. However, the question about JTV519's chemical group cannot be answered using this context. The answer \"1,4-benzothiazepine\" is derived from a **different context** (as shown in the initial example), not the one provided here. \n\n**No supporting sentence exists in the current context** for this question.", "retries": 1}
{"idx": 881, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer includes 'hypothyroidism,' which is not directly supported by the context as a characteristic of Pendred syndrome in patients with SLC26A4 mutations. The context specifies hypothyroidism more prominently in patients without mutations. While 'increased thyroglobulin levels' is accurate and aligns with the gold standard concept of thyroid abnormalities, the combination results in partial correctness. The supporting sentence is relevant but discusses findings (e.g., thyroid volume, radioiodine discharge) that do not directly cover the gold answer ('thyroid') or clarify the key abnormalities tied to Pendred syndrome.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "Answer: Hypothyroidism and increased thyroglobulin levels.", "model_support": "Supporting sentence: Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.  \n\n**Note**: While the context explicitly mentions **increased thyroglobulin levels** as a characteristic of Pendred syndrome (SLC26A4 mutations), **hypothyroidism** is not directly stated as an abnormality in mutation carriers. Instead, hypothyroidism is described in the subgroup of patients **without** SLC26A4 mutations. However, the answer provided by the user combines both findings, which may reflect broader clinical associations of Pendred syndrome beyond the specific context of this study.", "retries": 1}
{"idx": 882, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively demonstrates that Bach1 acts as a repressor by showing how its absence leads to high ho-1 expression.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: Gene targeting experiments in mice revealed that, in the absence of Bach1, ho-1 became expressed constitutively at high levels in various tissues under normal physiological conditions.  \n**Analysis**: This sentence indicates that Bach1 normally suppresses (represses) ho-1 expression, as its absence leads to constitutive (unrestrained) activation of the gene.", "retries": 1}
{"idx": 883, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' in essence, as 'acute stroke' is a specific and accurate description within the context of the ROSIER scale. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating the purpose of the ROSIER scale in differentiating acute stroke in the ER.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 884, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by mentioning TCR and its focus on transcribed strands, though it introduces additional details about Cockayne syndrome gene products that are not necessary to directly support the answer. This makes it slightly more verbose than the ideal supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 885, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'Eukaryota (or Eukarya)' is factually correct as a higher-level classification, the question specifically asks for the kingdom under the current classification scheme, which is 'fungi.' The supporting sentence mentions that microsporidia are eukaryotic but does not address their classification within the fungi kingdom, making it relevant but incomplete in covering the gold answer.\", \"match\": false}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Eukaryota (or Eukarya)", "model_support": "Supporting sentence: Microsporidia are obligate intracellular, **eukaryotic** pathogens that infect a wide range of animals from nematodes to humans, and in some cases, protists.", "retries": 1}
{"idx": 886, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is nearly identical to the gold supporting sentence, with only minor differences in punctuation that do not affect the meaning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 887, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'). The supporting sentence provided by the model acknowledges that the context does not explicitly mention betrixaban's mechanism, which is accurate. However, the gold supporting sentence directly provides evidence from the text, linking betrixaban to factor Xa inhibition, making the model's explanation slightly less ideal despite being factually correct.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given text to answer the question about which clotting factor betrixaban inhibits. The answer \"factor Xa\" is correct based on external knowledge, but the context does not include evidence for this claim.", "retries": 1}
{"idx": 888, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The reference to 'its aggregation' clearly points to alpha-synuclein as the main component of Lewy bodies.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation, so that antiaggregation strategies would be very useful to prevent alpha-synuclein fibril formation.  \n\n(Note: The pronoun \"its\" refers to **alpha-synuclein**, which is explicitly mentioned as the protein involved in aggregation and Lewy body formation.)", "retries": 1}
{"idx": 889, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'SERCA2a' is slightly more specific than the gold answer 'SERCA2', but it is still correct and aligns with the context. The supporting sentence provided by the model is relevant and supports the answer, but it does not directly describe SERCA2a as the main calcium pump of the sarcoplasmic reticulum, which makes it less precise compared to the gold supporting sentence. The supporting sentence mentions the functional importance of SERCA2a in improving cardiac function, but it lacks explicit mention of its role as the calcium pump in the sarcoplasmic reticulum. Therefore, a score of 4 is appropriate due to minor differences in specificity and precision.\", \"match\": true}", "gold_answer": "SERCA2", "gold_support": "The calcium pump SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure (HF).", "model_answer": "Answer: SERCA2a", "model_support": "Supporting sentence: Increasing SERCA2a expression in HF models improves cardiac function.", "retries": 1}
{"idx": 890, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer correctly identifies beta-Trcp as the E3 ubiquitin ligase involved in IFNAR1 ubiquitination and degradation, matching the gold standard. However, the supporting sentence, while relevant, contains slight redundancy by discussing Tyk2-mediated stabilization, which is not directly needed to support the answer. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: The E3 ubiquitin ligase is not explicitly named in the text. However, it is implied that beta-Trcp may be involved, as the stabilization of IFNAR1 by Tyk2 is described as being independent of its binding to beta-Trcp. Thus, beta-Trcp is likely the E3 ubiquitin ligase involved.", "model_support": "Supporting sentence: \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"  \nThis implies that **beta-Trcp** is the E3 ubiquitin ligase involved, as its binding is excluded from Tyk2-mediated stabilization, suggesting beta-Trcp's role in ubiquitination/degradation.", "retries": 1}
{"idx": 891, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('fungi') but is present in the context as a broader classification (Eukaryota). The supporting sentence is relevant but emphasizes eukaryotic nature rather than directly covering the gold answer about fungi. It misses the specific evidence pointing to fungi as the kingdom.\", \"match\": false}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Eukaryota (or Kingdom Fungi, based on evolutionary relationships)", "model_support": "Supporting sentence: Microsporidia are obligate intracellular, **eukaryotic** pathogens that infect a wide range of animals from nematodes to humans, and in some cases, protists.  \n\n**Additional context**: The text also notes their close evolutionary relationship with zygomycetes (fungi), but the explicit classification as \"eukaryotic\" is stated directly in the sentence above.", "retries": 1}
{"idx": 892, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' with only a minor difference in specificity (the inclusion of '1,4-'). The supporting sentence states that no supporting information exists in the provided context, which is accurate since the model's explanation acknowledges the lack of context and clarifies that the supporting sentence is derived from an external source. However, this creates slight redundancy when contrasted with the gold supporting sentence, which directly uses relevant information. Overall, the logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The provided context does **not** mention JTV519 or its chemical classification. Therefore, **no supporting sentence exists in the given context** to answer the question about JTV519's chemical group. The answer \"1,4-benzothiazepine\" and its supporting sentence are derived from a **different context** (the one provided in the initial example), not the current one.", "retries": 1}
{"idx": 893, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the topic of APOBEC3B's localization but does not cover the gold answer. It focuses on chromatin exclusion during mitosis, which does not address the post-mitotic nuclear localization specified in the gold supporting sentence. The logic is reasonable but incomplete.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "Answer: Cytoplasmic.", "model_support": "Supporting sentence: APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis.  \n\n**Analysis**: The sentence indicates that APOBEC3B is not present in chromatin (the nuclear compartment) during mitosis, implying its predominant localization is cytoplasmic, as chromatin exclusion during mitosis (when the nuclear envelope is disassembled) aligns with cytoplasmic distribution. This supports the conclusion that APOBEC3B is predominantly cytoplasmic.", "retries": 1}
{"idx": 894, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('parallel') does not match the gold standard ('antiparallel'), but the context supports the idea of antiparallel association. The supporting sentence provided by the model discusses supercoiling and alignment along full lengths, which could be misinterpreted as parallel. However, this reasoning is inconsistent with the gold supporting sentence that explicitly states 'antiparallel side-to-side association.' The model's supporting sentence lacks direct relevance to the correct answer and introduces ambiguity.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "The antiparallel side-to-side association of spectrin alpha and beta monomers is a two-step process which occurs in seconds even at 0 degrees C and at low concentrations.", "model_answer": "Answer: Parallel", "model_support": "Supporting sentence: \"After initial nucleation site binding, the remainder of the subunits quickly associate along their full lengths to reconstitute a normal dimer by supercoiling around each other to form a rope-like, flexible rod.\"  \n\nThis implies a parallel arrangement, as the subunits \"supercoil around each other\" and align along their full lengths to form a flexible rod, consistent with a parallel orientation.", "retries": 1}
{"idx": 895, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('Thyroid hormone concentrations are altered') is close to the gold standard ('thyroid'), though it is slightly more verbose. The supporting sentence provides relevant information about MCT8 mutations causing the syndrome and mentions its role in intellectual deficit and neurological impairment, but it does not directly mention the transport of thyroid hormones or their altered availability. While the logic connecting the mutation to thyroid hormone issues is reasonable, the supporting sentence lacks the specificity of the gold supporting sentence regarding T3 transport to neurons. Therefore, the answer matches the gold standard closely, but the supporting sentence has slight redundancy and misses some key details.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Mct8 transports thyroid hormones (T4 and T3), and the Allan-Herndon-Dudley syndrome is likely caused by lack of T3 transport to neurons during critical periods of fetal brain development.", "model_answer": "Answer: Thyroid hormone concentrations are altered.", "model_support": "Supporting sentence: Mutations of the monocarboxylate transporter 8 gene (MCT8, SLC16A2) cause the Allan-Herndon-Dudley syndrome, an X-linked syndrome of severe intellectual deficit and neurological impairment.  \n\n**Analysis**: While the context does not explicitly state that thyroid hormone concentrations are altered in patients, it establishes that MCT8 is a transporter for thyroid hormones (T4 and T3). The syndrome's pathophysiology involves impaired thyroid hormone transport due to MCT8 mutations, which indirectly implies altered thyroid hormone availability in target tissues (e.g., the brain). However, the direct link to \"thyroid hormone concentrations\" being altered in patients is inferred from the role of MCT8 in thyroid hormone transport, as described in the first sentence.", "retries": 1}
{"idx": 896, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is logical, but it is slightly less direct than the gold supporting sentence. The model's supporting sentence focuses on the suppression of estradiol concentrations, which is a consequence of CYP17A1 inhibition, rather than directly stating that Orteronel is an inhibitor of CYP17A1. This introduces minor redundancy but still supports the answer logically.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity.\"", "retries": 1}
{"idx": 897, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer logically, but it is slightly more verbose than necessary. The gold supporting sentence is more direct and concise.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a transcriptional repressor of heme oxygenase-1 (HO-1) and the beta-globin genes.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"The repression of HO-1 reporter activity by Bach1 was attenuated by co-transfecting IHABP in a dose-dependent manner.\"  \n\nThis sentence explicitly states that Bach1 represses HO-1 reporter activity, confirming its role as a repressor.", "retries": 1}
{"idx": 898, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'SERCA2a' is correct and specific to the heart, which aligns with the context provided. However, the gold answer 'SERCA' is more general and refers to the overall calcium pump of the sarcoplasmic reticulum without specifying the isoform. The supporting sentence is relevant and directly mentions SERCA2a's predominance in the heart, but it does not cover the broader concept of SERCA as described in the gold supporting sentence. The slight discrepancy between the model answer and the gold answer prevents a perfect score.\", \"match\": false}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "Answer: SERCA2a", "model_support": "Supporting sentence: \"SERCA is mainly represented by the SERCA2a isoform in the heart.\"", "retries": 1}
{"idx": 899, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'mechanistic target of rapamycin,' is factually correct but does not match the gold standard, 'mammalian target of rapamycin.' The supporting sentence is missing, which leaves the answer unsupported by the context. Although the term 'mTOR' is present in the context, its full form ('mammalian target of rapamycin') is explicitly stated in the gold supporting sentence, making the lack of direct support a significant issue.\", \"match\": false}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Beyond the JAK/signal transducer and activator of transcription network, a wide number of molecular alterations were described in MPN including the fosfatidilinositolo-3-chinasi (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway constitutive activation.", "model_answer": "Answer: mechanistic target of rapamycin", "model_support": "Supporting sentence: **[No supporting sentence is explicitly provided in the context. The acronym \"mTOR\" is used without its full form (mechanistic target of rapamycin) being stated in the text. The answer relies on general scientific knowledge rather than direct contextual evidence.]**  \n\n**Note:** While the answer \"mechanistic target of rapamycin\" is factually correct, the context does not include a sentence explicitly defining \"mTOR.\" The question may require external knowledge rather than direct textual support.", "retries": 1}
{"idx": 900, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing collagen, specifically alpha1(I) collagen, which is a type of collagen. However, the sentence includes additional context comparing amphibians and birds, which slightly reduces its directness and introduces minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "(Reports, 13 April 2007, p.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: \"association of alpha1(I) collagen sequences with amphibians rather than birds suggest that T. rex does not.\"  \n(Note: While the sentence explicitly mentions *alpha1(I) collagen*, the context implies that collagen is the bone protein used in archaeology for species identification, as the discussion revolves around analyzing collagen sequences for taxonomic classification.)", "retries": 1}
{"idx": 901, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. Although the model notes that the supporting sentence is not present in the provided context, the explanation correctly identifies that the answer is based on general medical knowledge, which aligns with the gold supporting sentence. The logic is strong and concise.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Romano-Ward syndrome is a subtype of prolonged QT syndrome with autosomal dominant inheritance.", "model_answer": "Answer: Autosomal dominant.", "model_support": "The context provided does not include any information about the mode of inheritance of Romano-Ward long QT syndrome. The answer \"Autosomal dominant\" is based on general medical knowledge, not the text of the case report. Therefore, **there is no supporting sentence in the given context** for the answer.", "retries": 1}
{"idx": 902, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard ('cysteine'), but the supporting sentence is somewhat misleading. While it mentions a 'cysteine-sparing mutation,' this does not directly support the idea that cysteine is the most frequently mutated residue in CADASIL syndrome. The logic could be improved by citing external knowledge or clearer contextual evidence.\", \"match\": true}", "gold_answer": "cysteine", "gold_support": "Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.", "model_answer": "Answer: Cysteine", "model_support": "Supporting sentence: \"carrying a novel cysteine-sparing mutation in exon 29 of the NOTCH3 gene\"  \n\n**Note**: While the context explicitly states the mutation is \"cysteine-sparing\" (i.e., does not involve cysteine), the answer \"cysteine\" may rely on external knowledge (as cysteine residues are commonly mutated in CADASIL). However, **the context does not directly support the claim that cysteine is the most frequently mutated residue** in CADASIL. The provided text focuses on a specific mutation that avoids cysteine, not on general trends across cases.", "retries": 1}
{"idx": 903, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor differences in capitalization ('adempas' vs. 'Adempas') do not affect the overall correctness.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "model_answer": "Riociguat", "model_support": "Supporting sentence: Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "retries": 1}
{"idx": 904, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Xist RNA' is very close to the gold standard 'Xist', with only a minor difference in wording that does not affect the correctness. The supporting sentence provides relevant information about Xist RNA and its role, though it introduces details about the A-repeat and tetraloop fold that are not necessary for supporting the answer directly. This makes the sentence slightly more verbose than the gold supporting sentence, which is concise and directly ties Xist to X-chromosome inactivation.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "X-chromosome inactivation (XCI) in female mammals depends on the noncoding RNA X inactivation specific transcript (Xist).", "model_answer": "Answer: Xist RNA", "model_support": "Supporting sentence: The Xist RNA A-repeat comprises a novel AUCG tetraloop fold and a platform for multimerization.", "retries": 1}
{"idx": 905, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking calcineurin to NFAT regulation through the effect of CHP. However, it is slightly verbose and includes details about AP-1 and NFkappaB that are not necessary to directly support the role of calcineurin in NFAT activation, making it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin, a Ca(2+)/calmodulin-stimulated protein phosphatase, plays a key role in T-cell activation by regulating the activity of NFAT (nuclear factor of activated T cells), a family of transcription factors required for the synthesis of several cytokine genes.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: \"In Jurkat and HeLa cells, overexpression of CHP specifically impaired the nuclear translocation and transcriptional activity of NFAT but had no effect on AP-1 transcriptional activity and only a small (<25%) inhibitory effect on the transcriptional activity of NFkappaB.\"  \n**Analysis**: This sentence demonstrates that calcineurin activity (inhibited by CHP) is directly linked to NFAT activation, as blocking calcineurin reduces NFAT function. The context also explicitly identifies calcineurin as the phosphatase targeted by immunosuppressants and inhibited by CHP, confirming its role in NFAT regulation.", "retries": 1}
{"idx": 906, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentence is relevant and provides details about thyroid hormone abnormalities; however, it does not cover the gold answer ('thyroid') directly. The focus of the gold answer is broader (thyroid-related issues), while the model's answer is more specific to TSH elevation with normal T3 and T4 levels.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "New case of thyroid dysgenesis and clinical signs of hypothyroidism in Williams syndrome.", "model_answer": "Answer: Thyrotropin (TSH) elevation with normal free T3 and T4 levels.", "model_support": "Supporting sentence: \"Thyrotropin level was very high (>50 microU/ml; normal value 0.2-4 microU/ml), while serum free T(3) (FT3) and free T(4) (FT4) levels were normal (FT3 3.6 pg/ml, normal value 2.8-5.6 pg/ml; FT4 11.6 pg/ml, normal value 6.6-14 pg/ml); antithyroid autoantibodies were absent.\"", "retries": 1}
{"idx": 907, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides a clear reference to the availability of LepChorionDB, which logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 908, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD'), though it is slightly more verbose by including the full name of the disease. The supporting sentence is relevant and covers the gold answer, but it is less comprehensive compared to the gold supporting sentence, omitting key details such as the role of D4Z4 macrosatellite repeats and the fact that DUX4 is a retrogene. Despite this, the logic connecting the disease to DUX4 expression is maintained.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\"", "retries": 1}
{"idx": 909, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of MCT8 in the condition by linking it to the neurological phenotype, which aligns well with the context provided.\",\n  \"match\": true\n}", "gold_answer": "MCT8", "gold_support": "Mutations of the monocarboxylate transporter 8 (MCT8) gene determine a distinct X-linked phenotype of severe psychomotor retardation and consistently elevated T(3) levels.", "model_answer": "Answer: MCT8", "model_support": "Supporting sentence: \"Lack of MCT8 transport of T(3) in neurons could explain the neurological phenotype.\"", "retries": 1}
{"idx": 910, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer 'Bcr-Abl tyrosine kinase' is equivalent to the gold answer 'BCR-ABL,' and the supporting sentence correctly identifies the Philadelphia chromosome and its association with the genetic abnormality leading to CML. However, it does not explicitly mention the BCR-ABL fusion gene or the constitutively activated tyrosine kinase, which would have made it more direct and concise.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The fusion gene that results (BCR-ABL) produces a constitutively activated tyrosine kinase that exists in different isoforms depending on BCR break-points.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: \"Chronic myeloid leukemia (CML) was the first human malignancy to be associated with a single genetic abnormality, characterized by a reciprocal translocation involving chromosomes 9 and 22 (the Philadelphia chromosome).\"  \n**Analysis**: The Philadelphia chromosome is caused by a translocation between chromosomes 9 and 22, which generates the **Bcr-Abl fusion protein** (a tyrosine kinase). While the context does not explicitly name \"Bcr-Abl\" in the quoted sentence, this genetic abnormality is the foundation for understanding that Imatinib (Gleevec) targets the **Bcr-Abl tyrosine kinase** (as implied by the review's focus on \"next generation of Bcr-Abl inhibitors\" and the context of CML pathogenesis). The direct link to Bcr-Abl is further supported by the mention of mutations in the Abl kinase protein (which is part of the Bcr-Abl fusion).", "retries": 1}
{"idx": 911, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about the enzyme are acceptable as they do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: Isoflavone reductase (IFR), the penultimate enzyme in **medicarpin** biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.", "retries": 1}
{"idx": 912, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor differences in phrasing ('the' vs. 'a') do not affect the accuracy or relevance.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the 'guardian of the genome'.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "retries": 1}
{"idx": 913, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' closely enough in this context, as 'acute stroke' is a specific and accurate description. The supporting sentence is concise, directly relevant, and logically explains the use of the ROSIER scale for differentiating acute stroke, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 914, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is nearly identical to the gold supporting sentence, with only minor rephrasing that does not affect meaning or relevance.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is often referred to as 'the guardian of the genome' because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 is often referred to as \"the guardian of the genome\" because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "retries": 1}
{"idx": 915, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly indirect. The model's supporting sentence refers to mutations in neurofibromin without explicitly stating that it is the product of the NF1 gene, introducing a small gap in clarity compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Lysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: \"Mutations of this lysine were detected in samples from a neurofibromatosis patient as well as from cancer patients.\"  \n(Implied connection: The context discusses mutations in *neurofibromin* (the protein product of the **NF1** gene) and their association with neurofibromatosis, establishing **NF1** as the gene mutated in type 1 neurofibromatosis.)", "retries": 1}
{"idx": 916, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and indirect. While the supporting sentence mentions the balance between NRF2 and BACH1, it does not explicitly state that BACH1 is a repressor, unlike the gold supporting sentence which directly identifies BACH1 as a repressor of the antioxidant response element.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "In HaCaT cells, FB and EC (200 μM) induced nuclear translocation of NRF2 protein after 24 h and reduced nuclear protein levels of BACH1, a repressor of the antioxidant response element.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: Phenylpropanoid glycosides from plant cell cultures induce heme oxygenase 1 gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and BACH1 transcription factors.  \n\n**Analysis:**  \nThe context states that PPGs influence the **balance** between NRF2 (an activator of HMOX1) and BACH1. Since NRF2 is described as the activator of HMOX1, BACH1 is implicitly positioned as the opposing regulatory factor (likely a repressor) in this balance. This is further supported by the later mention of PPGs modifying **Nrf2/Bach1 nuclear protein levels**, reinforcing their antagonistic roles in transcriptional regulation.", "retries": 1}
{"idx": 917, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking 'X-linked dystonia-parkinsonism' to 'Lubag disease'.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 918, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard in describing Groucho as a transcriptional repressor/corepressor. However, it adds extra mechanistic detail ('mediates repression through histone deacetylation and increased nucleosome density') not present in the gold answer, making it slightly more verbose. The supporting sentence is relevant and supports the answer well but does not directly match the gold supporting sentence's focus on Gro's interaction with Rpd3. Overall, the logic is strong, but there is minor redundancy.\", \"match\": true}", "gold_answer": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor", "gold_support": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts with the histone deacetylase Rpd3.", "model_answer": "Answer: A transcriptional repressor that mediates repression through histone deacetylation and increased nucleosome density.", "model_support": "Supporting sentence: We propose a model in which Gro-mediated histone deacetylation results in increased nucleosome density leading to transcriptional repression.", "retries": 1}
{"idx": 919, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by explaining that gevokizumab binds to IL-1β at an allosteric site, which aligns with the gold answer. The logic is strong and free of excessive content.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"gevokizumab occupies an allosteric site on IL-1β and complex formation results in a minor reduction of binding affinity to IL-1RI.\"", "retries": 1}
{"idx": 920, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it is slightly more focused on the diagnostic method rather than directly addressing the association between small-cell lung cancer and Lambert-Eaton syndrome as the gold supporting sentence does. This makes it slightly less ideal but still logically connected.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure.", "model_answer": "Answer: Small cell lung cancer (SCLC)", "model_support": "Supporting sentence: Cytologic examination of ultrasound-guided fine needle aspiration disclosed SCLC.", "retries": 1}
{"idx": 921, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('women'), but its supporting sentence introduces unnecessary complexity and does not directly use the most concise evidence from the context. While the model correctly identifies that the answer is based on general medical knowledge, it overcomplicates the explanation by discussing the lack of explicit prevalence data in the context rather than simply citing the clear evidence provided in the gold supporting sentence. The gold supporting sentence is more direct and relevant.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Answer: Rheumatoid Arthritis is more common in women.", "model_support": "The context does not explicitly state that Rheumatoid Arthritis is more common in men or women. However, the answer provided (\"Rheumatoid Arthritis is more common in women\") is based on **general medical knowledge** (RA is indeed more prevalent in women globally), not on the specific data presented in the context. \n\nThe context focuses on **gender-related differences in manifestations and risk factors** (e.g., women having earlier onset, polyautoimmunity, and abdominal obesity, while men have extra-articular manifestations) but does **not provide prevalence rates** or compare the frequency of RA between genders in the studied population. Therefore, **no sentence in the context directly supports the claim** that RA is more common in women. \n\nIf the answer must be derived solely from the context, it would be **unfounded**, as the context does not address the overall prevalence of RA by gender.", "retries": 1}
{"idx": 922, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Interleukin 17 (IL-17)' is very close to the gold standard 'interleukin-17A,' as IL-17A is a specific isoform of IL-17. However, it lacks the precision of specifying IL-17A. The supporting sentence is relevant and supports the answer by identifying IL-17 as a key cytokine in ankylosing spondylitis, but it does not explicitly mention secukinumab targeting IL-17A, introducing slight ambiguity. Overall, the logic is strong but could be more precise.\", \"match\": false}", "gold_answer": "interleukin-17A", "gold_support": "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.", "model_answer": "Answer: Interleukin 17 (IL-17)", "model_support": "Supporting sentence: Interleukin 17 (IL-17) is thought to be a key inflammatory cytokine in the development of ankylosing spondylitis, the prototypical form of spondyloarthritis.  \n\n**Note**: While the context does not explicitly state that *secukinumab* targets IL-17, the question assumes this based on the drug’s known mechanism (as an anti-IL-17 monoclonal antibody). The sentence above establishes IL-17 as the key cytokine in the disease, which, combined with the study’s focus on secukinumab as a therapeutic agent, supports the inference that the drug targets IL-17. However, a more direct statement (e.g., \"secukinumab is a monoclonal antibody targeting IL-17\") would have provided explicit support.", "retries": 1}
{"idx": 923, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are incorrect and do not align with the gold standard. The context explicitly mentions SEA0400 as an inhibitor selective for NCX(REV), so the claim that the question cannot be answered is false. Furthermore, the supporting sentence repeats this incorrect assertion without addressing the relevant information in the context.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The question cannot be answered based on the provided context.  \n**Reason:** The context discusses PPADS, KB-R7943, and SN-6 as inhibitors of the Na⁺/Ca²⁺ exchanger (NCX), but **SEA0400 is not mentioned** in the text. No information about SEA0400 or its molecular targets is present in the provided context.", "retries": 1}
{"idx": 924, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'JNK (c-Jun N-terminal kinase)' matches the gold standard 'Jnk' in substance, even if there is a minor formatting difference. The supporting sentence provided by the model is relevant but does not directly link JNK to the phosphorylation of c-Jun; instead, it vaguely mentions transcription factors regulated by MAP kinase phosphorylation without specifically highlighting JNK's role. While the logic connecting the model's supporting sentence to the answer could be stronger, it still points towards MAP kinase activity on transcription factors, making it somewhat supportive but less precise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: \"These substrates include transcription factors that are regulated by MAP kinase phosphorylation (e.g., Elk-1, c-Myc, c-Jun, c-Fos, and C/EBP beta).\" \n\n**Note:** While the context explicitly lists c-Jun as a target of MAP kinase phosphorylation (likely referring to Erk family members), it does not directly name JNK as the specific kinase responsible for this phosphorylation. The final sentence mentioning JNK (\"Evidence is presented here to demonstrate that Jnk is a distant relative of the MAP kinase group...\") introduces JNK as a related kinase but does not explicitly link it to c-Jun phosphorylation. The answer \"JNK\" may rely on external knowledge, as the context does not provide a direct connection.", "retries": 1}
{"idx": 925, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'β-TrCP' is technically correct but not as precise as the gold answer 'SCF(β-TrCP)', which specifies the full enzymatic complex. The supporting sentence is relevant and provides logical support for the role of β-TrCP in IκB degradation, though it does not explicitly mention SCF or ubiquitination. Slight imprecision in the answer and lack of full detail in the supporting sentence prevent a perfect score.\", \"match\": false}", "gold_answer": "SCF(β-TrCP)", "gold_support": "IKK activation and IκB degradation involve different ubiquitination modes; the latter is mediated by a specific E3 ubiquitin ligase SCF(β-TrCP) .", "model_answer": "Answer: β-TrCP", "model_support": "Supporting sentence: In vivo ablation of β-TrCP results in accumulation of all the IκBs and complete NF-κB inhibition.", "retries": 1}
{"idx": 926, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('iron') but is present in the context as the context lists 'iron deficiency' among other causes. The supporting sentence discusses periodic limb movement disorder (PLMD) rather than restless leg syndrome (RLS), which makes it relevant to the context but not directly supportive of the gold answer. It fails to highlight 'iron deficiency' as the specific cause of RLS.\", \"match\": false}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS), aging, pregnancy, uraemia, iron deficiency, polyneuropathy are some of the common causes of secondary PLMD.", "model_answer": "Answer: Restless leg syndrome is not caused by a deficiency mentioned in the provided context.", "model_support": "Supporting sentence: Periodic limb movement disorder (PLMD) is one of the commonest neurological disorders and causes significant disability, if left untreated. However, it is rarely diagnosed in clinical practice, probably due to lack of awareness and/or lack of necessary diagnostic facilities.  \n\n**Analysis**: The context discusses *periodic limb movement disorder (PLMD)*, not *restless leg syndrome (RLS)*, and does not mention any deficiency (e.g., iron deficiency, which is commonly associated with RLS in clinical literature) as a cause of RLS. The text explicitly focuses on PLMD and its diagnostic challenges, with no reference to RLS or its etiology. Thus, the answer is supported by the absence of relevant information in the context.", "retries": 1}
{"idx": 927, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning the suppression of estradiol concentrations, which is not necessary to directly support the answer about CYP17A1 inhibition. The logic is sound, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity.\"", "retries": 1}
{"idx": 928, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly explains that SEA0400 is not mentioned in the provided text, but it fails to infer the correct answer (NCX) from the broader context where NCX(REV) inhibitors are discussed. While the reasoning about missing information is valid, the model could have inferred the answer indirectly based on related details.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The question cannot be answered based on the provided context.  \n**Reason**: The context discusses PPADS, KB-R7943, and SN-6 as inhibitors of NCX(REV), but **SEA0400 is not mentioned** in the text. No information about SEA0400 or its target ion antiporter/exchanger is provided.", "retries": 1}
{"idx": 929, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Thyroid hormone synthesis abnormalities,' does not match the gold answer, 'thyroid,' but it is related to the context of Pendred syndrome. The supporting sentence provides relevant information about abnormal thyroid hormone synthesis but does not directly support the gold answer. It is somewhat verbose and focuses on secondary consequences rather than the core hormonal abnormality linked to Pendred syndrome.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "CONTEXT: Pendred syndrome is caused by mutations in the gene coding for pendrin, an apical Cl-/I- exchanger.", "model_answer": "Answer: Thyroid hormone synthesis abnormalities.", "model_support": "Supporting sentence: In more affected follicles, Duox and TPO are relocated in the cytosol, leading to abnormal intracellular thyroid hormone synthesis, which results in cell destruction presumably because intracellular OS cannot be buffered by antioxidant defenses.", "retries": 1}
{"idx": 930, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning the KFERQ motifs and their role in CMA, but it includes additional details (e.g., 'six KFERQ motifs' and 'recognition Hsc70') that are not necessary to directly support the answer, introducing slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.", "model_answer": "Answer: Chaperone-mediated autophagy (CMA)", "model_support": "Supporting sentence: \"In silico analysis also revealed that the RyR2 sequence harbours six KFERQ motifs which are required for the recognition Hsc70 and its degradation via CMA.\"", "retries": 1}
{"idx": 931, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The provided supporting sentence highlights Bach1's role in repression through its interaction with a specific gene element, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: We have identified a Maf recognition element in the human HO-1 gene that is required for repression of a reporter gene by hypoxia and targeted by Bach1.  \n\n**Explanation**: This sentence explicitly states that Bach1 (BACH1) is involved in the **repression** of the HO-1 gene through its interaction with a Maf recognition element, confirming its role as a repressor. Additionally, the context notes that Bach1 induction correlates with reduced HO-1 expression (e.g., under interferon-gamma or desferrioxamine treatment), further supporting its repressive function.", "retries": 1}
{"idx": 932, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information and correctly infers the relationship between transcription-coupled repair and the transcribed strand. However, it includes slight redundancy by over-explaining the logical inference from the term 'transcription-coupled repair,' which makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: The context does not explicitly state that transcription-coupled repair (TCR) targets the transcribed strand. However, the term \"transcription-coupled repair\" inherently implies a relationship with transcription, which occurs on the transcribed strand. While the provided context does not directly mention the transcribed strand, the name \"transcription-coupled repair\" logically infers that the repair mechanism is associated with the strand being transcribed. \n\n**Note**: The context does not explicitly quote the transcribed strand as the target of TCR, but the term \"transcription-coupled\" implies this relationship. If the question assumes prior knowledge, the answer is inferred rather than directly supported by the text.", "retries": 1}
{"idx": 933, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold answer 'stroke' in this context, meeting the criteria for an exact match. The supporting sentence is concise, directly relevant, and logically explains the purpose of the ROSIER scale as differentiating acute stroke from mimics, aligning well with the gold standard context.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 934, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides correct context, but it is slightly less specific than the gold supporting sentence. It does not directly mention the MR CLEAN study, which is central to the question, resulting in a minor reduction in precision.\",\n  \"match\": true\n}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.", "retries": 1}
{"idx": 935, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes details about the oat challenge, which introduces slight redundancy. The logic is sound, and the connection between gluten and dermatitis herpetiformis is clear, though the sentence could be more concise.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "Answer: Dermatitis herpetiformis.", "model_support": "Supporting sentence: Eleven patients with dermatitis herpetiformis in remission on a gluten-free diet were challenged daily with 50 g oats for six months.  \n\n**Analysis**: The sentence explicitly identifies *dermatitis herpetiformis* as the skin condition being studied in the context of gluten-free diets, directly linking the rash to gluten sensitivity. The context further supports this by noting that the rash is not activated by oats (a gluten-free grain), reinforcing that the rash is associated with gluten.", "retries": 1}
{"idx": 936, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold answer 'stroke,' making it a match. The supporting sentence is concise, directly relevant, and logically explains the use of the ROSIER scale for differentiating acute stroke in the emergency room, aligning well with the gold standard context.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 937, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke', with only a minor difference in specificity. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for differentiating acute stroke, but it includes slightly more detail than necessary by specifying 'from stroke mimics in the ER,' which adds redundancy. Overall, the logic is strong, but the extra detail prevents it from being perfectly concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 938, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for medicarpin being the major phytoalexin, but it contains slight redundancy by emphasizing de novo synthesis, which is not directly required to support the answer. The gold supporting sentence is more concise while still covering the essential point about medicarpin accumulation.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.\" \n\nThis sentence highlights that medicarpin is the primary product of de novo synthesis during elicitation, which aligns with its role as the major phytoalexin in alfalfa under stress conditions.", "retries": 1}
{"idx": 939, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly less direct than the gold supporting sentence. While it correctly explains the effect of Orteronel on CYP17A1 activity, it does not explicitly mention 'preferential inhibition of 17,20-lyase,' which adds specificity in the gold sentence. Slight verbosity is present but logical support is strong.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"Orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity.\"", "retries": 1}
{"idx": 940, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'Papulovesicular rash', is very close to the gold answer as it describes the typical rash associated with gluten sensitivity (Dermatitis herpetiformis). However, it does not directly name the condition ('Dermatitis herpetiformis') as required by the gold standard. The supporting sentence is somewhat relevant but focuses on how the rash presents rather than providing a clear connection to Dermatitis herpetiformis itself. It mixes partial information about presentation and association, making it less concise than ideal.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "Answer: Papulovesicular rash", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 941, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the Maf recognition element (MARE) by forming antagonizing hetero-oligomers with the small Maf family proteins.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: \"Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1.\"", "retries": 1}
{"idx": 942, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Ser129' matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of Ser129 phosphorylation in the formation of Lewy bodies, aligning well with the gold supporting sentence. Minor additional context in the model's supporting sentence does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "Parkinson", "gold_support": "Approximately 90% of α-syn deposited in Lewy bodies is phosphorylated at serine 129 (Ser129).", "model_answer": "Answer: Ser129", "model_support": "Supporting sentence: \"This suggests that the accumulation of Ser129-phosphorylated α-syn leads to the formation of Lewy bodies and dopaminergic neurodegeneration in Parkinson's disease.\"", "retries": 1}
{"idx": 943, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the SECIS element but is slightly less direct and includes additional details about photoreactive groups, which are not necessary for supporting the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "The machinery comprises the tRNA(Sec), a 3'-UTR mRNA stem-loop termed SElenoCysteine Insertion Sequence (SECIS), which is mandatory for recoding UGA as a Sec codon, the SECIS Binding Protein 2 (SBP2), and other proteins.", "model_answer": "Answer: SECIS", "model_support": "Supporting sentence: \"engineered minimal selenoprotein mRNAs containing SECIS elements derivatized with photoreactive groups.\"", "retries": 1}
{"idx": 944, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer '1,4-benzothiazepine' is correct based on external knowledge or a different context, but it does not match the gold standard answer 'benzothiazepine,' which is more general and appropriate given the question. The supporting sentence from the model mentions diltiazem as a 1,5-benzothiazepine derivative, which is irrelevant to JTV519's classification and does not support the gold answer. While the model's answer is present in the broader context of benzothiazepines, the supporting sentence fails to directly address JTV519's classification.\", \"match\": false}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Note**: The provided context does not explicitly state that JTV519 is a 1,4-benzothiazepine derivative. However, the answer \"1,4-benzothiazepine\" appears to be based on prior knowledge or a different context (as seen in the example). In the current context, only diltiazem's classification as a 1,5-benzothiazepine derivative is mentioned, not JTV519's.", "retries": 1}
{"idx": 945, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK') conceptually by identifying the XK gene, though it is slightly more verbose than necessary. The supporting sentence is relevant and covers the answer, but it is somewhat lengthy and includes information about other loci (e.g., DMD, CYBB), which is not directly needed to support the answer. This makes it less concise compared to the gold supporting sentence, which directly states that McLeod syndrome is caused by XK gene defects.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "It is caused by XK gene defects and may include large deletions in the Xp21 region.", "model_answer": "Answer: The mutation of the XK gene is associated with McLeod syndrome.", "model_support": "Supporting sentence: The McLeod syndrome is a rare X-linked recessive disorder characterized by blood group, neuromuscular and haematopoietic abnormalities. Analysis of three unrelated McLeod patients for the presence of the XK, DMD, CYBB, ETX1, RPGR and OTC loci...  \n\n**Note:** While the context does not explicitly state that the *XK* gene is mutated in McLeod syndrome, it is implied by the analysis of the *XK* locus in the patients and the exclusion of other loci (e.g., DMD, CYBB, etc.) as the site of the *XS* locus. This aligns with prior knowledge that McLeod syndrome is caused by mutations in the *XK* gene, which encodes a blood group antigen. However, the direct statement linking *XK* to the syndrome is not present in the provided text. The answer relies on the inclusion of the *XK* locus in the analysis of McLeod patients.", "retries": 1}
{"idx": 946, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Lysine 4 of histone H3 (H3K4)') is correct and matches the gold standard ('H3K4'). However, the supporting sentence does not cover the gold answer as it admits that the context does not provide explicit evidence for this claim. The gold supporting sentence directly references the involvement of MLL1 in methylating H3K4, which the model failed to extract or reference from the context. Therefore, while the answer is correct, the supporting sentence is insufficient and does not logically support the answer based on the provided context.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "While androgen suppresses EZH2 in CRPC cells, in LNCaP cells, physiological concentrations of androgen stimulate expression of PRC2 genes (EZH2, SUZ12, and EED), which is mediated by androgen-induced ANCCA and involves E2F and histone H3K4me3 methylase MLL1 complex.", "model_answer": "Answer: Lysine 4 of histone H3 (H3K4)", "model_support": "The context does not explicitly mention the histone residue methylated by MLL1 or provide any direct evidence for this claim. The text discusses the role of the MLL histone methylase complex in regulating chromatin regulators (EZH2 and ANCCA) in prostate development but does not specify the histone residue targeted by MLL1. The answer \"Lysine 4 of histone H3 (H3K4)\" is a well-known biological fact about MLL1, but it is not supported by the provided context. \n\n**Supporting sentence:** *None* (the context does not contain the required information).", "retries": 1}
{"idx": 947, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides useful details about the procedure (e.g., blood volume and rarity of complications), but it does not directly state that the epidural blood patch is the definitive treatment for low-pressure headache as clearly as the gold supporting sentence. It contains slight redundancy by mentioning complications, which are not necessary to justify the answer. Overall, the logic is strong, but the support could be more concise.\", \"match\": true}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch should be performed within 24-48 h of dural puncture.", "model_answer": "Answer: Epidural blood patch (EBP)", "model_support": "Supporting sentence: The optimum volume of blood has been shown to be 12-20 mL for adult patients. Complications of AEBP are rare.  \n(Note: While the context does not explicitly state that \"epidural blood patch (EBP)\" is the definitive treatment, the reference to \"AEBP\" (autologous epidural blood patch) and its associated blood volume and complication rates implies its use as a treatment for PDPH, which is a form of low-pressure headache. The term \"AEBP\" is commonly understood as the definitive treatment for PDPH in clinical practice.)", "retries": 1}
{"idx": 948, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('stroke'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly indicating that the ROSIER scale is used as a stroke recognition tool. Minor additional context in the supporting sentence does not detract from its clarity or relevance.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 949, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard; both mention 'calcitonin gene-related peptide receptor'. The supporting sentence is relevant and covers the answer but includes slight redundancy by specifying 'an oral' which is not necessary for answering the question directly. Overall, it provides logical support.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is a novel, orally active, and selective calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.", "model_answer": "Answer: calcitonin gene-related peptide receptor", "model_support": "Supporting sentence: Telcagepant, an oral calcitonin gene-related peptide receptor antagonist.", "retries": 1}
{"idx": 950, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The title of the study explicitly mentions flumazenil and its applicability in suspected benzodiazepine overdose, making it an ideal supporting sentence.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "STUDY OBJECTIVE: To develop clinical rules for the safe and effective use of flumazenil in suspected benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: Empiric use of flumazenil in comatose patients: limited applicability of criteria to define low risk.  \n\n**Analysis**: The title explicitly mentions \"flumazenil\" as the drug being studied for use in comatose patients with suspected drug overdose, directly linking it to the context of benzodiazepine overdose (implied by the study's focus on low-risk patients with \"uncomplicated benzodiazepine intoxication\" in the methods). While the body discusses its efficacy and safety, the title succinctly identifies flumazenil as the drug in question.", "retries": 1}
{"idx": 951, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by introducing positron emission tomography without directly emphasizing the synonym relationship. The logic is clear but could be more focused.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Regional and global metabolic rates for glucose (rCMRGlc and GMR) were estimated using [18F]fluorodeoxyglucose and positron emission tomography in 3 patients with Filipino X-linked dystonia-parkinsonism (lubag).", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Positron emission tomographic findings in Filipino X-linked dystonia-parkinsonism.  \n**Analysis**: The context introduces \"lubag\" as the disease name in the second sentence (\"In all 3 patients with lubag\"), while the first sentence explicitly states \"Filipino X-linked dystonia-parkinsonism\" as the full name of the condition. This establishes \"X-linked dystonia-parkinsonism\" as the synonym for \"lubag.\"", "retries": 1}
{"idx": 952, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Na+/Ca²⁺ exchanger (NCX)' is equivalent to 'NCX'). The supporting sentence provided by the model is relevant and supports the conclusion that SEA0400 inhibits NCX, but it contains slight redundancy by discussing additional effects like preserving high-energy phosphates and arrhythmias. This makes it less concise than the gold supporting sentence, which directly states the role of SEA0400 as an inhibitor of NCX.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: It is concluded that the selective inhibition of NCX may be effective to preserve high-energy phosphates and to improve cardiac function after reperfusion, but may not be able to prevent fatal arrhythmias.", "retries": 1}
{"idx": 953, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides specific evidence from the study that reinforces the answer.\", \"match\": true}", "gold_answer": "RET", "gold_support": "The RET proto-oncogene is involved in neural crest disorders.", "model_answer": "Answer: RET", "model_support": "Supporting sentence: Direct fluorescent sequencing of genomic DNA revealed a heterozygous mutation in the RET proto-oncogene in exon 10 at codon C609Y in both persons tested.", "retries": 1}
{"idx": 954, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke' and is accurate in context, though slightly more specific than necessary. The supporting sentence is relevant and supports the answer logically, but it is slightly verbose compared to the concise gold supporting sentence. The logic is strong, but the additional detail about 'stroke mimics' makes it less direct than ideal.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: *The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.*", "retries": 1}
{"idx": 955, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about p53, but it does not explicitly mention the 'guardian of the genome' phrase. The supporting sentence focuses on a specific function of p53 (regulatory domain stabilization) rather than its general role as described in the gold supporting sentence. Slight verbosity and indirectness reduce the score.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Note:** While the context does not explicitly state \"guardian of the genome,\" the sentence directly identifies **p53** as the subject of the study, which is widely recognized in biomedicine as \"the guardian of the genome\" in external knowledge. However, strictly based on the provided context, the supporting sentence refers to **p53** as the protein under discussion.", "retries": 1}
{"idx": 956, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states the question cannot be answered, while the context clearly mentions PBT2 in relation to Alzheimer's disease. The supporting sentence is also incorrect because the context does mention PBT2 as a potential treatment for Alzheimer's disease. Both the answer and supporting sentence fail to identify the correct information present in the context.\", \"match\": false}", "gold_answer": "Alzheimer's disease", "gold_support": "Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective.", "model_answer": "Answer: The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The context does not mention PBT2 or any disorder it has been tested for.", "retries": 1}
{"idx": 957, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant and includes an unnecessary disclaimer about external knowledge, while the gold supporting sentence is more concise and directly relevant.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "Answer: The transcribed strand.", "model_support": "The provided context does not explicitly mention which gene strand is targeted by transcription-coupled repair (TCR). The text focuses on TCR as a subpathway of nucleotide excision repair (NER) and its involvement with the RNA polymerase complex, but it does not specify the \"transcribed strand\" as the target. The answer \"the transcribed strand\" is a standard biological concept not directly supported by the sentences in the given context. \n\n**Note:** If the question assumes prior knowledge (e.g., TCR repairs lesions on the transcribed strand of actively transcribed genes), this would rely on external knowledge rather than the provided context.", "retries": 1}
{"idx": 958, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Factor Xa' is correct and matches the gold standard ('xa'), but the model's supporting sentence states that no supporting sentence can be quoted from the context, which is incorrect. The gold supporting sentence directly mentions betrixaban in the context of Factor X inhibitors, making the model's supporting sentence inaccurate and failing to cover the gold answer logically.\", \"match\": true}", "gold_answer": "xa", "gold_support": "X (rivaroxaban, apixaban, edoxaban, betrixaban)", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its specific mechanism of action. Therefore, **no supporting sentence** can be quoted from the given text to answer the question about which clotting factor is inhibited by betrixaban. The answer \"Factor Xa\" may be derived from external knowledge, but it is not supported by the context provided.", "retries": 1}
{"idx": 959, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context, as the context discusses p73 isoforms without specifying the number of TAp73 isoforms. The supporting sentence is relevant but fails to cover the gold answer, which is '7'. The sentence highlights controversy around p73 isoforms but does not provide information about the specific count of TAp73 isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: The role of various p73 isoforms in tumorigenesis has been controversial.  \n(No explicit number of TAp73 isoforms is mentioned in the context.)", "retries": 1}
{"idx": 960, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('RANK') does not match the gold standard ('RANKL'), but it is present in the context as part of the RANKL-RANK-OPG pathway. The supporting sentence mentions the correct pathway but focuses on RANK instead of RANKL, which is the ligand Denosumab binds to. While relevant, the supporting sentence does not directly cover the gold answer and contains slight redundancy by emphasizing RANK rather than RANKL.\", \"match\": false}", "gold_answer": "RANKL", "gold_support": "Denosumab, an anti-RANKL monoclonal antibody with proven antiosteoclast activity, may suppress immune responses.", "model_answer": "Answer: RANK (Receptor activator of nuclear factor-κB)", "model_support": "Supporting sentence: \"the receptor activator of nuclear factor-κΒ ligand/receptor activator of nuclear factor-κΒ/osteoprotegerin (RANKL-RANK-OPG) pathway.\"  \n\nThis sentence identifies **RANK** (receptor activator of nuclear factor-κB) as a key receptor in the pathway, which is the target of Denosumab (Prolia), a monoclonal antibody that binds to **RANKL** (ligand) to inhibit osteoclastogenesis. While the context does not explicitly mention Denosumab, the pathway's description provides the necessary framework for answering the question.", "retries": 1}
{"idx": 961, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Bone-anchor sub-urethral sling (BAUS) implantation,' does not match the gold standard 'AUS.' However, it is present in the context as a treatment option discussed in the study. The supporting sentence is relevant but does not cover the gold answer, as it focuses on BAUS rather than comparing it to AUS or identifying AUS as the gold standard.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "Answer: Bone-anchor sub-urethral sling (BAUS) implantation.", "model_support": "Supporting sentence: CONCLUSIONS: BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD. \n\n(Note: While the term \"gold standard\" is not explicitly used in the text, the conclusion emphasizes BAUS as a \"safe, effective, minimally invasive option,\" which implies its status as a preferred or standard treatment for this condition based on the study's findings.)", "retries": 1}
{"idx": 962, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'XK gene' matches the gold standard 'XK' in meaning, though it includes the word 'gene,' which is not strictly necessary but still accurate. The supporting sentence provides relevant information and logically connects the mutation in the XK gene to McLeod syndrome. However, it adds slight redundancy by mentioning both the general association and the specific E327K mutation, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"  \n\nAdditionally: \"Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome...\" (this specifies the mutation in the **XK gene**).", "retries": 1}
{"idx": 963, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes an extra device (BVM 6500) that was not part of the gold answer. The supporting sentence focuses on a limitation of the BVM 6500, which does not directly support the gold answer ('ultrasound'). While the logic connecting the methods is reasonable, the supporting sentence could be more concise and directly relevant to the gold answer.\",\n  \"match\": false\n}", "gold_answer": "ultrasound", "gold_support": "To compare repeatability and agreement of conventional ultrasound bladder wall thickness (BWT) measurements with automatically obtained BWT measurements by the BVM 6500 device.", "model_answer": "Answer: Bladder wall thickness is measured using conventional ultrasound and the BVM 6500 device.", "model_support": "Supporting sentence: \"The BVM 6500 device was not able to correctly measure BWTs above 4 mm.\"  \n(While this sentence specifically highlights a limitation of the BVM 6500 device, the context implies that both conventional ultrasound and the BVM 6500 device were used as measurement methods in the study, as stated in the title and results section.)  \n\n**Note**: The direct mention of \"conventional ultrasound\" appears in the results (\"Measurement variation between replicate measurements was smaller for conventional ultrasound...\"), and the BVM 6500 device is explicitly referenced in the results. Together, these sentences support the answer that bladder wall thickness is measured using conventional ultrasound and the BVM 6500 device.", "retries": 1}
{"idx": 964, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 965, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context provided does not explicitly mention the molecule, this is accurate since the model supporting sentence correctly identifies that no supporting information for interleukin-17A exists in the excerpt beyond the background sentence. The gold supporting sentence directly confirms the answer concisely and logically.\",\n  \"match\": true\n}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.", "model_answer": "Answer: Interleukin-17A (IL-17A)", "model_support": "The provided context does not explicitly mention the specific molecule targeted by secukinumab (e.g., IL-17A). The text focuses on the **efficacy, safety, and usability** of secukinumab administration via autoinjector/pen in psoriasis but does not include details about its **mechanism of action** or **targeted molecule**. \n\nThus, **no sentence in the given context supports the answer \"Interleukin-17A (IL-17A)\"**. The answer likely relies on external knowledge (secukinumab is a monoclonal antibody targeting IL-17A), but this information is not present in the provided text.", "retries": 1}
{"idx": 966, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xist'). The supporting sentence is relevant and covers the answer by referencing the X-inactivation center and mechanisms related to it. However, the model's explanation incorrectly claims that the context does not mention Xist, when in fact the gold supporting sentence shows that XIST/Xist is indeed mentioned in the context as causing failure of cis X-inactivation when deleted. This introduces slight redundancy and confusion, but the overall logic remains sound.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "Answer: Xist (X-inactive specific transcript)", "model_support": "The context provided does not explicitly mention the **Xist (X-inactive specific transcript)** or any transcript directly responsible for X-chromosome inactivation. The passage focuses on the **Xce locus**, **Xic (X-inactivation center)**, and mechanisms of X-inactivation regulation (e.g., parental origin, mutations, cell selection), but it does not identify or reference **Xist** as the transcript responsible for X-chromosome inactivation. \n\nThus, the answer **\"Xist (X-inactive specific transcript)\"** is not supported by the given context. The context lacks the necessary information to confirm this answer.", "retries": 1}
{"idx": 967, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The chosen supporting sentence discusses mutations and oncogenic functions of p53, which is relevant but more detailed than necessary compared to the concise gold supporting sentence that directly refers to 'the guardian of the genome'.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Not only do such mutations result in the abrogation of wild-type p53 activity, but the expressed p53 mutant proteins also tend to gain oncogenic functions, such as interference with wild-type p53-independent apoptosis.  \n\n(Note: While the term \"guardian of the genome\" is not explicitly stated in the context, the sentence above directly references p53's role as a tumor suppressor, which is widely recognized as the \"guardian of the genome\" in scientific literature. The context focuses on p53's tumor suppressor function, aligning with this characterization.)", "retries": 1}
{"idx": 968, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning phosphorylated alpha-synuclein, which is not necessary for directly supporting the answer about alpha-synuclein.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals...", "retries": 1}
{"idx": 969, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information about ZFHX1B and its role in Mowat-Wilson syndrome, including details on mutations and its involvement in the signaling pathway. However, it is somewhat lengthy and contains additional details not strictly necessary to support the answer, making it slightly redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "It is caused by de novo heterozygous mutations or deletions of the ZFHX1B gene located at 2q22.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: \"ZFHX1B encodes Smad-interacting protein-1 (SMADIP1 or SIP1), a transcriptional corepressor involved in the transforming growth factor-beta signaling pathway. It is a highly evolutionarily conserved gene, widely expressed in embryological development. Over 100 mutations have been described in patients with clinically typical MWS, who almost always have whole gene deletions or truncating mutations (nonsense or frameshift) of ZFHX1B, suggesting that haploinsufficiency is the basis of MWS pathology.\"", "retries": 1}
{"idx": 970, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by emphasizing the need for partner inputs, which is not directly required to define the characteristic domain. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "The fly complex contains a catalytic SET domain subunit, E(Z), plus three noncatalytic subunits, SU(Z)12, ESC, and NURF-55.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: \"Thus, the E(Z) SET domain requires multiple partner inputs to produce active HMTase.\"", "retries": 1}
{"idx": 971, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer, but it focuses on co-localization rather than directly stating the association between FANCA and BRG1 as part of the SWI/SNF complex. The logic is sound but slightly indirect compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: \"Finally, we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"", "retries": 1}
{"idx": 972, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the topic of TAp73 and its interaction with Delta Np73; however, it does not cover or logically support the gold answer regarding the number of TAp73 isoforms (7). The model correctly identifies that the text does not explicitly state the number, but this avoids addressing the gold answer directly.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: \"expression of the Delta Np73 is strongly up-regulated by the TA isoforms and by p53, thus creating a feedback loop...\"  \nThe context does not specify the number of TAp73 isoforms identified in humans. While it mentions \"TA isoforms\" (which likely refers to TAp73 isoforms), the text does not quantify them.", "retries": 1}
{"idx": 973, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer, but it contains slight redundancy by discussing broader impacts on cardiomyocyte contractility rather than focusing solely on PLN's regulatory role over SERCA2A as directly stated in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: \"regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility...\"  \n\nThis sentence explicitly links **Phospholamban (PLN)** as a central regulatory molecule interacting with **SERCA2A** in modulating sarcoplasmic reticulum calcium cycling, establishing its role as the main regulatory molecule for SERCA2A function.", "retries": 1}
{"idx": 974, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold answer specifies only 'stroke.' The supporting sentence mentions the expert panel diagnosing stroke or TIA, which introduces TIA into the reasoning unnecessarily. Although the context supports the use of the ROSIER scale for stroke identification, the inclusion of TIA makes the answer less precise and not fully aligned with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"Reference standard A consensus diagnosis of stroke or transient ischaemic attack (TIA) made after discussion by an expert panel...\"  \nThis sentence establishes that the ROSIER scale, as part of the study's focus, is used to identify **stroke and transient ischaemic attack (TIA)**.", "retries": 1}
{"idx": 975, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly (BCR-ABL). However, the supporting sentence is somewhat redundant and verbose. It explains that the context lacks explicit information about the molecular target of imatinib but still correctly identifies BCR-ABL as the target based on external knowledge. While accurate, the supporting sentence could be more concise by directly referencing the Philadelphia chromosome and/or BCR-ABL positivity mentioned in the context.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "All 1,063 patients selected met the following inclusion criteria: aged 18 or older and in chronic phase at the time of diagnosis, Philadelphia chromosome and/or BCR-ABL positive, received first-line treatment with imatinib, and not enrolled in a randomized clinical trial during the period of retrospective review.", "model_answer": "Answer: BCR-ABL", "model_support": "The context does not explicitly mention the specific tyrosine kinase targeted by imatinib (Gleevec) or reference the BCR-ABL fusion protein. The provided text focuses on treatment response patterns and prognostic indicators in CML patients but does not discuss the molecular mechanism of imatinib. The answer (BCR-ABL) relies on external biomedical knowledge rather than the context provided. \n\n**Note**: The question cannot be answered using the given context, as it lacks information about the molecular target of imatinib.", "retries": 1}
{"idx": 976, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence acknowledges the lack of explicit mention of Lewy bodies in the context but correctly identifies that the answer is based on widely accepted external knowledge about alpha-synuclein being the main component of Lewy bodies.\", \"match\": true}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis.", "model_answer": "Answer: Alpha-synuclein", "model_support": "The context does not mention **Lewy bodies** or their components. The provided text discusses **alpha-synuclein degradation** in relation to autophagy and Parkinson's disease but does not explicitly identify **alpha-synuclein** as the main component of Lewy bodies. The answer \"alpha-synuclein\" is based on external knowledge (a well-established fact in Parkinson's pathology), but **no sentence in the given context directly supports this claim**. \n\n**Note:** The context does not contain information about Lewy bodies or their composition.", "retries": 1}
{"idx": 977, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer by mentioning Tsix as the antisense partner of Xist, which indirectly highlights Xist's role in X-chromosome inactivation. However, it is slightly less direct and concise compared to the gold supporting sentence, which explicitly states Xist's role as a 'major effector' of X-inactivation.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Xist (X-inactive specific transcript) is a major effector of the X-inactivation process, and X-linked genes are highly expressed in brain tissue and consistent with a role in brain developments.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"Tsix (crucial noncoding antisense partner of Xist) and other X-linked genes (Mecp2, Hprt1, and Sts) were examined; Tsix was upregulated...\"  \nThis sentence identifies **Xist** as the transcript associated with X-chromosome inactivation (since Tsix is described as its \"noncoding antisense partner,\" implying Xist is the primary transcript involved in XCI).", "retries": 1}
{"idx": 978, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it focuses on tolcapone rather than benserazide, introducing slight redundancy. While the logic connecting L-dopa to benserazide is strong based on general knowledge, the choice of the supporting sentence could have been more precise by directly referencing benserazide from the context.\", \"match\": true}", "gold_answer": "L-dopa", "gold_support": "The administration of L-dopa (20 and 60 mg/kg p.o.) + benserazide (15 mg/kg p.o.) resulted in dose-dependent increase of dialysate levels of L-dopa and 3-O-methyl-DOPA.", "model_answer": "Answer: L-dopa", "model_support": "Supporting sentence: \"Tolcapone (30 mg/kg p.o.), given as adjunct to both doses of L-dopa, markedly enhanced the elevation or extracellular L-dopa...\"  \n\n**Note:** The context does not mention *benserazide* explicitly. However, the question may be based on general knowledge (benserazide is typically co-administered with L-dopa to inhibit peripheral metabolism of L-dopa). The provided context discusses *tolcapone* (a different COMT inhibitor) being used with L-dopa, which aligns with the answer but is not directly about benserazide. The supporting sentence is quoted from the context as per the question's structure.", "retries": 1}
{"idx": 979, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'Lysine 4 of histone H3 (H3K4)' matches the gold standard 'H3K4', though it is slightly more verbose. However, the supporting sentence provided by the model incorrectly states that the context does not mention the specific residue, while the gold supporting sentence directly references the context where H3K4 is explicitly mentioned. Despite this, the model's answer is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "Trimethylation of histone H3 Lys4 (H3K4) is associated with transcriptional activation.", "model_answer": "Answer: Lysine 4 of histone H3 (H3K4)", "model_support": "The context provided does **not** mention the specific histone residue (e.g., H3K4) methylated by MLL1. The answer \"Lysine 4 of histone H3 (H3K4)\" is a well-established biological fact outside the scope of the given context. Since the context lacks details about the specific residue, **no sentence in the provided text supports the answer**. \n\n**Note:** The answer relies on external knowledge rather than the context given.", "retries": 1}
{"idx": 980, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard conceptually (BCR-ABL tyrosine kinase is equivalent to BCR-ABL in this context), but it adds 'tyrosine kinase,' making it slightly more specific than necessary. The supporting sentence is relevant and covers the answer adequately, though it does not directly mention the Philadelphia chromosome or the constitutive activity of the kinase, which are key details from the gold supporting sentence. There is some redundancy in discussing 'control of tyrosyl phosphorylation' instead of focusing solely on the fusion gene encoding a tyrosine kinase.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: \"Chronic myeloid leukemia (CML) is caused by the BCR-ABL oncogene. Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling.\"  \n\nThis sentence establishes that CML is driven by the BCR-ABL oncogene (a tyrosine kinase) and that imatinib targets its activity, as it controls phosphorylation linked to this protein.", "retries": 1}
{"idx": 981, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about alpha-synuclein (AS) but focuses on posttranslational modifications rather than directly stating that AS is the main component of Lewy bodies. This makes it slightly less concise and direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "Answer: α-Synuclein (AS)", "model_support": "Supporting sentence: \"Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS.\"", "retries": 1}
{"idx": 982, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'BCR-ABL1' is very close to the gold standard 'BCR-ABL' and is commonly accepted as a correct variant in scientific literature. However, the supporting sentence does not explicitly state that imatinib targets BCR-ABL1; it only mentions that imatinib is a tyrosine kinase inhibitor that changed CML therapy, which is relevant but lacks direct coverage of the gold answer.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a paradigm for neoplasias that are defined by a unique genetic aberration, the BCR-ABL1 fusion gene.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: \"The development of protein tyrosine kinase inhibitor, imatinib, has entirely changed the strategy of therapy for CML.\"  \n\n**Note**: While the context does not explicitly name *BCR-ABL1* as the target of imatinib, this sentence implies that imatinib is a tyrosine kinase inhibitor used to treat CML, which is a well-established fact in biomedical knowledge (BCR-ABL1 is the fusion protein targeted by imatinib). However, the context provided does not directly state this connection. If the context were to include a sentence like \"imatinib specifically inhibits the BCR-ABL1 tyrosine kinase,\" that would be the supporting sentence.", "retries": 1}
{"idx": 983, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('SET domain') but is present in the context. The supporting sentences are relevant and describe nuclear localization signals and catalytic activity, which are accurate for G9a's function, but they do not directly cover or emphasize the 'SET domain' as the characteristic domain of histone methyltransferases. Instead, they focus on other structural aspects (NLS and C-terminus), making the support insufficient for the gold answer.\",\n  \"match\": false\n}", "gold_answer": "SET domain", "gold_support": "Murine G9a is a 1263 amino acid H3-K9 methyltransferase that possesses characteristic SET domain and ANK repeats.", "model_answer": "Answer: The characteristic domain of histone methyltransferases includes nuclear localization signals (NLS) for nuclear targeting and a catalytic domain in the C-terminus for methylation activity.", "model_support": "Supporting sentences:  \n1. \"we have used a series of green fluorescent protein-tagged deletion constructs to identify two nuclear localization signals (NLS), the first NLS embedded between amino acids 24 and 109 and the second between amino acids 394 and 401 of murine G9a.\"  \n2. \"mutation of conserved amino acids R1097A, W1103A, Y1120A, Y1138A and R1162A, or the metal binding C1168A in the catalytic region, resulted in catalytically impaired enzymes, thereby confirming the involvement of the C-terminus of G9a in catalysis.\"  \n3. \"Thus, distinct domains modulate nuclear targeting and catalytic functions of G9a.\"  \n\nThese sentences collectively highlight the **nuclear localization signals (NLS)** for nuclear targeting and the **C-terminus catalytic domain** responsible for methylation activity.", "retries": 1}
{"idx": 984, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by focusing on co-localization rather than directly stating the interaction between FANCA and BRG1 as part of the SWI/SNF complex.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: \"we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"", "retries": 1}
{"idx": 985, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by highlighting the obstacle in repairing the transcribed strand due to stalled RNA polymerase, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage.\"", "retries": 1}
{"idx": 986, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and covers the answer, but it contains some redundancy by mentioning all the other drugs (rivaroxaban, apixaban, edoxaban) instead of focusing solely on betrixaban. It could be more concise while still being logical and directly relevant.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"", "retries": 1}
{"idx": 987, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'None' when the gold answer clearly identifies HSP70 as upregulated during HSP90 inhibition. The supporting sentence is also incorrect and does not logically support the answer, as the context explicitly mentions HSP70 being induced in vitro upon HSP90 inhibition. This results in a failure to capture the correct information and reasoning.\", \"match\": false}", "gold_answer": "HSP70", "gold_support": "Conversely, inhibition of HSP90 significantly increased the expression of both VEGF and HGF mRNA, and induced HSP70 protein in PHH cultures in vitro.", "model_answer": "Answer: None. The context does not mention any heat shock protein being upregulated during HSP90 inhibition.", "model_support": "Supporting sentence: \"The context does not mention any heat shock protein being upregulated during HSP90 inhibition.\"  \n(No explicit sentence in the context directly states this, but the conclusion implies that HSP90 inhibition does not negatively affect liver regeneration, which by implication suggests no compensatory upregulation of other heat shock proteins is mentioned.)", "retries": 1}
{"idx": 988, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides logical support, but it contains slight redundancy. The mention of PRT4445, while correct, introduces additional information not directly necessary for answering the question. A more concise supporting sentence would have been preferable.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban belongs to the class of anticoagulants with anti-Xa activity, as its reversal agent (PRT4445) is specifically designed for factor Xa inhibitors.", "retries": 1}
{"idx": 989, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa' vs. 'Factor Xa' is a minor variation that does not affect correctness). The supporting sentence provides relevant information and logical reasoning, explaining how the answer is inferred from the study title and general knowledge of drug naming conventions. However, it is slightly more verbose than necessary because the context explicitly states that betrixaban is a Factor Xa inhibitor, making the inference from the title redundant.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not explicitly mention which clotting factor is inhibited by betrixaban. However, the study title **\"Explore-Xa\"** implies that the drug is targeting **Factor Xa**, as \"-Xa\" is a common suffix for Factor Xa inhibitors (e.g., rivaroxaban, apixaban). While the provided context does not include a direct statement about betrixaban's mechanism of action, the name of the study suggests its target. \n\n**Note:** The answer \"Factor Xa\" is inferred from the drug's classification (commonly known as a Factor Xa inhibitor) rather than being explicitly stated in the given context.", "retries": 1}
{"idx": 990, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is not provided by the model but the gold supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: **Not present in the provided context.**  \nThe context does not explicitly mention the chemical group (e.g., 1,4-benzothiazepine) to which JTV519 belongs. This information was present in the earlier example's context but is absent here.", "retries": 1}
{"idx": 991, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it indirectly implies the reasoning by contrasting SEA0400 with nifedipine, which introduces slight redundancy. While logical, it could be more concise by directly referencing that SEA0400 is a specific NCX inhibitor.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific NCX inhibitor SEA0400 blocked SNP-induced phosphorylation of ERK, JNK and p38 MAPK, and decrease in cell viability.", "model_answer": "Answer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: \"This increase in (45)Ca(2+) influx was blocked by SEA0400, but not the Ca(2+) channel blocker nifedipine.\"  \n(Implied context: SEA0400 specifically inhibits the Na+/Ca²⁺ exchanger (NCX), as the Ca²⁺ influx linked to NCX activity is blocked by SEA0400, distinguishing it from Ca²⁺ channel blockers like nifedipine.)", "retries": 1}
{"idx": 992, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"", "retries": 1}
{"idx": 993, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Xist RNA' is very close to the gold standard 'Xist,' with only a minor addition of 'RNA,' which does not detract from the correctness. The supporting sentence provides relevant information about Xist RNA's role in chromosome silencing but is slightly less direct and concise compared to the gold supporting sentence, which explicitly mentions the binding and propagation along the chromosome. The model’s supporting sentence introduces some redundancy by emphasizing the lack of understanding of the mechanisms rather than focusing solely on the description of Xist's function.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The process is mediated by the non-coding RNA X inactive specific transcript (Xist) that binds in cis and propagates along the inactive X chromosome elect, triggering chromosome-wide silencing.", "model_answer": "Answer: Xist RNA", "model_support": "Supporting sentence: The mechanisms by which Xist RNA binds and spreads along the chromosome, and initiates Xist-mediated chromosome silencing remain poorly understood.", "retries": 1}
{"idx": 994, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Insulin receptor function,' matches the gold standard conceptually, as it refers to the insulin receptor which is altered in Donohue syndrome. However, it does not explicitly name 'insulin' as the hormone, which is required for an exact match. The supporting sentence provided is relevant and covers the answer logically but contains slight redundancy by mentioning the specific mutation rather than focusing solely on the functional alteration of the insulin receptor. Overall, the logic is strong, and the information supports the answer well.\",\n  \"match\": false\n}", "gold_answer": "insulin", "gold_support": "Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.", "model_answer": "Answer: Insulin receptor function", "model_support": "Supporting sentence: \"A novel homozygous missense mutation p.Leu795Pro was found, located in the extracellular portion of the β subunit of the insulin receptor.\"  \n**OR**  \nSupporting sentence: \"...causing a severe decrease in IR autophosphorylation.\"  \n\nBoth sentences directly link Donohue syndrome to altered insulin receptor function via the identified mutation and its effect on receptor activity.", "retries": 1}
{"idx": 995, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer well, but it is slightly indirect compared to the gold supporting sentence. The model's supporting sentence refers to the effect of Bach1 absence, while the gold standard directly states that Bach1 is a repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: Gene targeting experiments in mice revealed that, in the absence of Bach1, ho-1 became expressed constitutively at high levels in various tissues under normal physiological conditions.", "retries": 1}
{"idx": 996, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the term 'antiparallel spectrin heterodimers,' which aligns well with the gold answer and provides sufficient context.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: *Influence of lateral association on forced unfolding of antiparallel spectrin heterodimers.*", "retries": 1}
{"idx": 997, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('iron') in essence, as 'iron deficiency' directly implies 'iron'. However, the supporting sentence is missing and explicitly stated as unavailable due to lack of direct context. The gold supporting sentence, while not quoted by the model, does exist in the context provided and succinctly supports the answer. Slight verbosity or explanation about the lack of context lowers the score slightly.\", \"match\": true}", "gold_answer": "iron", "gold_support": "That iron deficiency, per se, can cause these symptoms is poorly recognized.", "model_answer": "Answer: Iron deficiency.", "model_support": "The context does not mention restless leg syndrome or any deficiency associated with it. Therefore, **there is no supporting sentence** in the provided context for the claim that \"iron deficiency is the cause of restless leg syndrome.\" The context only discusses iron deficiency anemia and its relation to symptoms like fatigue and poor concentration in CKD patients.", "retries": 1}
{"idx": 998, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence effectively highlights the key information from the context without unnecessary verbosity.\", \"match\": true}", "gold_answer": "5-aminolevulinic acid", "gold_support": "OBJECTIVE: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan(®)) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6).", "model_answer": "5-aminolevulinic acid", "model_support": "Supporting sentence: Observational, retrospective study of the effectiveness of **5-aminolevulinic acid** in malignant glioma surgery in Spain (The VISIONA study).", "retries": 1}
{"idx": 999, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('BCR-ABL'), though it includes 'tyrosine kinase,' which is accurate but slightly more detailed than required. The supporting sentence provided by the model is incorrect in stating that no sentence supports the answer, as the context explicitly mentions the BCR-ABL fusion gene formed by the Philadelphia chromosome. Despite this flaw in identifying support, the overall logic connecting the answer to the context is sound.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is a genetically associated malignancy of haematopoietic stem cells, characterized by a t(9;22) translocation that forms the Philadelphia chromosome and creates a novel fusion gene, BCR-ABL.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "The context does not explicitly mention the specific tyrosine kinase targeted by Imatinib (Gleevec). The provided text discusses Imatinib resistance in CML patients and the efficacy of Dasatinib but does not identify the molecular target (e.g., BCR-ABL tyrosine kinase) of Imatinib. Therefore, **no sentence in the context supports the answer**. \n\n**Answer:** The context does not provide a supporting sentence for this answer.", "retries": 1}
